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In the third decade of the HIV/AIDS pandemic, ten thousand people are estimated to 
be infected every day, mostly in southern Africa. An international response has 
gained momentum in recent years and billions of dollars have been donated to a 
wide range of interventions aimed at changing sexual behaviour and delivering life-
preserving treatment for those already infected. In this thesis, mathematical models 
are developed to: (i) help monitor the epidemic and recognise where reductions in 
risk behaviour have led to downturns in HIV prevalence; and (ii), provide insights on 
how interventions - both to change sexual behaviour and deliver treatment - can be 
optimised. Throughout, the aim is to formulate specific recommendations for 
decision-makers and health professionals planning the next phase of struggle against 
HIV. 
By comparing observed and model epidemic trends, it was found that recent 
reductions in prevalence in Zimbabwe, parts of urban Kenya and Haiti, could be 
associated with changes in sexual behaviour. A method was developed and tested 
that could be used in the future to estimate incidence using serial measures of 
prevalence in general population surveys. 
The effect of interventions focussed on delaying first sex and reducing contact 
between young women and older men is dependent on the way in which these 
changes are accommodated by existing behavioural patterns. The impact of 
voluntary testing services relies upon high uptake and effective counselling leading to 
long-lasting behavioural changes among the young, the uninfected and those most at 
risk. Although a recent trial did not find evidence for an intervention aimed at high-risk 
group having a large population level impact, modelling suggests that insufficient 
time was allowed for the effect to develop. Analysis of a model of treatment delivery 
in Africa highlights the importance of frequent HIV testing, efficient referral and 
intensive monitoring in determining the success of such programmes. 
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1.1 Background 
In the summer of 1981, the first signs of Acquired Immunodeficiency Syndrome 
(AIDS) among homosexual men came to light [1]. The case report then was of five 
young men in California. By 2006 [2], 39.5 million people around the world were 
estimated to be living with the causative Human Immunodeficiency Virus (HIV) 
infection [3-5], with 4.3 million newly infected that year. It follows that a crude 
estimate of the number of new infections arising from each prevalent case is 
approximately 1.1, indicating that at the global level, the epidemic could still be 
expanding. 
However, international agencies and epidemiologists remain convinced that if 
the few regional successes were repeated on a wider scale, the pandemic could be 
brought under control [6, 7], In 2002, it was predicted that, with seemingly realistic 
levels of intervention success, and assuming that the required $27bn would be 
forthcoming, the number of new infections between 2001 and 2010 could be reduced 
by two-thirds, equivalent to 30 million infections averted. In 2006, new models 
indicated that half of the potential infections between 2005 and 2015 could be 
averted with an expanded response, at a cost of $122bn [7]. Whilst providing a cause 
for optimism, these two studies also tell another story - that for each days delay in 
fully implementing prevention interventions many more people unfortunately acquire 
the infection and the cost of turning back the epidemic increases. 
In the last years, combination antiretroviral therapy, which is capable of 
greatly prolonging survival of those infected with HIV [8], has started to become 
widely available through public health services in most parts of the world [9]. 
However, relying on this measure - reducing mortality in the short-term, but 
accumulating demand for therapy in the future - does not constitute a sufficient 
response [10]. Preventing new infections will have to be at the centre of all regional, 
national and international responses to the epidemic if the demand on the frailest 
health-care systems and economies is not going to rise inexorably. Yet finding 
effective and feasible mechanisms though which individuals will put themselves and 
others in the community at less risk of infection has been difficult. Although the 
history of the epidemic is dotted with isolated success stories, no 'magic bullet' has 
been found, and, most would agree, behaviour change programmes are failing in the 
battle to persuade many people to change their behaviours. 
This thesis is about the recent developments in the HIV epidemic and our 
response to it. Specifically, how to monitor the course the epidemic, projecting the 
impact of interventions and identifying ways in which programmes could be optimised 
to alleviate further infection and mortality. Data from a wide variety of sources are 
15 
collated and synthesised in mathematical models representing the complicated 
epidemiological processes to provide new methods and insights, as well as to identify 
areas of uncertainty and for further research. Throughout, the emphasis is on Africa, 
which has so far borne the brunt of the epidemic. 
In this introduction I describe the conditions that have allowed Africa to be so heavily 
affected by HIV, and the methods used to monitor the trends in the epidemic. I then 
describe some of the success stories in reducing HIV spread within communities. 
The epidemic has also been greatly altered by the international community's support 
of antiretroviral treatments, which I discuss. This has opened up the way to new 
interventions such as expanded testing and counselling which are described along 
with the prospects for new biomedical intervention technologies. Throughout the HIV 
epidemic mathematical models have been used to inform our understanding and 
guide policy. Mathematical models are a central tool within this thesis and the history 
of their use in the HIV field is briefly described. Lastly, the Manicaland HIV 
Prevention Study, which has been a major source of detailed information on patterns 
of behaviour and HIV, is detailed. 
1.2 HIV in Africa 
The global prevalence of HIV is 0.8% (37.2 million adults infected divided by world 
adult population 4700 million [11]), but there is great heterogeneity in the distribution 
of infection. Sub-Saharan Africa, with only 10% of the global population, is home to 
63% of all those infected and 72% of the children infected. It is also where 72% of 
AIDS deaths occur and where 80% of AIDS-orphans are left [2, 12]. In Africa, the HIV 
epidemic is thought to have claimed more than twenty million lives so far, including 
two million in the last year [2]. After an initial focus on men, most new infections are 
now among women [2], with the further consequence that more children than ever 
are being maternally orphaned; currently 25-30 million children are estimated to be 
orphans of the HIV/AIDS epidemic [2, 13]. 
In February 2000, the situation in Africa was considered so severe that it was 
raised at the United Nations Security Council [14], the part of the organisation 
charged with surveillance of international peace and security. The recognition that, in 
the years preceding that meeting, HIV/AIDS had killed ten times as many people as 
all the on-going conflicts in Africa, prompted the council, led by A1 Gore (then US vice 
President) to state that the epidemic was itself a serious threat to peace and stability 
[14]. 
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Within Africa, the furthest developed epidemic is in the east (including 
Uganda and Kenya) with an estimated average prevalence of between 15 and 20% 
in 1990, reducing slightly to between 10 and 15% by 2002 [15]. Countries in central 
and western Africa have supported lower prevalence epidemics, in most cases less 
than 5% [2, 15]. However, the worst epidemic has been observed in southern Africa, 
where HIV prevalence rose from 5% in 1990 to 25% ten years later [15]. Zimbabwe, 
a country that had typified this region with 30% HIV prevalence in 2000, now stands 
apart, showing a decline in prevalence to 24% [16, 17]. 
An important scientific research question has been why there is such 
heterogeneity in the prevalence of HIV globally and across Africa. 
1.3 A Perfect Storm 
There are thought to be two main reasons for the much greater spread of HIV in 
southern and eastern Africa that have combined to create a 'perfect storm' [18]; 
extra-marital sexual practices and low rates of male circumcision. 
In Africa it is common for men to have several sexual partners at the same 
time, that may either be called wives or classified as extra-martial partners [19-21]. 
This so-called concurrency allows faster transmission of HIV than serial monogamy 
(where the same number of partnerships are formed over time, but such that they do 
not overlap) because, from the point of view of the virus, it can spread between 
contacts without waiting for the partner to change. This subtle difference in sexual 
behaviour means that broad indicators of sexual behaviour such as the average 
number of partners, while being important variables in the spread of infection, do not 
explain the differences in the global distribution of infection [21, 22]. Mathematical 
modelling confirms the importance of this effect, with one model estimating that when 
half of the partnerships in a population are concurrent, the size of the epidemic after 
five years is ten-times as large as when everyone practices sequential monogamy 
[23]. This effect will probably be augmented by the chance of transmission being 
highest immediately after infection. If partnerships did not overlap, this most 
dangerous period would normally pass whilst the newly infected individual remains in 
the partnership with someone already infected. The 'zero-grazing' policy in Uganda, 
which sought specifically to discourage this practice of concurrent partnerships, has 
been credited for the dramatic downturn in prevalence in the early 1990s [24]. 
When examined in this way, reports of sexual behaviour from a wide range of 
countries help explain why the epidemic rages in Africa and not (so far) in Asia [20]. 
For instance, in Lesotho, 55% of men reported having more than one regular sexual 
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partner at the same time (including spouses) compared to 3% of men in Thailand, 
and 2% of men in Sri Lanka and Singapore [19]. 
In contrast, differences in sexual behaviour do not seem to explain why 
Western Africa has been saved from the worst epidemics in the continent [25]. 
Instead, the key factor for the lower epidemic levels in these parts may be the high 
rates of male circumcision [26, 27]. A large body of literature has built up that 
suggests that circumcision can decrease the chance that a man is infected with HIV 
by about 40-60% [28, 29]. Recently, three randomised control trials in South Africa, 
Kenya and Uganda reported a c.60% reduction in the risk of HIV acquisition for men 
[30-32]. The effect of circumcision on the probability of transmission is not clear and 
another trial in Uganda seeking to examine this was stopped early because of a 
higher rate of acquisition in the partners of those circumcised, seemingly due to men 
resuming sexual activity before their wound had fully healed [33]. Nonetheless, 
observational studies that find partners of circumcised men to be less likely infected 
than others [34-36] are consistent with a reduction in transmission after the wound 
has healed. 
1.4 Why is HIV still spreading? 
Some diseases, like small pox and SARS have been successfully controlled, so why 
has the global spread of HIV not been curbed since it first appeared almost thirty 
years ago? It has been suggested that there could be a range of epidemiological and 
socio-cultural reasons why HIV has proved particularly difficult to control: 
1- Asymptomatic transmission. Without regular testing of everyone in the 
population, public health interventions to prevent transmission of an infectious 
agent rely on the appearance of symptoms to identify those infected. With 
symptoms, individuals may tend naturally to mix less in the population, or 
public health programmes could quarantine such individuals until the chance 
that they infect someone passes. The timing of symptoms and the timing of 
infectiousness may overlap considerably, so that an efficient quarantine 
programme can isolate individuals for most of the time for which they are 
infectious. The degree of overlap, together with the basic reproductive 
number Ro (a measure of the tendency for an infectious agent to spread in a 
particular population [37]), characterise the chance that infections can be 
controlled [38]. For example, individuals with SARS typically developed 
symptoms as soon as they became infectious so that (together with a low 
tendency for epidemic spread) the epidemic could be successfully controlled 
with quarantining measures. HIV, by contrast, leaves individuals transmitting 
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the virus for on average ten years, unaware that they are infected. When 
symptoms develop, there may be a "self-quarantining" effect, whereby ill 
individuals become less likely to form new sexual partnerships, but by this 
time, it is probably too late. Thus, even though HIV and SARS have 
comparably low basic reproductive numbers (approximately 2-7 [38]), the way 
that transmission of HIV is 'silent' has helped it to evade control. 
2- Communitv-level risk. Sexual contact is the major route of transmission for 
most new infections in the regions worst hit by the epidemic [2]. Unlike the 
forms of contact that mediate transmission of other diseases (such as casual 
contact, or living in the same building), or for HIV (such as injecting drug 
users sharing needles [39]), sexual contact is determined by a large number 
of cultural and social practices than can be resistant to change. A sexual 
contact also (normally) requires a specific partner to consent [40, 41]) so that 
a successful intervention has not only to change the intentions of individuals, 
but the social norms that prevail across the community. In addition, the 
continuing spread of HIV may be supported by only a small fraction of the 
population [42] and the epidemic will persist even if most other individuals 
reduce their sexual risk behaviour. This makes it likely that programmes with 
insufficient coverage or capacity will fail to make a substantial impact. 
3- Povertv and priorities. Although there are other proximate biological and 
behavioural reasons why the spread of HIV has gone as far as it has in Africa, 
a key underlying factor must be poverty. Poverty, or at least disparity in 
wealth, is thought to support sex work and transactional relationships, which 
are recognised to play such an important role in facilitating HIV spread [40, 
41]. However, poverty may also make individuals resistant to changing their 
sexual behaviour, because other issues are more pressing. As the President 
of Uganda has written, "In countries like ours, where a mother often has to 
walk 20 miles to get an aspirin for her sick child or five miles to get any water 
at all, the question of getting a constant supply of condoms may never be 
resolved" [43]. 
1.5 How is the HIV epidemic monitored? 
It was clear from early in the epidemic that relying on reported AIDS deaths to 
monitor the epidemic could be misleading. The coverage of death-reporting systems 
were not complete, it was possible that the cause of death could be given as the 
proximate condition instead of HIV/AIDS, the long incubation period from infection to 
death would obscure recent trends in the epidemic, and there would be danger that 
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identifying cases would lead to the stigmatisation of their families [44, 45]. 
Prevalence of infection (fraction of population living with the virus) is a better 
measure because it relates to the current scale of the epidemic, but it requires HIV 
testing in a chosen population. Women attending ante-natal clinics (ANCs) were 
chosen as a convenient sample in which to measure HIV prevalence (blood was 
already taken to test for syphilis). Routine testing minimises selection biases [45] and 
anonymity was retained by unlinking test results from other personal data. 
There are several issues to consider when using such data to make estimates 
and projections for the course of the epidemic. First, the sample is only of women 
and it is not always clear how this relates to prevalence among men. Second, the 
women being tested are pregnant and have been able and chosen to attend an ANC, 
which could introduce several conflicting biases. On the one hand, the women who 
get pregnant may have been having more unprotected sex, and may therefore be 
more likely to be infected than others. This bias probably operates most at young 
ages, with pregnancy indicating early sexual activity, but it could also act at older 
ages, with the women that are able to use modern methods of contraception being 
the most likely to adopt practices to avoid the risk of infection. On the other hand, 
bacterial sexually transmitted infections (STIs) and HIV lead to sub-fertility [46], so 
pregnancy at older ages could be a marker for women that have not been at high risk 
for acquiring infection. This bias could increase over time, as more women reach 
advanced stages of HIV-related diseases when fertility is lowest [47]. But if AIDS 
progressively removes those individuals that spread bacterial STI, the overall change 
in fertility over time may be small [48]. Depending on which of these factors is the 
most powerful, the estimate of prevalence could either be too high or too low relative 
to prevalence among women of reproductive ages in the general population. The 
balance is likely to depend on the background fertility level in the population and 
change over time as the epidemic reaches women with lower risk behaviour [48]. 
Changes in age at first sex could also introduce artificial changes in prevalence seen 
at the ANC [49] and the fertility transition, which is ongoing in some parts of sub-
Saharan Africa, could add further layers of shifting biases which are hard to 
determine. 
It has been possible to directly compare prevalence at ANCs and prevalence 
in the general population in a few settings, which has been used to assess the 
usefulness of ANC in sentinel surveillance. Generally, ANC estimates of prevalence 
are lower than comparable estimates among women in the general population, but, 
given that men generally have a lower prevalence in established epidemics [50], 
ANC estimates may be taken as representative of the general population. In high-
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fertility populations, where most women are exposed to unprotected sexual contact, it 
seems that sub-fertility due to HIV infection depresses prevalence in ANC clinics, by, 
on average, 25% [46]. In populations where contraceptive use is higher, such as 
Zambia [51] and Zimbabwe [52], the bias is smaller, possibly because the sub-fertility 
effects are counteracted by pregnancy correlating with riskier sexual behaviour. 
A further problem in interpreting ANC data is that there is no definite 
catchment population. Given the strong urban-rural gradient in infection, there is a 
danger that mobile individuals could contaminate estimates, if, for example, urban-
living women go their rural home during pregnancy [52]. Also, as the surveillance 
system has been extended, more remote sites have been added in rural areas, which 
have had the result of bringing down average prevalence estimates in recent years 
[53]. When examining trends in prevalence over time, it is essential to only consider 
data from sites that have been sampled continuously. 
Another important disadvantage in using prevalence data to monitor the 
course of the epidemic is that secular trends in prevalence can be generated without 
any change in individual risk behaviour. Those at most risk of acquiring HIV will be 
infected first so that HIV incidence will quickly increase, but it will then decrease as 
new infections occur more slowly among those at lower risk. This means that 
prevalence, which is determined by the balance between new infections and mortality 
among those infected, can decrease in a mature epidemic as part of the internal 
"natural dynamics" [54]. Thus, when prevalence declines are observed, apart from 
checking that the trend is valid in a statistical sense, it should also be checked 
whether it is valid in an epidemiological sense. One way to do this is to use a model 
of HIV transmission model to test whether the observed decline could be consistent 
with behaviour staying constant [54, 55]. In Chapter 2, this method is extended and 
applied to recently reported prevalence declines in Zimbabwe, Kenya and Haiti. 
Given the potential biases in the data and the way in which trends can be 
spuriously generated by endogenous epidemiological processes, it is important to 
simultaneously monitor trends in behaviour, especially when there is a suggestion 
that prevalence has declined. This has been advocated by the Joint United Nation 
Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), as 
"second generation surveillance" [56]. Serial measures of a range of behaviour 
indicators also allows changes in incidence to be attributed to particular types of 
behaviour change, but probably not to distinct intervention [57, 58]. 
For the official UNAIDS estimates, time-series of prevalence at ANCs are 
used to fit four-parameters of an epidemic model that estimates the associated 
changes in incidence [59]. The model is usually fit to data aggregated by urban or 
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rural parts of one country. Although the model is semi-mechanistic (meaning that its 
description of the epidemic is partly based on realistic assumptions, and partly on 
features chosen for analytic convenience), the model can also be used to make 
short-term predictions. The Epidemic Projection Package (EPP) implements this 
model and is distributed to national level surveillance experts. From the model fit, the 
number of people currently infected and the number newly infected each year can be 
calculated but estimates of past and future mortality rates and other key demographic 
and economic indicators are estimated using an additional piece of software called 
the Spectrum Projection Package (Futures Group) [60]. This program imports the 
EPP epidemic curve (prevalence over time) and sets it against its own demographic 
cohort model, distributing the number of cases by age and gender according to fixed 
templates based on aggregated observational data [60]. 
In recent years, demographic and health surveys (DHS) have been extended 
to incorporate HIV testing ('DHS+') [61]. The key advantages to such a 
measurement, compared to ANC estimates, are that they have better geographical 
representation and they include non-pregnant women and men. Prevalence 
estimates from the DHS+ have tended to be substantially lower than the UN AIDS 
estimates based on ANC data [62] but this does not necessarily mean that the scale 
of the epidemic has been over-stated. The disadvantage of the DHS+ prevalence 
estimates, and the probable reason why the derived estimates are lower, is that for 
people to be included in the survey they have to be found and agree to participate. 
For instance, mobile people and those with unusual living arrangements (e.g. live in 
hostels or army posts) are not typically included in the DHS+ sample, although it is 
expected that prevalence amongst them would be higher than average. Non-
response in the DHS surveys is also substantial, with 25-40% of those eligible not 
being tested [62]. Although it is impossible to know how HIV prevalence is correlated 
with non-response, early studies have indicated that those who chose not to respond 
were more likely to be infected than others [44]. In contrast, ANCs in Africa are 
attended by the vast majority of women (including those who are mobile or in unusual 
living arrangements), and HIV testing is routine so there is very little non-response. 
There is no gold standard for population level estimates with which to compare these 
alternative methods. However, given the extreme difficulties in interpreting ANC 
prevalence data, the DHS+ is probably more useful for assessing the current scale of 
the epidemic. Future studies will better inform how non-response might be related to 
infection and then correction procedures can be adopted. In the next rounds of the 
DHS+, new efforts could be also be made to improve coverage of high-risk 
populations and improve response rates. Despite the usefulness of the DHS+ data. 
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ANC data should continue to be collected because long time-series will be the most 
important source of information for measuring epidemic trends. 
In the last few years, assays have been developed that can discriminate 
recently acquired prevalent infections from older ones, which could be used to make 
an estimate of HIV incidence [63]. incidence (the rate at which new infections arise 
among uninfected individuals) would be more useful for monitoring epidemic trends, 
identifying risk groups and making comparisons between populations. The assay 
which has so far received the greatest attention and been tested in a variety of 
settings is the BED capture enzyme immunoassay [64], which identifies new 
infections by measuring the proportion of a type of immunoglobulin that is HIV 
antibody, which increases with time since seroconversion. This relies on good 
knowledge of how fast that proportion changes over time since infection [65]. In a 
validation exercise, BED-derived incidence estimates were in close agreement with 
cohort estimates, indicating that this method could be a useful surveillance tool [65]. 
However, that test was for a population in Europe; in developing countries where 
similar studies have been done, BED-derived estimates of incidence are substantially 
higher than other estimates of incidence [66]. The reason for the error is probably to 
do with old infections being incorrectly classified as new infections by the test, 
because in African populations, the proportion of HIV antibody can get very low at 
advanced stages of infection [66]. Nonetheless, calibration may be possible with high 
quality clinical data. 
In Chapter 3, other methods for estimating HIV incidence are developed and 
tested. These methods could take advantage of the DHS+ sero-surveys, which will 
be repeated in the same population every five years. By decomposing the observed 
changes in prevalence between the sero-surveys into the contribution of new 
infections and mortality [67-69], HIV incidence can be estimated. By validating these 
methods with data simulated in a mathematical model and actual data collected in 
African cohort studies, it is hoped that these methods could confidently be used with 
data from future rounds of DHS+ surveys to supplement the existing surveillance 
tools. 
HIV surveillance has equipped public health professionals with the information 
required to mount a response to the epidemic. Surveillance data has also been used 
to monitor the effects of interventions [70]. This has provided powerful evidence of a 
number of intervention "success stories", which have been influential in setting the 
international agenda for action against HIV/AIDS. 
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1.6 The First Success Story - Thailand 
In Thailand, surveillance systems were quickly set up after pockets of infection 
among injecting drug users were discovered in 1988. They recorded a sharp rise in 
prevalence among sex workers from 3.1% in 1989 to 15.2% in 1991 and a 
simultaneous increase in prevalence among young men recruited to the military, from 
0.5% to 3% [71]. Men who have sex with sex workers and also have steady 
girlfriends or wives form a bridge between the small high prevalence sex worker 
population and the large low-risk general population [72]. Targeting sex worker and 
their clients was therefore a quickly recognised priority. 
Almost as soon as the epidemic in brothel-based sex workers was detected, a 
programme to enforce condom use was piloted in one region (Ratchaburi) [71]. The 
rationale was that brothels that required condom use would lose business to others 
that did not, generating an economic disincentive to safer sex practices. The plan 
was to make all brothels require condoms with financial penalties for those that failed 
to do so, tipping the economic scale in the opposite direction. The pilot study 
successfully reduced local rates of sexually transmitted infections (STIs) and the 
programme was unrolled nationally in 1991 together with a package of measures that 
promoted and distributed condoms and legislature to maintain high production 
standards for condoms. A year later, the fraction of female sex workers that report 
using a condom with the most recent partner exceeded 90% (and has since 
increased to more than 95%) [71]. At the national level, the number of men reporting 
sexually transmitted diseases dropped substantially between 1989 and 1994. 
Further evidence came from monitoring recruitment to the army, which occurs 
via a lottery of healthy twenty-one year-old men and involves an HIV test and a face-
to-face interview. This provides regularly-spaced random samples of young men, 
which are likely to be directly comparable over time and representative of the 
population from which they came. Since prevalence among young people is a good 
proxy for incidence, changes in these samples can be confidently attributed to 
regional trends in risk. Among recruits from northern regions, between 1991 and 
1995, prevalence reduced by about half (from 10.4 - 12.5% in 1991 to 6.7-6.8% in 
1994) [73], and by 1998, prevalence fell by more than half again, to 2.4% [74]. 
Reporting of the most significant risk behaviours also declined sharply; the fraction 
that said they had visited a sex worker in the previous year fell from 57% in 1991 to 
24% in 1994, and the fraction that reported using a condom on the last visit to a sex 
worker increased from 61% to 93%. Interestingly, although there remained an excess 
risk of infection associated with unprotected sex with a sex worker, this differential 
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reduced over time, indicating that contact with sex worl<ers got less risky, potentially 
as prevalence amongst them declined. 
A programme in Cambodia, following in Thailand's footsteps, may also have 
been successful, although the evidence is much less clear [75]. 
1.7 The Ugandan Success Story 
The first story of behaviour change turning the tide on a generalised epidemic came 
from Uganda. At the start of the 1990s, HIV prevalence in most African countries was 
low [2], but almost one in three women attending ante-natal clinics in Kampala, the 
capital of Uganda, were infected [76]. The situation was almost as bad in the 
country's other urban centres, where prevalence peaked in 1991 and 1992 at 18% 
(median) and was rather less severe in rural areas where the highest prevalence was 
12% in 1994 [76]. For many years a civil war had disrupted normal life, exacerbated 
poverty and driven migration that has scattered families around the country, often 
separating children from their families [77]. 
The president, then and now, Mr Yoweri Musveni, is widely credited with 
acting promptly and responsibly in the face of this new humanitarian crisis. In 1986 
he established the National AIDS Control Program (NACP), which was the first of its 
kind in Africa, and began a national response to the epidemic that is thought to have 
been open, multilateral and resourced with strong political leaders at all levels [77, 
78]. The 'zero-grazing' campaign is widely regarded as the most significant action of 
NACP [77]. In the form of advertisements on the radio and on poster bill-boards, the 
message was relayed that men should not have more than one sexual partner at the 
same time. The unusual choice of wording was intentionally humorous, recalling how 
an efficient farmer should graze his livestock exclusively in one paddock, and 
designed to catch the eye of this largely agricultural population. The practice of 
sustaining long-term extra-marital partnerships had been wide-spread, with 36% of 
men in 1989 reporting having had such a partner in the last year [24]. Other initiatives 
focussed on persuading young people to delay sexual debut, and creating 
magazines such as Straight Talk and Young Talk. Condom distribution was not 
initially a focus of the NACP approach, but in 1991 a policy of "quiet promotion and 
responsible use of condoms" was begun [77]. The distributions of condoms thereafter 
rocketed, from 10 million procured in 1994 to 30 million in 1997 and then 120 million 
in 2003 [79]. 
By the 1995 demographic and health survey, a dramatic change in sexual 
behaviour was apparent [24, 80]. Three types of behaviour change stood out: 
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1. Young people reported that they had, on average, started sex two years 
later; 
2. 60% fewer men reported that they had had a casual partner in the last year 
(apparently, this was incorrectly reported as 9% in the first analysis [80]); 
3. More men (from 5% to 28%) and women (from 0% to 20%) reported having 
used condoms with a non-regular partner in the last year. 
These three elements have come to be summarised as 'ABC, for Abstinence, Being 
faithful and using Condoms. 
Throughout the 1990's, ANC prevalence estimates show a sustained decline 
[76] and by the year 2000, prevalence in Kampala was just over 10%. In urban and 
rural centres, average prevalence had reduced by more than half. Despite the large 
prevalence reductions, there remained some doubt as to whether it could be due to 
the rising toll of AIDS deaths rather than to a reduction in incidence. Mathematical 
simulations confirmed that the prevalence decline was unlikely to completely 
attributable to AIDS deaths and that it could be associated with changes in sexual 
behaviour [54, 55]. Direct incidence measures in a rural community-based cohort 
between 1989 and 1999 confirm a sustained decline in incidence throughout this 
period [81]. Further modelling work has compared the total effect of the behavioural 
changes to that of an HIV vaccine that was 80% effective [24]. 
Identifying the behavioural changes that underlie the reduction in risk is 
essential if the success of Uganda is to be repeated elsewhere [24, 78] and the 
relative contributions of the three types of behaviour change has been hotly debated 
[82]. Re-analyses have suggested that the contribution of increased condom use 
may be low, on the basis that incidence probably decreased before condom use 
distribution increased, and that the level of condom use after the prevalence decline 
is comparable with levels in other countries with growing or stable epidemics [24]. 
The number of men and women with a casual partner and the fraction of young men 
who have started sex, on the other hand, dropped to much lower levels than 
observed in neighbouring countries. The stable fertility rate since the 1980s [77] 
indicates that women are exposed to the same number of unprotected sexual acts, 
which also suggests that condom use did not change substantially, even though 
condom distribution and reports of condom use did. However, even if increased 
condom use did not underlie the initial change in risk, it may have played a 
substantial role in sustaining and augmenting other types of risk reduction. After all, 
demand for condoms drove the massive ten-fold increase in supply, and it seems 
unlikely that no more were used or averted any infections. My own simulation 
studies suggest that the reduction in partner acquisition would have to be substantial 
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to reproduce the observed decline in prevalence without a simultaneous increase in 
condom use [70]. It can also be argued that comparing prevalence and a crude 
indicator of condom use across neighbouring countries is invalid because the 
frequency of other types of behaviour and the overall pattern of transmission could 
vary, so that condom use in a particular type of partnership could have more or less 
epidemiological significance in other places. Reports between different countries 
may also be subject to differing degree of reporting biases. 
1.8 Uganda and PEPFAR 
Although efforts to control the spread of HIV have been co-ordinated by 
governments, WHO and UNAIDS, substantial funding has been sourced from 
charities, non-governmental organisations, international agencies and 
philanthropists. At the international level, a major funder of intervention activities is 
The Global Fund for AIDS, TB and Malaria [83]. This organisation collects money 
from states and individuals all over the world and distributes it to many local projects. 
Latterly, in his state of the union address in 2003, George W Bush announced 
a new American initiative that would take a rather different approach. The President's 
Emergency Plan for AIDS Relief (PEPFAR) [84] committed $15bn over five years, 
with a focus on fifteen chosen countries. The plan was to use the best science 
available to guide the response to the epidemic on the three fronts - prevention, care 
and treatment. For prevention, the conclusion taken by PEPFAR from the Uganda 
story was that condom use should be restricted to the minority engaging in high risk 
behaviours, and that the primary tools for avoiding infection should be delaying first 
sex and then remaining faithful to one sexual partner. 
1.9 The Controversy of the American Initiative 
To many, PEPFAR is an extension of the 'strings attached' model of foreign aid that 
America has followed since the Second World War. It has been alleged that the 
selection of focus countries, which have received special attention in the programme, 
was made on the basis of American interests and domestic pressure and not 
epidemiological need [85]. Stories abound of how funding opportunities in PEPFAR 
have been directed away from those involved in family planning, or supporting 
abortion practices or women in sex work [85]. 
Epidemiologists have objected to PEPFAR for the way in which it promotes its 
own science for application to many different countries. They argue that a 'one-size 
fits air approach is unlikely to maximise the intervention effect when the practices 
and customs in countries with severe HIV epidemics vary so widely. The relative 
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contributions of the 'ABC components (in particular the role of condoms, versus 
abstinence and faithfulness) of an intervention will need to vary according to 
epidemiological context [86], especially the age-range and current behaviours of the 
target population. Although, it is expected (and acceptable) for implementing 
agencies to be more comfortable promoting some elements of ABC than others, it is 
not right for information and scientific evidence on the effectiveness of the 
alternatives to be withheld [87] or for the information to be coloured with ideological 
moralising. However, there has been suspicion that exactly this has happened in the 
first years of PEPFAR [85]. 
Randall Tobias, the first Global AIDS co-ordinator in charge of PEPFAR, 
signalled his scepticism on the usefulness of condoms in preventing new infections 
by noting that although condoms had been the principal intervention tool over the last 
decades, the HIV epidemic had continued to spread [88]. One third of US state 
funding is directed toward 'abstinence-only' programs, which do not mention 
condoms as an alternative to abstinence for avoiding the risk of HIV infection. Human 
Rights Watch [88] allege that information on the safe use of condoms was removed 
from a CDC fact sheet in 2002, although I have not been able to verify this claim. The 
American Foundation for AIDS Research [89] has responded to these trends with a 
statement that, "the scientific evidence does not support the recent shift in U.S. 
government policy that stresses lack of condom efficacy" and has conducted 
research showing that the efficacy at reducing HIV transmission is 80-95% (the 
scientific evidence on the use of condoms is discussed in greater detail below). The 
position of the new Global AIDS co-ordinator, Mark Dybal, may be slightly less 
antagonistic, at least in rhetoric. However, in Uganda, where the ABC programme 
had it first success, condoms sales have declined over recent years, as links 
between Washington and Kampala have strengthened [85]. And worryingly, this has 
been accompanied by a stabilization or slight upward trend in HIV prevalence and 
incidence rates in some parts [90]. 
The evidence from Uganda is that the declines in incidence were not driven 
by a change in a single dimension of sexual behaviour. The distortion of evidence is 
unfortunate and unlikely to assist is generating an adequate response elsewhere. 
1.10 A New Story - Zimbabwe 
Zimbabwe makes an unlikely candidate for a success story with HIV rates declining. 
Land redistribution, increased migration, a failing economy and increasingly brutal 
state conduct, have combined to considerably increase the hardship of the average 
28 
Zimbabwean in the last decade. However, during this time, HIV prevalence has 
declined substantially [17]. 
Median prevalence across twelve national surveillance locations exceeded 
30% in the year 2000, making Zimbabwe one of the worst affected countries in the 
world. However, 2001, 2002 and 2004 saw successively lower prevalence estimates 
and the estimate for 2004 was 22%. That is to say, over five years, the number of 
people living with HIV reduced by more than a quarter. Naturally in the face of such a 
striking result, important questions have been raised about its validity. In 2005, 
UNAIDS sought to address these concerns with a comprehensive scientific review of 
the epidemiological data [17]. 
The HIV test ('Genscreen') used in the surveillance protocol has a lower 
specificity than had been presumed, meaning that prevalence could be slightly 
overestimated. However, since the same protocol has been used throughout these 
surveys, this could not contribute to the observed trend. An unusual feature of the 
data is that the reduction in prevalence is approximately equal in all age-groups, 
whereas one might predict that a change in incidence in a mature epidemic would 
lead to greater declines in prevalence at younger ages. However, this assumes that 
the change in risk is the same in each age-group, and greater changes in behaviour 
in older age-groups could generate the observed pattern of prevalence decline. 
Alternatively, average fertility rates in older infected women may have decreased 
further over time, leaving the sample progressively more dominated by uninfected 
women, contributing to the observed prevalence decline at older ages. There has 
also been a lot of emigration from Zimbabwe, which could drive the decline in 
prevalence if those infected are more likely to leave than others. This could be the 
case, for instance, if they were leaving for South Africa in search of treatment, which 
was not available in Zimbabwe. This issue can be taken up with mathematical 
modelling, by exploring the degree of emigration needed to generate the observed 
prevalence decline (see chapter 2). 
Further weight is leant to the national-level studies by parallel observations in 
a cohort of postnatal women in Harare [17] and an open cohort in the rural 
Manicaland region in the eastern highlands [91]. Among the Harare women, 
prevalence rose and fell through November 1997 to January 2000. Taken together 
with comparable ANC data, this period seems to capture the point of incipient 
prevalence decline. It would be expected that changing risk behaviour would develop 
first in more educated urban populations [92], and this pattern of prevalence decline 
does slightly precede the changes seen at the national level. In the rural cohort, a 
significant prevalence decline was detected between 1998 and 2003 from 21% to 
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19%. Prevalence declined by almost two-thirds among men and women aged under 
twenty years, conforming to the expectation that changes are greatest at young ages. 
During the period of prevalence decline, available data also indicate 
substantial changes in sexual behaviour. A clear trend from nationally [17] and 
locally-collected data [91] is that, in more recent surveys, fewer men report having a 
casual partnership in the last year. At the national level, there has been little change 
in number of partnerships formed by women, but in Manicaland, they also report 
engaging in fewer sexual partnerships and having fewer sexual partnerships at the 
same time. Recent measures of condom use at the national level have not changed 
in the last five years, although reported use with causal partners is quite high and the 
changes in risk associated with the current prevalence decline probably precede the 
period for which there are data. In fact, the number of condoms distributed increased 
by nearly ten fold during the 1990s, with a particular surge after 1997, when social 
marketing of condoms began, so it is credible that condom use increased as well. 
There is evidence from Manicaland that young men and women are starting sex 
later, although there is little suggestion of this in the national level data. 
The standard of evidence for the prevalence decline in the Manicaland study 
is much higher than that from national level studies in either Zimbabwe or Uganda 
because it refers to the same general population sample at two time-points. In this 
way, changes in the composition of the sample or biases in those attending clinics do 
not contribute to observed trends. Because this study also collects detailed sexual 
behaviour in the same population, changes in risk can be confidently associated with 
changes in prevalence. Future rounds of the Manicaland cohort study will furnish 
successive incidence measurements, which could provide an even greater level of 
evidence for the ongoing epidemic changes. 
In common with Uganda and contrary to popular opinion, Zimbabwe benefited 
from strong political leadership and openness about the epidemic from early on. 
Zimbabwe was the first country in the region to start an AIDS levy, a tax stream 
dedicated to funding the national response to the HIV/AIDS epidemic [93]. There was 
also a successful STI control program in the early 1990s [17, 94] which may have 
directly contributed to reducing transmission. The documented changes in Zimbabwe 
and Uganda share particularly strong evidence for reductions in the number of casual 
partnerships. That might be because reducing the number of casual partners is the 
most feasible and effective change, or because it is the simple indicator that most 
closely measures general risk behaviour or is most susceptible to social desirability 
bias. 
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In order to better identify the interventions (or other factors) that contributed to 
the epidemic changes in Zimbabwe, the timing of the risk reduction is investigated in 
Chapter 2. In Uganda, the change in risk behaviour may have begun in the phase of 
the epidemic when mortality grew in lower risk groups [24] and it has been 
hypothesised that the motivation could have been attending funerals of close friends, 
neighbours and family members [95]. The average Zimbabwean citizen may have 
gone through this sad process about ten years after his peers in Uganda, but the 
effects may have been the same. 
These successes, in Thailand, Uganda and Zimbabwe, are the exception not the rule 
for the result of interventions against the HIV epidemic. Moreover, in the case of 
Uganda and Zimbabwe, it is unclear how much of the "success" was a consequence 
of specific planned interventions and policies, if the true motivational force was AIDS 
mortality and funerals. Must other countries wait for their epidemics to spread further 
before the death toll is sufficient to inspire more effective action? There has been 
extensive research into the best way to prevent infection in limited resource settings. 
The opportunity cost of other interventions has created tensions between proponents 
of alternative strategies, and the evidence has not always been assessed objectively. 
The first major intervention activity was the distribution of male condoms, about 
which controversies have already been mentioned. 
1.11 Trends in Interventions - First, Condoms 
In the 1990s, when the magnitude of the HIV epidemic and it potential for devastation 
was first realised, condom distribution increased significantly, by about ten to one 
hundred fold in some places [75]. It has been suggested that the lack of evidence for 
the success of this approach in turning back the generalised epidemics is 
conspicuous. One example is illustrative; in Botswana between 1993 and 2001, 
condom distribution tripled while prevalence leaped from 27% to 45%. 
However, one cannot know how much faster the epidemics would have grown 
if these efforts in condom promotion had not been made. There are also some 
important reasons why distributing condoms has not had the hoped for effect. 
First, condoms are not perfectly effective. Their efficacy (use under idealised 
conditions) can never be measured because this would require randomising 
serodiscordant couples to use condoms or not (ethically unacceptable) and demand 
perfect adherence throughout the trial (which could not been verified). Effectiveness 
(use "in the real world") has been estimated in many studies [96], and a meta-
analysis indicates a 90-95% reduction in the chance of transmission per sex act. 
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which is roughly the same as their contraceptive effect [97]. Probable reasons for the 
imperfect effectiveness are improper use and poor storage conditions. 
Second, condom distribution is not an indicator of condom use. For the 
millions of condom distributed, many contacts will be unprotected even if everyone 
wanted to use a condom. In Zimbabwe, for example, the 80 million distributed in 
2004 [17] amounts to 25 per man, or approximately one condom for every six sex 
acts. Although most sex acts will remain unprotected even with high levels of condom 
distribution, this does not necessarily argue that the limiting factor has been 
insufficient distribution. The number of condoms currently distributed would probably 
be more than enough if they were selectively used in sero-discordant partnerships, 
so a confounding problem is lack of knowledge of infection status. Condom use in 
many countries is much higher with a 'casual' (or non-cohabiting) partner than with a 
regular partner [75]. Mathematical models have highlighted the particular importance 
of condom use in such high-risk partnerships, particularly if either partner has an STI 
[98]. For example, for the same reduction in women's lifetime risk of infection, one 
sixth as many condoms are required if they are used when a partner has an STI, as 
when they are used 50% of the time irrespective of STI symptoms. However, it is 
also now recognised that partnerships perceived as stable and low risk, and in which 
condom use is low [98], tend to run concurrently so that the chance of transmission 
between them is high [72]. In summary, the lack of association between increased 
condom distribution and declines in incidence could be due to an insufficient number 
of condoms, or insufficient knowledge about the risk of getting infected with HIV and 
when to use a condom. 
Third, occasional condom use is not enough. Consider an infected man and 
' an uninfected woman forming a five year relationship: assume that there are three 
sex acts per week (780 sex acts in total), that the chance of male-to-female 
transmission is 0.001 [99] and that the effectiveness of condoms in preventing 
transmission is 95% [97]. What is the chance there is a transmission event 
sometime in the partnership? Without any condom use, the chance she gets infected 
is 54%, whereas if condoms are used in every act, the chance is 4%. However, 
compared to using condoms in all sex acts, the chance of infection is five time higher 
if condoms are used in 75% of sex acts, and nine times higher if condoms are used 
in 50% of sex acts (still perceived as a "high" value). In fact, the overall risk of 
infection when condoms are used in half of all sex acts is 37% less than if condoms 
were not used at all, illustrating the faster-than-linear payoff of using condoms in 
more sex acts. 
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The sensitivity to infrequent use of condoms is greater for longer 
partnerships, because the absolute number of unprotected acts increases. Models 
suggest that with the same average condom use, a small number of people using 
condoms consistently can have more effect than a larger number using them 
inconsistently [98, 100]. It is notable that in those instances where condoms can be 
credited with leading to a substantial population-level effect, condom use was strictly 
enforced and high levels of compliance recorded - in Thailand (see above), and 
Nevada [101], for instance. For the general population, it is one thing to supply some 
condoms and encourage people to use them sometimes, but quite another to 
stimulate demand for consistent use and develop the supply chain to support it. It 
also means that studies showing that high but incomplete usage of condoms is not 
associated with lower incidence should not be interpreted as condoms being unable 
to provide a high level of protection against infection when they are used properly. 
Given that the protection afforded by condoms is jeopardised by infrequent 
use, there is a genuine danger that a focus on condoms could lead to deleterious 
interactions with other interventions activities. For instance, there has been concern 
that promoting condoms to young people will lead to starting sex earlier and having 
more sex but with inconsistent condom use. However, the limited data available do 
not support this [102] and, in some settings, the opposite is true. For example, 
condom promotion has been associated with other forms of behaviour change, 
including less visits to sex workers in Thailand [103] and fewer casual sex partners in 
Brazil [104]. 
If alternative types of behaviour change intervention are not antagonistic then 
another important argument for a multi-pronged approach is that risk-reducing 
behaviour changes are more powerful in combination than in isolation. This arises 
because the association between risk behaviour and the chance of infection is not 
linear, but a multiplicative function of both risk behaviour and the level of infection 
already in circulation [37]. Thus, using condoms could decrease an individual's 
chance of infection by a certain amount, but the reduction in incidence at the 
population level could be greater if accompanied by other behaviour changes in other 
parts of the population, such as reduced partner change or "zero-grazing". This effect 
means that attributing Uganda's success, for instance, to one particular aspect, 
though tempting, is prone to understate the role of certain behaviours (such as 
condom use) which may have been mostly restricted to marginalised parts of society. 
1.12 Treatment of STIs 
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With clear evidence that curable STIs (such as gonorrhoea, Chlamydia and syphilis) 
increase the chance that HIV is acquired and transmitted [105], treating STIs with 
cheap drugs (antibiotics) at basic clinics seemed like a promising way to tackle HIV 
epidemics [106]. To test whether controlling STIs could have an effect on HIV 
incidence, it was necessary to conduct randomised control trials but the unit of study 
was the community because the intervention (treating STIs) and the outcome (HIV 
incidence) both relate to the community, not the individual. Treating STIs is expected 
to reduce STI prevalence, which will impact on both the acquisition and transmission 
of HIV and lead to lower HIV prevalence in the community, so that even people who 
are not directly involved with the intervention itself stand to benefit. 
Ten years ago the first positive trial result for this approach came from the 
rural Mwanza area in southern Tanzania [107]. This was the first time an HIV 
intervention was shown to work and many countries started to adopt STI treatment 
as part of epidemic control programmes [108]. In the trial, twelve communities were 
organised into pairs on the basis of HIV prevalence, STI prevalence and other 
environmental factors. One community in each pair was randomly assigned to the 
treatment arm, which provided improved syndromic management of STIs, and the 
other to the control arm, where basic health care services were continued. The effect 
of the community-wide interventions was gauged in 1000 adults, randomly chosen 
from each community. In fully adjusted analyses, over two years the HIV incidence 
rate in the intervention communities was about 40% lower than in the control 
communities. 
This strikingly successful trial led others to be set up, all based on the idea of 
treating STIs, but aiming to deal with asymptomatic reservoirs in the Rakai trial [109], 
and combining STI treatment with behaviour change interventions in the Masaka 
[110] and Manicaland trials [94]. In the Rakai trial, one group of communities were 
offered antibiotics every 10 months, as a 'mass treatment' of STIs, for those with or 
without symptoms. In the Masaka trial, communities were either given behavioural 
counselling services, or behavioural counselling services in addition to a Mwanza-
style syndromic STI management service, whilst the existing health care services 
were maintained in other comparison communities. In Manicaland, the approach was 
slightly different again; in addition to improving syndromic management of STIs, 
peer-led behaviour change counselling was directed to sex workers and their clients. 
However, none of these more recent trials has been able to reproduce a 
positive result. The apparently contradictory results of the Mwanza, Rakai and 
Masaka trials have been explained by differences in the epidemiological contexts in 
which the trials were run and difficulties in implementing the mass treatment 
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intervention. Essentially, the Mwanza trial was a special case; curable STIs were 
unusually prevalent and existing STI services were unusually poor [111, 112]. In 
Rakai, genital herpes, an STI that has been shown to potentially be an important 
cofactor enhancing HIV transmission [113] but which cannot be treated with 
antibiotics, was very common and probably supported much HIV transmission [108, 
114]. Also, in the Mwanza trial, the STI treatment services were provided 
continuously, so that STI prevalence remained low, but, in the Rakai trial, infections 
could have been reintroduced between rounds of mass treatment [108]. Lower 
coverage of treatment services among those most at risk could also undermine the 
impact of treatment on HIV incidence [115]. It has been suggested that providing a 
syndromic management service (but not a mass treatment service) also acts as a 
behaviour change intervention because with STI symptoms, patients would be 
advised to be temporarily abstinent [116]. In this way, new STI symptoms will tend to 
coincide with the individual having had a risky exposure, through which they may 
also have acquired HIV; by avoiding sex in the period immediately after, the chance 
of transmitting the HIV infection is then substantially reduced. 
Another well accepted reason for the success in Mwanza and not elsewhere 
is that, in contrast to the contexts of the other trials, the epidemic in Mwanza was 
younger, at a lower prevalence, and growing during the trial. In such a phase, the 
HIV epidemic remains largely in those with the riskiest sexual behaviour who are 
most likely to have STIs, so that the fraction of HIV infections attributed to curable 
STIs is high [117]. Later, when most new infections occur within lower risk, long-term 
partnerships, amplification in the transmission probability has a relatively smaller 
effect on the overall chance of transmission in the partnership, because of the 
greater number of sexual acts. 
Taken together in a detailed mathematical model, these effects can explain 
the differences between the trial outcomes in Mwanza, Rakai and Masaka [118,119]. 
However, further issues surround the Manicaland trial, where a reduction in HIV 
incidence was detected in the immediate male target group, but not in the wider 
community [94]. This raises the question of whether a positive result would have 
been recorded if the trial had run for longer. However, the incidence rate ratio 
showed no trend to decrease in the intervention communities; indeed the trend was 
in the opposite direction. In the mature Zimbabwean epidemic, the prevalence of 
STIs was already low [17], the contribution to transmission of high-risk behaviours 
may have been be small, or high-risk behaviours may not have been effectively 
targeted. It also seems possible that the effect of the intervention and the chance of 
detecting a statistically significant result could have been influenced by the large 
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epidemiological changes that occurred in Zimbabwe over the course of the trial [91]. 
These questions are the subject of chapter 6. 
In summary, STIs can be successfully controlled with inexpensive treatments, 
which should be a goal in its own right, since such disease are amongst the leading 
cause of morbidity among prime-aged men and women [108]. In addition, syndromic 
management of STIs has been shown in one study to reduce HIV incidence, but in a 
particular set of circumstances i.e. in growing epidemics, where curable STIs are 
common. Although the effect of treating STIs on HIV has not been shown in trials in 
other contexts, it may still make a important contribution to limiting HIV incidence 
rates, and is likely to remain a cost-effective option given the cheapness of treatment 
and the size of the mature epidemics [120]. The conditions for STI treatment to have 
a major impact may no longer apply in most African countries, but it could still be a 
promising intervention in south and central America, India and many other parts of 
Asia [2, 108]. 
Amid the many and varied approaches to behaviour change intervention currently 
being advocated and implemented, two themes seem particularly prominent. These 
are: a focus on young women's sexual behaviour, especially their sexual 
partnerships with older men; and, voluntary counselling and testing. 
1.13 Current Trends in Interventions - Young Women's Sexual Behaviour 
Observational studies show that HIV prevalence among young women usually far 
exceeds that among young men [121], which has prompted some to stress the 
importance of protecting young women in particular from infection [121-125]. 
Statistical analyses of individual behaviour data show that the risk of HIV infection is 
lower amongst women that avoid older sexual partners [40, 126] and begin sexual 
activity later [40, 127, 128]. In Manicaland, women whose last partner was at least 
ten years older were twice as likely to have a prevalent infection than women whose 
last partner was less than five years older [40]. Young women (15-24 years) who 
began sex younger than seventeen were 30% more likely to be infected than those 
who started after their twenty-first birthday [40, 129]. For these reasons, it has been 
suggested that behaviour interventions should focus on reducing cross-generational 
sex and delaying sexual debut [121, 130,131]. However, further analysis on timing of 
sexual debut reveals that the apparent protective effect of delaying first sex is short-
term [127] and is mostly driven by the association between early first sex and riskier 
sexual behaviour later in life [127, 129, 132]. The impact of delaying sex and 
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changing the pattern of age mixing on transmission at the population-level has been 
presumed but not scientifically investigated and quantified [41, 121, 125, 126, 130, 
131, 133-135]. Mathematical models can provide insight into how individual 
behaviour changes relate to epidemic patterns and this is taken up in Chapter 4. 
1.14 Current Trends in Interventions - Voluntary Counselling and Testing 
As mentioned above, one of the limiting factors to challenging the spread of the 
epidemic is that most of those transmitting infection do not know that they are 
infected. The reducing price and increasing speed and ease of HIV testing has made 
it possible to offer a testing service so that individuals that want to find out if they are 
infected can do so and get the result immediately. Before and after the test, there is 
an opportunity for counselling and a randomised control trial in the United States of 
America demonstrated the extra power of counselling to enable behaviour change 
when it is integrated with an HIV test result [136]. In low-income countries, other trials 
have shown that voluntary counselling and testing (VCT) is an effective and cost-
efficient means of reducing HIV risk behaviours [137-139]. However, in a recent 
cluster-randomised trial for VCT delivered at the workplace [140], there was no net 
reduction in HIV incidence associated with VCT and, in another study, where VCT 
was conducted outside of a formal trial [141], only small behaviour changes were 
detected after VCT, and some individuals that found they were not infected went on 
to increase their risk behaviour. Another potential problem with VCT is that 
serodiscordant couples with an infected woman may be more likely to end the 
relationship after VCT [142], which could lead the infected women to form more new 
partnerships, increasing the potential for onward transmission. 
VCT is also used as an entry-point to the health-care system [143] so that 
those found to be infected can be referred for treatment of opportunistic infections, 
prevention of mother-to-child transmission services and ART, if it is available. 
In many countries there is a drive to roll-out VCT facilities. Some of the 
earliest approaches were led by the commercial sector, with Population Services 
International aiming to stimulate demand for VCT with social marketing techniques 
[144]. Television and print media advertisement were used to target specific 
population sub-groups (adolescents, young couples and mobile workers, in 
particular) and the pilot 'New Start' centres in Zimbabwe have now tested 660,000 
individuals [144]. However, many of these tests were delivered to the same people 
attending multiple times, and the coverage of the adult population may be much less 
than 10%. Uptake is thought to be much lower in most other settings, where as few 
as 8-25% of people living with HIV are estimated to know they are infected [145]. It 
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has been presumed that the major barriers to testing are stigma and lack of 
convenience. To combat both of these, on-site VCT services have been proposed 
and a study in Zimbabwe found that uptake of VCT of on-site services was much 
greater than comparable off-site services [146]. In Botswana, although ART has been 
available for many years, relatively few were receiving therapy because most people 
have not been tested and do not know they are infected with HIV. In 2004 the 
government made testing routine, so that at each visit to a doctor, the patient is 
tested for HIV unless they "opt-out" [147]. This had been met with mixed feelings, 
with many respondents reporting that it would have been difficult to decline the test, 
and with lower testing coverage remaining in important groups, such as those with 
only basic education and those with stigmatising attitudes [147]. 
Although there is political and commercial support for VCT, the potential 
impact of the services at the population level has not been quantified. VCT also 
raises the possibility of new types of behaviour change, such as sero-sorting and 
selectively using condoms in 'known' serodiscordant partnerships, the impact and 
relative advantage of which may depend on certain elements of the VCT service. 
Other programmatic questions, such as whether to frequently repeat test individuals, 
the effect of targeting services to particular groups and the potential antagonism 
between the two roles of VCT (promoting behaviour change and entry to health care 
services) are relevant for public health officials and decision-makers in charge of 
delivering these services [148, 149]. With limited service coverage and data on these 
issues, mathematical modelling can provide a useful investigative tool and VCT is the 
subject of Chapter 5. 
1.15 Anti-retroviral Therapy 
Although it took time for the political community to accept that a new lethal retrovirus 
was spreading beyond marginalised groups in the early 1980s, efforts to alleviate 
infection and mortality have since been exceptionally well funded [150]. In the United 
States, the National Institute of Health established the AIDS Clinical Trials group 
(ACTG) in 1986, which has tested hundreds of suggested compounds. AZT 
(Zidovudine) was the first to be licensed after initially promising results, although it 
was considered costly, toxic and ultimately not very successful at slowing the onset 
of AIDS [150]. The break-through that became known as (Highly Active) Antiretroviral 
Therapy ((HA)ART) came a decade later [151, 152]. 
The success of ART in the US is evidenced by the sharp and sustained 
decline in AIDS deaths from a peak of 50,000 in 1994, to slightly more than 10,000 a 
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year in 1999. The therapy is really a package of three distinct treatments that 
interrupt different phases of viral replication. Managing these three types of drug and 
coping with their toxicities and associated metabolic disorders can be difficult [153]. 
The best-practice guidelines for delivering ART in western populations have shifted in 
the time that therapy has been available [154, 155]. Initially, a "hit hard, hit early" 
approach was advocated [156], whereby ART was given almost as soon as the 
patient was found to be infected with HIV. A meta-analysis of western cohorts 
suggests great advantages of starting therapy earlier: a young patient starting 
therapy before any symptoms of immune-suppression have started (that is, with 350 
or more CD4 cells/pL and a viral load below 100,000 copies/mL) has a 3.4% chance 
of dying of AIDS within three years, whereas a patient starting therapy in the very 
advanced stages of disease (that is, with fewer than 50 CD4 cells/pL and a viral load 
greater than 100,000 copies/mL), has a 50% chance [157]. However, the toxicity 
[153] of the drugs and the associated issues of low adherence and the emergence of 
drug resistance [158] have lead some to recommend starting therapy later [159]. 
Another benefit of ART is that by reducing viral load, it probably reduces the 
chance of HIV transmission [160]. Many mathematical models have been used to 
investigate whether this would lead to HIV incidence being reduced at the population 
level, with conflicting results [161]. However, the consensus is that is very unlikely 
that ART alone could bring the epidemic under control [10,161]. 
1.16 Universal Access to Anti-retrovirals in Africa 
Until 2001, the price of ART was too high for almost anyone in the developing world 
to afford but, in response to growing international pressure, the pharmaceutical 
companies made two commercial concessions. First, they agreed to sell the drugs at 
a lower price in the developing world, and second, they agreed to let other 
companies produce the same drugs without their branding (i.e. 'generic' copies) [85, 
150]. This brought the price of ART crashing down, by approximately 90-99%. For 
example, 30 days of triple therapy (with branded drugs) in Uganda cost $479-$556 in 
1998, but about $70 (down 86%) in 2002 and about $30 (down 93%) for unbranded 
products [162]. 
Two programs have led the increase in access to anti-retrovirals since 2003. 
The first was PEPFAR, which set itself the goal of putting two million on treatment 
over its five year run [163]. At the half way mark, they are slightly behind schedule -
as of September, 2006, it was estimated that 822,000 people were receiving therapy 
from PEPFAR in the 15 focus countries [164]. 
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Later that year, on World AIDS day (1st December), the WHO and UNAIDS 
launched the "3 by 5" initiative, a plan to provide therapy to three million by 2005. 
When it was announced, about 400,000 were on therapy (mostly in Latin America, 
where cheap drugs had been widely available for some time already), representing 
about 5% of those in need. The ambitious target of three million was estimated to 
equate to about 50% of those in need [165]. A review in 2006 indicated that progress 
had been slower than hoped for, suggesting that, by the middle of 2005, about one 
million were on therapy - about 15% of those in need - only a third of the way to the 
target [9]. 
A new commitment was made at the G8 summit of the world's richest 
industrialised countries in 2005, hosted by the British government in Gleneagles, 
Scotland. By 2010, they agreed, there should be 'as close as possible to universal 
access to treatment' [166]. This new target goes much further than the WHO dared in 
2003 and would require an incredible surge in finance and roll-out of services, little 
evidence for which can be found two years on. 
How well does therapy work in the developing world? There was scepticism 
that therapy could be as effective in poorer settings, where maintaining good 
adherence and precisely timing doses was thought by some to be impractical [167]. 
However, a recent meta-analysis indicates that adherence to therapy is actually 
better in Africa than in north America [168]. On the other hand, a meta-analysis of 
survival on ART has found that many more individuals in lower-income countries die 
in the first year of treatment than in high-income countries [8]. However, this is partly 
because patients in low-income countries tend to start therapy later and the chance 
of death while on ART is higher in low-income countries only during the first months 
and by the ninth month the survival outcomes for patients in low-income and high-
income countries are statistically indistinguishable [8]. 
The question of when to start ART has taken on a new dimension in poorer 
countries. Whilst in western countries the decision to initiate ART can be informed by 
a range of high-technology tools [169, 170], in poorer countries a more pragmatic 
public-health approach has been adopted [171]. The decision to start therapy may be 
taken without any laboratory support at all, using instead standard symptom staging 
criteria. Studies from India and Africa show that, although early signs of disease can 
be apparent within a few years of infection [172, 173], advanced immune depletion is 
not always associated with severe clinical symptoms [174-176]. To better identify 
those in need of treatment, the WHO has recommended using CD4 counts [177] and, 
in the "3 by 5" program, almost all the focus countries used CD4 counts to help judge 
when ART should be initiated [178]. CD4 cells are the principle target of the virus and 
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their numbers are steadily depleted with time since infection, so that a count of the 
number of CD4 cells in a sample of peripheral blood indicates the degree of immune-
suppression and the immediacy of the need for therapy [179]. 
It has been argued that such is the priority for delivering these life-saving 
drugs, there is no time for a more sophisticated medical infrastructure to be 
developed [180]. However, given that the prognosis on ART is linked so closely with 
the state of the immune-system when therapy is started, it seems that the CD4 
counting technology could provide a useful "early warning system" for the need for 
therapy, and substantially increase the life-years saved. Other aspects of the health-
care system could also play a role in maximising the impact of ART programmes, 
such as enabling earlier diagnosis of infection through increased uptake of VCT, and 
regular observation of patients not yet in need of ART. These issues are examined in 
Chapter 7. 
1.17 The Future 
It has been said that a quarter of a century into the epidemic, we now stand at a 
cross-roads [181]. Without doubt, momentum and political agitation for success in the 
global response to the epidemic has grown in recent years. Since 2000, 
commitments for HIV/AIDS have increased; the Global Fund has distributed 
$5.2billion, PEPFAR has committed $15billion; the UN has discussed AIDS as an 
international security issue; the World Bank has become much more active in AIDS-
related lending, increasing its commitments from $500million in 1998 to $2.7billion in 
2006; UNAIDS has successfully drawn support from its international partners and 
member states and mounted a coherent response strategy [181]. 
These grand multilateral or ideologically driven ventures can place a concern 
in the spot light and mobilise substantial resources, but they can also fall short of 
high expectations and distract focus other methods of effective action. Competition 
and antagonism between programmes could undermine their total eventual 
contribution. There may also be a case that numerical targets for treatment - though 
of pressing importance - could distract from the priority of preventing new infections. 
The line of least resistance might be to rely on familiar supply-chain and programme 
management skills to distribute a product or service (condoms or ART) in Africa to 
meet specific targets, rather than to engage with the more complex issues of sexual 
behaviour and behaviour change. The successes that there have been (in Uganda 
and Thailand) are characterised by properties that PEPFAR, the Global Fund and the 
UN cannot buy; strong political leadership at all levels and a simple behavioural 
response developed from the beginning by the people working at the frontline. 
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However, the "next generation" of interventions offer ways of reducing the risk of 
infection without individuals changing (by very much) their sexual behaviour. 
In the short-term, male circumcision and acyclovir treatment for genital herpes 
look like promising options. After having encouraged countries to make preparations 
for many months [182, 183], this spring, UNAIDS and WHO officially endorsed male 
circumcision as an intervention [184]. The evidence for male circumcision reducing 
the risk of HIV acquisition (among men) is now ovenwhelming and includes three 
randomised control trials in three different countries [30-32]. Given the cheapness of 
the operation and the high cost of treating opportunistic infection and providing ART, 
it is no surprise that such an intervention is likely to be cost-effective [185]. There are 
concerns, though, that a man would tend to use condoms less after being 
circumcised (behavioural 'disinhibition'), potentially overturning any protective effects 
at the population level, and that "back-street surgeons" could offer the operation 
cheaply but with sub-standard practices, expose individuals to the risk of serious 
bacterial infections. As discussed above, circumcising infected men may lead also to 
an increased chance of transmission, at least in the short-term [33]. 
Genital herpes, mainly associated with Herpes simplex virus type 2 (HSV-2), 
an incurable viral infection [186], is known to increase the chance of HIV infection 
and onward transmission [113, 187]. Although, disappointingly, a trial recently 
reported that treating HSV infection with acyclovir in suppressive therapy failed to 
reduce the risk of HIV acquisition [188], there is some evidence that suppressive or 
episodic treatment could reduce HIV viral shedding and therefore reduce the rate of 
transmission [189, 190]. There are many reasons why this is not the same as 
treatment of bacterial STIs, which, as discussed, has not worked in a number of 
African trials. The co-factor effect of HSV when ulcers are themselves present is 
greater than bacterial STIs; the prevalence of HSV is often much higher and is more 
common in lower risk couples, making the contribution of HSV to HIV spread 
increase over time [114, 117, 191]; and, the effect of HSV could be greater in mature 
epidemics because advanced immune-suppression makes episodes, when 
infectiousness is highest, more frequent. 
On the horizon, there are two more medical-type interventions. The result of 
efficacy and safety trials of topical microbicides are expected in 2008 [192]. These 
are chemical agents used topically within the vagina by women prior to sex. Many 
have been developed and several are currently in phase III clinical trials. They work 
by destroying the viral envelope, preventing binding, or by blocking transcription by 
the virus [192, 193]. Critically, they could provide a prevention tool that is under the 
control of women. Although they are unlikely to be completely effective (probably 
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reducing rates of infection by between 30 and 60% [192]), they could nonetheless 
lead to substantial reductions in infection, especially if combined with condom use. 
Since microbicides are less effective than using condoms, there is a risk that 
"condom migration" could put some women at increased risk [194]. Other modelling 
studies suggest that within the range of efficacies expected, adherence will be a 
stronger determinant of effectiveness than biological efficacy [195]. New technologies 
aim to improve adherence by, for instance, using resident vaginal rings that maintain 
a slow release of the active agent over a period of weeks or months [192]. 
In the long-term, there is also the prospect of a pre-exposure prophylactic 
vaccine [196]. A result seems as distant as ever and we are told not to expect a 
vaccine any time in the next decade [196]. Yet work is encouraged by modelling 
projections that suggest that even a partially effective vaccine could have a 
significant impact, provided that it does not lead to increases in risk behaviour [197, 
198]: for instance, it is estimated that achieving 30% coverage with a 50% efficacious 
vaccine could reduce the number of new infections worldwide by about a half [199]. 
For the foreseeable future, there will be no magic bullet which can in isolation 
eradicate HIV infection. But, there is cause for optimism that, in combination, the 
multiplying number of tools could send the epidemic into decline. The Achilles heal of 
each approach, though, is behavioural disinhibition [200]; encouraging volitional 
behaviour change will have to remain at the centre of all HIV/AIDS intervention 
projects. 
1.18 Mathematical Modelling in HiV epidemiology 
The methods used in this thesis involve the application of mathematical models to 
data analysis, informing the interpretation of surveillance data or the design of 
interventions. Mathematical models are a precise way of describing assumptions 
about the transmission dynamics of an infectious disease and can be used to 
generate predictions for the course of an epidemic and can provide insights into how 
it can be monitored and controlled [201]. 
Models of infectious disease epidemiology have a long history, beginning with 
the work of Daniel Bernoulli in 1760 investigating the impact of small pox on life-
expectancy [202]. The architecture of most mathematical models used today was 
established a century ago, when a "mass-action" assumption was first used to 
characterise net transmission as the rate of random contact between infectious and 
susceptible individuals [203, 204]. With the simplest of such random-mixing models 
(where individuals are only classified as either susceptible or infectious), the 
important finding emerges that incidence can decline over time as the number of 
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susceptible individuals diminishes [201]. This means that the contribution of 
epidemiological dynamics must be considered when interpreting observed 
epidemiological trends [54, 55]. With such a model, it can also be shown that, for 
infections with long generations times, prevalence lags any changes in incidence, 
which has the implication that the impact of successful interventions may not be 
apparent for many years after they start. These basic findings are the starting point 
for the work in Chapters 2, 3 and 6, where methods for monitoring epidemics and 
evaluating trials are developed. 
Over time, as greater biological knowledge about the natural history of HIV 
and data on sexual behaviour has accumulated, models have been progressively 
adapted to incorporate further complexities. Important modifications include: variation 
in risk behaviour in the population [205] and patterns of mixing [42, 206, 207], 
variable patterns of infectiousness and disease over time [208, 209], the temporal 
relationship of partnerships [23, 210] and many other important details of the sexual 
behaviour network [211, 212]. These additions have contributed to better 
understanding the course of HIV epidemics, the global variation in epidemic profiles 
and the distribution of infection within communities. In particular, simple homogenous 
random-mixing models of HIV cannot readily reconcile the low transmission 
probability of the virus [160], the quick initial epidemic spread, and the relatively low 
endemic prevalence. 
Under the random-mixing assumption, the potential for epidemic spread is 
greatly enhanced by variation in the rate of forming sexual partnerships [210]. This 
provided one of the first solutions to the paradox whereby behavioural surveys reveal 
superficially similar levels of (mean) risk factors in communities with high and low HIV 
endemic levels [21, 25]. The extent of contact between those at most risk with others 
can also determine the extent to which the infection can spread. HIV will be restricted 
to only those with the highest risk if they mostly form partnerships with one another, 
whereas prevalence can reach higher levels over the whole population if those at 
most risk often form partnerships with others [42, 213, 214]. When the finite duration 
of partnerships is incorporated in models (in many other models it is assumed that 
contact is instantaneous), is it clear that the potential for epidemic spread (Ro) 
depends on both the average partnership duration and the inter-partnership gap, with 
transmission promoted when individuals are released from partnerships and are able 
to re-form more partnerships before the period of infectiousness runs out [215]. (Ro is 
the basic reproductive number, defined as the number of secondary infections arising 
from one infection in entirely susceptible population [37]). As already discussed, it 
has further been shown that communities in which partnerships tend to temporally 
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overlap can support faster epidemic growth [23, 216]. Other diseases can also act as 
co-factors for HIV transmission, including malaria [217], tuberculosis [218] and 
classical STIs [105], thereby shaping the pattern of HIV spread. Ulcerative STIs (in 
particular chancroid) are thought to have played a particularly important role in the 
early phases of the HIV epidemic, when the transmission was concentrated amongst 
those at the highest risk and before improved STI management helped reduce ST! 
prevalence [119, 219]. The contribution of HSV to HIV transmission (which is chronic 
and untreated [186]), on the other hand, may increase over time, as the infection 
spreads to lower risk groups [114]. By increasing (HIV) viral load, malaria makes 
infected individuals more likely to transmit the virus, and in addition, malaria-infected 
individuals are more likely to acquire HIV [217]. Co-infection with tuberculosis (TB), 
however, tends to reduce survival with HIV, potentially contributing negatively to Ro 
[218]. 
Models have also been developed to explore specific questions such as the 
impact of HIV on demography [220], the epidemiological changes associated with 
using HAART [198, 221, 222], and the impact of particular interventions like 
hypothetical vaccines [223, 224], STI management [119] and proposed/actual 
behaviour change interventions [24, 75], which have been described in this chapter. 
The range of mathematical models used varies greatly in complexity, usually trading 
analytic tractability against biological realism and specificity. For example, the 
potential impact of interventions that offer male circumcision has been the focus of 
several recent studies. In some, the general case was considered analytically by 
considering expected changes in the basic reproductive number, Ro [27, 225], 
whereas others explored various scenarios in stochastic (micro-)simulation models, 
incorporating many details of sexual behaviour measured in particular African 
communities [226, 227]. 
Models are best developed in a step-wise fashion, testing the importance of 
each particular assumption [201]. In tackling each of the questions posed in this 
thesis, mathematical models were developed that included only sufficient complexity 
to tackle the problem at hand. In each chapter, the choices for the model structure 
are justified and the issue of whether this was adequate is taken up in the conclusion 
chapter (chapter 8). 
1.19 A Note on the Manicaland Study 
Although most of the chapters do not relate specifically to Zimbabwe or the Eastern 
Highlands area of Manicaland, it has been useful to ground analyses in a specific 
setting rather than a hypothetical "typical" southern African population. Data collected 
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in tine Manicaland HIV/STD Prevention Project have been used extensively to 
parameterise models in all chapters and a summary of the study is provided here. 
Other data sources are identified as they are used. 
The Manicaland Project collects behavioural and biomedical data in a 
stratified community-based open cohort. Data from two rounds are used in this 
thesis; the first round was between July 1998 and February 2000, and the second 
was between July 2001 to February 2003 [40, 91, 94]. The population strata 
comprised twelve distinct communities: two forestry plantations, two tea and coffee 
estates, four subsistence farming areas, two small towns and two roadside trading 
centres. A preliminary household census enumerated 8233 of 8386 (98%) known 
households in the study areas. One man or woman from each marital grouping in a 
household was invited to participate in the survey. In total, 4331 men aged 17-54 
years and 5149 women aged 15-44 years agreed to participate (77% of those 
eligible). In the closed cohort, the follow-up rate between the first and second survey 
was 55% (75% of those from the baseline survey that were still alive and resident at 
time of second survey). 
Structured interviews were conducted face-to-face by trained social science 
graduates familiar with the local culture but from outside the study area. Some 
personal questions came after there had been a time for informal discussion to build 
up rapport between the interviewer and subject. Response to other sensitive 
questions about sexual behaviour were recorded using an informal confidential voting 
interview (ICVI) method in three-quarters of the interviews with literate respondents 
(selected at random) [228]. This method entails the participant writing his or her 
response to certain questions on a card so that the interviewer cannot read them and 
then deposing them in a locked box. It has been found that in the interviews using the 
ICVI, the respondent tended to report more sexual partners, suggesting that data 
collected in this way may be less subject to socially desirability bias. 
Midway through the interview, a sample of blood was taken on filter paper 
and tested for HIV with a standard dipstick test [94]. 
Written informed consent was sought as a condition of enrolment and both 
free voluntary HIV counselling and testing and free STI treatment was made 
available in each study area. Prior ethical approval for the study was obtained from 
the Research Council of Zimbabwe (Number 02187) and from the Applied and 
Qualitative Research Ethics Committee, Oxford, UK, N97.039. Custom-made forms 
in SPSS-PC version 5.0 were used for data entry and validation. 
1.20 Organisation of Chapters 
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This thesis aims to tackle some of the questions that have been current and pressing 
in the last three years, in the fields of surveillance, behaviour change intervention and 
delivering ART. 
Chapter 2 addresses how to use the available biological and behavioural 
surveillance data to ascertain whether detected trends in HIV prevalence can be 
related to changes in risk behaviour. The first part of that chapter analyses national 
level data from eight countries. The second part analyses regional data from 
Zimbabwe to estimate the timing of the change in risk behaviour. Chapter 3 presents 
and tests methods that can use the new DHS+ surveillance data to estimate 
incidence in the general population. Chapters 4 and 5 explore the population level 
impact of two types of behaviour change intervention that have received attention in 
recent years; reducing cross-generational mixing and delaying first sex (Chapter 4) 
and effective testing and counselling for behaviour change (Chapter 5). In chapter 6, 
the obstacles to measuring the effectiveness of such interventions are considered in 
relation to the recent community randomised trial in Manicaland. The role that the 
healthcare system plays in determining the effectiveness of ART programmes is 
addressed in Chapter 7. Overall conclusions are discussed in Chapter 8. 
A different mathematical model was used in each of the six results chapters 
but there are substantial similarities between the ones used in Chapters 2 and 4 and 
6. A full description of that model is given in Chapter 2 and details of pertinent 
modifications are given in subsequent chapters. 
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Chapter 2: Natural Dynamics and Behaviour 
Change in Mature Generalised HIV Epidemics 
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2.11ntroduction 
Heterogeneity in the risk of acquisition and transmission of an infectious disease can 
have consequences for the pattern of spread of the infection, the evolution of the 
pathogen, and the chance of bringing an epidemic under control [37]. Patterns of 
unprotected sex, the risk behaviour for acquiring and transmitting a sexually 
transmitted infection, varies greatly from person to person which can lead to temporal 
changes in incidence, even if individual risk behaviour stays constant [37, 42, 229]. 
Incidence will rise quickly at first as the infection spreads among those with the 
riskiest sexual behaviour but it will then decline as further infections will be among 
those at lower risk (Figure 2.1(a)). For HIV, which leads to AIDS and death after a 
decade [230], there may be a longer-term reduction in incidence because the 
individuals with the riskiest sexual behaviour are selectively removed from the 
population. This can have a direct effect on incidence, because there will be fewer 
high-risk individuals to spread the infection, and an indirect effect, because low-risk 
individuals will have less opportunity to form risky sexual partnerships [231]. The 
overall effect is that incidence rises quickly early in the epidemic and falls to a lower 
level later on. However, in most settings, sentinel surveillance is based on monitoring 
prevalence [56], which is determined by the balance between incidence and mortality 
(and migration). The long interval between HIV infection and AIDS deaths means that 
the surge in mortality caused by the early spike in incidence will not occur until after 
incidence has settled at a lower level. This means that for a short time in a mature 
epidemic, AIDS deaths can exceed current incidence levels and lead to a decline in 
prevalence (Figure 2.1(b)). After that wave of mortality, and in the absence of further 
changes in incidence, prevalence will remain constant. 
When declines in prevalence are recorded, it is tempting to conclude that risk 
behaviour must have changed and that interventions are working. However, since 
there are conditions when HIV prevalence could decline without changes in individual 
risk behaviour, a check should be made as to whether the observed decline could be 
generated by the natural dynamics alone. Mathematical models are a precise way of 
describing assumptions about the transmission dynamics of an infectious disease 
and can be used to generate predictions [232]. It is possible to generate predictions 
of HIV prevalence over time with and without behaviour change, and test which 
predictions are consistent with observed patterns of prevalence. In the 1990's, a 
downturn in prevalence was detected in Uganda and the belief that behaviour 
change was responsible was strengthened through comparing observed prevalence 
trends with those generated by mathematical models with and without changes in 
risk behaviour [55]. This national success story has been extensively re-analysed to 
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try to identify the root cause the reduction in the individual risk of infection. By 
estimating that incidence started to reduce before large-scale condom distribution 
was underway, it has been possible to attribute at least some of the prevalence 
decline to reductions in casual sexual partnerships [24]. This has had profound 
implications for global policy on HIV control leading to the development of prevention 
strategies and substantial investment in programmes promoting such behavioural 
change [124, 163]. 
In 2004, declines in prevalence were reported in a number of African 
countries [15] and the UNAIDS Reference Group on Modelling, Estimates and 
Projections convened a meeting to analyse prevalence and behavioural data from a 
number of countries experiencing severe generalised maturing epidemics [233]. A 
number of countries reported declines in prevalence for the first time. In addition, for 
Zimbabwe there is a relatively long time-series of prevalence estimates, a recently 
compiled comprehensive review of behavioural changes [17] and an analysis of 
trends in sexually transmitted infections is underway. This provides an opportunity to 
estimate the timing of risk reduction and generate hypotheses about the changes that 
have driven the Zimbabwean prevalence decline, contributing to the current debate 
over the best way to prevent infections in sub-Saharan Africa. 
In the first part of this chapter, a method for creating null epidemic projections 
with the steepest decline in prevalence generated by natural dynamics alone, to test 
whether the observed declines could be consistent with behaviour not having 
changed. In the second part, data from Zimbabwe is analysed further to help identify 











Figure 2.1 Model projections of (a) incidence (b) prevalence for a generalised HIV epidemic in the 
absence of behaviour change (solid lines) and with behaviour change (50% reduction in partner change 
rate) starting in 1990, 1995 and 2000. 
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2.2 Methods 
2.2.1 Mathematical Model for Country-level Analyses - Summary 
A deterministic mathematical model of the heterosexual transmission of HIV in a sex, 
age and sexual activity (defined according the rate of sexual partner change) 
stratified population, based on earlier published models [48] was developed. To focus 
on trends in prevalence in young women attending antenatal clinics, the model 
included a detailed yearly age structure of young adults allowing changes in ages of 
sexual debut and rates of partner change in those recently entering the sexually 
active population. 
HIV is assumed to be transmitted through sexual partnerships or at the time 
of birth from an infected mother to her child. The population is divided into five sexual 
activity groups, characterised by the number of sexual partnerships formed per year. 
On sexual debut most individuals enter the group with the lowest sexual activity, but 
a minority enter groups with much higher sexual activity. In response to differential 
mortality in these groups two assumptions are possible: first, the highest sexual 
activity groups can be depleted if those with high rist( suffer greater mortality; second, 
the relative sizes of the groups are maintained by recruiting individuals from other 
sexual activity groups into the higher activity groups. An individual of a particular sex, 
age and sexual activity forms a number of sexual partnerships each year with 
partnerships preferentially directed between older men and younger women and with 
individuals of the corresponding sexual activity class of the opposite gender. 
Transmission of HIV is assumed to be prevented by correct and consistent condom 
use throughout the partnership and the probability of consistent use depends on the 
age of both partners. To represent the long and variable incubation period of HIV and 
the higher transmission probability associated with initial and later stages of infection, 
those infected progress through three stages of asymptomatic infection prior to AIDS: 
a first stage lasting 3 months with a high transmission probability: a second stage 
lasting several years with the lowest transmission probability; and a third stage 
lasting 6 months with a high transmission probability. 
The growth of the model epidemic was roughly matched to the earliest 
available ANC prevalence data by adjusting the transmission probability per sexual 
partnership and the assortativeness of mixing between the high and low sexual 
activity groups. The date of the start of the epidemic was chosen in consultation with 
local epidemiologists. Other model parameters values were chosen to maximise the 
natural decline in HIV prevalence and create a robust 'null model' of trends without 
extrinsic behaviour change. These assumptions are outlined in the results. A model 
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scenario witii no exogenous behaviour change was compared with one where 
behaviour change was assumed. Where behaviour change data were available 
(using the same indicator in successive surveys) these were used to estimate the 
change in parameter values for the alternative model run. If no such data were 
available a stepwise change in the transmission probability per partnership was used 
instead. 
2.2.2 Mathematical Model for Country-level Analyses- Full definition 
The model is defined by a set of partial differential equations with respect to time and 
age that are solved numerically with a four-stage Runge-Kutta algorithm (time-step = 
0.02 years). The population is stratified by sex (k=1 for males, k=2 for females) and 
sexual activity (m=0 (lowest) to 4 (highest)). The model treats HIV infection status as 
either HIV negative (X), HIV acute infection (Y^), latent infection (Y^), pre-AIDS (Y^) 
or full blown AIDS (Z). The model is run for 100 years to establish a stable 
population structure before the introduction of infection with 0.01% of males aged 25-
29 years in the highest sexual activity group moving from X to Y\ The partial 
differential equations are: 
(/'t (")• + 4 , m ( " 'O) 
gyl gy ' 
d t " ~ ( ^ ' 0 - ^ k.m ~ ^k.m ( ^ ) + " l ) 
) 
ay3 ay3 
= 1^2 (a)<m - ( « ) + ) 
az, _ az. 
//^(a)is the gender and age-specific per-capita death rate; \ ^(a,t)\s the force of 
infection to individual of that gender, age and activity-group at time t; — , —-— and 
— are the mean number of years spent with acute infection, latent infection and pre-
V, 
AIDS, respectively; a is the mortality rate for those with AIDS. 
At each moment, the number of new-borns introduced into each gender and 
sexual activity-group in the population is: 
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^(p{a)Y,X2,,M,t)da 
+ (1 - (y) (a, 0 + (a, f) + (a. 
y \ . « ( 0 . 0 = ( ^ . 0 + K O + (a,f)] ja 
. . . (2 .2) 
where (p{a) is the age-specific fertility and f^, / , and / j are the reduction in fertility 
associated with acute infection, latent infection and pre-AIDS, respectively: a is the 
probability of mother-to-child transmission, is the fraction of babies born that 
gender and 7„, is the fraction entering that sexual activity-group. For simplicity, 
entering into a sexual activity class is assumed to be at birth but that sexual activity 
does not occur until they individuals reach older age groups. 
The risk of a susceptible individual becoming infected is a function of the 
yearly age group rather than a continuous function of age such that 
A ; ^ ^ i i - 0 . 5 < i < i + 0.5,t) = Fi^.^^{t). We define the pattern of contact within the 
population through a matrix determining the age and activity group-specific rates of 
partnerships formation with the age and activity groups of the opposite gender. Here 
one's own age and activity category is denoted / and m, respectively, and those of 
members of the opposite gender are distinguished with a prime (/'and m). 
The force of infection is calculated as: 
f . = 1 1 .O'P.,,.'«).(!-f,,,.)) ) A ' < i < A ' 
m ' f' 
^k,i,m ( 0 = 0 } Otherwise 
... (2.3) 
where q , is the number of partnerships formed with individuals of the 
opposite gender by age and activity group, is the risk of acquiring infection 
when forming partnerships with individuals of the opposite gender by age and sexual 
activity, and y/^. is the chance that condoms are used consistently in partnerships 
formed between individuals of age / and /', and and A^ are the ages at which 
sexual activity begins and ends, respectively. The definition of these terms follows. 
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Q,i,m is the total number of partnerships formed each year and they are 





where N^..^.\s the number of sexually-active individuals and is the 
identity matrix. Thus the pattern of mixing with respect to activity ranges from 
assortative (like-with-like, e=0) to random (£=1) and the pattern of mixing with respect 
to age is determined by the distribution the fraction of partnerships that are 
formed between individuals age / and /'. Here we assume that depends only on 
the age difference between partners: (age of male minus age of female); which for 
females is; 
. . . ( 2 . 6 ) 
^ 2.i,r - 0 otherwise 
And for males is: 
'^ 1,1,1' •" ^2J\i •••• (2-^) 
i' 
A-
A j , i s scaled so that ^A , , . . - 1 . Here k , p and rare the shape parameters for log-
i ' = A ' 
logistic distribution. This distribution allows most partnerships to be formed between 
women and men a few years older but a few partnerships to involve women and men 
many more years their senior. 
The difference in rate of partnership formation between the sexual activity 
groups is defined as: 
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M, 
Here is the gender and age-specific geometric mean of partnership 
formation rate and r independently determines the common ratio of the partner 
change rates between the sexual-activity categories. For example, for a mean 
partner change rate of 1.6, the number of sexual partners per year for each group 
(and percent of population in that group) would be: 0.79 (59%), 2.38 (25%), 7.13 
(10%), 21.39 (5%) and 64.16 (1%). 
At each moment, the pattern of partnership formation ( q ,,,,,-.,,,.) is constrained 
such that the total number of sexual partnerships formed by males of type i,m with 
females type /'.m'must equal the total number of partnerships formed by females of 
type /',m'with males of type i,m. That is: 
If this does not hold the following adjustment is made: 
^2,r.m\i.m 
- (2-9) 
In this way, equal proportionate changes are made for males and females in 
the overall partner change rate and mixing pattern. 
The other two components of are the chance of infection per 
partnership and the probability that condoms are used correctly and consistently 
throughout those sexual partnerships. The probability of getting infected through a 
sexual partnership in which condoms are not used with individuals of the opposite 
gender aged / and in sexual activity group m, is: 
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...(2.10) 
+ ^\,n t)da 
y-4j 
where yg', /3^ and are the probabilities of transmission of HIV during 
acute infection, latent infection, pre-AIDS and AIDS respectively. 
The chance that condoms are used correctly and consistently in sexual 
partnerships between individuals aged / and /' is y.... We write i / r . = 8%... so that the 
pattern of condom use reported in cross-sectional data collected in rural Zimbabwe 
[40] Zix. is scaled by © to match the age-specific levels of condom use reported in 
each country's behavioural surveys. 
If the relative sizes of each sexual activity group are to be kept constant (with 
respect to time and age) individuals may need to move between sexual activity 
groups to compensate for the greater AIDS mortality the higher sexual activity groups 
may suffer; 
O, ...(2.11) 
Then iterating for m=4,3,2,1: 
^ av , 
y 1 y 1 
•wl . y l I k.i.m-i /~\ \ y 1 ^ ^ 
I k,i,m —> / k,i,m H —> 1 k,i,m-\ 
^ ^ ^ n . ...(2.12) 
y3 y3 
I k,i,m — > / t . i . m H i i , - / s i , -
^ ^ k,i,m-\ 
Z 7 
y V 7 I '••'•'"-I r\ 7 X y ^ 
The modelled HIV prevalence among women attending clinics can be weighted to 
take into account the potential under-representation of those with advanced disease 
[47] or less risky behaviour: 
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f 




+ lf3W„,Yl„ia,t)dm+ jf,w,Jl„{a,t)dm 
da 
where is the relative chance of women in that sexual activity group attending 
clinic, and , A and are the relative chance (with respect to uninfected 
women) of women with acute, latent, pre-AIDS and AIDS attending clinic. 
Default model parameters are listed in Tables 2.1, 2.2, 2.3, 2.4, 2.5 and 2.6. 
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P a r a m e t e r V a l u e S y m b o l D e f a u l t V a l u e S o u r c e 
M o r t a l i t y r a t e T a b l e 2 . 2 [ 2 0 0 ] 
F e r t i l i t y r a t e T a b l e 2 . 2 [ 2 0 0 ] 
M e a n t i m e i n a c u t e i n f e c t i o n s t a g e 1/v , 3 m o n t h s [ 4 7 ] 
M e a n t i m e i n l a t e n t i n f e c t i o n s t a g e 1 / K j ( a ) T a b l e 2 . 3 * * [ 4 7 ] 
M e a n t i m e i n p r e - A I D S s t a g e I / V 3 6 m o n t h s [ 4 7 ] 
M e a n t i m e w i t h f u l l b l o w n A I D S b e f o r e 
d y i n g 
Ha 6 m o n t h s [ 4 7 ] 
T r a n s m i s s i o n p r o b a b i l i t y ( l a t e n t i n f e c t i o n 
s t a g e ) P ( 0 . 0 1 - 0 , 0 6 ) * * [ 9 7 ] 
T r a n s m i s s i o n p r o b a b i l i t y ( p r i m a r y s t a g e , 
t e r t i a r y s t a g e a n d f u l l b l o w n A I D S ) 
l O y g ( 0 . 1 - 0 . 6 ) * * [ 9 7 ] 
P r o b a b i l i t y o f v e r t i c a l t r a n s m i s s i o n a 0 . 3 5 [ 4 7 ] 
F r a c t i o n o f c o n t a c t s m a d e r a n d o m l y w i t h 
r e s p e c t t o s e x u a l a c t i v i t y c l a s s 
£ ( 0 . 3 - 0 . 6 ) * * [ 4 7 ] 
A g e - d i f f e r e n c e b e t w e e n s e x u a l p a r t n e r s 
( s h a p e p a r a m e t e r s f o r l o g - l o g i s t i c 




0 . 1 5 * 
2 
0 . 2 5 
B e h a v i o u r a l 
s u r v e y i n 
r u r a l 
Z i m b a b w e 
[ 3 9 ] 
N u m b e r o f p a r t n e r s h i p s f o r m e d p e r y e a r : 
C o m m o n r a t i o b e t w e e n s e x u a l a c t i v i t y 
g r o u p s 
A g e a n d g e n d e r - s p e c i f i c g e o m e t r i c m e a n 
t 
T a b l e 2 . 4 
D H S s u r v e y 
from C o t e 
D ' l v o i r e 
( 1 9 9 4 ) 
[ 2 2 5 ] . 
P r o b a b i l i t y o f c o n s i s t e n t c o n d o m u s e : 
A g e - s p e c i f i c p a t t e r n 
S c a l a r 
^a.a' 
0 
T a b l e 2 . 5 
1 . 0 0 * 
B e h a v i o u r a l 
s u r v e y i n 
r u r a l 
Z i m b a b w e 
[ 3 9 ] 
A g e a t first s e x a\ 1 6 * 
A g e a t l a s t s e x a\ 5 5 * 
P r o p o r t i o n o f p o p u l a t i o n b o m i n t o e a c h 






0 . 5 9 
0 . 2 5 
0 . 1 0 
0 . 0 5 
0 . 0 1 
R e l a t i v e c h a n c e o f a p p e a r i n g i n A N C 
s a m p l e : 
a c u t e s t a g e r e l a t i v e t o H I V n e g a t i v e 
l a t e n t s t a g e r e l a t i v e t o H I V n e g a t i v e 
p r e - A I D S s t a g e r e l a t i v e t o H I V n e g a t i v e 





0 . 5 8 
0 . 4 7 
0 . 4 3 
0 . 1 4 
[ 4 6 ] 
R e l a t i v e c h a n c e o f w o m e n i n t h a t s e x u a l 
a c t i v i t y g r o u p a t t e n d i n g A N C . 
1.00** 
Table 2.1 Default parameter values for the country-level analyses model. * indicates that this 
parameter was used to fit to the model to country-specific data. ** indicates that the effect of this 
parameter on trends in prevalence was investigated and a value was chosen so as to maximise the drop 
in prevalence (Table 2.7). 
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Deaths per person-year (/t(a)) Births per female person-year (^(a)) 
Age-range Male Female 
<1 0.117 0.100 0 
1-4 0.019 0.019 0 
5-9 0.007 0.006 0 
10-14 0.004 0.004 0 
15-19 0.004 0.004 0.175 
20-24 0.006 0.005 0.313 
25-29 0.007 0.006 0.324 
30-34 0.007 0.006 0.271 
35-39 0.008 0.007 0.201 
40-44 0.010 0.008 0.125 
45-49 0.012 0.009 0.053 
50-54 0.016 0.012 0 
55-59 0.021 0.016 0 
60-64 0.030 0.024 0 
65-69 0.044 0.038 0 
70-74 0.068 0.060 0 
75-79 0.105 0.094 0 
80+ 0.189 0.174 0 
Table 2.2 Demographic data for the country-level analyses model. Per-capita mortality rate for males 
and females, and per-capita fertility rate for females (data from [207]). These data generate population 
growth of approximately 4% per year and a life expectancy at birth of 52.1 for males and 54.7 for 
females. 
Age-range 
Mean years spent in 




















Table 2.3 Mean time spent in secondary stage of infection in the country-level analyses model. Older 
individuals remain in the secondary stage of infection for less time giving an overall faster progression 
from infection to AIDS (values based on data from [234]). 
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Mean number of partnerships formed 
per year % , ) 
Age-range Males Females 
15-19 1.6 1.2 
20-24 1.6 1.2 
25-29 1.6 1.1 
30-39 1.7 1.5 
40-49 1.6 1.1 
50+ 1 1* 
Table 2.4 Mean rate of partnership formation by gender and age. Mean number of sexual partners in 
last twelve months, by age and gender (Cote d'lvoire DHS 1994 [235]). *this value was not available 
from the survey - the value used for females was set equal to that for males. 
Male aged <25 
Male aged 25+ 
Probability condom used in partnerships C%,,) 
Female aged <25 Female aged 25+ 
0.32 0.29 
0.10 0.07 
Table 2.5 ProbabiHty of correct and consistent condom use. The fraction of sexual partnerships (by 
male and female age) in which a condom was used last time, as reported by either male or female (data 
from rural Zimbabwe [40]). 
2.2.3 Data Sources for Country-level Analyses 
To avoid trends in prevalence reflecting changes in the sampled population, only 
data collected from the same ANC sites over time were included in the analysis. 
Where sample sizes were available we could construct 95% confidence intervals 
around the prevalence estimates. If such data were not available we include a ±3% 
uncertainty interval, which approximates the width of 95% confidence intervals if the 
sample was of -300 individuals. 
A brief summary of the HIV prevalence data used follows: Haiti Five urban 
Ante-natal clinic (ANC) sites from 1993 to 2003 [236]; Kenya Thirteen urban ANC 
sites from 1990 to 2003 [237]; Zimbabwe Nationwide ANC sites from 2000 to 2004 
(Genscreen test) [16]; Cote d'lvoire Ten urban sites from 1997 to 2002 [233]; 
Malawi Nineteen nationwide sites from 1996 to 2003 [238]; Rwanda Twenty-four 
nationwide ANC sites in 2002 and 2003 [239]; Uganda Five ANC sites from 1992 to 
2002 (St Marys Hospital, Lacor, Gulu (northern Uganda), St Francis Hospital, 
Kampala (central Uganda), Mbarara Hospital (south western Uganda), Jinja Hospital 
(eastern Uganda) and Mbale Hospital (eastern Uganda) [240]; Ethiopia Urban sites 
from 2001 to 2003 [241]. 
From each of these counties the following data were sought for model 
parameterisation: median age at first sex for males and females, age-specific use of 
condoms (at last sex and with last non-regular partner), age-specific mean number of 
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sexual partners in last year and age of spouse or last partner. A brief summary of the 
sexual behaviour data that were received and that were used follows: Haiti Mean 
number of different sexual partners per year, age at first sex for males and females 
and condom use (at last sexual intercourse) for 1994/5 [236]; Kenya Age at first sex 
from the Kenyan Demographic and Health Survey (KDHS) 1993, condom use (at last 
sex with any partner) from KDHS 1998 and difference in median age at marriage 
from KDHS 2003 [237]; Zimbabwe Condom usage (with any partner in last four 
weeks) taken from the Zimbabwe Demographic and Health Survey 1994 [16]; Cote 
d'lvoire Total number of different sexual partners in last year, condom usage (with 
any partner in last two months), age of spouse and females' age at first sex from the 
Cote d'lvoire Demographic and Health Survey (CDHS) 1994 and males' age at first 
sex from CDHS 1998/9; Malawi Condom use (at last sex with non-marital/non-
cohabitating partners) from Knowledge, Attitudes and Practices in Health Survey 
1996, percent married by age from Malawi Demographic and Health Survey (MDHS) 
1992 and age at first sex from MDHS, 2000 [238]; Rwanda Median age at first sex 
from Enqete Demographique et de Sante (2000) [239]; Uganda Condom use (at last 
sex with any partner) from Ugandan Demographic and Health Survey (UDHS) (2000) 
and median age at first sex from UDHS (1995) [240]; Ethiopia Condom use (at last 
sex with any partner) and age at first sex from the Ethiopian Demographic and Health 
Survey (2000) [241]. These data are given in Table 2.6. 
These population averages fail to specify some of the details of individual 
behaviour required to fully parameterise the model. To overcome this lack of detail in 
country-wide data we used detailed sexual behaviour data from a household-based 
population survey in rural Zimbabwe [40] to specify the heterogeneity in sexual 
partner change rates and the dependency of condom use on age of both partners. 
For each country all values were altered to generate the observed averages. The 
mean age difference between sexual partners was estimated by either the mean age 
difference between spouses or the difference in the median age of marriage between 
men and women. Where no data were available default model parameters were 
based on the rural Zimbabwe data, with the exception of partner acquisition rates as 
a function of age which were based instead on observed patterns reported in Cote 
D'lvoire for 1994, which it was thought would be more representative of national 
averages. Parameter values for each country are given in Table 2.7. All simulations 
were run using a common demographic background rates [207] such that in the 
absence of infection the population would grow at approximately 4% per year and life 
expectancy at birth for males and females is 52.1 and 54.7 respectively. 
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i f i 
Baseline settings 
1 
A g e a t f i r s t s e x ( M a l e s ) 1 8 1 7 1 7 1 7 1 7 2 0 1 8 1 8 1 7 ' 
A g e a t first s e x ( F e m a l e ) 1 9 1 7 1 7 1 7 1 7 1 6 1 6 1 7 1 7 ' 
P r o b a b i l i t y o f c o n s i s t e n t 
c o n d o m p e r p a r t n e r s h i p 
( m a l e < 2 4 w i t h f e m a l e < 2 4 ) 
0 . 0 9 0 . 2 9 0 . 0 6 0.42 0 . 4 2 0 . 1 1 0 . 2 7 0 . 3 2 0 . 3 2 ' 
M e a n a g e d i f f e r e n c e 
b e t w e e n p a r t n e r s ( m a l e a g e 
m i n u s f e m a l e a g e ) 
6 . 4 5 . 4 7 . 3 ' 7 . 3 ' 7 . 3 ' 7 . 3 ' 8 . 6 5 . 8 7 . 3 ' 
Behavioural changes (year 
implemented) 
P r o b a b i l i t y o f H I V 
t r a n s m i s s i o n (proportionate 
reduction). 
n / a n / a 
5 0 % 
( 2 0 0 0 ) 
75% 
( 1 9 9 0 ) 
8 0 % 
( 1 9 9 4 ) 
n / a n / a n / a n / a 
D e l a y i n a g e a t f i r s t s e x , 
m a l e s (years). n / a n / a n / a n / a n / a n / a n / a n / a n / a 
D e l a y i n a g e a t first s e x , 
f e m a l e s (years). n / a 
+ 1 
( 1 9 9 9 ) 
F * 3 0 % 
( 1 9 9 9 ) 
n / a n / a n / a n / a n / a n / a n / a 
N u m b e r o f s e x u a l 
p a r t n e r s h i p s p e r y e a r 
(proportionate reduction) 
1 0 % 
( 1 9 9 5 ) 
M* 
26% 
( 1 9 9 9 ) ; 
0 . 8 0 
( 2 0 0 1 ) 
n / a n / a n / a n / a n / a n / a n / a 
P r o b a b i l i t y o f c o n s i s t e n t 
c o n d o m p e r p a r t n e r s h i p 
(proportionate increase) 
100% 
( 1 9 9 5 ) 
n / a n / a n / a n / a n / a n / a n / a n / a 
Table 2.6 Behavioural data used in parameterisation of the model, fdenotes that the default parameter 
was used in place of country-specific data. $ F-Females, M-Males. * Uganda sites were provided 
separately as N-Northem (St Marys Hospital, Lacor, Gulu), C-Central (St Francis Hospital, Nsambya, 
Kampala), Western (Mbarara Hospital,), E-Eastem (Jinja Hospital and Mbale Hospital). Sources for 






1 I 1 
1 1 I i I .5 ^ .5 . 
O i f l S g % 'Q g, T) 
I I I l l l l a l l 
Transmission 
probability per 
partnership for 0.01 0.02 0.02 0.03 0.05 0.04 0.04 0.04 0.08 0.03 
secondary stage of 
infection (P) 
Mean years from 
infection to death 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 
(aged<30years)* 
Common ratio in 
partner-change rate 
between sexual 3.3 2.7 3.3 2.7 2.2 2.7 2.7 2.1 3.0 4.0 
activity groups (t) 
Randomness of mixing 
between sexual 0.3 0.6 0.6 0.8 0.3 0.6 0.6 0.3 0.3 0.3 
activity groups (s). 
1.0 0.1 0.5 0.1 0.1 1.0 1.0 1.0 1.0 1.0 
Probability of adults 
1.0 0.2 0.5 0.2 0.2 1.0 1.0 1.0 1.0 1.0 
being in ANC^ sample 
by sexual activity 1.0 0.5 0.5 0.5 0.5 1.0 1.0 1.0 1.0 1.0 
group (ascending) 
1.0 1.0 1.0 1.0 1.0 1,0 1.0 1.0 1.0 1.0 
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Table 2.7 Values of parameter used in the application of the model to specific countries. These 
parameters are the most influential on the trends in prevalence and were used to maximise the drop in 
prevalence and fit the model to data as closely as possible. Due to paucity of available data, the large 
number of parameters and the absence of uncertainty estimates for the recorded prevalence, statistical 
fitting could not be satisfactorily applied: a subjective graphical fitting method was used instead. ^ANC 
stands ante-natal clinic. *see table 2.3 for full details of relationship between age and time spent in 
second stage of HIV infection, t Urban Kenya sites - Busia, Meru, Nakaru and Thika, $ Urban Kenya 
sites of Garissa, Kisii, Kitui and Nyeri.**lJganda sites were provided separately as N-Northem (St 
Marys Hospital, Lacor, Gulu), C-Central (St Francis Hospital, Nsambya, Kampala), Western (Mbarara 
Hospital,), E-Eastem (Jinja Hospital and Mbale Hospital). 
2.2.4 Data Sources for Further Analysis of Zimbabwe Epidemic Changes 
The t ime at which incidence may have declined in Zimbabwe was estimated by fitting 
a simplified mathematical model to observed changes in prevalence from individual 
ANC sites. Since the pattern of prevalence decline in maturing epidemics is 
determined by the rate of growth earlier in the epidemic, ANC sites with the longest 
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time series were selected. In Zimbabwe, there are 12 sites with data from 1997 and 
some of these sites have collected data from as early as 1990. The estimates from 
before 1997 were made by the World Health Organization using slightly different 
methods from that used for estimates made later by the Centers for Disease Control. 
The fitting procedure was therefore repeated taking the earliest data into account 
("Fit 1") and rejecting the data from before 1997 ("Fit 2"). The full dataset is shown in 
Table 2.8. 
HIV Prevalence Estimates (Genscreen test) 
Location Site Year: 1989 1991 1992 1993 1994 1995 1997 2000 2001 2002 2004 
Urban Bindura 40.0 27.0 29.3 32.1 25.9 34.3 26.1 
Nkulamane (Bulawayo) 10.0 17.1 25.8 30.0 24.0 31.1 27.9 26.4 18.8 
Chitungwiza (Harare) 29.0 41.7 23.3 33.5 30.7 33.9 22.5 
Gweru 28.1 24.0 21 22.9 24.0 36.4 28.5 27.7 26.9 
Kuwadzana (Harare) 28.1 27.8 30.5 26.9 20.3 
Chinotimba 42.6 55.7 45.3 36.3 35.8 
Median 10.0 22.6 26.5 23.4 40.9 27.0 26.1 32.8 29.5 30.8 24.3 
Other Beitbridge 46.0 41.2 28.9 36.2 28.0 
Chiredzi 32.1 37.3 20.4 
Gwanda 48.0 30.4 42.2 42.4 30.7 
Median (exd Chiredzi) 47.0 35.8 35.6 39.3 29.4 
Rural Binga 13.6 11.5 9.2 13.0 19.1 19.6 12.4 
Karanda 23.9 18.3 19.3 23.5 14.2 
Mutoko 20.7 13.4 33.7 33.2 22.7 22.0 
Sadza 22.0 42.7 31.6 34.2 26.4 
Median 17.2 11.5 17.7 26.0 25,5 23.1 18.1 
Table 2.8 HIV prevalence estimates in Zimbabwe from consistently samples ANC sites. 
2.2.5 Model for Further Analysis of Zimbabwe Data 
The model used here is also a deterministic representation of the heterosexual 
transmission of HIV in a sex and sexual activity stratified population. In contrast to 
the previous model, there is no age-structure and the population is set to grow at a 
constant rate in the absence of HIV/AIDS. This makes the model much quicker to 
execute, which is an important consideration in model design when computationally-
intensive fitting procedures are used. Since the data are not specified by age and 
patterns of sexual behaviour over age were not found to be influential in the process 
of epidemic maturation, this simplification should not interfere with the analysis. 
The model is defined by the following set of ordinary differential equations, for 
which a numerical solution was found using Euler's method (time-step 0.05 years). 
The state variables are X^, where k is gender {k=^ for males; k=2 for 
females), / is the sexual-activity group (/=1 (highest) to 3 (lowest)) and s is the 
disease-state (s=1 for susceptible; s=2 for acute infections; 5=3 to 6 for latent 
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infection; s=7 for pre-AIDS; s=8 for AIDS). Where possible, the symbols chosen are 
the same as in the first model definition; a full list of parameter meanings and values 
is given in Table 2.9. 
The ordinary differential equations are: 
2 ^ J f dt 
dt 
dt 
} fo rs = 2,3,....8 
...(2.13) 
The force of infection is calculated as the product of a scalar "risk" parameter 
R(t) and, as above, the partner change rate for that group and a matrix describing the 
distribution of contact with respect to the sexual activity groups of the opposite 
gender. 
Pk,i,V 
A . U ' = ( 1 - ^ ) 3 , / + ^ -
s-2 
i'=i 
V V s=2 y 
...(2.14) 
The problem of 'balancing' the supply and demand of sexual partnership by 
males and females is tackled in the same way as the previous model: 
D . . . = • 
Pzrj X ^2.1-
s=2 
P2,i.r ^ (A,u y 
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Unlike in the earlier model, the partner change rates in the different activity 
groups are parameterised by the arithmetic mean across all groups and proportional 
differences between each group and the group with the lowest rate: 
— 
...(2.16) 
} for 1 = 2,3 
The timing of the risk reduction is estimated by fitting the initial risk level, r , , 
the time of change T , and the eventual risk level, . At the time of change, the 
overall risk decreases linearly for three years: 
R{t) = r, i f t < T 
R(t) = r, - (r, - ...(2.17) 
R{t) - r j if t > T + 3 
The model output, to which the ANC prevalence data is fitted, is weighted HIV 
prevalence among females. 
Weighted prevalence = . . .(2.18) 
An important difference between this model and the one described earlier in 
the chapter is that the compartment for latent infection (s=3 to 7) is split into four 
compartments, so that the overall sun/ival time from infection to death is gamma 
distributed, giving a better agreement with observed survival distributions [230, 234] 
(Figure 2.2). Whereas in the previous model, the decline in prevalence was to be 
exaggerated by assuming a fast progression to death, it is important in this 
application to have a more realistic temporal distribution of mortality so that the timing 
of changes in incidence can be accurately estimated from prevalence data. 
Changes in all types of sexual risk behaviour (multiple sexual partners, 
concurrency of sexual partners, STIs, condom use, and so on) are subsumed into a 
single parameter, R, which describes overall "risk". An initial match to the growth 
part of the epidemic is found manually by varying r, and w,. The values of and T 
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are fitted using a general-purpose searcti algoritlim, which implements a form of the 
Nelder-Mead simplex method [242]. Information on the sample sizes associated with 
each estimate was not available so goodness-of-fit was assessed using sum-of-
squared errors assigning equal weighting to each data-point. 
Estimates of prevalence at ANCs can be very high compared to models 
parameterised using reported behaviour data. This is because current reports of risk 
behaviour probably represent the lower bound of the range of risk behaviour that 
existed when the epidemic started, since some individuals will have changed their 
risk behaviour, some individuals with risky sexual behaviour will have died [231], and 
social desirability biases may tend to make reports of behaviour increasingly 
conservative over time [228]. In addition, ANC prevalence may over-estimate 
prevalence in the general population, since pregnant women may have been 
disproportionately exposed to unprotected sex, and because women not using 
modern methods of contraception may be least likely to take measures to protect 
themselves from HIV infection [52]. For the model to fit observed prevalence data, a 
high level of risk at the start of the epidemic is required (r,), which suppresses the 
natural epidemiological dynamics later on, and potentially leads to over-estimating 
any estimate of the reduction in risk. To overcome this, observed ANC prevalence 
estimates are matched with model prevalence values weighted to favour the 
contribution of the higher risk sexual activity group. This negates the need for a high 
level of risk at the beginning of the epidemic and maximises the contribution of the 
natural epidemiological dynamics to the downturn in prevalence during maturation. 
= 0.6 
!0 0.4 
10 15 20 
Years since infection 
Figure 2.2 Distribution of time from 
infection to death in the simplified model 
used in the analysis of Zimbabwean ANC 
site data. 
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Interpretation Symbol (or formula) Default Value 
Y e a r s s p e n t s e x u a l l y a c t i v e 
P o p u l a t i o n g r o w t h r a t e i n t h e a b s e n c e o f H I V / A I D S 
M e a n t i m e w i t h a c u t e i n f e c t i o n 
M e a n t i m e w i t h l a t e n t i n f e c t i o n 
M e a n t i m e w i t h p r e - A I D S 
M e a n t i m e w i t h A I D S 
P e r s e x - a c t t r a n s m i s s i o n p r o b a b i l i t y f r o m i n d i v i d u a l s w i t h 
a c u t e i n f e c t i o n 
P e r s e x - a c t t r a n s m i s s i o n p r o b a b i l i t y f r o m i n d i v i d u a l s w i t h 
l a t e n t i n f e c t i o n 
P e r s e x - a c t t r a n s m i s s i o n p r o b a b i l i t y f r o m i n d i v i d u a l s w i t h 
p r e - A I D S i n f e c t i o n 
R e l a t i v e t r a n s m i s s i o n p r o b a b i l i t y from m a l e - t o - f e m a l e 
c o m p a r e d w i t h f e m a l e - t o - m a l e ( X \ = l b y d e f i n i t i o n ) 
N u m b e r o f u n p r o t e c t e d s e x a c t s i n p a r t n e r s h i p s w i t h 
i n d i v i d u a l s i n h i g h e s t r i s k g r o u p 
N u m b e r o f u n p r o t e c t e d s e x a c t s i n p a r t n e r s h i p s w i t h 
i n d i v i d u a l s i n m i d d l e r i s k g r o u p 
N u m b e r o f u n p r o t e c t e d s e x a c t s i n p a r t n e r s h i p s w i t h 
i n d i v i d u a l s i n l o w e s t r i s k g r o u p 
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M e a n p a r t n e r c h a n g e r a t e f o r f e m a l e s 3.5 
R e l a t i v e p a r t n e r c h a n g e r a t e f o r i n d i v i d u a l s i n h i g h e s t s e x u a l 
a c t i v i t y g r o u p c o m p a r e d w i t h t h o s e i n t h e l o w e s t ( C 7 j 3 = 1 b y 
d e f i n i t i o n ) . 
R e l a t i v e p a r t n e r c h a n g e r a t e f o r i n d i v i d u a l s i n m i d d l e s e x u a l 
a c t i v i t y g r o u p c o m p a r e d w i t h t h o s e i n t h e l o w e s t . 
F r a c t i o n o f i n d i v i d u a l s t h a t s t a r t s e x i n h i g h e s t s e x u a l a c t i v i t y 
g r o u p . 
F r a c t i o n o f i n d i v i d u a l s t h a t s t a r t s e x i n m i d d l e s e x u a l a c t i v i t y 
g r o u p . 
F r a c t i o n o f i n d i v i d u a l s t h a t s t a r t s e x i n l o w e s t s e x u a l a c t i v i t y 










Table 2.9 Default parameter values for the simplified model used in the analysis of Zimbabwean ANC 
site data. 
2.3 Contributions 
I am grateful to a large number of people for providing access to the data used in this 
chapter - their names are listed at the end of this chapter. In addition to my 
supervisors, I received constructive comments from John Stover (Futures Group, 
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Washington D.C.) and an anonymous referee who both read initial versions of the 
paper on which this chapter is based. 
2.4 Results 
2.4.1 l\/]aximisina Natural Dynamics Prevalence Declines 
The aim of modelling the transmission dynamics of HIV here was to predict the 
course of the epidemic in the absence of behaviour change. In order for the 
contribution of natural dynamics to be excluded when interpreting any observed 
reductions in prevalence. For a conservative analysis, assumptions were made that 
maximise the predicted declines in prevalence. 
As HIV spreads first among those with the highest risk of acquiring infection, 
incidence increases sharply. This rapid local "saturation" of those at highest risk is a 
consequence of the extreme variance in sexual activity within the population with the 
majority forming few new sexual partnerships each year and a minority forming very 
many more. Incidence will increase more quickly if there is a high transmission 
probability of the virus in those recently infected. Subsequent infection mainly occurs 
in those with lower risk sexual behaviour and the number of new cases and the risk 
per susceptible decreases. A prevalence decline ten to twenty years into the 
epidemic could be the product of that historic reduction in incidence or a more recent 
reduction in incidence associated with the deliberate adoption of safer sexual 
behaviour. Understanding the determinants of that initial decline in incidence and 
how it influences later trends in prevalence is crucial in our analysis. Whether the 
initial decline in incidence generates a subsequent fall in prevalence is determined by 
how spread out deaths are and how closely incidence and prevalence are coupled, 
i.e. the interval between infection and death Figure 2.3(A). A long interval means that 
prevalence will record information about the risk experience accumulated over many 
years with the early reduction in incidence not manifest, but a shorter interval allows 
prevalence to follow the drop in incidence more closely. The relationship between 
prevalence and incidence is easier to interpret in young people because infections 
will have been acquired recently as they have only recently become at risk (as they 
begin sexual activity) and there will be few deaths to AIDS [49]. Thus, in young 
adults, prevalence is more a reflection of the current pattern of HIV transmission and 
changes in prevalence following the adoption of safer sexual behaviour should 
appear first and most clearly among young people Figure 2.3(B). 
Following the initial growth of an HIV epidemic, and as those with riskiest 
sexual behaviour who are infected die or reduce their sexual activity due to illness, 
the structure of the sexual network could begin to change; both because the high risk 
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behaviour itself is lost, and because the opportunity for other individuals to form high 
risk partnerships is removed [231]. This depends upon how an individual's risk 
behaviour changes as they age and the change in risk behaviour of those that remain 
following the deaths of those most at risk. At one extreme, if individuals remain at the 
same level of risk throughout their life, average sexual behaviour naturally becomes 
safer as those with risky behaviour die Figure 2.3(C). For this reason, changes in 
average sexual behaviour should be interpreted with some caution, since any safer 
average behaviour may not be a consequence of the deliberate behaviour change. In 
the model it is possible to assume that as the number of high-risk individuals declines 
less risky individuals can adopt higher risk behaviour to keep constant average rate 
of partner acquisition. In this case, incidence remains high and may balance the 
surge in AIDS-related mortality, maintaining a steady prevalence of infection Figure 
2.3(D). 
In interpreting trends in HIV prevalence we also need to be concerned with 
changing biases in the ANC population as a sample of women [46]. First, reductions 
in fertility caused by the progression of HIV infection could exaggerate the decline in 
prevalence seen in the ANC sample relative to the general population. Recent data 
suggest that fertility is suppressed before the final stages of HIV infection [47, 243]). 
Simulations show that this sub-fertility and exclusion from the ANC sample of those 
infected will occur rapidly (Figure 2.4(A)). The early decline in fertility is in part a 
product of the initial acute peak in incidence, but without this pattern a more gradual 
decline in prevalence ins produced. Second, the ANC sample might over-represent 
the women most likely to be infected with HIV, since sexual behaviour that exposes 
the women to the infection (e.g. unprotected sex) also exposes the women to the risk 
of pregnancy [46]. Because prevalence estimated biased towards those higher risk 
women rises quickly and falls steeply, such an ANC sample may represent the most 
extreme changes in prevalence (Figure 2.4(B)). 
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Figure 2.3 Natural dynamics of generalised HIV epidemic. (A) Predicted HIV incidence per 100 
person years at risk (thick black line) and HIV prevalence among women for varying periods from 
infection to death. For 25 year olds mean interval from infection until death is 11 years (thin black 
line), 9 years (dark grey line), 7 years (light grey line), 5 year (dashed line), and 3 years (dotted/dashed 
line). (B) HIV prevalence among women aged 20-24 years (grey lines) and 30-35 years (black lines) 
without behaviour change (solid lines) and with the transmission probability halving at year 15 (dashed 
lines). (C) The proportion of men and women currently forming more than one sexual partnership per 
year. (D) Predicted HIV incidence per 100 person years at risk (solid lines) and HIV prevalence among 
women (dashed lines) with the relative size of sexual activity groups being allowed to change freely 
(grey lines) and being held constant with recruitment to the high activity groups from lower activity 
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Figure 2.4 Biases in antenatal clinic (ANC) sample. (A) Ratio of percentage of women attending 
ANCs who are HIV+ and percentage of all HIV+ women, assuming that the probability of women 
being included in the ANC sample depends on stage of HIV (solid line) and the fraction of HIV cases 
in late stage of infection (tertiary stage or full-blown AIDS) (dashed line). (B) Percentage of women 
attending ANC who are HIV+ (dashed line) and percentage of all women HIV+ (solid line), assuming 
that the probability of being included in the ANC sample depends on sexual activity group. 
The exploratory analysis found that the most extreme natural declines in 
prevalence arise from the greatest contrast between the initial peak and subsequent 
low incidence level, and from the shortest period from infection to death. Within 
reasonable limits, the initial heterogeneity in rate of sexual partnership formation and 
the variation in transmission probability with stage of HIV infection are maximised. 
The acute peak in incidence reflects a lack of geographic space, stochastic effects 
and waiting times between sexual partnership formation and HIV transmission. 
These all distribute the peak in incidence over time and lessen the predicted 
prevalence decline. Prevalence declines most when there is no compensatory 
recruitment into the high sexual activity groups in response to differential mortality 
and appears most extreme when assuming that the ANC over-samples high risk 
individuals. 
2.4.2 Analysis of Country-level Data 
In the case of Uganda, urban Kenya, Zimbabwe and urban Haiti, under a range of 
realistic and extreme assumptions, our model can only replicate observed declines in 
prevalence by assuming that risk behaviour has also declined. 
The decline in Uganda is the earliest and most researched [24, 55]. Sites in 
the north, centre and west of the country have a similar epidemic curve with 
prevalence amongst 15-49 year-old and 20-24 year-old women both declining from 
approximately 30% to 10% (Figure 2.5(A-B)). These declines could be generated in 
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the model with a reduction in the transmission probability per partnership of 75% in 
1992 - a similar reduction to that previously estimated [24, 55]. No subsequent 
reduction is necessary to generate the observed trends and the assumed change in 
risk predates observational cohort data from Rakai used to argue that incidence has 
not fallen [244]. In Eastern sites (Jinja hospital and Mbale hospital) the decline in 
prevalence in women aged 15-49 from approximately 15% to 5% (Figure 2.5(C)) is 
only possible with behaviour change, whereas prevalence estimates for women aged 
20-24 show more fluctuations and are possible to model without risk behaviour 
changing (Figure 2.5(D)). Such seemingly contradictory results may arise from the 
greater error in prevalence estimates from a more restricted age group (sample sizes 
were not available to estimate confidence intervals), or from shifting behavioural 
parameters (in particular, age at first sex),which alter the distribution of the infection 
with respect to age, at the same time as overall prevalence is decreasing [49]. 
In parts of urban Kenya, HIV prevalence amongst women aged 15 to 49 fell 
from approximately 12% in 2001 to 9% in 2003 with a concomitant decline in those 
age 20-24 from 13% to 10%. The downturn in prevalence was particularly 
pronounced in four urban sites (Busia, Meru, Nakaru and Thika) where median 
prevalence fell from 28% in 1999 to 9% in 2003 among 15-49 year old women and 
from 29% in 1998 to 9% in 2002 among 15-24 year olds (Figure 2.5(E-F)). Again, to 
reproduce these changes requires assuming that risk behaviour has changed. 
Between behavioural surveys in 1993, 1998 and 2003 there were substantial 
reductions in the proportions of men and women having more than one sexual 
partner. Additionally, between 1998 and 2003, median age at first sex for females 
increased. To represent these changes in the model, reductions in the mean rate of 
partner change were assumed in 1998 and 2001 and a step change in females' age 
at first sex was included in 2001. The decrease in prevalence, though, is better 
matched with a reduction in the transmission probability of 70% in 1997 (dotted 
lines). Four other urban sites (Garissa, Kisii, Kitui and Nyeri) also experienced a 
reduction in median prevalence: 14% in 2000 to 7% in 2003 among 15-49 years old 
and the same behaviour changes were assumed to bring the model into agreement 
with the data (Figure 2.5(G)). However, the trend in prevalence among 15-24 year 
olds is less clear and does not seem inconsistent with the null model (Figure 2.5(H)). 
In Zimbabwe a decline in prevalence from 29% to 24% is recorded between 
2002 and 2004 amongst 15-49 year-old women, and from 25% to 20% among 
women aged 15-24 year-old (Figure 2.5(I-J)). In both cases, the observed trend 
cannot be reproduced through the natural evolution of the epidemic alone, but can be 
generated if the overall probability of infection is reduced by half in 2001. 
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In urban Haiti, prevalence has decreased since 2000 from approximately 
5.5% to 3% among 15-44 year women - a decline that could not be generated in the 
absence of behaviour change (Figure 2.5(K)). Among 15-24 year olds, prevalence 
has also declined although the uncertainty associated with these estimates not does 
rule out the possibility that prevalence has remained constant (Figure 2.5(L)). In 
behavioural surveys there was a 20% decline in the mean number of sexual partners 
between 1994 and 2000 and condom use increased two- to threefold between 
2000/1 and 2002. These changes were represented in the model by a step-change in 
partner change rates in 1994 and in condom use in 1999. 
Another effect that could lead to changes in prevalence without changes in 
incidence is the selective migration of infected people. Particularly in Zimbabwe, 
there has been extensive migration since 1990, which accelerated after 2000 [17]. If 
infected individuals are more likely to leave the country than others (e.g. in search of 
treatment) national estimates of HIV prevalence would decrease. To investigate this 
effect, five different scenarios were simulated where the natural decline in prevalence 
is augmented by coincident increases in different patterns of migration (Figure 2.6). 
The scenarios are: (1) natural dynamics and no migration; (2) natural dynamics and a 
linear increase in migration from 0-5% of the total population per annum, 1997-2000, 
followed by constant 5% migration per annum - symptomatic individuals (pre-AIDS & 
AIDS) five-times as likely to migrate as others; (3) as for (2) but with maximum 
migration rate of 10% per year; (4) as for (3) except that symptomatic individuals are 
twenty-times more likely to migrate than uninfected individuals; (5) as for (4) except 
that asymptomatic HIV-positive individuals are also (on average) 20% more likely to 
migrate than uninfected Individuals. All scenarios assume no volitional behaviour 
change. Only in scenario (5), where asymptomatic individuals disproportionately 
migrate, can this null model reproduce a decline in prevalence almost as great as 
those observed. 
Adult prevalence (15-49 years) in urban Ethiopia fell from 14% in 2001 to 
12% in 2003 (Figure 2.7(A)) and from 15% to 13% over the same time among 20-24 
year olds (Figure 2.7(B)). These modest declines could be reproduced by the model 
without assuming any changes to sexual risk behaviour. 
The data analysed from Malawi, urban Cote d'lvoire and Rwanda show no 
sign of a decrease in prevalence amongst all adults, or selected age-groups (Figure 
2.7(C-E)). There is some evidence that the fraction of men and women having had 
more than one or two sexual partners in the last twelve months has deceased in 
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Figure 2.5 ANC prevalence data (dots), model output assuming no behaviour change (full lines) and 
model output assuming behaviour change (dashed lines). Uganda: St Mary's Hospital, Lacor, Gulu, St 
Francis Hospital, Nsambya, Kampala, and Mbarara Hospital (A) 15-^9 years olds and (B) 20-24 year 
olds; Jinja Hospital (C) 15-49 year olds and (D) 20-24 year olds (error bars ± 3%). Urban Kenya: 
Busia, Meru, Nakuru, and Thika (E) 15-49 year olds and (F) 15-24 year olds (error bars show range); 
Garissa, Kisii, Kitui and Nyeri (G) 15-49 year olds and (H) 15-24 year olds (error bars show range). 
Zimbabwe: (I) 15-44 year olds and (J) 15-24 year olds, (error bars ± 3%). Urban Haiti: (K) 15-44 year 
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Figure 2.6 Mathematical model projections of the potential impact of international out-migration on 
recent trends in HIV prevalence in Zimbabwe: (1) no migration; (2) linear increase in migration from 
0-5% of the total population per annum, 1997-2000, followed by constant 5% migration per annum; (3) 
linear increase in migration from 0-10% of the total population per annum, 1997-2000, followed by 
constant 10% migration per annum; (4) as for (3) except that HIV-positive persons with symptomatic 
infection (AIDS) are 20-times more likely to migrate than uninfected individuals; (5) as for (4) except 
that non-symptomatic HIV-positive are 20% more likely to migrate than others. 
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Figure 2.7 ANC prevalence data (dots) and model output assuming no behaviour change (full lines). 
Urban Ethiopia: (A) 1 5 ^ 9 year olds, and (B) 20-24 year olds (error bars are 95% CI). (C) Urban Cote 
d'lvoire 15-49 year olds (error bars are j 3%). (D) Rwanda 20-24 year olds (error bars are ±3%). (E) 
Malawi: 15-34 year olds (error bars are + 3%). 
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2.4.3 Further Analysis of Zimbabwe Data 
In most consistently sampled ANC sites in Zimbabwe, there have been substantial 
declines in prevalence since year 2000 (Table 2.8). The speed and magnitude of the 
decline is consistent with a large reduction in risk before year 2000 (Figure 2.8 and 
Table 2.10). The estimate of the magnitude of the risk reduction depends on the 
weighting given to the prevalence estimates from early in the epidemic, which may 
not be perfectly comparable with later estimates. In general, these early data indicate 
that HIV prevalence had reached a very high level by the mid-1990s and when these 
data are taken into account in the model fitting, the reduction in risk required to 
generate the observed decline in prevalence is less. This is because without this 
information, the model assumes that small differences in prevalence between 1997, 
2000 and 2001 indicate that the epidemic is still growing fast at that time; this means 
that the risk level fitted before the intervention is higher and so the proportional 
reduction to get the same decline in prevalence must be greater. With the earlier 
data, the fitting process interprets changes between 1997 and 2001 as random 
variation. 
The effect of sampling error cannot be taken into account without sample 
sizes, but we expect this error to be smaller when the sites are aggregated by 
location (urban, rural and other) and the comparable model estimates of risk 
reduction may therefore be more reliable. Taking all urban sites together, the decline 
in prevalence is consistent with risk reducing from 1998 or 1999, depending on 
whether the earliest data are used or not (Figure 2.9). In rural areas, the decline in 
risk may have been greater and occurred slightly later. The decline in other (semi-
urban) areas may have occurred before the change in urban areas, but this finding 
cannot be confirmed without data from the earlier in the epidemic. 
The average time from HIV infection to death could influence the estimated 
changes in risk. With shorter survival times, the same reduction in risk leads to faster 
and larger reductions in prevalence (Figure 2.10(A)) and the same decline in 
prevalence can be fit with smaller reductions in risk (Figure 2.10(B)). However, the 
estimate of the timing of behaviour change is not very sensitive to the survival 
assumptions, within a realistic range (Figure 2.10). 
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Fitl Fitl 
1st Yr of 1st Yr of 
Risk % Risk Risk % Risk 
Reduc. Reduc. Reduc. Reduc. 
Urban 
Sites Bindura 2001 71 2001 100 
Nkulamane (Bulawayo) 2000 100 NA NA 
Chitungwiza (Haraie) 2000 78 NA NA 
Gweru None None 2001 100 
Kuwadzana (Harare) 2001 83 2000 100 
Chinotimba 2000 38 2000 100 
Aggregate 7998 27 /999 66 
Other Sites Beitbridge 1997 77 NA NA 
Chiredzi 2001 100 1997 100 
Gwanda 2001 100 1997 66 
Aggregate 2000 36 7996 68 
Rural Sites Binga 2001 100 2000 100 
Karanda 2001 87 2001 100 
Mutoko 2001 100 2000 100 
Sadza 2000 44 1999 100 
Aggregate 2000 88 2000 95 
Table 2.10 Summary of result from model fitting. The fitted year of change and fractional decrease in 
risk are given for each site. Fit 1 makes use of all data available, although estimates from before 1997 
may not be comparable with later estimates; Fit 2 only uses measurements from 1997 onwards. The % 
risk reduction is the reduction in the value from baseline of R, a composite measure of risk. 
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Figure 2.8 Model fits to data for each antenatal clinic site. Bars show data and lines show model fits. 
Solid lines show epidemic with fitted change in risk; dotted lines show the course of the epidemic in 
the absence of changes in risk. The red line is "Fit 1" (includes all data available); the blue line is "Fit 
2" (includes only data from 1997 onwards). Fitted parameter vales are given in the legend in each 
panel. 
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Figure 2.9 Model fits to data for the antenatal clinics sites grouped by location. Bars show median 
prevalence among ANC sites from 1997; crosses show median prevalence at earlier time, where 
possible. The red line is "Fit 1" (includes all data available); the blue line is "Fit 2" (includes only data 
from 1997 onwards). Fitted parameter vales are given in the legend in each panel. 
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Figure 2.10 The effect of mean survival time after infection on the estimated reduction in risk, (a) 
With a 50% reduction in risk, a better fit is achieved with shorter survival times, (b) A lower reduction 
in risk is required to fit to data when a shorter survival time is assumed. Data from Nkulamane (near 
Bulwayao, Zimbabwe) is used to illustrate (bars). 
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2.5 Discussion 
The model illustrates the potential for HIV prevalence to decline without individuals 
deliberately adopting safer sexual behaviours. However, the inability of the model to 
replicate the extent of observed declines allows us to be more confident that changes 
in prevalence in Uganda, urban Kenya, Zimbabwe and urban Haiti are unlikely to be 
a product of these natural dynamics. The declines observed can be contrasted with 
urban Ethiopia where the prevalence patterns could be reproduced with sexual 
behaviour and HIV transmission remaining unchanged and urban Cote d'lvoire, 
Malawi and Rwanda where aggregated prevalence has not recently decreased, 
although this does not exclude the possibility that behaviour change has had a 
significant impact on the HIV epidemic. In Zimbabwe, risk may have substantially 
reduced between 1998 and 2002, which coincides with the timing of behaviour 
change that has been recorded in independent surveys [17]. 
The model of HIV transmission is influenced by a large number of interacting 
variables which, without a dramatic increase in data sources, limits the possibility of 
statistically fitting the model and estimating the most likely value of particular 
parameters. A statistical interpretation of the results depends upon the confidence 
intervals around the prevalence estimates at particular time points and whether the 
extreme decline in prevalence falls within them. It should be noted that some of the 
prevalence estimates used here did not have reported sample sizes or statistical 
confidence intervals. In addition to statistical error, changing biases could lead to the 
observed and predicted trends separating. One such bias is suggested by recent 
data indicating that fertility is suppressed before the final stages of HIV infection [47]. 
Sub-fertility in those with long standing HIV infection could lead to their exclusion 
from the ANC sample, but the model indicates that the effects of this bias will predate 
the declines in prevalence recently observed. Nationally, estimates of prevalence 
often fall as samples are recruited from progressively remoter populations or as HIV 
tests become more specific. To avoid these problems, only data from consistently 
sampled clinics were used. 
For Zimbabwe, there is the additional concern that the decline in prevalence 
could have been driven by migration, which has greatly increased over recent years 
[17]. In the range of scenarios simulated, the decline in prevalence observed could 
only be replicated without individual behaviour change when it was assumed that 
asymptomatic individuals are more likely than other to migrate. This scenario is 
equivalent to approximately 10% of asymptomatic individuals knowing their status 
and being three-times more likely to migrate than uninfected individuals, which would 
have been unlikely given that HIV testing was uncommon until recently [148]. A more 
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plausible scenario would be if both migration and HIV infection were correlated with a 
third variable such as educational attainment. This could lead to greater migration of 
HIV positives. However, in an investigation of migration from Manicaland, no such 
relationship has been found [245]. HIV prevalence among Zimbabwean-born women 
in the UK (one of the main destination of emigrants) has not substantially increased 
during the time of prevalence decline [17] and HIV prevalence among Zimbabwean-
born women in the UK is much lower than in Zimbabwe, indicating that overall, 
Zimbabwean migrants are disproportionately nof infected. 
Restricting HIV prevalence data to the younger age-groups often fails to help 
identify recent reductions in HIV incidence. In young age-groups the confounding 
effects of mortality and sub-fertility on prevalence trends are minimised and 
reductions in incidence will be translated rapidly into reduced prevalence. However, 
the uncertainty associated with the prevalence point-estimates is often too great to 
detect trends. In contrast, although prevalence estimates from across all adult ages 
are prone to natural reductions, they may be determined more precisely and so allow 
trends due to the natural evolution of the epidemic and due to behaviour change to 
be distinguished. 
One of the problems in reconstructing HIV epidemics is that current sexual 
behaviour already includes reductions in risky sexual behaviour brought about by the 
HIV epidemic and associated mortality in those who were previously at the greatest 
risk of infection [54, 231]. To overcome this, it can be assumed that the heterogeneity 
in sexual partner change rates was originally greater than that observed today. 
Although it was the aim to reconstruct country specific epidemics, local patterns of 
risk were often not available, necessitating the adoption of standard patterns for 
condom use and age-specific partner change rates. Fortunately, despite being 
important for fitting age and sex-specific prevalence, these patterns have little 
bearing on the course of the epidemic once its magnitude is established. 
It was estimated that the decline in risk behaviour in Zimbabwe occurred 
between 1998 and 2002 and happened first in urban areas. This seems to be 
consistent with data on behavioural changes. A recent comprehensive 
epidemiological review in Zimbabwe [17] found declines in the proportion of men and 
women that reported a non-regular partner in the last year since the late 1990s 
(although there was little data from earlier) and sales of socially-marked condoms 
increased dramatically from 1997. Behaviour change between 1994 and 1999 was 
also greatest in urban areas, where programmes were usually focussed initially [246]. 
The estimates of the timing of risk reduction were made using a model that 
takes a naive view of risk; that individuals stayed at the same risk level for their entire 
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lives; that risk had been constant until the behaviour change and then declined 
linearly for three years; and, that risk reductions occurred to all individuals at the 
same time regardless of age or sexual behaviour. In reality, risk is more likely to have 
changed gradually over time, although it may have gathered momentum and 
changed most over a shorter period. This model does not distinguish between 
different types of risk behaviour (concurrency of sexual partners, condom use, 
sexually transmitted infection etc), but instead measures a proportional decrease in 
the total risk behaviour. More data would be required to determine the relative 
contributions of particular aspects of risk behaviour. 
Without sample sizes, it is not possible to quantify the uncertainty in the 
estimates of the changes in patterns of risk behaviour. It is also unclear whether all 
the measurement of prevalence were made in the same way. The data points in 
1997 are low compared with those from 2000, which may be due to different methods 
being used. If it is assumed that they are directly comparable, the model interprets 
the difference between them as indicating substantial epidemic growth in this period 
which is difficult to reconcile with independent estimates that incidence peaked in 
about 1991 [16, 246]. To generate epidemic growth between 1997 and 2000 and 
peak incidence in 1991, a high risk level is fitted, which could lead to overestimates in 
the reduction in risk subsequently required to match the observed decline in 
prevalence. Data collected earlier in the epidemic show that prevalence was high and 
stable by the mid 1990s, which is broadly consistent with peak incidence in 1991, 
and allows a more conservative estimate of the initial risk level. 
Estimates of the magnitude of the risk reduction will be sensitive to 
assumptions about survival from infection to death. In this model the distribution of 
time from infection to death would is gamma distributed, which should lead to more 
realistic temporal changes in prevalence than are generated in the earlier model. 
However, there is only one estimate of median survival time for infected individuals in 
Africa [230]. In that study, participants were afforded good access to medical care 
[230, 247], which could mean that the estimated survival time was longer than in 
more typical settings. Smaller reductions in risk are consistent with observed 
prevalence declines when shorter survival times are assumed, although the 
estimated timing of behaviour change is not severely affected. 
The estimated magnitudes of the reduction in risk behaviour are very large for 
some sites and for all the rural areas taken together. These estimates are particularly 
sensitive to the most recent prevalence estimate and will be substantially over-
estimated if there are small downward biases. For this reason, it is too early to make 
firm conclusions on the timing and magnitude of behaviour change in Zimbabwe. Ten 
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years ago, there was a similar problem in analysing prevalence trends in Kampala, 
Uganda [54, 55]. As more data has become available, initial estimates of very large 
risk reduction (80%) have been verified [24]. 
This method of estimating timing of incidence reduction is unable to detect 
changes in risk behaviour that took place before the time-series starts. For example, 
prevalence could have been steadily declining since 1995, but this could not be 
detected if the first estimate of prevalence is in 1997. Furthermore, even if 
prevalence estimates are available from before prevalence began to decline, it would 
still be impossible to detect the impact of behaviour change if it occurred before 
incidence peaked. In this case, prevalence would never reach the level that it would 
have if risk had not reduced, and recent prevalence estimates will be steady or 
decline slightly (due to natural dynamics), leading to the erroneous conclusion that 
risk behaviour has not changed (Figure 2.1 (dashed lines)). This severely 
compromises our ability to form firm conclusions on the causes of risk reduction. 
Thus, while we can detect a change in risk after the mid 1990s, we cannot know if 
there were earlier successful programmes before this. 
Why did behaviour change occur at this time and why has it occurred in 
Zimbabwe and not neighbouring countries with similarly severe epidemics? In 2000 
the Zimbabwean government introduced a special tax ("AIDS levy") dedicated to 
responding to the HIV/AIDS epidemic [93]. At this time, many non-governmental 
organisations were also working intensively on intervention projects, and uptake of 
voluntary counselling and testing (VCT) increased substantially [248]. However, none 
of the trials of interventions proved very successful [17, 94, 249] and there is little 
evidence that VCT can have a strong effect on behaviour in this setting [17, 140, 
250]. One of the most persuasive theories is that the true motivation for behaviour 
change is to witness first-hand a loss of a close friend or relative to the disease - the 
"funeral effect", first identified amongst gay men in San Francisco [95]. Models 
suggest that by the late 1990s mortality was rising fast in lower risk parts of the 
population, and an increasing fraction of the population had suffered a loss. In other 
countries, knowledge of the disease may be just as high, but the funeral effect may 
not yet have bitten so hard; it is notable that the epidemic decline in Zimbabwe took 
hold at a comparable stage of the epidemic to that in Uganda [24, 55]. The 
Zimbabwean population is also better educated than neighbouring countries and 
education may help empower individuals to make the changes that are personally 
relevant [92]. 
For a long time Uganda [24, 55] has been the key national level example of 
success in reducing HIV incidence in a generalised epidemic and the main source of 
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evidence on HIV prevention. Perhaps it is time for Kenya and Zimbabwe to be added 
to the list. 
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Chapter 3: Estimating Incidence from 
Prevalence - Methods and Validation 
3.1 Introduction 
Monitoring the continuing spread of the HIV epidemic is essential for determining 
public health priorities, assessing the impact of interventions and making estimates of 
current and future health care needs [2], Currently, surveillance systems in 
generalized epidemics primarily rely on HIV prevalence (fraction of population 
infected) data collected from women attending selected antenatal clinics [44, 56]. 
Interpretation of these data is complicated by natural epidemiological changes that 
arise from the long and variable incubation of HIV and AIDS-related mortality [54, 
251], by biases in the sample due to sub-fertility associated with bacterial STIs and 
HIV [46], and the disproportionate selection of sites in urban areas [53]. Recently 
serological testing has been added to the Demographic and Health Surveys (DHS+) 
[61, 62], giving estimates of HIV prevalence in the general adult population based on 
a standard methodology. In addition, a number of countries have conducted other 
general population-based sero-surveys [252]. Measures that relate to the general 
population are more useful, but there remain several important limitations in using 
prevalence data to monitor the epidemic. These include: 
(i) Changes in prevalence do not necessarily indicate a reduction in risk of 
infection (see Chapter One and ref. [251]); 
(ii) Changes in prevalence lag behind real changes in risk, particularly at 
older ages; 
(iii) Comparisons of prevalence between countries can be confounded by 
different survival times following infection (e.g. if survival following 
infection is shorter in Asia than in Europe or Africa [230, 234, 253], 
prevalence would be lower even if incidence rates were the same); 
(iv) The weak association between prevalent infection and risk makes it 
difficult to identify "high risk" groups (e.g. higher average prevalence 
among women does not necessarily mean they are at overall greater risk 
then men). 
A better measure for monitoring the HIV epidemic is incidence (rate of new 
infections among those at risk). If incidence is known, temporal changes in the 
epidemic can be better identified and characterised, the pattern of risk over age can 
be examined to aid the understanding of transmission patterns and highlight targets 
for interventions, and future health care needs can be predicted. However, whereas 
prevalence can be measured with independent, anonymised, cross-sectional sero-
surveys, direct measurement of incidence would require individuals to be identified 
and followed-up from one sero-survey to the next. In all settings, achieving high 
follow-up rates is a major logistical challenge and is more expensive than selecting a 
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new panel of participants at each survey round. New types of HIV test that can 
discriminate recent infections from a single specimen have not so far been able to 
generate reliable estimates of incidence [64, 66]. The DHS+ surveys will not follow-
up individuals but it may still be possible to estimate incidence from prevalence 
estimates in successive surveys, without resort to complex projection packages. This 
chapter describes and tests two methods for doing this, with the intention that they 
can be applied in future to sequential prevalence data collected in DHS+ surveys. 
Several methods have already been proposed to estimate incidence from one 
or two measures of prevalence [68, 69, 254-260]. Some of these only work under 
stable conditions, with long time-series or involve complicated and computationally 
intensive model fitting procedures. None of the methods have been validated by 
comparing derived estimates with actual measurements from general population 
samples of African communities with mature HIV epidemics. 
Both of the methods presented here are simple to use and are based on the 
idea of demographic accounting [69]. They examine the change in HIV prevalence in 
a cohort observed at two time periods, allowing for changes due to new infections 
and mortality among infected and uninfected persons. To gather the mortality data 
required to do this exactly would also need cohort follow-up, but it is suggested that 
mortality information collected from external sources, such as long-running cohort 
studies, can be used in place of direct measurements. Method 1 uses cohort 
mortality rates among those infected whilst Method 2 uses the distribution of survival 
after infection. The performance of these methods is tested using data generated by 
a mathematical simulation model and actual measurements of prevalence and 
incidence from three community-based cohort studies in sub-Saharan Africa. 
3.2 Methods 
3.2.1 Calculating incidence from cross-sectional prevalence 
Consider two cross-sectional measures of prevalence separated by an interval of 
7years in age-groups of width r years (Figure 3.1). Denote the total number of 
individuals in age-group i, at time j as N^j and the number of HIV-infected 
individuals as Prevalence is defined as p.j=H.jlN... If cohort age-groups 
( r A 
are constructed centred on ages a. a, — , a , +— at the start of each interval, then 
V 2 2 J 
' r ^ r ^ 
the age-groups at the end of the interval will be a,. — - v T — 
V 2 2 y 
. Denote the 
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cohort experiences of incidence as A,, and the incidence rate in the cross-sectional 
age-groups a. -^,ai +^\ as A. (Figure 3.1). In addition, is defined as the 
fraction of infected individuals in the age-group at the start of the interval that 
survive to the second sero-survey. 
In a real cohort, an estimate of HIV incidence can be obtained by considering 
the change in the number of HIV-infected individuals and finding an approximation to 
the person-years spent at risk of infection in the cohort [67], as follows: 
Number of sero-conversions ~ (3.1) 















Figure 3.1 Lexis diagram showing values used in the methods. Two sero-surveys T years apart 
quantify prevalence in age-groups of width r . One age-group ( / ) is shown. N. j is the total number 
in survey; H - j is the number infected; j is HIV prevalence; is the fraction of infected 
individuals that survive between surveys; in. is mortality rate of infected individuals in the cohort; A-
is the rate of HIV incidence in the cohort. N and H are not required to use the methods but do appear in 
the mathematical derivation. 
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From equations (3.1) and (3.2) on estimates of the number of seroconversions and 
person-years in the cohort, an estimate of incidence can be derived: 
X.= seroconversions 
person - years 
.... (3.3) 
Then replacing values of H.. with ^ = PjjN. j and dividing the numerator and the 
denominator by N. ^: 
Pi,T 
^r 




Here Q,. represents the change in size of the cohort over time. Ignoring the possibility 
of sero-conversion and death occurring in the same interval, 2,. can be approximated 
in the following way: 
.... (3.5) 
where //,. is the mortality rate for those not infected with HIV. Dividing by yv,. „ ; 
Q = « 1 - (1 - ) P i o - ( 1 -exp( -^ ,T) ) ( l - p.Q) .... (3.6) 
For the calculations presented here, //. = 0.01 is used for all ages, which 
approximates the observed crude rate for uninfected individuals [261]. 
To estimate incidence in the cohort that is not included in the data at the start 
of the time interval (but enters the youngest cross-sectional age-group during the 
interval), it can be assumed that incidence is zero at all ages younger than the 
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youngest person in tlie dataset (i.e. younger than a, If incidence is further 
assumed to be constant over the interval and that mortality is negligibly small at this 
age, then prevalence in this unseen cohort can be described 
as\pgj = 1 - e x p ( - r ^ /2 ) , where pg j is the prevalence in the second sero-survey 
in the age range r r 
—,(2,— + T . From this, a corresponding estimate of 
incidence can be generated: 
3.2.2 Method 1 
Method 1 makes use of empirical values of age-specific cohort mortality rates among 
those infected, which we denote in. (Figure 3.1). In this way, can be 
approximated by in.T). Values of m. used in subsequent calculations are 
shown in Table 3.1. 
Males Females 
Age-group Cohort mortality rates Cohort mortality rates 
low average high low average high 
15-19 0.020 0.032 0.046 0.027 0.046 0.066 
20-24 0.028 0.046 0.067 0.033 0.055 0.079 
25-29 0.039 0.063 0.091 0.038 0.064 0.092 
30-34 0.050 0.081 0.118 0.043 0.073 0.104 
35-39 0.062 0.102 0.147 0.048 0.081 0.116 
40-44 0.076 0.124 0.179 0.053 0.090 0.128 
45-49 0.090 0.147 0.214 0.058 0.098 0.139 
50-54 0.106 0.173 0.250 0.062 0.105 0.151 
55-59 0.122 0.199 0.289 0.067 0.113 0.162 
60-64 0.139 0.228 0.330 0.072 0.121 0.173 
Table 3.1 Cohort mortality rates for HIV-infected persons (rh.^), tabulated by age of cohort at start of 
5-year interval [261]. 'Average' values were used in calculations but 'low' and 'high' values are also 
included so that a credible interval of incidence estimates may be calculated. 
3.2.3 Method 2 
Alternatively, if cohort mortality rates are not available, can be estimated using 
survival after infection information [69] and an approximation of the current age-
specific pattern of HIV incidence. If s(a,z) is defined as the probability of survival to 
age z given infection at age a, and assuming that the age-pattern of incidence has 
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remained constant for as long as the oldest person in the data has been at risk of 
infection, then provided T ~r\ 
TV: ~ 
s{a^ - — , a j + r ) 
- - . O y ) 
r wT ^ _ f k-\ 
^(#1 - — ,<3, +T)XQ + ^ \ s {a i ^ + ~ ' ^ ; + T ) \ exp 
^ k=\ [ ^ V ;=1 y 
r ~ f r ~ ( ~ ^1 
sia,--,ai)Aa + J]\s(ai^+-,a.)X^exp \ 
^ t=l [ ^ V :=1 J) 
.... (3.8) 
This expression works out the chance that infected individuals die during the 
follow-up period by assuming that the composition of the infected populations at each 
age-group reflects the pattern of incidence at younger ages. Assuming that the 
pattern of incidence over time has remained constant and T~r, the cohort 
incidence estimates from younger ages reflect the experiences of the older cohorts 
(Figure 3.2(a)). The overall chance of survival is calculated as the weighted average 
of survival from the mid-point of the younger ages (dotted lines) to the end of the 
inter-survey period. 
When T <r the estimates of incidence calculated from younger cohorts do 
not directly reflect the experience of incidence in older cohorts because they pertain 
to different age ranges at different times. However, experimentation using equation 
(3.8) when T suggests that small departures (<2 years) from this do not 
introduce large errors. A more satisfactory solution is found by calculating the 
experience of incidence for the current cohorts by approximating incidence in the 
younger cross-sectional age groups (Figure 3.2(b)). Incidence in the period of time 
that the average member of an age-group has spent at risk since they entered the 
age-group (for which a cross-sectional measure cannot be found), can be estimated 
by the cohort measure of incidence for the overlapping period. Hence, strictly this 




s{a^,a^_ + T)2^ +5(^2 - r!A,a2 + T)X._^ exp(- A,) 
s{a^,a^)A^+ s i a ^ - r I A,a^ )X_, exp(- /I,) 
7t. 
/-I r ^ k-\ / /-I 
«/ + T)^k exp - ^ 4 \ + s(a, - r/4,a,. + r)I ._, exp - ^ / I , . 
/ - I 
r H ~ f 
V z=l /J V k=l J 
....(3.9) 
for i > 2 
Since values of n. are calculated using estimates of incidence from younger age-
groups, which themselves depend on n., the order of calculation matters, and should 
be; ^1, i j , ^2, J j , and so on. Using standard spreadsheet software, these 
expressions can be evaluated in full automatically by using arbitrary initial conditions. 
Survival after infection is modelled as a Weibull distribution 
( ^ (x ) = exp(-{(x//?)*'})) where k and P are the shape and scale parameters, 





Figure 3.2 Lexis diagram showing the basis for estimating cohort mortality rates using only data on 
survival after infection, (a) When the inter-survey period is the same as the width of the age-groups, 
and if the pattern of incidence is constant, then the experience of incidence in one cohort (here i — 3), 
can be estimated from the estimates of incidence in younger cohorts, (b) When the inter-survey period 
is shorter, the experience of incidence in a cohort can be approximated using estimates of incidence in 
younger cross-sectional age-groups. 
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Ape-group Weibull survival distribution parameters 
shape scale median 
15-19 2.0 16.0 13.3 
20-24 2.0 15.4 12.8 
25-29 2.0 14.1 11.7 
30-34 2.0 12.1 10.0 
35-39 2.0 11.0 9.1 
40-44 2.0 10.1 8.4 
45-49 2.0 7.9 8.6 
Table 3.2 Parametric model estimates of survival after infection in southern Africa. These values are 
model fits to previously published data [230, 262-264] [261]. 
3.2.4 Methods 1 and 2: derivation of cross-sectional measures 
The final step for Methods 1 and 2 is to convert the cohort incidence rates into 
incidence rates that relate to conventional cross-sectional age-groups (Figure 3.3). 
By assuming that the seroconversions in the cohorts are distributed uniformly over 
the follow-up period, an average incidence rate can be calculated from these two 
cohort incidence rates, weighted according to the time spent by the cohorts in the 
fixed age-group. The time spent by each cohort is proportional to the shaded areas In 
Figure 3.3. 
Total person-years spent in fixed age-group: T.r 
Fraction of person-years spent by cohort i -1: 0.5T^/T.r - Tjlr 
Fraction of person-years spent by cohort i: l-Tflr 
% ^ r V ( 
" 1 7 
x + I,_, .... (3.10) 
The estimate pertains to the interval between two sero-surveys and relies on the 
inter-survey interval being no greater that the width of the age-groups (T <r), both 
of which are usually five years. If T > r then the same logic holds but, because more 
cohorts pass through the cross-sectional age-groups in the period T, a new 
expression 3.10 for the relative weightings of the cohorts should be found. 
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Figure 3.3 Incidence in tiie cross-sectional age-group can be approximated by measures of cohort 
incidence (A.- and ) from two different cohorts. The relative contribution of each cohort to 
incidence in the cross-sectional age-group can be found by considering the person-years that each 
spends in the age-group, which is proportional to area in a Lexis diagram. For details see text. 
3.2.5 Details of simulation model 
A simulation model was used to validate the methods. The simulation model 
generates prevalence and mortality measurement as a function of time for a given 
pattern of incidence. Here a is the time since started sex, S(a) is the number of 
susceptible and 1(a) is the number infected with that many years of sexual activity. 
The rate of change of S(a) and 1(a) is described by the following partial differential 
equations. 
—s(a,t)-i s(a, f ) = —S{a,t){A(a, t) -t- /u(a)) 
dt da 
— l{a,t,w) + — l{a,t, w) +—I {a,t,w) - A(a,t)S{a,t) -1 {a,t, z)ih(a - w, w) + /J.(a)) 
dt da dw 




A(a,t) is the instantaneous incidence rate;//(a) is the rate of mortality from causes 
other than AIDS; h(x,z) is the hazard of AIDS-death for those infected at age x that 
have survived z years. In these simulations, survival after infection is parameterised 
using the values given Table 3.2 and the background mortality rates are based on 
World Bank estimates for Africa in the pre-AIDS era [207]. 
The boundary conditions are: 
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7(0.0.0) = 0 
S{a,0) = (p(a)NQ ...(3.12) 
where ^{a)\s the fraction of the population that age, in the absence of AIDS-
mortality. 
Three scenarios for the pattern incidence over age are considered - constant 
over age, incidence highest at older ages (reflecting patterns expected early in 
epidemics) and incidence highest at younger age (reflecting patterns observed in 
mature epidemics) (see later for exact pattern). To generate changes over time, age-
specific rates are multiplied by a variable, which is set to unity and then increases or 
decreases (or remain the same) after ten years. 
3.2.6 Validating the methods in community-based cohort studies in Africa 
To test how well these methods perform, incidence estimates derived using these 
two methods were compared with actual measurements made in cohort studies. Data 
were available from three community cohort studies in sub-Saharan Africa; the 
Manicaland HIV/STD Prevention Project in Zimbabwe [91], the MRC/UVRI Uganda 
Research Unit on AIDS, which runs a cohort in Masaka district [265] and the NIMR 
TAZAMA cohort study in Kisesa ward, Tanzania [266]. The Manicaland study 
furnishes suitable data for only one time interval (two sero-surveys three years 
apart); the Kisesa study covers three intervals (four surveys, each separated by 
about three years). The Masaka study has conducted seventeen annual sero-
surveys, but one-year intervals do not generate enough incident cases for robust 
age-specific incidence estimates. To overcome this, longitudinal knowledge of HIV 
status was used to establish HIV prevalence measures at four points in time giving 
three intervals in which to measure prevalence, separated by roughly four years. 
For validation purposes, the data used are from "closed cohorts"; that is, 
individuals who entered the cohort during a particular interval or were not seen at 
follow-up and were not known to have died, were not included. Sero-conversion 
dates were assigned between the last negative and first positive test results in 
accordance with analysis procedures developed at each site [90, 267-269]. Poisson-
based confidence intervals were calculated for each incidence measurement, which 
do not take account of any clustering effects in the samples. 
Objective measures of goodness-of-fit (between estimates and observation) 
were chosen a priori to assess the relative performance of the two methods. These 
were: 
1. Root-mean-square-error divided by average measured incidence. 
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2. Fraction of estimates (over all ages and both genders from one period) that 
fall within the 95% confidence interval of the cohort measurement. 
3. Estimated cumulative risk of infection [69] (here called lifetime risk of infection 
(LTR) for convenience) divided by measured LTR. Here we calculate LTR as: 
Lr/? = exp - ^ r X . 
alii 
4. Maximum absolute error divided by measured incidence rate. 
5. Difference in location of estimate and observation, with the location 
summarised by: 
alii 
3.2.7 Application to DHS Data 
The methods have been designed to make use of two successive rounds of cross-
sectional prevalence measures, as will soon be available for a number of countries 
[61]. However, as an interim measure, preliminary estimates can be made using a 
single sero-survey if we assume that prevalence has been stable for r years 
preceding the survey: p. 2 = . This restriction means that incidence estimates 
can not be made for the oldest age-group for which there is prevalence data so 
estimates of incidence are restricted in the range 15-44 years. 
3.3 Contributions 
In addition my supervisors, I am indebted to Basia Zaba (London School of Hygiene 
and Tropical Medicine, and National Institute for Medical Research, Tanzania) and 
Ties Boerma (World Health Organization) for the constructive collaboration that 
helped develop the paper that forms the basis of this chapter. In particular, BZ and 
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mortality rates. For access to the data and assistance in its analysis, I am grateful to 
Ben Lopman (Department of Infectious Disease Epidemiology), Jim Todd 
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3.4.1 Testing the methods on simulated data 
Simulating data and comparing the known incidence rates with estimates using these 
methods confirms that incidence can be accurately estimated from serial measures 
of cross-sectional prevalence. Both methods slightly under-estimate incidence when 
the rate is high and in younger age-groups, because infections occur rapidly and the 
person-years spent at risk are over-estimated estimated by the linear assumptions 
that underlie the approximations. Although the methods assume that incidence is 
constant in the period between sero-surveys, accurate estimates of average 
incidence can be obtained for this period if incidence is increasing or decreasing 
(Figure 3.4(a-b)). When incidence falls suddenly, estimates of incidence are 
immediately reduced and continue to estimate incidence accurately (Figure 3.4(c)). In 
these circumstances, measures of prevalence are slower to respond; after a dramatic 
fall in incidence of 50% over five years, prevalence has declined by only 14% 
whereas estimates of incidence indicate a 22% reduction (the true average reduction 
in the five-year interval is 25%). Immediately after a sudden change in incidence, the 
estimates are slightly too low because mortality in the older age-groups is transiently 
higher than at equilibrium with the new pattern of incidence. This bias is smaller 
when the reduction in incidence is more gradual or when incidence is lower in older 
age-groups. 
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Figure 3.4 Comparison of 'true' simulated incidence rate (blue dashed lines) and estimates using 
Method 2 (Method 1 gives same results) (red solid line) when true incidence (a) increases steadily; (b) 
decreases steadily; (c) decreases suddenly. (Incidence assumed to be constant over age). The vertical 
lines indicate when five-yearly sero-surveys are done. The estimates of incidence are made at the time 
of the sero-survey (red crosses) but relate to the preceding five-year period. 
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The methods for estimating incidence depend on using mortality information 
from an external source. A potential difficulty is that the pattern of mortality actually 
depends on the pattern of incidence, which is determined by many behavioural 
factors and could vary between populations and over time. Simulating two alternative 
scenarios, where incidence is highest at young ages (typical in mature epidemics for 
women) or highest at middles ages (typical in nascent epidemics and in mature 
epidemics for men), we can compare the attendant patterns of mortality (Figure 
3.5(a)). For both scenarios, mortality is low at young ages but much higher at older 
ages if incidence peaks at young ages. Estimating incidence using Method 1 requires 
age-specific mortality rates for infected individuals and if the rates used accurately 
reflect the pattern or mortality in the population, the estimates will be good (Figure 
3.5(b) - solid lines). However, if the mortality rates are taken from a population with a 
different distribution of incidence and mortality, the derived incidence estimates will 
be biased, particularly at older ages (Figure 3.5(b) - dashed lines). This bias is small 
if incidence is concentrated at young ages. Method 2, which does not rely on using 
age-specific mortality rates, is able to accurately predict incidence in either scenario 
using the same data on survival after infection and assuming that incidence age 
patterns in the years preceding the survey have remained constant. 
3.4.2 Testing the methods on data from cohort studies 
Measurements of incidence in adult and young people, together with the estimates 
from both methods are given in Table 3.3. The goodness-of-fit indicators are shown 
in Table 3.4. Ail estimates from both methods fall within the 95% confidence interval 
of the corresponding measurement. The difference between the measurement and 
estimate is less than 10% in half of the comparisons for each method. The mean 
difference between measurements of incidence and estimates is 14% for both 
methods. Neither method tends to systematically over or under-estimate incidence. 
Measured and estimated incidence rates are compared by age-group in 
Figure 3.6. The overall performance of both methods is very good; the pattern and 
approximate level of incidence is captured successfully in all cases. The estimates 
from both Methods are inside the 95% confidence interval in about 90% of 
comparisons. The average error across all estimates is 20-40%, with estimates at 
older age-ages the most likely to deviate substantially. Aggregate measures of risk 
are estimated very accurately; the error in the estimate of LTR is usually less than 
10% (5% excluding Masaka) and the measure of location is rarely more than one 
year out. Both methods give very similar estimates in most cases and none of the 
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goodness-of-fit statistics indicate a clear advantage to eitlier iVIethod. The estimates 
of incidence for tine first period in Masaka are the least accurate. 
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Figure 3,5 (a) The age-specific mortality rates for HIV-infected individuals when incidence is highest 
at young ages (dark line with crosses) or middle ages (light line with triangles), (b) Estimates of 
incidence using Method 2 (solid lines), and Method 1 when the "wrong" pattern age-specific mortality 
rates (i.e. from the alternative scenario - see part (a)) are used (dashed lines). Bars show actual 
simulated incidence rates. 
103 
Population and period Gender Age-qroup 
Measurement 
Obs 95% CI 
Estimate (age-standardised) 
Metliod 1 Metliod 2 
Adults 
Manicaland - 1 Males 15-54 1.76 1.43 2.16 1.83 ... 1.74 * " 
Manicaland - 1 Females 15-54 1.48 1.23 1.79 1.60 ... 1.78 * 
Masaka - 1 Males 15-44 0.44 0.29 0.67 0.24 0.28 
Masaka - 1 Females 15-44 0.61 0.43 0.86 0.40 0.38 
Masaka - 2 Males 15-44 0.63 0.43 0.91 0.54 • * 0.52 " 
Masaka - 2 Females 15-44 0.37 0.23 0.61 0.35 ... 0.40 " * 
Masaka - 3 Males 15-44 0.40 0.28 0.57 0.41 ... 0.42 * " 
Masaka - 3 Females 15-44 0.57 0.43 0.75 0.49 * • 0.53 *•* 
Kisesa - 1 Males 15-44 0.74 0.51 1.09 0.77 ... 0.74 " * 
Kisesa - 1 Females 15-44 0.87 0.63 1.21 0.84 ... 0.81 
Kisesa - 2 Males 15-44 1.42 1.09 1.84 1.20 • • 1.17 ** 
Kisesa - 2 Females 15-44 1.32 1.03 1.67 1.07 .. 1.08 " 
Kisesa - 3 Males 15-54 1.21 0.93 1.58 1.04 .. 1.05 " 
Kisesa - 3 Females 15-54 1.19 0.94 1.49 1.04 * * 1.11 
Young people 
Manicaland - 1 Males 17-25 1.24 0.59 2.61 1.56 1.56 * 
Manicaland - 1 Females 15-25 2.00 1.33 3.01 2.18 ... 2.18 
Masaka - 1 Males 15-24 0.31 0.16 0.62 0.35 .. 0.34 *** 
Masaka - 1 Females 15-24 0.98 0.64 1.50 0.89 ... 0.80 ** 
Masaka - 2 Males 15-24 0.29 0.14 0.61 0.40 0.39 
Masaka - 2 Females 15-24 0.52 0.28 0.97 0.60 * * 0.52 * " 
Masaka - 3 Males 15-24 0.27 0.15 0.50 0.42 0.41 
Masaka - 3 Females 15-24 0.73 0.50 1.07 0.86 0.80 
Kisesa - 1 Males 15-24 0.39 0.10 1.56 0.45 * • 0.44 ** 
Kisesa - 1 Females 15-24 1.09 0,45 2.61 1.10 ... 1.02 " * 
Kisesa - 2 Males 15-24 1.42 0.68 2.98 1.48 1.47 * " 
Kisesa - 2 Females 15-24 1.93 1.17 3.21 1.54 * 1.48 • 
Kisesa - 3 Males 15-24 1.15 0.37 3.57 1.15 1.13 *** 
Kisesa - 3 Females 15-24 1.25 0.56 2.79 1.01 0.93 * 
Table 3.3 Results of cohort studies analysis. Measurements and estimates of incidence in adults. All 
incidence values given per 100 person-years at risk. Estimated values are standardised to the same age-
distribution as the measurement. Stars indicate level of agreement between estimate and measurement: 
*** absolute error <10%; ** <20%; * <30%. 
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Obieciive Measure: 1: RMSD / average incidence 
iUetiiod 1 Metliod 2 lUIetliod 3 
2: Fraction Ests witliln 95% Ci Obs 
iWethod 1 Metiiod 2 Metiiod 3 
Manicaland Males 0.38 0.29 0.28 0.88 1.00 0.88 
Manicaland Females 0.34 0.52 0.26 1.00 0.75 1.00 
Masaka (PI) Males 0.70 0.71 0.89 0.67 0.67 0.67 
Masaka (P1) Females 0.42 0.49 0.64 0.33 0.87 0.33 
Masaka (P2) Males 0.20 0.44 0.44 1.00 0.67 0.67 
Masaka (P2) Females 0.29 0.24 0.39 1.00 1.00 1.00 
Masaka (P3) Males 0.39 0.27 0.35 1.00 1.00 1.00 
Masaka (PS) Femalea 0.35 0.34 0.56 0.67 1.00 0.33 
Kisesa (P1) Males 0.29 0.30 0.51 1.00 1.00 0.83 
Klsesa (P1) Females 0.21 0.24 0.23 1.00 1.00 1.00 
Kisesa (P1) Males 0.30 0.35 0.48 0.83 0.83 0.67 
Kisesa (P2) Females 0.37 0.39 0.29 0.83 0.83 0.83 
Kisesa (P3) Males 0.29 0.31 0.35 1.00 1.00 1.00 
Kisesa (P3) Females 0.26 0,29 0.47 1.00 0.88 0.75 
Average 0.34 0.37 0.44 0.87 0.88 0.78 
3; LTR, Est / Obs 4; Max Relative Error 5: Location, Obs - Est 
iVIethiod 1 Methiod 2 Metiiod 3 Metiiod 1 Metiiod 2 Mettiod 3 Metiiod 1 Metiiod 2 Method 3 
Manicaland Males 1.15 0.95 1.00 2.18 1.04 0.71 1.01 -0.39 -1.23 
Manicaland Females 0.97 0.99 0.88 0.95 1.47 1.08 2.20 4.25 1.88 
Masaka (P1) Males 0.65 0.57 0.46 0.81 0.82 1.00 0.01 -0.74 -3.78 
Masaka (P1) Females 0.64 0.59 0.43 1.00 0.78 1.00 -3.49 -1.89 -4.88 
Masaka (P2) Males 0.93 0.72 0.80 0.38 0.73 0.79 -1.50 -2,90 -3.52 
Masaka (P2) Females 1.00 1.06 0.73 0.55 0.89 0.52 -1.97 0.34 -1.32 
Masaka (P3) Males 1.26 0.94 1,04 0.52 0.46 0.64 -0.02 -1.69 -0.95 
Masaka (P3) Femalea 0.90 0.89 0.73 0.62 0.34 1.00 -2.04 -0.51 -3.48 
Kisesa (P1) Males 1.07 1.02 1.10 0.39 0.44 1.00 0.55 0.72 0,54 
Kisesa (P1) Females 1.00 0.97 0.99 0.73 0.87 0.60 -0.17 0.36 -0.65 
Kisesa (P1) Males 0.86 0.81 0.82 0.47 0.54 0.93 -0.95 -1.39 -2.79 
Kisesa (P2) Females 0.85 0.83 0.83 0.44 0.46 0.58 1.11 1.49 0.10 
Kisesa (P3) Males 0.99 0.86 0.94 0.95 0.92 1.85 0.37 -1.04 -1.22 
Kisesa (P3) Females 0.98 0.97 0.97 0.39 0.47 0.65 1.42 1.99 2.10 
Average Error 0.12 0.14 0.18 0.74 0.73 0.88 1.20 1.41 2.03 
Table 3.4 Results of cohort studies analysis. The value of each of the five objective measures of fit are 
given for the two methods for each site and period. See text for details of the indicators. 
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Figure 3.6 Result from the cohort studies analysis. For each panel, the bars show incidence measured 
in the closed cohort with 95% confidence intervals and the lines show derived incidence estimates 
using Method 1 (dark grey lines) and Method 2 (light grey line). 
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3.4.3 Application of the methods to DHS data 
The methods are applied to the first DHS+ sero-surveys, with the additional 
assumption that prevalence has remained constant in the last five years. The mean 
prevalence (15-49 years) in these countries ranges from 1% (Senegal) to 27% 
(Lesotho) and is generally higher in Southern and Eastern African countries. The 
pattern of prevalence over age varies substantially between countries, particularly at 
older ages in women and in men (Figure 3.7). The incidence estimates are shown for 
a selection of countries in Figure 8. Methods 1 and 2 give similar estimates for 
younger ages but disparities arise at older ages with Method 2 giving higher 
estimates that Method 1. The contribution to changes in prevalence is driven by 
deaths more than new infections at older ages and the mortality rates predicted here 
by Method 2 are greater than those used in Method 1. 
Although the pattern of incidence varies substantially between countries, a 
familiar theme is apparent in nearly all; at young ages, incidence is higher among 
women than men but at older ages incidence is higher for men. In many countries 
there are two peaks in incidence; one in young people (15-24 years) and a second 
among older people (40-54 years). There is a 10-fold difference between LTR in the 
lowest (Senegal) and highest (Lesotho) risk countries (Figure 3.9). In two countries 
(Zimbabwe and Lesotho), it is estimated that the chance that a 15 year old is infected 
before their 45th birthday exceeds 50%. 
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Figure 3.7 Prevalence in countries in southern, eastern and western Africa measured in the first DHS+ 
sero-surveys. Values are normalized to the same vertical scale for comparison. 
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Figure 3.8 Results of DHS analysis. Prevalence (bars on left axis) and derived incidence estimates 
(lines on right axis; dashed line for Method 1; solid line for Method 2) for in (a) Cameron; (b) Guinea; 
(c) Zambia; (d) Cote d'lvoire. In each case, lines and bars are blue for men and orange for women. 
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Figure 3.9 Cumulative lisk of infection ('lifetime risk') between 15-45 years of age for men (lighter 
bars) and women (darker bars) estimated for the first round of DHS+ sero-surveys using Method 2 
(Method 1 gives very similar results). 
3.5 Discussion 
Two methods were developed for estimating incidence in the general population 
using successive rounds of cross-sectional prevalence data, and they were tested 
using simulated data and real data from three African cohort studies. Both methods 
were able to accurately estimate incidence in adults and young people and to capture 
the pattern of incidence with respect to age. These methods could, therefore, be of 
substantial use in the analysis of serial measures of cross-sectional prevalence as 
will be shortly available from DHS+ surveys. 
In the comparison with actual measurements of incidence, estimates of 
incidence in adult and young people were in very close agreement, whereas greater 
errors sometimes occurred at older ages. This is because the estimates at older ages 
are most sensitive to the assumptions about mortality and because the incidence 
measurement itself is more uncertain due to relatively small numbers of 
seroconversions. Both methods markedly underestimate incidence in the first period 
from Masaka among 25-34 year old men and women. This error is unlikely to result 
from the application of inappropriate mortality data because at this time (1991-5) the 
epidemic was still growing in this region [269] and mortality among infected 
individuals would be lower than later on, which should lead to the derived estimates 
being greater than the measurement. The cause of this discrepancy is therefore 
unclear, but the role of random errors in the prevalence measurements or miss-
representative samples followed-up cannot be ruled out. 
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For both methods, the mean error in these estimates of incidence in adults is 
14%, or 10% if the early data from Masaka are excluded. The uncertainty in 
estimates made in other settings is hard to quantify and will extend beyond random 
statistical errors because the extent to which assumptions and approximations made 
in the methods hold will not be known. A further insight into the uncertainty of the 
estimates could be derived by using a range of scenarios for the mortality data (Table 
3.1). 
The choice of which method to use will depend on which assumptions seem 
more likely to be true for the population in question and on the availability of locally-
collected data. The investigations using simulated data highlight the danger of using 
the wrong age-specific mortality rates in Method 1, which can vary according to the 
phase of the epidemic and the prevailing pattern of incidence. It is reassuring that, at 
least in these three settings, the age-specific mortality rates are remarkably similar 
but this not does necessarily mean that they will be so elsewhere (e.g. urban 
communities or sites in Southern, Central or Western Africa). Method 2, on the other 
hand, may be applied to settings with different incidence patterns using the same 
data on survival after infection because it effectively calculates its own mortality rates 
by assuming that incidence patterns have remained constant in the recent past. The 
agreement between the results from the two methods indicates how successfully the 
procedure for estimating mortality rates in Method 2 works. Therefore the 
recommendation is that Method / should be used where recent age-specific cohort 
mortality data that pertain to the population in question is available; when they are 
not. Method 2 can be used instead with a regional estimate on survival after infection. 
In the tests against actual measurement of incidence, the mortality data used 
were taken from the same cohort studies. This may overstate how well Method 1 will 
perform at a national level because there would not necessarily be such agreement 
between the actual mortality in the population in question and in the external mortality 
rates that are used. Also, whilst in these tests it was possible to use closed cohorts to 
measure incidence, in the application to the DHS+ sero-surveys, prevalence 
measures for birth cohorts will be used. However, as long as participation rates 
remain constant with respect to sero-status over age, no additional biases will be 
introduced. 
The methods do not correct for differential migration between infected and 
uninfected individuals and, by using closed populations in the tests, the effect of 
migration has been removed from the test data, which may improve their 
performance. However, at the national level, the difference in net migration between 
infected and uninfected individuals should be small enough to ignore. If effective 
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treatment with anti-retroviral therapy (ART) becomes more common, the mortality 
rate of infected people will change and the values used here would lead to 
substantial over-estimates of incidence, particularly at older ages where the effect of 
ART will be greatest. As ART access increases, new mortality measurements from 
cohort studies will be needed, and their utility will depend on criteria for treatment 
access and uptake levels being broadly similar in the cohort studies and national 
populations. It is also expected that estimates of incidence among young people 
derived in this way using existing data will remain reliable even when ART is 
common. 
An important application of these methods could be to the DHS+ sero-survey 
data and a preliminary analysis was done on just one round of data, making the 
additional assumption that prevalence in the next survey will be roughly the same. 
The derived estimates highlight the greater risk that young women experience 
compared with their male peers and the much higher incidence rate among older 
men compared to older women. They also reveal that there are two periods of 
elevated risk for women - at young and older ages. In fact, this has been observed in 
the cohort studies too (see Figure 3.6 and [260, 270]) and it may be linked to 
increases in risk behaviour as older women 'reconnect' to the sexual network after 
their spouses die or divorce [270]. 
A reliable comparison of risk between populations is cumulative risk of 
infection (LTR) [69] and the methods quantify a ten-fold difference in the LTR 
between the lowest and highest prevalence countries in this analysis, that are all 
classified as experiencing "generalised epidemics" [2]. In nearly all countries, LTR in 
the range 15-44 is higher in women than men, although over a wider age-range it 
would probably be higher for men because incidence in older men is greater than 
among older women. 
In conclusion, it is possible to estimate incidence from cross-sectional 
prevalence with sufficient accuracy to monitor the epidemic. The choice of method (1 
or 2) will depend on the local availability of mortality data. In comparison to other 
methods suggested [68, 69, 254-260], these methods are simple to understand and 
implement, they do not require opaque and computationally-intensive fitting 
procedures, and they have been validated with observed incidence estimates for the 
general population in several African countries experiencing mature generalised 
epidemics. 
I l l 
Chapter 4: The impact of reducing cross-
generational sex and delaying age at sexual 
debut in a mature generalised epidemic 
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4.11ntroduction 
In the generalised epidemics of sub-Saharan Africa, the majority of infection risk is 
associated with heterosexual sex [124, 271-273] and behaviour change is essential 
to reduce the number of new infections. Funding has been made available for 
interventions to promote behaviour change [83, 163] but care must be taken to target 
resources at changing those aspects of sexual behaviour that are most important to 
the spread of HIV. 
Observational studies show that HIV prevalence among young women 
usually far exceeds that among young men [121] and this has prompted some to 
stress the importance of protecting young women from infection in particular [121-
125]. Statistical analyses of individual behaviour data show that the risk of HIV 
infection is lower amongst women that avoid older sexual partners [40, 126] and 
begin sexual activity later [40, 127, 128]. For this reason, it has been suggested that 
behaviour interventions should focus on reducing cross-generational sex and 
delaying sexual debut [121, 130, 131]. The importance of these changes at the 
population-level has been presumed but not scientifically investigated and quantified 
[41, 121, 125, 126, 130, 131, 133, 134]. 
Mathematical models allow an assessment of the potential effects of 
proposed interventions aimed at changing behaviour and can provide a guide to the 
factors most critical to their success [86]. Increasingly, the insights gained from 
mathematical models are well understood and applied [201, 274, 275], and 
consulting mathematical models before implementing epidemiological interventions 
has become standard practice for emerging epidemiological problems [276-278]. It 
can be argued that the same approach should be used to assess the effects of 
proposed behavioural change interventions on generalized HIV epidemics. 
Two questions about proposed behavioural change interventions are 
considered: 
(i) What population-level effect could reducing cross-generational sex 
and delayed age at first sex have on the HIV epidemic? 
(ii) What properties of the sexual network determine the size of this 
impact? 
To address these questions, a deterministic mathematical model of the heterosexual 
transmission of HIV was developed with a detailed yearly age-structure so that 
changes in age at sexual debut, ages of sexual partners and rates of partner change 
in those recently entering the sexually active population could be investigated. These 
interventions are compared with increases in condom use by older men, which is 
currently very low, possibly related to the power imbalance in partnerships between 
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older men and young women [40, 41]. The model was parameterised using data 
collected in a cross-sectional survey in rural Zimbabwe [40] in order to provide a 
detailed and well informed example to illustrate the qualitative results rather than 
provide an exhaustive description of the various generalised HIV epidemics in Africa. 
4.2 Methods 
A deterministic mathematical model of the heterosexual transmission of HIV in a sex, 
age and activity-stratified population was used. To permit study of the effect of 
varying age at first sex and the pattern of partnership formation with respect to age, a 
detailed yearly age-structure was incorporated. The model is based on the one used 
in Chapter 2, but with some modifications. Sexual behaviour data from Manicaland, 
Zimbabwe [40] were used to parameterise the mean number of sexual partnerships 
formed by age and gender, the pattern of age mixing and the usage of condoms. 
4.2.1 Changes to the Mathematical Simulation Model 
As described in Chapter 2, for consistency, the derived pattern of partnership-
formation for one gender must match that of the other and the extent to which males' 
demand for sexual partnerships is accommodated by the female population (or vice 
versa) has to be specified. In analyses relating to the impact of changing the pattern 
of mixing it is necessary to assume that one sex controls the mixing pattern. If this 
was not the case, the parameterised pattern of mixing could be distorted by the age-
specific partner change rates of males and females, because male and female 
reports of sexual behaviour do not necessarily 'agree' in the way they have to in a 
mathematical model. Furthermore, the pattern of age mixing could be modified over 
time as the age-structure of the population changes in response to AIDS deaths. By 
choosing one gender to control the mixing pattern, the distribution of their contacts 
across the ages of the other gender will remained fixed in the simulation so that 
alternative patterns can be compared properly. It was decided that the pattern of 
mixing by age should be parameterised from females' reports and therefore that the 
pattern of partnership formation should be mostly controlled by females. This was to 
make the model structure simpler because preliminary investigations indicated that 
whilst the distribution of age differences between sexual partners was similar for 
females of all ages it was not for males. Following others [48, 279], equation 2.9 in 
the original specification was replaced with equation 4.2 with ^ = 0.1: 
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^2,r,m\i.m i,m,r,m' 
where q is the number of partnerships formed by individuals of gender k (1 for 
males, 2 for females), age i and activity group m, with individuals of the opposite 
gender aged i' and in activity group m', and is the number of sexually-active 
individuals of that gender, age and activity group. quantifies the disparity 
between the number of partnerships formed between each group and 0 determines 
the extent to which the males control the resulting overall pattern of partnership 
formation. In other analyses, the influence of the parameter 0 is investigated. 
Another model modification was that the parameterisation of the fraction of 
partnerships in which there is consistent condom use was adapted so that it could 
vary according to the sexual activity groups' of the partners. In the updated model, the 
chance that condoms are used throughout a sexual partnership is so that 
condom use is determined by the ages of the partners and the sexual activity group 
of the partner in the highest sexual activity group. 
A measure of the risk of infection is the "lifetime risk" (7?^), which is the 
expected probability at birth that an individual of that sex will be infected with HIV by 
their 55'^ birthday [69]. The measure is taken ten years after the intervention is 
implemented at time T. 
f=0 
/ (43 ) 
V m 
where is the force of infection for individuals of that gender, age and activity 
group, at time t. 
The impact of an intervention can be summarised with the relative lifetime 
risk, which is denoted RR,^. This compares the lifetime risk of HIV infection when the 
intervention operates (Rl) with that to when there is no intervention {R°). 
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The fractional reduction in lifetime risk is then equal to l-RR. 
The importance of the timing of marriage when first sex is delayed is 
investigated with a different analytical model that divides a woman's sexual lifetime 
into years spent before marriage and years spent married. Here, the lifetime risk of 
infection, p, can be approximated by: 
p{y, y) = 1 - (l - r„ f (l - r„, ... (4.5) 
where S is total years spent sexually active (before of after marriage); j is age at 
sexual debut and Y is the age at first marriage; is the yearly chance of infection 
when sexually active before marriage; and, is the yearly chance of infection when 
sexually active after marriage. 
4.2.2 Model Parameterisation 
The model was parameterised using data from the Manicaland HIV/STD Prevention 
project [40]. This source has already been described in Chapter 1, but a brief note is 
also included here. The data is from a stratified population-based survey that was 
carried out in the Manicaland province of eastern Zimbabwe between July 1998 and 
January 2000 [40] and a follow-up survey completed after 3 years [91]. A structured 
face-to-face questionnaire was conducted with almost ten thousand men and women 
in twelve distinct communities; two forestry plantations, two tea and coffee estates, 
two small towns, two roadside trading centres and four subsistence farming areas. In 
three-quarters of interviews with literate respondents, answers to sensitive questions 
about sexual behaviour were recorded using a confidential voting method, the use of 
which has been associated with reporting of greater sexual activity [228]. 
Participants were asked how many different sexual partners each had in the 
last year (Table 4.1). The number of partnerships formed by men declines over age, 
but is greater than the number reported by women at all ages. In the model, it was 
assumed that these values represent yearly rates of sexual partnership formation 
{Mk,i in equation 2.8). 
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Mean number of sexual partnerships 
formed in the last year 
Age-range Male Female 
<25 2.1 1.0 
25-34 1.9 1.1 
35-44 1.7 0.92 
45+ 1.6 . * 
Table 4.1 Reported mean number of sexual partners in the last year, in the baseline Manicaland 
survey. *No data was collected for females aged 45 years or older, but in the model it was assumed that 
the rate was the same as for women aged 35-44 years. 
Women were asked the age of their last sexual partner and from this the 
distribution of age-difference between sexual partners {d = male's age minus 
female's age) was calculated (Figure 4.1(a)). The distribution takes a similar form for 
women of all ages (Figure 4.1(a)); the mean age-difference is seven years and in 
approximately 25% of partnerships the age-difference is ten years or more. The 
distribution can be modelled by a log-logistic function (Equation 4.1) with the 
following fitted parameter values: r = 0.11, a: = 3.04, yC = 2.85 (Figure 4.1(b)). 
P ( d ) Kp^jd + ry-' ( l + ( f W + r % r ) : for d > 0 ...(4.1) 
Data 
— Fitted log-logistic 
E 8% 
® 4% 
^ 0 5 M 15 M 3 30 
Years older male partner 
M 15 M K 
Years older male partner 
Figure 4.1 Observed distribution of age-difference in last reported sexual partnership, (a) The 
percentage of females' partnerships formed with males a given number of years older by females aged 
15-19 (blue), 20-24 (dark green), 25-29 (red), 30-34 (light green), 35-39 (purple) and 40-44 (yellow) 
years, (b) Age-difference (male age minus female age) for all sexual partnerships reported by females 
(triangles) with fitted log-logistic distribution for all non-negative age-differences (line). 
Condoms were reported to be used in all reported sex acts in the last sexual 
partnership by 17% of males and 8% of females that had a sexual partnership in the 
last month. Sex acts were self-defined in the questionnaire, but here we assume that 
all sex acts are insertive penile-vaginal. Reported condom use is particularly low for 
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older men (25 years or older) but is higher if either partner has had many sexual 
partners (here defined as having more than six lifetime partners) (Figure 4.2). 
Low sexual activity High sexual activity 
ti" 
K E 
Female age Male age Female age 
Figure 4.2 The proportion of reported partnerships in which condoms were used in all sex acts, by the 
age of each partner and whether the reporting partner had six or more previous sexual partners ("high 
sexually activity")- Values are the averages of reports from males and females. 
For the analytical model that investigates the risk of infection before marriage 
and when married, S is set to 55 years and the yearly risk of HIV infection has been 
estimated in the Manicaiand observation cohort [267] as r„ = 0.02 for sexually active 
unmarried women and r =0.01 sexually active married women. 
4.2.3. Simulated Intervention 
• 4.2.3.1 Changes in cross-generational mixing 
Two types of intervention to reduce cross-generational mixing are simulated; 
(i) A change in the distributional form of the allocation of young 
women's partnerships among older men, preserving the total 
number of partnerships formed (Figure 4.3); 
(ii) Removal of a fraction of partnerships with a ten year or more age-
difference, so that there are less partnerships in total. 
Both of these interventions can generate the same reduction in the fraction of young 
women's sexual partnerships that are 'cross-generational' but the former replaces 
those cross-generational partnerships with partnerships among peers, whereas the 
latter does not. 
To simulate 'peer-to-peer mixing', individuals enter the population in yearly 
cohorts and form partnerships exclusively within their own cohort. In an alternative 
scenario, 0.5% of partnerships are directed to individuals one year older and 0.5% of 
partnerships are directed to individuals one year younger. 
^ 15 # 
Years older male partner 
Figure 4.3 Alternative model scenarios with different degrees of cross-generational sex; 1% (pink), 
5%, (light blue) 10% (orange), 20% (dark blue), 30% (purple), 40% (dark red), 50% (green). These are 
the distributions used to create Figure 4.4(a). 
• 4.2.3.2 Changes in age at first sex 
The parameter specifies the age at which individuals of that gender begin sexual 
activity. When age at first sex is delayed by years, the distribution of sexual 
partnerships formed as a function of age changes as: 
(4.3) 
If males seek to maintain their current number of sexual partnerships formed per year 
then the following change is also made: 
'^2+^2 
+ ... (4.4) 
H 
This allows males to seek to recoup the sexual partnerships they lost when their 
young would-be partners became abstinent from the sexual partnerships offered by 
young women in the first H years of sexually activity. The extent to which this new 
preference is reflected in the pattern of partnerships formed is determined by the 
parameter 0. 
In some analyses it assumed that the biological susceptibility of women 
decreases as they age between 15 and 22 years [280, 281]. To represent this, the 
probability of male-to-female transmission is multiplied by a coefficient that takes the 
value 1.5 for females aged younger than 15 years, decreases linearly to 1.0 between 
ages 15 and 22 and remains at 1.0 for all older ages. 
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The influence of the timing of marriage and delaying first sex on the lifetime 
risk of infection for women was investigated using the simple analytical model by 
examining the surface R{y,Y), varying y (the age at sexual debut) and 7 (the age 
at first marriage) simultaneously. 
• 4.2.3.3 Changes in condom use 
The probability that condoms are used consistently in sexual partnerships 
( i s altered in two different ways 
(i) The fraction of partnerships in which condoms are used consistently is 
doubled, irrespective of the partners involved 
(ii) The fraction of partnerships with men aged 25 years or older in which 
condoms are used consistently is increased to match the reported 
fraction of partnerships with men younger than 25 years in which 
condoms are used consistently. 
?^l,[25,B,],i',max(m,m'> ^^l,24,i',max(m,ra') 
... (4./) 
?^2,i,[25,Bi],maxCm,m') ^ ?^2,i,24,max(m,m') 
where g, is the age at which males are assumed to stop sex. 
4.3 Contributions 
The analysis of age-difference between sexual partners was informed by previous 
work by Nick Grassley and James JC Lewis, and the incidence of HIV infected for 
married and unmarried women was investigated in collaboration with Ben Lopman. 
4.4 Results 
Running the model with the different mixing patterns shows that, with more cross-
generational mixing, endemic prevalence (among those aged 15-49 years) is slightly 
higher (Figure 4.4(a) bars). Female-to-male prevalence ratios for 15-24 year-olds at 
least equal to those observed can be created in the model without assuming any 
difference in susceptibility to HIV infection between men or women or over age 
(Figure 4.4(a) line). 
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If all sexual partnerships are formed between peers the epidemic cannot 
become established (Figure 4.4(b)). If 1% of sexual partnerships are formed with 
partners one year older or younger, HIV can become endemic. 
Simulating an intervention that reduces cross-generational mixing but 
preserves the total number of sexual partnerships formed, shows that such a 
behavioural change could substantially reduce HIV prevalence among young women 
but prevalence among young men might rise (Figure 4.4(c) - solid lines). With this 
intervention, the lifetime risk of infection (the expected chance at birth that an 
individual will have been infected with HIV by their 55"" birthday) is only slightly 
reduced; by 10% for females and 5% for males. In contrast, if the same reduction in 
cross-generational mixing is simulated but without any compensatory increase in the 
number of partnerships among peers (dashed lines), prevalence among males can 
decrease and prevalence among females can decrease further. With this 
intervention, the lifetime risk of infection is reduced much more; by 25% for females 
and 22% for males. 
The observed pattern of sexual mixing (young women forming partnerships 
with older men) means that the impact of young women delaying sexual debut is 
sensitive to the behavioural response of older men - i.e. if males' prospective young 
sexual partners become abstinent, they may seek to replace those lost partnerships 
with the youngest sexually active females that are still "available". Females' risk of 
infection in the first years of sexual activity is therefore linked to whether or not males 
seek to replace lost partnerships and the extent to which males control the structure 
of the sexual network (Figure 4.5(a)). If males do seek to replace the lost 
partnerships, incidence is increased among women for the first years of sexual 
activity and this effect is greater if males are able to control the structure of the 
sexual network. The reduction in lifetime risk of infection for women is greater if 
males do not seek to replace lost partnerships (Figure 4.5(b)). The benefit of delaying 
sexual debut is even greater if women become less susceptible to infection as they 
get older. However, under all scenarios the reduction in lifetime risk of infection 
associated with delaying sexual debut is modest. 
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(b) 
1% 5% 10% 20% 307. 40% 50% 
Percent partnerships 'cross-generational' 
Year 
Figure 4.4 The impact of reducing cross-generational sex on the heterosexual spread of HIV. (a) HIV 
prevalence among 15-49 year-olds (bars) and ratio of female-to-male prevalence among 15-24 year-
olds (line) with different levels of cross-generational mixing (percent of females' partnerships formed 
with males 10 or more years older), 20 years after infection introduced, (b) HIV prevalence over time if 
all partnerships are formed between individuals the same age (grey line) or if 1% of partnerships are 
formed between individuals one year older or younger (black line), or if an intervention eliminates any 
non-peer-to-peer partnerships at year 20 (dashed line), (c) HIV prevalence over time for 15-24 year-old 
males (black) and females (grey) if the proportion of cross-generational partnerships is reduced from 
20% to 5% at year 20 and if there is replacement with peer-to-peer partnerships (solid lines) or if there 
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Figure 4.5 The impact of delaying age at first sex on the heterosexual spread of HIV. (a) HIV 
incidence ratio (relative to the no intervention scenario) for women when age at first sex is delayed by 
two years for both sexes if males seek to maintain their current level of sexual activity and if mixing is 
determined by males (black line), females (grey line) or is an equal compromise (dashed line), (b) 
Relative lifetime risk of infection when age at first sex is increased from 16 years if males seek to 
maintain their number of sexual partnerships (black line) or if partnerships are not replaced (grey line) 
or if partnerships are not replaced and susceptibility to infection decreases with age (dashed hne). 
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A further issue is the relative timing of sexual debut and marriage [282]. The 
association between lifetime risk of infection for women when the age at first sex and 
the age at first marriage vary (with all other factors remaining constant) is shown in 
Figure 4.6. In recent years in Manicaland, the risk of infection when sexually active 
but not married is greater than when married. This means that the benefit of delaying 
first sex depends on the time spent unmarried. For example, increasing the age at 
first sex from 18 to 21 could lead to lifetime risk of infection being reduced by 9% (if 
women are unmarried for 12 months less), reduced by 6% (no change in relative 
timing of marriage) or remain almost unchanged (if women are unmarried for an extra 
3 years). 
g 0.15 
Unmantedbf 1 Year 
- Unmarried for 2 years 
Unmarried for 3 years 
- Unmarried for 4 years 
- Unmarried for 5 yeans 
AgeaKMRHsex 
23 
Figure 4.6 Estimated lifetime risk of infection for women, by age at first sex and age at first marriage. 
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In rural Zimbabwe, the probability of reporting having used a condom 
consistently with their most recent sexual partner is particularly low for older men (25 
years or older) but is higher if either the man of his partner has had many sexual 
partners (Figure 4.2). If condom use by older men is increased to the level currently 
reported by younger men, the lifetime risk of infection could be reduced by -20% for 
both males and females. This exceeds the impact of doubling condom use in the 
whole population or males and females delaying sexual debut by 2 years under the 
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Figure 4.7 The impact of increasing condom use 
on the heterosexual spread of HIV. Relative 
lifetime risk of infection for males and females if 
(0 condom use among males older than 25 
increases to the level reported by males under 25 
(open bars), (;;) condom use overall is doubled 
(grey bars). The horizontal grey shading gives the 
comparable range of effects that could be 
expected if age at first sex for males and females 
is increased by 2 years. 
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4.5 Discussion 
Sexual behaviour change is crucial to prevent HIV infections in sub-Saharan Africa 
[124]. Cross-sectional surveys of individuals' self-reported sexual behaviour show 
that young women that have had sex with an older man or begun sexual activity 
when young are more likely to have been infected with HIV [40, 126-128]. On this 
basis, interventions aiming to change behaviour have been proposed that focus on 
discouraging cross-generational sex and delaying sexual debut [121, 130, 131]. 
Although it is clear that these changes will somewhat reduce the risk of infection to 
the individual it was not known what impact they could have on the spread of HIV 
through the population. Despite this uncertainty the importance of cross-generational 
sex in supporting high HIV prevalence has been presumed [131] and an increase in 
abstinence among young people has been partially credited with the decline in HIV 
prevalence rates in Uganda [24, 80]. In this chapter, a mathematical model was used 
to quantify the reduction in the average lifetime risk of HIV infection that reducing 
cross-generational sex and delaying first sex could bring. The model was carefully 
parameterised using detailed data from a rural district in eastern Zimbabwe [40] but it 
can be expected that the qualitative insights will be transferable to other African 
settings with generalised epidemics. 
The model simulations suggest that HIV prevalence is only slightly higher with 
much more cross-generational mixing. Furthermore, even if 99% of sexual 
partnerships are formed between peers, HIV can still reach a high endemic level. 
This is contrary to the suggestion that without cross-generational mixing HIV could 
not persist endemically [131]. Cross-generational sex helps increase prevalence 
because few of the partnerships of infected older males are with already-infected 
older females and are more likely to be with uninfected younger females. However, 
the link is not strong because the infection will reach all age-groups eventually under 
almost any mixing scenario, and then young women will be exposed instead to the 
high rates of sexual activity of their male peers. Sex with older men is more risky than 
sex with younger men partly because the former are more likely to be infected with 
HIV, having been exposed to the risk of infection for longer. However, the observed 
gradient in HIV prevalence among males by age is partly a result of the cross-
generational mixing: prevalence among young men is suppressed by cross-
generational mixing because they have only limited access to their peers and instead 
have sex with even younger uninfected women. A switch to peer-to-peer mixing will 
increase prevalence among young men making, from a female perspective, formerly 
'low-risk' contacts increasingly 'high-risk'. In this way, the benefit of peer-to-peer over 
cross-generational mixing to the young women is negatively frequency-dependent; 
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one young woman will put herself at less risk by choosing partners her own age over 
older men but as more women come to do the same the benefit of this behaviour 
change is reduced as HIV prevalence among young men increases. 
The real impact of cross-generational sex on the population level spread of 
HIV is the power imbalance in those partnerships and the implications this has for the 
chance that condoms will be used [40, 41]. The results show that behaviour change 
interventions should aim to minimise unprotected sexual contact by young women 
with anyone and not target the age difference between sexual partners per se. 
Nonetheless, this pattern of partnership formation between older men and younger 
women does seem to underlie the high female-to-male HIV prevalence ratio among 
young people; the model generates ratios at least as extreme as those observed 
without assuming any difference in susceptibility to infection by gender or age. Cross-
generational mixing must be considered when examining other types of behavioural 
intervention: the demand for their sexual partnerships could undermine the benefit 
young women get from remaining abstinent for longer and the importance of 
transmission from older men makes the frequency with which they use condoms 
especially important. 
Abstinence (through delaying the onset of sexual activity) removes the risk of 
infection for only a few years - a small fraction of one's lifetime exposure. This period 
may be important because the first years of a woman's sexual activity may carry the 
greatest risk of transmission for a number of biological [280, 281, 283] and 
behavioural [40, 133] reasons. However, even assuming that susceptibility declines 
strongly with age, the lifetime benefit of delaying sex for two years is expected to be, 
at most, only 8%. The benefit is smaller (3%) if the "demand" for their sexual 
partnerships is not reduced. Although abstinence undeniably reduces the risk of 
infection, its impact on the spread of HIV and the average chance of infection over a 
lifetime is small. Corroborating this conclusion, detailed statistical analyses indicate 
that most of the excess risk of prevalent infection that is associated with earlier 
sexual debut is actually mediated by risk behaviour later in life [127, 129]. 
Given the limited population-level effect of delaying age at first sex, it is 
unlikely that the dramatic prevalence decline in Uganda [24] was primarily driven by 
the two year delay in first sex [80]. Nonetheless, in the American HIV/AIDS PEPFAR 
initiative [163], abstinence gets equal billing with increased condom use and 
decreasing casual sex, which have been shown to have a much greater impact on 
lifetime risk of infection [23, 75, 77]. 
In the coming years, on-going and proposed behaviour interventions will be 
assessed and their potential effect estimated. This modelling work has highlighted 
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the sensitivity of the effectiveness of some behaviour changes to unknown properties 
of the sexual network (e.g. the response of males to female behaviour change) and 
projections should incorporate this uncertainty. From an individual-level perspective it 
is possible to identify those elements of sexual behaviour that are associated with the 
highest risk of infection. However, without a dynamic description of HIV transmission 
it is not clear how these changes will limit the spread of HIV at the population-level. 
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Chapters: The Role of Testing and Counselling 
For HIV Prevention and Care in the Era of 
Scaling-Up Antiretroviral Therapy 
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5.1 Introduction 
Testing and counselling (TC) services, whereby individuals are tested for HIV and 
receive behaviour change advice, are being scaled-up in many African countries 
[143, 147, 248]. in addition, recent years have seen unprecedented financial and 
logistical commitments to providing antiretroviral treatment (ART) to those in need 
[284, 285]. Testing centres therefore have a dual-role; providing arguably the best 
opportunity to motivate behavioural changes to curb the spread of HIV, and as a 
point of entry to the health care system and ART programmes. 
The laudable clinical goal of saving individuals from AIDS will be sustainable 
only if new infections can simultaneously be prevented [10]. ART may contribute to 
prevention efforts by reducing transmission directly through decreased infectiousness 
[286] and indirectly through reduced stigma [287]. However, programme policy that 
focuses on achieving clinical care targets without an explicit focus on prevention 
through behaviour change may lead to a testing strategy dominated by identifying 
HIV-positive individuals requiring ART rather than also providing HIV-negative 
individuals with behaviour change services to prevent future HIV infections and 
reduce the need for ART [288, 289]. 
High quality HIV prevention counselling is focused on promoting sexual 
behaviours that minimise the risk of acquiring and transmitting infection and includes 
the following elements: personalized risk assessment; support for positive changes 
already made; clarification of critical misconceptions; negotiated achievable 
behaviour change steps; flexibility in the HIV prevention approach; an opportunity to 
build skills; and, use of clear language to explain test results [290]. Periodic 
assessments of counselling services can help maintain these standards [290]. In one 
trial in America (Project REPSECT), HIV testing and high quality infection-prevention 
counselling was shown to reduce the incidence of sexually transmitted infections 
among HIV-negative men and women [136]. Other TC services, which may not 
include all the elements outlined above, have also been shown to lead to protective 
behavioural changes in low-income settings, particularly among those already 
infected [137]. However, observational studies, where TC was not delivered as part 
of a trial, indicate less promising results, and a tendency for only infected individuals 
to make protective behaviour changes [139]. Furthermore, in two recent studies in 
Zimbabwe, there are indications that some uninfected individuals increase their risk 
behaviour following TC [140, 250]. 
Given the complicated transmission dynamics in mature generalised HIV 
epidemics, the multifaceted nature of TC and the range of observed behavioural 
outcomes in studies and trials, the impact of TC at the population level is not clear 
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[291]. Mathematical models have generated important insights about the spread of 
the virus through networks of sexual partnerships and the impact of HIV interventions 
[275]. Optimistic predictions of the impact of multiple interventions, including TC, on 
the incidence of HIV globally were influential in setting the target of preventing seven 
million infections that was adopted by the U.S. President's Emergency Plan for AIDS 
Relief (PEPFAR) programmes [6]. However, the contribution of TC to the predicted 
prevention goals has not been analysed, nor has the influence of particular aspects 
of behaviour change associated with TC or patterns of roll out of TC been explored. 
In order to provide information to policymakers, the impact of TC programmes on the 
spread of HIV was investigated through mathematical modelling. 
5.2 Methods 
5.2.1 Introduction to the Model 
The model used in this chapter is similar to those described in earlier chapters in the 
way that it simulates the transmission of HIV in a gender, age, and sexual-activity 
structured population. However, significant developments have been made to 
incorporate the following aspects of TC; 
• Change over time in number of individuals that receive TC; 
- Individuals changing behaviour following TC dependant on HIV status; 
• individuals needing ART at advanced stages of infection; 
• Choice of sexual partners and condom use depending upon HIV status; 
• Incorrect 'knowledge' of HIV status (where individuals are infected after 
receiving a negative test result). 
The structure of TC delivery in the model and its effect on sexual behaviour is 
shown diagrammatically in Figure 5.1. It is assumed that only a fraction of the 
population has access to TC services - this is called the 'TC catchment". The size of 
the TC catchment can increase over time to reflect TC reaching more disconnected 
members of the community as well as its widening geographic availability (labelled 
(i)). The rate at which individuals in the catchment receive TC is an independent 
parameter, called "TC uptake". This can also change over time to reflect increasing 
demand for TC. Uptake can vary between population sub-groups to simulate 
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differences in the demand for TC (e.g. higher for older individuals or for those with 
symptoms of immune-suppression). 
The hatched area in Figure 5.1 shows the fraction of the population that have 
received TC and have changed their sexual behaviour. It assumed that all individuals 
that receive TC change their sexual behaviour: the way in which they do so is 
parameterised to reflect the findings of studies of the effect of TC in African 
populations (see later for details). This behavioural change can be permanent, or 
individuals may revert to their previous patterns of behaviour over time (labelled (ill)). 
Among those individuals that have received TC and have changed their 
behaviour, some will not be infected and have received a negative test result, others 
will be infected and have received a positive test result, but a few will be infected and 
have received a negative test result (because they were infected after receiving TC). 
In the model, individual behaviour can be set by the perceived HIV-status (i.e. result 
at last test) and, for brevity, the technical specification refers to the behaviour of 
individuals that "think" they are infected or uninfected, and individuals that have not 
received TC are said to "not know" their HIV-status. 




Individuals with Individuals that 
sexual received TC, but 
behaviour sexual 
changed by TC behaviour 
reverted 
Individuals that have 
gone for TC 
(eligible for ART & 
PMTCT) 
Figure 5.1 Structure of the TC model, showing (i) expanding catchment of TC, (ii) uptake of TC, and 
(iii) individuals that have received TC reverting to previous patterns of sexual behaviour. The hatched 
area shows the fraction of the population that have received TC and whose sexual behaviour is 
changed. 
The full technical specification of the model is detailed in four sections: 
i. Simulating Heterosexual Transmission of HIV; 
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ii. Simulating The Effects of TC; 
iii. Fitting to Epidemiological Conditions in Zimbabwe; 
iv. Parameters for behaviour change scenarios. 
5.2.2 Simulating Heterosexual Transmission of HIV 
The model is defined by a set of ordinary differential equations which are solved 
numerically using Euler's method with a time-step of 1/12 years. The state variables 
are given by : k refers to gender [k=0 men and k=1 women); I refers to sexual 
activity group {1=1 sex work group (i.e. female sex workers and their male clients), 1=2 
casual sex group (i.e. men and women that have casual partners) and 1=3 spousal 
sex group (i.e. men and women in stable relationships)); a refers to age (five-year 
group: a=0:15-19 years, a=1: 20-24 years, ..., a=14: 80-84 years); s refers to HIV-
status {s=0 susceptible, s=1 primary HIV infection, s=2 latent HIV infection, s=3 pre-
AIDS, s=4 full-blown AIDS, s=5 HIV infection and on ART and s=6 HIV infection and 
ART failed); v refers to TC-status and serostatus that the individual "thinks" they are 
(v=0 "thinks HIV negative", v=t "thinks HIV positive", v=2 "doesn't know but is in the 
TC catchment", v=3 "doesn't know and is not in the TC catchment", t/=4 "has 
received TC but reverted to previous sexual behaviour"). 




- + A./.a +^ll.a(0)Xu,a ...(5.1) 
dt 
In the equations: is the rate at which individuals of that gender, age, sexual 
activity group and perception of HIV-status are infected with HIV; , „ (0 is the rate at 
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which individuals of that gender, age, sexual activity group and HIV-status receive 
TC; r \s the rate at which those who think they are HIV negative are retested; is 
the per capita death rate; tts is the probability of the test returning a positive result for 
an individual of HIV-status s (so that ttq is the probability of a positive result for an 
HIV negative individual and is equal to one minus the test specificity). The rate at 
which those who have received TC revert to the behaviour of those that do not know 
their HIV-status is g\ these individuals will not receive TC again but are eligible for 
ART when they develop symptoms of immune-suppression (ie. start pre-AIDS) or 
treatment to prevent mother-to-child transmission (PMTCT) when pregnant. 
The number of individuals entering the youngest sexually-active age group of 
each gender and sexual activity group each year is Bl'J {t); 
3 2 8 
j=0 /=1 a=\ (Gd - ) + (1 - 6)(1 - (f - A ) + ( f - A)] 
( 0 = ( 1 -
s=0 /= ! a= l 
...(5.2) 
(1" C (^ - ^) + {t-A) + {t - A)] + 
where A is the age at which individuals begin sexual activity; k^. is the fraction of 
those that begin sexual activity of that gender; , is the fraction of those that begin 
sexual activity of that gender that enter that sexual activity group; 9{t) is the fraction 
of the population to which TC is available at time t (i.e. "catchment"); q is the fraction 
of live births that survive to age A\ is the fertility rate (live births per person-year) 
of females of that age group; C, is the probability that a woman of that HIV-status 
transmits the infection to her baby; Q is the fraction of pregnant women that know 
they are infected that receive PMTCT; P is the efficacy of PMTCT (fractional change 
in probability of transmission of infection from mother-to-child). This assumes that no 
child born with HIV lives older than A to enter the sexually-active population and that 
women with AIDS and those on ART are infertile. 
The number of infants born each year that will die of maternally-transmitted 
HIV infection is: 
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2 , 2 . 2 . : : . 
J=1 /=1 fl=l v+ z i . (f - ^ ) + (f - A) + (f -
...(5.3) 
These deaths can be included in calculations of all AIDS-related deaths, distributed 
exponentially (with mean 5 years) after birth. 
The number of new heterosexually-acquired and vertically-acquired infections 
at time t are; 
3 2 4 
V J,0 
2 , / . a 
i=l /=1 v=0 a=\ 
5=1 /=1 0=1 
...(5.4) 
dt 
The equations describing those with primary HIV infection are: 






jv i .o 
= -Ky, + r;r. + g % 
The equations describing those in the later stages of HIV infection that do not 
know they are infected, or who have reverted to their patterns of sexual behaviour 
before receiving TC, are: 
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da: sA kj 
~ - ~ iP-k.a + kla + + ^kla ) dt 
rIY 
dX 
^ - W*..+(T,+ 
dt 
d% J,0 k,l ,a 
= (0(1 - ;r,)%;;,% - (;/,_, + (7, + r;r, + g)x;;;;. 
.(5.6) 
J.2 
for J = 2,3,4 
Here % is the rate of progress from stage of HIV infection s to the next stage, s+1. 
The parameter a* is the AIDS-associated death rate. 
The equations describing those in the later stages of HIV infection that know 






'3,2 3,0 '3,1 
4,2 '4,0 




^ = ( ^ 6 ) - (//*.+<^7 
dt 
rIY 
f ± w ^ _ „v6.1 
dt 
...(5.7) 
- S^kia -(Mk.a+<^6)^k.la 
where the fraction of those that have received TC and found to be infected that 
receive ART is f, the rate of failure for those on treatment is %; the rate of mortality 
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for those who treatment has failed is oy. It follows that the rate of adult AIDS-related 
death (including those whose treated has failed) at time f is: 
...(5.8) 
The per capita force of infection is defined with respect to gender, HIV-status, 
TC-status, and sexual activity group in the following way. For ease of notation, the 
state variables ( ) are re-classified as ^, where b is the behaviour-mode 
variable (corresponding to perception of own HIV-status). The parameter Ss 
determines the relative partner change rate (i.e. sexual activity) with respect to HIV-
status; those who have full-blown AIDS or failed ART are assumed not to be sexually 
active; those with pre-AIDS are assumed to partnerships at half the rate they had 
previously. 
)(b = 2;doesn't know HIVstatus) 
j=0 
6 
^k.i,a (b = 1; thinks HIV positive) ...(5.9) 
j=0 
6 
^°i,a - X ^ s ^ k l a (b = 0; thinks HIV negative) 
j=0 
In this way 'sero-sorting' can be simulated by a tendency for assortative mixing with 
respect to b: that is, males that think they are HIV negative (6=0) preferentially 
forming partnerships with females that also think they are HIV negative; males that 
think they are HIV positive (b=1) preferentially forming partnerships with females that 
also think they are HIV positive; and, males that do not know their serostatus 
preferentially forming partnerships with females that do not know their HIV status 
either. The tendency of individuals to form sexual partnerships assortatively with 
respect to behavioural-mode isgg. 
There is also a tendency for males to preferentially form sexual partnerships 
with females in the same sexual activity group, which is specified byc^. 
The number of partnerships formed per year is for individuals of that 
gender, sexual activity group, age group and behaviour mode, if they are sexually 
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active (i.e. not full-blown AIDS or failed ART). For males this is parameterised with a 
mean rate of partnership formation for each age group (c^(f)) and two ratios of 
partnership formation rate for the two higher sexual activity groups relative to those in 
the lowest sexual activity group (<«, and The rate of partner change for each 
male sexual activity group is then calculated as: 
...(5.10) 
cAO 
The females' rates of partner change are determined by the distribution of 
partnership formation by the males: 
W 
4 . ' = 4 . . ^ ...(5.11) 
Pi.ej,g.h,m,n defined as the proportion of sexual partnerships that a male of sexual 
activity group e, age group / and behavioural-mode g forms with females in activity 
group h, age group m and behavioural-mode n; 
,g,h.m,n 
''2,2,m 2^,2,m + 2^,3^ 2,3.n^  
r W" 
^2,l,m^2,l,ra + ^2,2,m^2,2,m + 2,3.m^2.3.n 
...(5.12) 
Here Ay ^ is the proportion of sexual partnerships of males in age group fthat are 
8 
formed with females in age group m (X!^/,m =1)- As in other models in this thesis, 
Ay ^ is parameterised so that most partnerships are formed between men and 
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women who are 5-10 years younger (mean = 7.4 years). j is the identity 
matrix; <5^J = 1 if i=i; d^ . = 0 otherwise. 
From this, the distribution of each female's partnerships is calculated; 
P2,h,m,n.e,f,g the proportlon of sexual partnerships that a female of sexual activity 
group h, age group m and behavioural-mode n forms with males in sexual activity 
group e, age group f and behavioural-mode g: 
Pl.h.m.n.eJ ,g Pl.e.f ,g,h,m.n 
c W" 
.(5.13) 
The number of sexual acts that comprise a sexual partnership depends on the sexual 
activity group and behavioural modes of both partners The proportion of 
sexual acts in which a condom is used throughout depends on the sexual activity 
group, age group and behavioural-mode of both partners 7,^ a,b,r,a\b'0)• Since these 
values are the same when calculating the force of infection for males or females, it is 
easier to distinguish the characteristic of the individual {k, s, a, I, b) from those of their 
sexual partners with a prime {K, s', a', f, b'). It is assumed that condom use 
eliminates the chance of HIV transmission. 
The overall risk of transmission per partnership is thus given by '• 




; _ fey 
' 6 
f o rb '=Oor l 
j'=0 
'^ (,a,b,r,a',i>'W - ^l,b,rj>'^^~ l^,a,b,r,a\b'(0) ...(16) 
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where is the average infectiousness of sexual partners of that gender, sexual 
activity group, age and behavioural mode; T,^a,b.w(t) is the number of unprotected 
sex acts; is the number of sex acts in a partnership between individuals of 
those sexual activity groups and behavioural modes, and 7, a.b.i\a\iAf) is the fraction 
of sex acts in which condoms are used correctly and consistently in partnerships 
involving individuals of those sexual activity groups, age groups and behavioural 
modes, a .^ is the probability of acquiring HIV in one sex act with a partner of that 
gender and HIV-status. It is assumed that transmission from males-to-females is 
twice as efficacious as from females-to-maies [292, 293], that transmission during 
acute infection and full-blown AIDS is ten times as efficacious as during latent 
infection [286], that transmission is five times as efficacious during pre-AIDS as 
during latent infection, and that infectiousness of individuals on ART is reduced by a 
fraction E relative to those with pre-AIDS: 
lOa^ 
a l = 5 a l ...(5.17) 
af = (1 -E )a^ 
^2 = 2a/ 
The overall force of infection to individuals of each gender, sexual activity group and 
behavioural mode is thus the product of the number of partnerships made and the 
rist< of infection associated with each such partnership; 
3 8 2 
\ . l . a ~ \ , l - \ , l 
; •=! a ' = l b '= 0 
3 8 2 . 
^.l,a ...(5.18) 
i=\ a=lb'=0 
0 3 9 2 / \ 
/ ' = ! fl'=l 6 - 0 
individuals have a "preference" for the fraction of sexual acts in which 
condoms are used consistently based on their age and sexual activity group (haa and 
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hbi,, respectively). However, condom use in a particular type of partnership is a 
compromise of the preferences of both partners, with the preferences of the older 
partner and the partner with in the lowest sexual activity group taking precedence: 
7/,a,3,/',a',3 ~ ^ (^^max(a,a') + ^^max(/,/') ) ...(5.19) 
Default parameters (used in all simulations unless otherwise stated) for the 
HIV transmission component of the model are listed in tables 5.1 and 5.2 
Symbol Interpretation Default Value 
Age at first sex A Age at which individuals become sexually 
active 15 years 
Survival 0 to A 
years q Fraction of live-births that survive to age A. 0.84 
Fraction females in 
sexual activity 
group 1 
A . i 
Fraction of females in highest sexual activity 
group. 0.1 
Fraction females in 
sexual activity 
group 2 
Fraction of females in next-highest sexual 
activity group. 0.3 




Fraction of males in highest sexual activity 
group. 0.1 




Fraction of males in next-highest sexual 
activity group. 0.3 
Ratio of sexual 
partnership 
acquisition rate 
(group 1 relative to 
Q), 
Ratio of rate of partnership formation 




Ratio of sexual 
partnership 
acquisition rate 
Ratio of rate of partnership formation 
between next-highest and lowest sexual 20 
(group 2 relative to activity group. 
group 3) 
Fraction of males' partnerships allocated to 





Mean years with primary HIV infection for 
those that do not know they are HIV+. 1 year 
Years latent 
infection 
Mean years with latent HIV infection for 
l/CTj those that do not know they are HIV+: varies 
with age 
8 years 
Years pre-AIDS 1/<73 Mean years with pre-AIDS for those that do 




Mean years with AIDS (before dying) for 




transmission rate per a\ 
Probability of a male acquiring HIV infection 
during one sexual act with an female with 0.0012 




A - ^2 - ^3 - ^4 
Probability that a woman of that HlV-status 
transmits the infection to her baby. 0.35 
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Fraction of sexual acts in which condoms are 
Condom use (sexual 
activity group 1) 
hbj used correctly and consistently throughout, in 
partnerships by individuals in highest sexual 
activity group. 
0.5 
Fraction of sexual acts in which condoms are 
Condom use (sexual 
activity group 2) 
hbj used correctly and consistently throughout, in 
partnerships by individuals in next-highest 
sexual activity group. 
0.25 
Fraction of sexual acts in which condom is 
Condom use (sexual 
activity group 3) 
hbi used coiTectly and consistently throughout, in 
partnerships by individuals in lowest sexual 
activity group 
0.10 
Number of sex acts 
per partnership 
(sexual activity 
group 1) for l'<3 
Number of sexual acts per partnership in 
partnerships formed by individuals in highest 
sexual activity group 
4 





Number of sexual acts per partnership in 
partnerships formed by individuals in next-
highest sexual activity group 
40 





Number of sexual acts per partnership in 
partnerships formed by individuals in the 
lowest sexual activity group 
100 
Fractional reductions in the probability of 
PMTCT efficacy P mother-to-child transmission for those who 
receive treatment relative to those that do not. 
0.5 
Time on ART 1/(7, Mean years spent on ART before treatment failure and progression to full-blown AIDS 5 
Reduction in Fractional reduction in probability of 
transmission on E transmission for those receiving ART relative 0.99 
ART to those in pre-AIDS 
Relative partner 










Individuals with pre-AIDS are assumed to 
form half the number of partnerships of those 
with acute or latent infections or those 
susceptible. Individuals with full-blown 
AIDS or failed ART are assumed not to form 








Table 5.1 Default parameters (used in all simulations unless otherwise stated). 
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Fraction of sexual acts in Mean number of new sexual 
Age which condomjysed, by age partnerships formed per year ( ) 
15-19 030 2 2 
20-24 0.25 2.3 
25-29 0.20 2.4 
30-34 0.15 2.6 
35-39 0.10 2.1 
40-44 0.05 1.5 
45-49 0.02 1.0 
50-54 0.01 0.2 
55-84 0.0* 
Table 5.2 Condom use and mean partners per year assumed in the model. Based on sexual behaviour 
data from rural eastern Zimbabwe [40]. NA: Not applicable ; * These ages are assumed to be not 
sexually active. 
5.2.3 Fitting to EDidemioloaical Conditions in Zimbabwe 
To ground the analysis in a particular setting, the model was parameterised with 
sexual behaviour and demographic data from Zimbabwe [17, 91], where the two 
most recent TC studies were based [140, 250], in consultation with public health 
professionals and national decision-makers (participants at a workshop in Harare, 
July 2005: see end of this chapter). To represent the demographic conditions in 
Zimbabwe, on which the simulations presented here are based, the initial 
background mortality and fertility rates are based on World Bank estimates from the 
pre-AIDS era [207]. These generate population growth of approximately 4% per year 
and a life expectancy at birth of 52.1 for males and 54.7 for females. Successive 
demographic health surveys [294-296] in Zimbabwe suggest that fertility has 
decreased since 1998, which can be attributed to social factors as well as AIDS-
related sub-fertility [297]. We assume that age-specific fertility rates have declined 
linearly from 1980 (total fertility rate=7) to 1999 (total fertility rate=4) and remain 
constant thereafter (Table 5.3). 
To reflect the changes in sexual behaviour that have been reported in 
Zimbabwe in recent years [17, 91], between 1997 and 2003 the overall number of 
partnerships formed decreases by 20% and the probability of condom use doubles, 
for all types of individuals in all partnerships. The timing and magnitude of these 
changes is informed by a recent review of the epidemiological literature in Zimbabwe 
[17], and through fitting simplified transmission models to prevalence time-series at 
individual ante-natal clinic surveillance sites (Chapter 2). 
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The overall agreement between the model and available HIV-surveillance 
data is shown in Figure 5.2. Adjustments in the value of the following parameters 
were used to improve the fit of the model to the data; the basic HIV transmission rate 
(af) , the sizes of the sexual activity groups ,) and the unprotected number of sex 
acts per partnership and hbl). The value used for the transmission rate 
(0.0012) is similar to an empirical estimate from Uganda [286] (0.0011: 95% 
confidence interval 0.008-0.0015). These sexual behaviour parameter were chosen 
for fitting because they could not be reliably estimated from sexual behaviour reports 
in general population surveys [228]. This is because they require individuals to be 
classified in "sexual activity groups" but those with the riskiest behaviour are likely to 
be under-represented in surveys and reporting biases could distort the true 
distribution of risk in the population and substantially alter the epidemic projections 
[228, 231, 298]. 
National HIV prevalence estimates in Zimbabwe mainly come from women 
attending selected antenatal clinics (ANC). When analysing trends in such data, only 
consistently sampled sites that used the same testing methodology should be 
included [53]. The national aggregated data used here are based on 12 sites (4 rural, 
6 urban and 3 peri-urban), weighted according to the urban-rural composition of the 
national population. These data are used to determine the timing of epidemic growth, 
plateau and maturation in the model but not the absolute level of HIV prevalence. 
This is because prevalence estimates among pregnant women are not representative 
of the general population [48, 52] and the HIV testing protocol that was used 
throughout this period (Genscreen) tends to over-estimate prevalence [16, 17]. 
Instead, the level of the epidemic is set by the (provisional) estimate from the 2005/6 
Demographic and Health Survey (DHS) [299]. This is the only nationally-
representative estimate of HIV prevalence in the general population. 
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Figure 5.2 Model HIV incidence and prevalence, estimates of HIV prevalence among women 
attending selected ANCs (2000, 2001, 2002 and 2004) and the (provisional) DHS estimate of HIV 
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Source World Bank World Bank World Z-DHS Z-DHS Z-DHS 
1991$ 1991 [300] Bank (1988)[294] (1994)[295] (1999)[296] 
Age-
1991 [300] 
Males Females Males Females 7990 ypgg 7999 
range 
15-19 373 365 0.004 0.004 0.175 0.103 0.099 0.112 
20-24 304 299 0.006 0.005 0.313 0.247 0.21 0.199 
25-29 247 244 0.007 0.006 0.324 0.247 0.194 0.18 
30-34 200 198 0,007 0.006 0.271 ( )219 0.172 0.135 
35-39 161 161 0.008 0.007 0.201 0.16 0.117 0.108 
40-44 129 129 0.010 0.008 0.125 0.086 0.052 0.046 
45-49 102 103 0.012 0.009 0.053 0.036 0.014 0.015 
50-54 79 81 0.016 0.012 0 0 0 0 
55-59 61 63 0.021 0.016 0 0 0 0 
60-64 46 49 0.030 0.024 0 0 0 0 
65-69 33 36 0.044 CI.038 0 0 0 0 
70-74 21 23 0.068 0.060 0 0 0 0 
75-79 11 13 0.105 0.094 0 0 0 0 
80+ 4 5 0.189 0.174 0 0 0 0 
Table 5.3 Demographic assumptions used in the model. *Total size of population in 1980 chosen to 
generate population size in 1997 equivalent to population DHS estimate (6.65 million aged 15 or 
older). **Female fertility is assumed to decrease linearly from 1980 to 1999 (trend fitted through these 
data) and remain constant after 1999. 
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5.2.4 Simulating the Effects of TC 
The average rate at which individuals receive TC ("uptake") is v'(?)and the fraction 
of the population for which TC is available ("catchment") is d{t). Both of these 
parameters can vary over time, increasing linearly from zero to a constant level at a 
specified time and rate: 
v ' (0 = 0 
v'(f) 
v ' (0 = V 
t - t . 
for t < t . 
for t. < t < t . 
for t > t . 
...(5.20) 
90) = 0 
6 ^ ) = 9^ fort , < t < t , 
for t > t„ 
..(5.21) 
where ts and fe respectively refer to the start of implementing the intervention and the 
time at which the maximum level is reached. 
For the same number of individuals receiving TC, the relative probability that 
individuals from different parts of the population receive TC can be altered according 
to gender (//A:^), HIV-status sexual activity group (;;/,) and age {rja^). The 
per-capita rate at which individuals of a particular gender, age, HIV-status and sexual 
activity group receive TC is , ^ (0 ; 
T/(f) 
= 5 3 « 
*=! J=0 /=! <2=1 
...(5.22) 
For the parameters (77^ ^ ,775^ . ,77/, and 77aJ a value greater than one implies that 
individuals in that sub-group are more likely to receive TC than others; a value of one 
implies that the chance of receiving TC is the same as the average for the 
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population. For simplicity, the evaluation of these parameters is set by 'short-hand' 
summary parameters which are referred to in the main text (Table 5.4). 
Short-hand for parameter 
Model Parameter 
(used in main text) 
"Focus on females" 
#2=10; Tlk.=\ 
(i.e. females more likely to receive TC than males) 
"Focus on males" 
77 ,^ =0.1; 77/:. =1 
(i.e. males more likely to receive TC than females) 
"Focus on high-risk" 
(i.e. those with casual partners more likely to receive TC Vh ^^0; 77^ 2 "1*^' V h 
than those without) 
"Focus on low-risk" 
(i.e. those without casual partners more likely to receive Vh "^-1' ^7/2 =0.1; T]l^  =1 
TC than those with) 
"Focus on sick" 7/^ ^ =10; 77^4=10; 
(i.e. those with symptoms of immune-suppression versus 
those without) 7/5', =1; 775'2=1 
"Focus on healthy" =0.1; T]S^ =0.1; 
(i.e. those without symptoms of immune-suppression 
versus those with) 
F = 1 0 = 
"Focus on young" 
(i.e. Linear trend in rate of receiving TC, such that 15-19 
year-olds are (ten times) more likely to receive TC than 
those aged 30-34 years.) 
"Focus on old" 
(i.e. Linear trend in rate of receiving TC, such that 30-34 F =Q.\ * 
year-olds are (ten times) more likely to receive TC than 
those 15-19 years.) 
Table 5.4 Parameters that specify TC targeting. All parameters set to unity to represent "random" 
distribution of those receiving TC. *where Tja^ — F*'' . 
The expansion of the catchment area is simulated by, at each time-step, 
moving individuals into the catchment as follows. 
yJ.3 V y^.3 +7^ ' 
Y S , 4 . y _ 7 s , 
^ k,l,a k.l.a ^k,l.a ' 
7^ - V .^4 
^k,l,a - YY ...(5.23) 
TT _ 
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The model allows individuals that have gone for TC to make the following 
behavioural/biomedical changes; 
• Change the proportion of sex acts in which condoms are used 
The basic pattern of condom use with respect to the sexual activity group and age 
group of both partners when neither know their HIV-status is The 
proportionate change in condom use when individuals know their HIV-status, by 
sexual activity group is, Ni^. 
7i.a,Q,r.a'b' = yi.a.b.r.a.o = ^i.i7i.a,3,r.a,i fot b Or b'= 0,2 (at least one known uninfected partner) 
Ti.a.uwb' = 7i,a.b.w = Ni.2Yi.a.xr.a.3 for b or b' = 1,2 (at least one known HIV infected partner) 
= = (knownsero-discordantpartnership) 
...(5.24) 
• Change the number of sexual acts per partnership 
Relative to those that do not know their HIV-status, the change in number of sexual 
acts per partnership for individuals in each sexual activity group that think they are 
not infected or are infected is or respectively, such that: 
~^l,b,l\2 " ^l,2'^l,S,l\3 . . .(5.25) 
= min(M , M 
• Change the rate of partnership formation 
Relative to those that do not know their HIV-status, the change in the rate of sexual 
partnerships formed by individuals that think they are not infected or infected is H, or 
, respectively, such that: 
(partner change rate by those that think they are infected) ...(5.26) 
(partner change rate by those that think they are not infected). 
• 'Sero-sorting' 
As detailed above, the extent to which males that think they are not infected, males 
that think they are infected and males that do not know their HIV-status bias the 
147 
selection of their sexual partners to females that think they are not infected, infected 
or do not know their HIV-status, respectively, is El. 
• Treatment with ART 
As detailed above, a fraction, f (which is constant over time), of those that know they 
are infected are provided with ART when they develop symptoms of immune-
suppression. The infectiousness of those on ART is reduced by E relative to those 
with pre-AIDS: 
al={\-E)al ...(5.27) 
Individuals on ART progress to AIDS (following treatment failure) after, on average, 
l / ( jg years. 
• PMTCT 
As detailed above, the chance that a baby born to a woman of HIV-status s is Cs and 
the reduction in this probability brought about through, PMTCT to mothers that know 
they are infected is P. The fraction of pregnant women that know they are infected 
that receive PMTCT treatment is Q. 
(iv) Parameters for behaviour change scenarios. 
To estimate the behavioural changes that might be expected among those that 
receive TC, a literature review and meta-analysis was conducted that included 
studies that have investigated the effects of TC in Africa. {This was performed by S 
Dube, in consultation with the author of this thesis.) 
A search was made using MEDLINE 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) for studies published between 
January 1985 and August 2005 using the MeSH terms: "Voluntary Counselling and 
Testing" AND "HIV", OR "VCT" AND "HIV" AND "AFRICA". Due to the lack of quality 
randomised controlled trials in Africa, observational studies were included as well as 
trials. In total, six studies were identified (cited in legend to Figure 5.3). No particular 
measure of sexual behaviour change was quoted in all studies, but various 
definitions of change in condom use were the most comparable. 
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There is significant heterogeneity in the effects reported in these studies, but 
the estimated combined effect of TC is a two-fold increase in the odds of 'condom 






















Tea for heterogeneity: Q= 186.976 cm 5 degrees of &eedom (p= 0.000) 
Figure 5.3 Results from meta-analysis - the effect of TC on changes in condom use in African settings. 
Various measures of 'condom use' were given in the studies: Kamaga, 1991 [301], "chance of always 
using condom with regular partner" among discordant married couples followed over 12 months"; 
Allen, 1992 [302, 303], "chance of often condom use with regular or irregular partner" by women 
followed up for 12 months"; Jackson, 1997 [304], "chance of using condom in the past 3 months in any 
extra-marital sex": followed up for 4-6 months"; Manicaland, 2001, "chance of using condom with any 
partner in the past 2 months" (this is an adapted analysis based on the findings later published by Sherr 
et al. [250]); VCT Efficacy Group, 2000 [137], "chance of using condom in the past 2 months with all 
partners", followed-up over 12 months"; Motovu, 2005 [305], "chance of using condom with any 
partner in the past 6 months". 
In Zimbabwe, TC services are set to be greatly expanded in the coming years. In the 
projections for Zimbabwe (Figure 3 in the main text), it was assumed that the fraction 
of the population that can access TC will increase steadily to 80% over 10 years 
(2005-2015), and with uptake in the population such that the average time between 
services becoming available and attending TC is 2.5 years (Table 5.5). In these 
projections, no targeting of TC is simulated. This 'optimistic' expansion will be 
realistic if TC policies include routine 'opt-out' testing [146, 306], home-based 
services [307] or services integrated with antenatal care [308]. 
A number of scenarios for the behaviour changes associated with TC are 
simulated. The results of the large efficacy trial in low-income settings [137] are in 
good agreement with those from the other observational studies (Figure 5.3) and due 
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to the comparative wealth of data and the strength of evidence of such a randomised 
trial, we parameterised one behaviour change scenario using data only from this one 
study (Table 5.6). Reports of condom use with the primary partner were taken to 
relate to partnerships involving the lower two risk groups (/=2,3), whereas reports of 
condom use with non-primary partner were taken to relate to partnerships involving 
the riskiest sexual activity groups (/=1). 
An alternative scenario is derived from TC delivered in eastern Zimbabwe 
(Manicaland HIV/STD Prevention Project) [250] (Analysis undertaken jointly with I 
Cremin and B Lopman). Behaviour change is estimated from the change in reported 
sexual behaviour in two surveys conducted three years apart, among those that 
attended TC within one year of the first survey. HIV-status of individuals at each 
round was ascertained using standard laboratory procedures [250] and it was 
assumed that HIV-status recorded at the first survey was the same as the test result 
received at TC. In line with secular changes in sexual behaviour that have been 
recorded across Zimbabwe [17], reported numbers of sexual partners in the last year 
tended to decrease over time for all individuals, irrespective of whether they attended 
TC. Although multivariate multinomial analyses suggest that uninfected individuals 
are more likely to increase the number of partnerships formed than either those 
receiving TC who were infected or those that did not receive TC [250], the overall 
trend in the mean number of partnership formed was for fewer partnerships for both 
infected and uninfected individuals receiving TC. The mean individual change, 
adjusting for secular changes among those not receiving TC, was a 40% reduction in 
partnerships formed in the last year for those infected receiving TC, and a 20% 
reduction for those uninfected receiving TC (Table 5.6). There were no substantial 
changes in reporting consistent condom use in the last two weeks (with any partner), 
either for those uninfected (no change) or those infected (down 2%). 
Results from other studies in Africa (Figure 5.3) suggest that behaviour 
change following TC can be greater than is reflected in either of these two scenarios. 
In a large multi-centre study in America (Project RESPECT), changes in behaviour 
among uninfected individuals were even greater, with reported 100% condom use 
almost tripling following TC [136]. To reflect the potential for greater degrees of 
behaviour change following high quality TC, a scenario was devised whereby the 
probability of consistent condom use doubles following TC, irrespective of HIV-status. 
This is approximately the same as the average change in condom use over several 
studies in the meta-analysis (Figure 5.3). In addition, it assumed that the changes in 
the rate of sexual partnership formation observed among infected men and women in 
Manicaland are repeated for all individuals receiving TC (Table 5.6). Although this 
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scenario is clearly somewhat hypothetical, such behaviour changes are arguably 
realistic and achievable. 
It is not clear how long behavioural changes are sustained after going for TC 
(the length of the studies is not longer than approximately three years), so two 
versions of each scenario are simulated, where the mean duration of the behaviour 
change is 2 years or 8 years. 
Symbol Interpretation Default Value* 
Max catchment 
Maximum TC uptake 




Time until re-test 
TC focus by gender 
TC focus by HIV-
status 
TC focus by sexual 
activity group 









Fraction of population (catchment) that can receive 0.8 
TC when scale up of services is complete. 
Rate at which individuals in the TC catchment 0.4 
receive TC. 
Calendar year in which TC programme scale-up 2005 
begins 
Calendar year in which TC programme scale-up 2015 
reaches maximum level 
Mean number of years between first TC visit and re- 0 
test, and between all further re-tests 
The relative probability of individuals going for TC 1 for all k 
according to their gender 
The relative probabihty of individuals going for TC 1 for all s 
according to their HIV-status. 
The relative probabihty of individuals going for TC 1 for all I 
according to their sexual activity group. 
The relative probability of individuals going for TC 1 for all a 
according to their age group. 
Table 5.5 Intervention scale-up assumptions used in the model. *Used in simulation unless otherwise 
stated. 
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Ratio of condom use if 
Change in 
condom use 
( H I V ) 
Nij 
one partner is thought to 
be uninfected relative to 
partnerships where HIV-
















one partner is thought to 
be infected relative to 
partnerships where HIV-















( H I V ) 
Mu 
sexual acts if one partner 
is thought to be 








status is not known for 
either partner. 
0.93 1 1 





sexual acts if one partner 
is thought to be infected 
relative to partnerships 
where HIV-status is not 














rate (HIV ) 
H , 
acquisition rate if thought 
to be uninfected relative 
to partnerships where 
HIV-status is not known 
















acquisition rate if thought 
to be infected relative to 
partnerships where HIV-














Mean number of years 
before behaviour of TC 
attendees reverts to the 
behaviour of those that 
do not know their HIV-
status 
2 or 8 2 or 8 2 or 8 
Table 5.6 TC behaviour change intervention scenarios. *Values are given for each sexual activity 
group in ascending order; (=1,2,3. (NB. 1=1 has the highest rate of partner acquisition). 
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5.3 Contributions 
Sabada Dube (Imperial College London) conducted the meta-analysis, fde Cremin 
and Ben Lopman (both Imperial College London) analysed data from the Manicaland 
cohort study that was used to parameterise some aspects of the model. My 
supervisors (Geoff Garnett and Simon Gregson) and our collaborator at the Centers 
for Disease Control and Prevention in Zimbabwe, Stacie Greby, have all made 
contributions to writing a manuscript, which helped develop this chapter. 
This work originates from a report written about a workshop held in Harare in 
July 2005. The participants (listed in the appendix to this chapter) made some 
suggestions of questions to explore in model analyses. 
5.4 Results 
TC programming policy is mainly concerned with two issues: (i) content (what the TC 
process includes), and (ii) coverage (who gets tested). The influence of content was 
investigated by varying the model parameters to reflect different types and degrees 
of behaviour change following TC. The effect of widening service coverage was 
investigated by increasing the fraction of the population that can receive TC (the 
'catchment population'), and adjusting the rate at which individuals receive TC 
according to their gender, age, sexual activity or presence of symptoms of immune-
suppression. 
in studies of TC, behaviour change has been greatest among infected 
individuals [137, 139]. In the model, behaviour change among those infected has a 
greater effect in reducing HIV incidence than the same changes among those not 
infected, because they are more likely to be part of ongoing HIV transmission (Figure 
5.4(a)). However, for a given number of individuals counselled, the population level 
impact of TC is greater when uninfected individuals change their behaviour instead 
















2 4 6 8 
Number of people changed behaviour 
10 
x1^  
2 4 6 8 
Number of people received VCT 
Figure 5.4 The impact of behaviour change, by sero-status of individual. Infections averted over 20 
years if only uninfected (blue lines) or only infected (red lines) individuals double condom use, shown 
in (a) as per person changing their behaviour and in (b) as per person receiving TC. 
Maintaining behaviour change is crucial to the impact of the intervention. For 
example, in the model, a 20-30% increase in condom use that is maintained 
permanently is equivalent in terms of infections averted over twenty years to a three-
fold increase in condom use that lasts for only one year (Figure 5.5(a))). The 
maintenance of behaviour change is especially important for young clients who are at 













fold-increase In condom use If HIV+ 
5 10 IS 
Years behaviour changed 
Figure 5.5 The impact of duration of behaviour change, (a) Infections averted over 20 years if 
increased condom use by infected individuals is maintained for 1 year (blue line), 5 years (green line), 
10 years (orange line) or permanently (red line), (b) Infections averted over 20 years if condom use is 
increased by young (red line) or old (blue line) TC attendees (15-19 year-olds are 10 and 0.1 times as 
likely than 30-34 year-old to attend TC, respectively) as a function of mean time for which behaviour 
change is maintained. 
Repeat testing is defined here as testing people with a negative result after 
several months or years (rather than re-testing within a few weeks to confirm a 
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negative result). Repeat testing can identify individuals with highly infectious incident 
infections and prevent false complacency in individuals who test negative but 
continue high risk behaviour, and will be most productive in groups with high 
incidence. However, the benefits of using limited resources to repeat test people are 
outweighed by the lost opportunity to test more people once. For the same number of 
tests and counselling sessions, more infections and AIDS-deaths are averted if 
priority is given to testing more people once rather than fewer people many times 
(Figure 5.6). 
(a) 
Double condom use if HIV+ 
More first-time tests, 
(b) 
IVlore repeat tests 
50% of eligible on ART 
More first-_ 
time tests 
More repeat tests 
0.5 1 1.5 2 
Number of tests + repeat tests xlo= 
0.5 1 1.5 2 
Number of tests + repeat tests % i o» 
Figure 5.6 The impact of repeat testing, (a) Infections averted over 20 years if infected individuals 
double condom use and if individuals are retested every 20 years or every 2 years with TC available to 
30% of the population ("more repeat tests"; blue line) or individuals are tested only once with TC 
available to 50 to 95% of the population ("more first time tests"; red line). Horizontal axis shows total 
number of tests (first time tests plus every repeat test). Values of coverage and repeat testing are chosen 
to given similar total numbers of tests, (b) As for (a) but with AIDS-deaths averted, assutning no 
behaviour change and that ART is supplied to 50% of those eligible (diagnosed infection and immune-
suppressed). 
Provided individuals are willing to disclose their HIV-status, increased testing 
creates the opportunity for couples to alter behaviour according to the status of both 
partners, or for partner choice to depend, in part, on HIV-status. High levels of 
condom use have been observed in discordant couples aware of their status [301, 
309] and the model suggests that when knowledge and disclosure of HIV-status is 
high, consistent condom use in such partnerships could generate a greater reduction 
in HIV incidence than smaller increases in condom use by infected individuals in all 















Condoms used more 
frequently regardless 
of sero-status 
x2.5 if high-risk 
Number gone for VCT 
10 
X 10® 
Figure 5.7 The impact of alternative 
patterns of increased condom use 
following testing. Infections averted 
over 20 years if individuals use 
condoms in all sex acts in 
partnerships known to be sero-
discordant (red line), or if infected 
individuals that have gone for TC use 
condoms more frequently regardless 
of partners' HIV-status; 1.5 times as 
frequently in all partnerships (blue 
line), 2 times as frequently in all 
partnerships (solid green line) or 2.5 
times as frequently in 'casual' 
partnerships (between members of 
the high-risk groups) (dashed green 
line). 
30 r 
Tested every 2 years -






Number received VCT 
Figure 5.8 The impact of sero-
sorting. Infections averted over 
20 years if 5% (blue lines), 50% 
(green lines) or 95% (red lines) 
of sexual partnerships are 'sero-
sorted' and if individuals are 
tested every two years (dashed 
lines) or every ten years (solid 
lines). 
The impact of sero-sorting, where individuals tend to form sexual partnerships 
preferentially with individuals of the same HIV-status as themselves, is weak unless 
unrealistically large proportions of partnerships are sero-sorted and individuals 
frequently return for testing (Figure 5.8). Without frequent testing, individuals can 
incorrectly think they are uninfected (having been infected since their last test) and 
will preferentially form sero-discordant partnerships. However, up to the extreme 
level of 95% of sero-sorting, repeat testing fails to outweigh the benefit of testing 
more people once. 
Resource constraints will be the major determinant of TC implementation, but 
the ideal distribution of clients can be explored to help guide policy. In the model it is 
possible to keep the number of people receiving TC constant whilst adjusting the 
relative probability that an individual receives TC according to their gender, age, 
sexual behaviour and disease symptoms. The optimal target population depends 
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greatly on the primary role of TC. To maximise the identification of those that will 
require ART, TC should be focussed on those groups in the population with the 
highest HIV prevalence, i.e. individuals at most risk of infection, older individuals and 
those with symptoms of immune-suppression (Figure 5.9). In addition, targeting 
women could increase uptake of measures to prevent mother-to-child transmission, 
and therefore avert more child deaths. To promote behaviour change using high 
quality HIV prevention counselling, more infections are averted if those at highest risk 
and younger individuals are targeted (Figure 5.9) because these groups contribute 
disproportionately to the spread of infection [40]. Targeting those with symptoms is 
not an effective way to avert more infections because they will form few new sexual 
partnerships in the following years. Therefore, to increase the number of people in 
care and prevent AIDS deaths immediately, targeted testing of older people, those 
experiencing symptoms of immune-suppression and women is the recommended 
strategy. However, to optimise prevention through behaviour change and 
substantially decrease AIDS deaths in the future, providing TC to the young should 















D Infections averted with behaviour change 
HaIDS deaths averted if ART distributed 
C T 
Women High-risk Sick 
Focus population 
Young 
Figure 5.9 The impact of targeting. T w o types of TC intervention are simulated: behaviour change 
fol lowing TC but no A R T (dark bars), and (ii) A R T offered to those receiving TC but individuals do 
not change their sexual behaviour (light bars). The eff icacies of these interventions are measured as 
infections averted over twenty years and A I D S deaths averted over twenty years, respectively. The 
relative eff icacy is the ratio of the eff icacy of the intervention when uptake is ten-times higher among a 
particular sub-group (women, those at most risk of infection, those with symptoms of immune-
suppression and younger individuals) to where uptake is ten-times higher among the alternative group 
(men, those at least risk of infection, those without symptoms and older individuals). In all scenarios, 
the number receiving TC is held constant. A value of more than one signifies that targeting that sub-
group is advantageous, whereas a value less than one signifies that it would be better to target the 
alternative sub-group. 
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The expansion of TC services across countries in sub-Saharan Africa will be 
a primary tool in the fight against the HIV/AIDS epidemic [6, 284]. In Zimbabwe, TC 
services are set to be greatly expanded in the coming years. In the following 
projections it is assumed that the fraction that can access TC increases steadily to 
80% over 10 years (2005-2015), and that uptake in the population is such that the 
average time between services becoming available and attending TC is 2.5 years. As 
stated above, this rate of expansion will be realistic if TC policies include routine 'opt-
out' testing [146, 306], home-based services [307] or services integrated with 
antenatal care [308]. 
Based on recent epidemiological and demographic data [17, 91], the model 
projects that there will be -2.9 million new infections among adults over 20 years 
(2005-2025) without further intervention. If the behavioural changes following TC are 
similar to those observed in a large efficacy trial in low-income settings [137] and last 
for 2 years on average, then ~4% of expected HIV infections would be averted over 
20 years (116,000 infections) (Figure 5.10, scenario 2: blue solid line). If the changes 
lasted for 8 years instead, almost twice as many infections would be averted 
(218,000) (Figure 5.10, scenario 2; blue dashed line). Alternatively, if the behavioural 
changes observed in a rural Zimbabwean cohort [250] are repeated at the national 
level and last for two years, then the rapid expansion of TC across the country would 
avert less than 3% of infections over 20 years (84,000) (Figure 5.10, scenario 2: 
green solid lines). However, with the greater levels of protective behaviour change -
including among uninfected individuals - generated by high quality HIV prevention 
counselling that are indicated in other studies (Figure 5.3), the model predicts that 
there could be 12%-23% (348,000-667,000) fewer infections over a 20 year period 
(Figure 5.10, scenario 3: red lines). The high HIV incidence rate in Zimbabwe (and 
other countries in the region) means that it is important to scale-up TC quickly. 
Assuming that these optimistic behavioural changes last 8 years, the model projects 
that if TC is scaled-up to 80% of the population over 5 years instead of 10 years, 
-200,000 more infections could be averted (Figure 5.11). 
An important goal of testing is to identify those who can benefit from 
treatment. Without an effective TC programme, the model projects that the total 
number of individuals that will be indicated for ART in Zimbabwe over 50 years will 
be -6.8 million. With high quality HIV prevention counselling, protective behaviour 
change would lead to fewer people acquiring HIV and 1.8 million less would need to 
start ART (Figure 5.12). The difference in the number needing ART between the 
alternative scenarios increases over time as the epidemic is set to reach more and 
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more people if services are not optimised, but could be sent into decline if high-
quality TC is implemented (Figure 5.12). 
3 0 r 
Behav. chg 
lasts 8 years 
Behav. chg. 
lasts 2 year 
2015 
Figure 5.10 Cumulative 
infections averted if the 
behaviour changes following 
TC are: (1) as observed in a 
large efficacy study [137] (blue 
lines); (2) as observed in lural 
Zimbabwe [250] (green lines); 
or, (3) if greater behaviour 
changes can be generated with 
high quality counselling and 
testing (red lines). (Table 5.5 for 
details) The behaviour changes 
are assumed to last for two years 
(solid lines) or eight years 
(dashed lines). In each case it is 
assumed that TC is rolled out to 
80% of the population over ten 
years with a mean time-to-visit 
of 2.5 years. 




• Scaled-Lp over 2 years 
" 5 years 
10 years 
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Catchment (% of population) 
- Scaled-up over 2 years 
• 5 years 
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Catchment (% of population) 
Figure 5.11 The influence of speed of 
scale-up on the impact of interventions. 
Infections averted over 20 years if TC 
is rolled out to the catchment 
population after 2 years (black lines), 5 
years (dark grey lines) or 10 years 
(light grey lines). The assumed 
behaviour change following TC 
represents the effect of high quality 
prevention counselling (scenario 3: 
Table 5.5) which lasts for, on average 
(a) 2 years; and, (b) 8 years, 
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Figure 5.12 Cumulative number of 
individuals that are indicated for ART, 
if the behaviour changes following TC 
are: (1) as observed in a large efficacy 
study[137] (blue lines); (2) as observed 
in rural Zimbabwe [250] (green lines); 
or, (3) if greater behaviour changes can 
be generated with high quality 
counselling and testing (red lines). 
(Table 5.5 for details). The behaviour 
changes are assumed to last for two 
years (solid lines) or eight years 
(dashed lines). In each case it is 
assumed that TC is rolled out to 80% 
of the population over ten years with a 
2055 mean time-to-visit of 2.5 years. 
5.5 Discussion 
Major changes in HIV risk behaviour throughout populations are required to reverse 
the HIV pandemic. The expansion of TC across Zimbabwe and other countries in 
sub-Saharan Africa [248, 284, 310] will be a primary tool in the fight against the 
HIV/AIDS epidemic, providing the gateway to ART and arguably the best chance to 
motivate behaviour change. Although treating existing HIV/AIDS patients is an urgent 
priority, tailoring TC services to those in need of ART will not substantially alter the 
course of the epidemic and eventually providing treatment may not be sustainable. 
These results, using a model specific to Zimbabwe, show that TC programmes that 
do not use available resources to provide high quality HIV prevention counselling and 
enable HIV-negative individuals to adopt less risky behaviours will certainly not 
achieve their full potential. The prevention impact of TC can be maximised by 
providing services to as many individuals as possible, focussing on those at most risk 
of acquiring and transmitting infection, urging the young to maintain less risky sexual 
behaviour, and warning against HIV-status based behaviour change for those that 
have not tested recently. 
The duration of behaviour change was found to be extremely important in 
determining the prevention benefits derived from TC. Unfortunately, studies of 
behaviour change associated with TC have not extended beyond a few years, 
leaving considerable uncertainty about its long-term effect. It is unlikely that trials 
would be able to explore the duration of behaviour change, but observational studies 
should aim to examine first, whether behaviour does change and then how long it 
lasts. Ideally, exploring how best to promote a long lasting change, either at the 
primary counselling session itself, through follow-up visits or via community level 
work, should be a priority. 
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A major limitation of the model in exploring TC is its failure to represent 
couples in stable partnerships. Since this model does not include couples testing 
together, it may under-estimate the effect of condom use in discordant partnerships 
because TC delivered to couples together may be a more efficient way of finding 
discordant partnerships and facilitating behaviour change [309]. Further work using a 
simulation of individuals and the explicit representation of their partnerships would 
provide better insights into the potential epidemiological impact of providing testing 
and counselling to couples. However, if the scale-up of services is focussed on 
clinical settings [311], it will be more likely that individuals will be tested by 
themselves, than if dedicated stand-alone facilities become more widespread. 
The recent emphasis on TC in the international community has attempted to 
normalise HIV as an infection where diagnosis is the key to accessing health care 
services [311]. The long-term success of changes in testing policy will depend on 
providing high quality HIV prevention counselling that can translate into effective 
behaviour change, preventing new infections to allow sustainable clinical care. As 
policies are adopted and TC coverage is expanded, high quality HIV prevention 
counselling must be provided consistently to ensure that the potential of the 
counselling intervention to change behaviour is maintained. Without such an 
approach, the good news stories associated with roll out of ART [284, 285] will 
merely prove a temporary period of remission in the tragic story of AIDS as the 
number of people requiring ART rises inexorably. 
5.6 Participants at the Harare Workshop 
Some elements of the model and the analysis were informed through consultation at 
a workshop held in Harare in July 2005. The participants are listed here 
alphabetically. 
- E Chidombwe, Zimbabwe Aids Prevention Services Organisation 
• S Dube, Imperial College London, UK 
• GP Garnett, Imperial College London, UK 
• E Gonese, Ministry of Health and Child Welfare, Zimbabwe 
• S Greby, Centers for Disease Control and Prevention, Zimbabwe 
• S Gregson, Imperial College London, UK and the Biomedical Research and 
Training Institute, Zimbabwe 
• S Hader, Centers for Disease Control and Prevention, Zimbabwe 
" T Hallett, Imperial College London, UK 
• K Hatzold, Population Services International 
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A Mahomva, Ministry of Health and Child Welfare, Zimbabwe 
C Makufa, PACT Zimbabwe 
S Makumbe, PACT Zimbabwe 
M Manyasha, PACT Zimbabwe 
S Moyo, Zimbabwe AIDS Prevention Project 
O Mugurungi, Ministry of Health and Child Welfare, Zimbabwe 
G Ncube, Ministry of Health and Child Welfare, Zimbabwe 
N Taruberekera, Population Services International 
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Chapter 6: Measuring Effectiveness in 




Whilst a few individual-randomised controlled trials have recorded changes in 
behaviour [136, 137], demonstrations of successful interventions in reducing HIV 
incidence at the population level are rare. However, the translation of intervention 
activities into behavioural outcomes and then into a population-level impact on 
transmission is not inevitable and so the key measure of intervention success must 
be HIV incidence. Some success in reversing the HIV epidemic at a national level 
was detected in Uganda and Thailand through an evaluation of trends in prevalence 
and risk behaviours [24, 55, 73, 312] and more recently similar national trends have 
been observed in Zimbabwe [16, 17, 91], urban Haiti [236], parts of urban Kenya 
[237, 251], and south India [313]. In these circumstances the cause of behaviour 
change is uncertain. To justify the ongoing commitment and support for interventions, 
it is helpful if their effectiveness has been rigorously demonstrated [314] and the 
community-randomised controlled trial (CRCT) is the experimental design that 
provides a test of an intervention's effectiveness within the population [315]. Such 
trials at the community-level have been used initially to explore the impact of 
controlling bacterial sexually transmitted infections (STIs) on the incidence of HIV 
and latterly to explore interventions which additionally aim to reduce sexual risk 
behaviour. 
The four reported CRCTs of HIV-prevention interventions have each 
employed different strategies to reduce transmission from and to those at most risk of 
infection (the "high-risk" groups - sex workers and their clients, those with STIs etc), 
in the Mwanza Trial in north-west Tanzania, syndromic management (treating those 
with symptoms) of STIs was found to reduce HIV incidence by 40% [107]. The Rakai 
Trial in Uganda attempted to improve on the control of STIs using mass antibiotic 
administration to target asymptomatic infections [109] and the Masaka Trial, also in 
Uganda, added a general population Information, Education and Communication 
(lEC) component to syndromic management of STIs [110]. Most recently, the 
Manicaland Trial focussed on peer-led education and awareness targeted to sex 
workers and their clients in a rural Zimbabwean community [94]. Unfortunately, none 
of the latter three (Rakai, Masaka and Manicaland) CRCTs found significant 
reductions in HIV incidence and in the Manicaland trial incidence may even have 
been higher in the intervention communities. Explanations as to why these trial 
results differ from the original success in Mwanza include the epidemiological 
context, with HIV having spread beyond the high-risk group where bacterial STIs play 
a critical role in transmission [119]. 
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There are many problems in assessing how well complex multifaceted 
interventions have been implemented, in estimating how long they need to take effect 
and in discerning whether the changing epidemiology of HIV has influenced the 
results. In planning and interpreting trials of HIV prevention interventions, it is worth 
exploring the expected impact of behavioural change on HIV incidence over time to 
identify the circumstances when the effectiveness of an intervention would be 
apparent. Standard power calculations for CRCTs [316, 317] are available and 
elaborations have been suggested to optimise study design and analysis [318-321]. 
However, the implications of the dynamic response of incidence to a targeted 
intervention have not been considered. To examine this, a simulation model of the 
heterosexual spread of HIV was developed and used to investigate the chance of 
detecting a statistically significant effect of a powerful intervention in various trial 
conditions. Whilst this theoretical exploration provides general insights for 
community-randomised HIV intervention trials, in some cases the model is 
parameterised to represent aspects of the most recent trial (in Manicaland) in order 
to ground the analyses in an actual scenario. 
6.2 Methods 
6.2.1 Epidemic Simulation Model 
The model used was a deterministic representation of the heterosexual transmission 
of HIV in a sex, age and sexual activity stratified population. The model is based on 
the first one described in Chapter 2 with the following modifications (details given at 
end of this chapter). 
1) To better characterise targeted increases in condom use, the chance of 
infection through sexual partnerships was adapted to reflect the number of 
unprotected sex acts in the partnership and the transmission probability per sex act. 
2) To reflect the recently recorded behavioural changes in Zimbabwe [17, 91], 
between year 19 and 24 of the epidemic, the mean number of sexual partnerships 
formed per year was reduced by 25% and the proportion of sex acts in which a 
condom is used was increased almost three-fold (Figure 6.1). Baseline values of 
these parameters are chosen such that, with these changes, the behaviour in 1998 
matches reports from a sexual behaviour survey in Manicaland [40]. The timing of 
scale of this change is informed by the analyses in chapter 2. 
3) The simulated intervention only directly affects female sex workers and 
their clients (the high-risk group) and generates a four-fold increase in the frequency 
with which they used condoms with any partner. These changes start in year 20 and 
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are completed within 3 years, but the speed of behaviour change is specified by the 
fraction of the change completed by time t, f{t): 
V for20<t<23 ....(6.1) 
Here r determines the speed with which behaviour change takes place (r<0 convex 
growth curve, r>0 concave growth curve; unless otherwise specified r=-3) (Figure 
6 .2 ) . 
(a) (b) 
' Without behaviour changes 
• With behaviour changes (fitted) 
• Data 
1985 1990 1995 2000 2005 2010 2015 2020 
Year 
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1997 1998 2001 
Figure 6.1 The epidemic context in Zimbabwe, (a) Model output showing prevalence over time in the 
absence of the intervention (b) Schematic diagram showing how the timing of the background 
behaviour change (from 1997) and the intervention (three years from 1998). 
0.5 1 1.5 2 2.5 
Years since intervention started 
Figure 6.2 The development of the behaviour change due to the intervention, can accelerate (r>0; solid 
lines) or decelerate (r<0; dashed hne) over time. In these simulations, from top-most line down, the 
values of r used are -10, -3, -1, 0.1, 1, 3 and 10. 
Other minor changes to the model are listed at in the appendix to this chapter. 
6.2.2 Power Calculations 
The aim of the power calculation is to estimate the chance that, for a given 
deterministic change in incidence associated with the intervention, a statistically 
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significant difference between intervention and control communities could be 
detected. The problem is approached by running a series of stochastic realisations of 
the trial, and at the end of each, assessing whether the data that would have been 
collected would be sufficient to give a statistically significant result. Because 
incidence and losses to follow-up are experienced probabilistically, different trial 
outcomes are recorded each time, despite assuming the same underlying 
deterministic effect of the intervention. After a large number of repetitions (in this 
case, 5000), the proportion of simulations in which a significant result is obtained can 
be used to estimate the probability of detecting a statistically significant result in one 
real trial. 
in each trial simulated trial, there are n pairs of communities; one is randomly 
assigned to the intervention arm and the other to the control arm. Let Qj.t represent 
the number of infections that occur in each community at time f for the pair in the / ' ' 
arm (/=1 for control community and y=2 for intervention communities). This is drawn 
from a Poisson distribution with mean equal to the expected the number of infections 
based on the deterministic simulations: 
C: I.J.I -(6.2) 
Here Yi j , are the person-years at risk spent in that community during that time-step; 
incidence in the control communities is A, ,, and incidence in the corresponding 
intervention communities is . Incidence rates in both types of community (control 
and intervention) are assumed to be normally distributed with mean equal to the 
corresponding output from the dynamic simulation model: / , , and /2,, respectively 
(see appendix for calculation). The variance of the distribution is parameterised with 
the coefficient-of-variation (CV) for the between-cluster variation in incidence, which 
is assumed to be the same in both arms of the trial. 
...(6.3) 
The number of person-years spent at risk in that community during that time-step is 
given by: 
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YiJ.l = ...(6.4) 
where Nf j , is the number of susceptible individuals in that community at that time 
and changes through time as: 
where g is the rate at which individuals move out of the community or are otherwise 
lost from the study per year follow-up and r is the duration of the time-step. The 
results of the modelling are not sensitive to the chosen distribution of true incidence 
rates (i.e. distribution of £). 
The overall measured incidence rate ratio (MIRR) after Fyears of follow-up {MIRRp) 
is calculated as the geometric mean of the MIRR in each pair: 
r , . iJ.F F 
UK,., 
( = 0 
MIRR^ = J f j ^ . . . . ( 6 . 6 ) 
'=1 i^XF 
The hypothesis test is based on the statistic T being distributed under the null 
hypothesis as f with n-1 degrees of freedom [322]: 
1=1 
..(6.7) 
— 1 = 1 
Sj — i-l 
n-\ 
From simulations, it has been calculated that the type I error rate (significant result 
with no true difference between incidence in intervention and community sites) of this 
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test at the significance level of 5% is in the range 0.046-0.057 for all scenarios 
examined. 
6.3 Contributions 
In addition to my supervisors, 1 am grateful to Peter White and Nick Grassiy (both 
Imperial College London) for useful discussion on this work. 
6.4 Results 
6.4.1 The Theoretical Effectiveness of an Intervention Targeted to High-risk 
Individuals 
Behaviour change by the high-risk group of women and men (representing sex 
workers and their clients) can have a substantial impact on HIV incidence in the 
whole population: the dramatic behaviour change assumed (quadrupling condom use 
frequency and 90% reduction in prevalence of co-factor STis) immediately generates 
-70% reduction in incidence in the high-risk group (10% of population) and incidence 
in the whole population is reduced by ~35% after 10 years. An intervention targeted 
at the high-risk group is likely to have a bigger impact when implemented earlier in 
the epidemic than when implemented later because at the beginning most new 
infections occur in the high-risk groups (Figure 6.3(a)). The impact of behaviour 
change by the high-risk group is also sensitive to the structure of the sexual network. 
Behaviour change by the high-risk group will only be translated into a substantial 
reduction in incidence in the low-risk group if it is common for high-risk individuals to 
form sexual partnerships with low-risk individuals ("random mixing") (Figure 6.3(b)). If 
high-risk individuals rarely form partnerships with low-risk individuals ("assortative 
mixing") then any reduction in incidence in the high-risk group is not shared with the 
low-risk group. 
The reduction in incidence in the whole population is not instantaneous - first, 
it takes time for average behaviour to change in the high-risk group, and second, 
there is a delay before the reduced risk behaviour by the high-risk group is translated 
into a reduction in incidence in the whole population (Figure 6.3(c)). The latter of 
these effects is probably the more important since, even with instantaneous 
behaviour change by the high-risk group, the full impact of the intervention is not 
realised for many years after the intervention starts (Figure 6.3(c) - black dotted line). 
6.4.2 The Chance of Detecting a Statistically Significant Result for an Effective 
' intervention 
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In practice, the effect of an intervention in a CRCT is measured as the total number 
of events during follow-up divided by (estimated) person-years of observation. This 
will be identified as the 'measured incidence rate ratio' (MIRR). However, the 
potential usefulness of the intervention in programmes is indicated by the 
instantaneous incidence rate ratio (IRR) after the intervention has taken effect 
(Instantaneous incidence is the rate of new infections per person-year at risk). When 
rates of infection are low (as for HIV), MIRR will approximate the average of IRR over 
the follow-up period. 
If the full effect of the intervention is exerted immediately, then MIRR would 
equal IRR. If the full effect of the intervention takes time to develop, MIRR will be 
closer to one than IRR, reflecting a smaller effect of the intervention at first (Figure 
6.4(a-b)). The size of the discrepancy between the two measures is greatest when 
the reduction in incidence increases gradually over time. Although in the long-term 
the two measures converge, over the first years of the intervention, the difference 
between MIRR and IRR increases if the impact of the intervention grows very quickly. 
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Figure 6 .3 Theoretical Effectiveness of an Intervention Targeted to High-risk Individuals, (a) Predicted 
IRR 5 years after intervention starts as a function of the calendar year in which the intervention starts 
(solid black line on left-hand vertical axis) and modelled IRR in Manicaland between 1980 and 2015 
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(grey line on right-hand vertical axis) showing phase of epidemic, (b) Predicted IRR among low-risk 
(dark bars) and the high-risk (light bars) groups 10 years after the high-risk targeted intervention starts 
if the pattern of sexual partnership formation is "random" or "assortative". (c) IRR as a function of time 
since intervention starts if behaviour change takes 3 years and progresses at a constant rate (v=0.01, 
black dashed line) or takes 3 years and the rate of change increases (v=3,solid black line) or decreases 
(v=-3, black dotted line). Shown as a comparison, the assumption about IRR made in standard power 
calculations: IRR is reduced instantaneously (grey dashed line). 
These three factors (time for behaviour change, time for effect to spread from 
the high-risk group, measurement of IVIIRR not IRR) are not considered in most 
estimates of study power, which implicitly assume an instantaneous reduction in 
incidence (Figure 6.2(a) - dashed grey line). This simplifying assumption will lead to 
over-estimating the chance that the study returns a statistically significant result for 
an intervention that works (the power of the study) (Figure 6.4(c)). For example, the 
standard estimate of power for a theoretical five-year study with ideal study 
conditions (no loss to follow-up; six identical communities per arm with 1000 
individuals per community) could exceed 0.99, but when the gradual reduction in 
incidence is allowed for, the estimate of power is reduced to approximately 0.71. 
Under more likely study conditions (3 years follow-up with 44% lost; 6 communities 
per arm with 788 individuals per community and between-community coefficient of 
variation 0.14 [94]), although power is estimated to be 0.82 with standard 
assumptions, it could be as low as 0.25 if incidence changes in the way predicted by 
the model. 
Given the slow speed with which a substantial reduction in IVIIRR develops, 
the requirements for other aspects of the study design become more stringent if 
sufficient power is to be achieved with a short follow-up period (Figure 6.4(d)). Whilst 
traditional calculations would suggest that a wide range of study conditions would 
give a good chance of detecting an effect, these simulations suggest that only with 
very optimistic assumptions about the number of individuals in each community, 
between-community variation and the follow-up rate, would there be a good chance 
(probability>0.8) of recording a statistically significant result within 5, or even 10 
years. Of the key aspects of study design, between-community variation and length 
of follow-up have the strongest influence on study power. For a given total number of 
study participants, increasing the number of communities increases power more than 
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Figure 6.4 The Chance of Detecting a Statistically Significant Result for an Effective Intervention, (a) 
MIRR (black solid line) and IRR (black dashed line) as a function of time since intervention starts. 
Shown as a comparison, assumption about IRR made in standard power calculations: IRR is reduced 
instantaneously (grey dashed hne). (b) Distribution of MIRR over 5000 stochastic runs after 3, 5 and 
10 years follow-up, assuming no between-community variation and no losses to follow-up. Box shows 
inter-quartile range, horizontal tick indicates median and whiskers extend to 5th and 95th percentiles. 
Dashed horizontal lines show corresponding IRR. (c) Estimated power of the CRCT (two-tailed test at 
the 5% significance level) as a function of years of follow-up, assuming no between-community 
variation and no losses to follow-up if behaviour change is instantaneous (black dotted line), takes 3 
years and progresses at a constant rate (black dashed line) or takes 3 years and the rate of change 
increases (solid black line) or if IRR is reduced instantaneously (grey dashed line). Other assumptions 
as in (a) and (c). (d) Estimated power of the CRCT for a range of study condition scenarios: (I) 6 
communities per arm, 1000 individuals per community, CV of between-cominunity variation = 0,15, 
47% followed-up after 5 years; (II) as for I but with 3000 individuals per community; (III) as for II but 
with 12 communities per arm; (IV) as for III but with 100% followed-up after 5 years (V) as for IV but 
with CV=0,05, White bars show estimate using standard power calculations with 5 years follow-up; 
light grey bars show estimate based on gradual changes in incidence over time with 5 years follow-up; 
dark grey bars show estimate based on gradual changes in incidence over time with 10 years follow-up. 
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Estimate of Power (±2 standard deviations) Relative Increase 
Years of Follow-up 
3 years (r) 0.29 (0.27-0.30) 1.00 
5 years 0.38 (0.37-0.39) 1.32 
7 years 0.44 (0,42-0.45) 1.51 
10 years 0.50 (0.49-0.52) 1.76 
Variation between communities 
CV=0.15(r) 0.27 (0.25-0.28) 1.00 
CV=0.10 0.38 (0.36-0.39) 1.42 
CV=0.05 0.52 (0.51-0.53) 1.96 
CV=0.02 0.60 (0.59-0.61) 2.26 
Follow-up rate (% after 5 years) 
47% (r) 0.27 (0.26-0.29) 1.00 
61% 0.28 (0.27-0.30) 1.04 
78% 0.31 (0.29-0.32) 1.12 
100% 0.31 (0.30-0.33) 1.15 
Number individuals per community 
1000 (r) 0.27 (0.25-0.28) 1.00 
1500 0.31 (0.30-0.32) 1.16 
2000 0.33 (0.32-0.35) 1.25 
3000 0.34 (0.33-0.35) 1.27 
Number of communities per arm 
6(r ) 0.27 (0.25-0.28) 1.00 
8 0.32 (0.30-0.33) 1.18 
10 0.38 (0.37-0.39) 1.42 
12 0.45 (0.44-0.47) 1.69 
Table 6.1: Elements of study design and study conditions that could improve study power. 
(CV=coefficient of variation). In each univariate analyses, other parameter values used are indicated by 
(r); these are based on the conditions of the recent trial in Manicaland, Zimbabwe [94]. 
6.4.3 The Influence of Epidemiological Context 
The epidemiological background against which the intervention is tested can 
influence the magnitude of the impact of the intervention and the chance of detecting 
a statistically significant effect. The potential for epidemic spread can be summarised 
by Ro, the basic reproductive number (the number of infections that occur when one 
infected individuals enters an entirely susceptible population [37]). The effect of an 
intervention that reduces Ro is greater when Ro is lower [37], so it is expected that 
background behaviour changes occurring during the follow-up period could enhance 
the reduction in incidence associated with the trial intervention (Figure 6.5(a) - left 
panel). Despite there being fewer incident infection observed, these simulations 
indicate that this could mean that background behaviour change increases the 
chance of detecting a statistically significant effect (Figure 6.5(a) - right panel). 
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Figure 6.5: The Influence of Epidemiological Context, (a) Predicted IRR and the estimated power to 
detect a statistically significant effect of a high-risk targeted intervention (two-tailed test at the 5% 
significance level) after 3 (dark grey bars) or 10 (light grey bars) years assuming that there is no 
background behaviour change or that condom use increases by 30%, 100% or 280% and partner 
acquisition rate decrease by 5, 15 or 25% ("small", "medium" and "large" amounts of behaviour 
change, respectively) linearly throughout the fol low-up period equally in all communities. Study design 
and conditions assumed to be: 6 communities per trial arm, 1000 individuals per community, no 
variation between communities and no losses to fol low-up. (b) Predicted MIRR after ten years when 
there are imbalances in Rq between intervention and control communities. Assumptions made are: the 
intervention is not effect ive and there is no background behaviour change (black bars); the intervention 
is not effective but there is background behaviour change (dark grey bars); the intervention is effective 
but there is no background behaviour change (light grey bars); and, the intervention is effective and 
there is background behaviour change. High and low values of Ro generate prevalence at the start of the 
trial of 24% and 21%, respectively. 
Due to the small number of communities that are randomized it is likely that, 
by chance, HIV prevalence and incidence in the control and intervention communities 
is not equal. Such an imbalance means that, even before the intervention, IRR would 
not be equal to one. Moreover, if the differences reflect variation in the potential for 
epidemic spread, then the impact of behavioural changes - whether related to the 
trial or not - would be greater in communities with lower baseline incidence [37]. This 
means that the impact of an effective intervention would be under-estimated if Ro is 
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initially higher in the intervention communities, and the impact of an ineffective 
intervention would be over-estimated if Rq is initially lower in the intervention 
communities, especially if there are background behaviour changes. In the 
Manicaland trial, for instance, mean baseline HIV prevalence was 21% in the control 
communities and 24% in the intervention communities. Simulating this prevalence 
imbalance by varying Rq between the control and intervention communities and 
assuming no background behaviour change, MIRR after ten years ( M I R R 1 0 ) would be 
0.86 if Rq was the same in all communities, but 1.02 if Rq was higher in intervention 
communities and 0.74 if Ro was higher in control communities (Figure 6.5(b)). With 
background behaviour changes, the corresponding MIRR10 estimates would be 0.75, 
0.90 and 0.60. If the intervention was not effective but there were secular behavioural 
changes, M I R R 1 0 would be 1.22 if Ro was higher in intervention communities and 
0.82 if Ro was higher in control communities (Figure 6.5(b)). 
6.5 Discussion 
The CRCT study design can provide strong evidence of the effectiveness of an 
intervention, although generalising the result to all contexts is not necessarily 
possible [86, 118]. However, in planning and interpreting trials of HIV prevention 
interventions it is worth exploring the expected impact of behavioural change on HIV 
incidence over time to identify the circumstances when the effectiveness of an 
intervention would be apparent. The scientific interpretation of a trial that returns a 
negative or null result must be informed by these considerations. 
The model suggests that a tendency for random mixing (for example, high-
risk men forming sexual partnerships with low-risk young women [40]) would allow a 
reduction in incidence among the high-risk group to spread throughout the 
population. However, in a CRCT, this would not necessarily be expected to be 
reflected in a substantial or statistically significant reduction in MIRR after a short 
follow-up period. The reasons for this are; 1) the intervention may take some time to 
get to scale or to change the behaviour of the high-risk group, and 2) there is a delay 
before the reduced risk behaviour by the high-risk group is translated into a reduction 
in incidence in the whole population. Delays in reductions in incidence will lessen the 
difference between measured incidence rates in the two study arms. This means that 
evidence for the effectiveness of interventions that reduce incidence gradually over a 
few years (such as those that operate through high-risk groups), and which could 
avert many infections in the longer terms in actual programmes, might not be found 
in CRCTs. 
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One of the purposes of CRCTs is to establish whether an intervention 'works' 
and should be included in programmes. Estimating the chance that an 
epidemiologically relevant reduction in incidence would be detected statistically is an 
integral part of CRCT study design and standard methods for power calculations 
have been published [316, 317]. However, the results show that these calculations 
can over-estimate power because they assume that the reduction in incidence in the 
whole population is immediate. This conclusion is likely to be conservative since the 
model of the transmission dynamics used here is deterministic and does not take 
account of the chance events which would likely further slow the impact of the 
intervention. Implicitly taking account of this effect when deciding the predicted effect 
size in standard power calculations can be misleading because it masks the 
assumptions (i.e. degree of optimism) about the actual long-term impact of the 
intervention. Over-estimating the power of a study may encourage the interpretation 
of a non-significant result as evidence for lack of effect, whereas these simulations 
suggest that a probable explanation for a non-significant result will often be the slow 
speed with which the effect of the intervention develops. Mathematical simulation 
modelling provides a convenient way to examine how the study power is related to 
study conditions, and consider the effect of incidence declining gradually over time, 
whether this is due to the intervention starting more slowly than planned or patterns 
of transmission changing gradually. 
It is difficult to say which of the different ways a trial can improve its ability to 
detect a significant effect will be the most practical. The choice of communities will 
probably be determined by many practical matters besides their similarity and there 
may be a trade-off between using two similar communities close to each other or two 
that are less similar but further apart, which may reduce contaminating migration. 
There is also the danger that pairing of communities by attributes that do not 
correlate highly with the true incidence rate could be counter-productive when 
dealing with a small number of communities [323, 324]. Increasing the total number 
of individuals followed-up in a study will be associated with greater costs, but this will 
be spent more effectively if the number of communities is increased rather than the 
number of individuals in each community [316]. Increasing the number of 
communities also helps minimise the danger that, by chance, the two study arms do 
not have the same basic reproductive number (Ro) and the simulations show that 
even small differences at baseline can lead to large biases in MIRR. In the extreme 
cases, this could completely obscure the impact of truly efficacious intervention, or 
artificially generate a positive result for an ineffective intervention [219]. Generally, 
statistically controlling for differences in prevalence between sites will be insufficient 
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to eliminate this bias because not only does the value of Ro determine the expected 
incidence rates under the null hypothesis, but it can also modify the actual the effect 
of the intervention and background behaviour changes. This leads lead to greater 
variation in the observed effects of the intervention than can be explained by 
variation in baseline prevalence, which itself will not fully capture variation in Rq. 
Losses at follow-up might be reduced by more frequent visits but these 
simulations suggest that, when taking other difficulties into account, a substantial 
increase in power is unlikely even with almost no losses to follow-up. Furthermore, if 
loss to follow-up is mostly accounted for by migration and mortality, as was the case 
in Manicaland [94], then extra visits will do little to help. On the other hand, having an 
interim round to recruit new migrants could help boost power and allow a measure of 
incidence later in the study, when the intervention is to scale and beginning to have 
an effect. Using detuned assays [64] at the follow-up round would also provide a way 
of measuring incidence later in the follow-up period, but the statistical uncertainty 
associated with estimates based on small numbers of recent seroconversions would 
limit the usefulness of this approach without following-up many more individuals. 
Increasing the length of the follow-up period may be the most certain way to 
increase the chance that the study captures the effect of an intervention. However, 
commitment to a trial for a decade or longer may be difficult for funding agencies and 
investigators and runs the risk that the findings of the study will be out-of-date by the 
time it is complete. These difficulties may mean that, although a sufficiently powered 
CRCT is the best way to test the effectiveness of an intervention, observational 
studies based on sentinel surveillance may be increasingly relied upon to gauge the 
effect of on-going large-scale interventions without control groups [70,118]. 
Some of the trials [94, 109, 110] were set against a background of 
generalised behaviour change that took place equally in all communities and was 
independent of the intervention. It has been assumed that a declining incidence of 
HIV would mask the impact of a successful intervention because there are fewer 
events in the control community which it is hoped will be prevented in the intervention 
community. Conversely, these results suggest that interventions can have a larger 
effect when other risk behaviour is reduced and this can outweigh the difficulties 
involved in establishing statistical differences between small numbers. Therefore, it is 
unlikely that secular changes in behaviour obscured the impact of the interventions in 
the African CRCTs, but this remains a concern in other settings where the incidence 
of HIV is lower. 
CRCTs of HIV prevention interventions are more susceptible to these 
problems than other infectious diseases, particularly those that focus on individuals 
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with the riskiest sexual behaviour (e.g. those with STIs or involved in sex work). First, 
the private and psychologically substantive nature of sexual risk behaviour will tend 
to make changes slower. Next, the variation in sexual risk behaviour is greater and 
the pattern of contact with respect to risk may be more likely to be assortative than 
other forms of more casual contacts [325]. Both these factors slow the percolation of 
the effect of an intervention through the population. Third, the long duration of HIV 
infection delays the impact of intervention spreading beyond the highest-risk group, 
particularly if the changes reduce the chance of infection acquisition rather than 
transmission (e.g. treating ulcerative STIs among women [105], or male circumcision 
[30, 31, 226]). If the chance of acquisition is reduced and the infection lasted less 
time, prevalence among the high-risk group would decline faster, and the risk 
associated with contact with that group would reduce more quickly. If the chance of 
transmission is reduced, the spread of the impact is most limited by the extent of 
contact between high and low-risk individuals, and only to a lesser extent the 
duration of infection. Added to this is the fact that incident HIV infection is a relatively 
rare outcome in the general population and the chance of infection in intervention 
and control sites is sensitive to epidemic phase and subject to secular trends, driven 
by natural dynamics [251] and/or widespread behaviour change, which may differ 
slightly between superficially similar communities. 
Other infectious diseases may share one or more of these attributes and 
therefore face a similar problem. For example, sexual behaviour change to reduce 
the incidence of other STIs may also take time to work, although the epidemiological 
response may be quick [22, 115]. The impact of interventions to prevent or treat 
tuberculosis will be slow to develop because there is a slow turnover of the infected 
population. On the other hand, interventions that aim to reduce the population of 
insect vectors of diseases such as malaria will be less affected by these issues since 
the turn-over of vectors is high and an effective reduction in the risk of infection to 
humans can develop quickly [37]. 
The CRCT is the gold-standard for demonstrating the effectiveness of an 
intervention in a specific context [314, 315]. If a negative or null result is obtained, 
after assessing how well the intervention was realised, one has to consider whether 
the intervention was not appropriate for the epidemiological context or whether the 
study design (as implemented) was able to detect a real effect. Mathematical 
descriptions of the transmission of HIV can help explore how efficacious the 
intervention could be, but to rule out the chance the study failed to detect an effect, 
CRCTs for the prevention of HIV infection in generalized epidemics may need to 
include more communities or run for much longer. 
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6.6 Appendix 
Details of Changes to the Model Specification 
Except in the ways detailed below, the model used to generate the simulations was 
the same as the first one described in Chapter 2. 
1) Force of infection re-written according to number of unprotected sex acts and 
transmission probability per sex act: 
Equation (2.3) in the original model specification was replaced with equation 6.8; 
= E Z - (1 - ( 0 ) " " " " )) . . . (6 .8) 
m ' f' 
where C/c,/,„,;>• is the number of partnerships formed by individuals of that gender, age 
and activity-group with individuals of the opposite gender of that age and activity-
group, Pf'm' is the risk per unprotected sex act of acquiring infection when forming 
partnerships with individuals of the opposite gender of that age and activity-group, 
and y/... is the number of unprotected sexual acts that comprise each sexual 
partnerships with individuals of the opposite gender of that age and activity-group. 
The number of unprotected sexual acts per partnerships is defined 
as: 
Wk,i,m.Vjn' •••(6.9) 
where is the total number of sexual acts per partnerships and 'S the 
fraction of sexual acts in which a condom is used correctly and consistently. The 
parameterisation of is simplified so that individuals have a "tendency" for 
number of sex acts based on their activity-group and in each partnership the 
individual from the higher activity-group "decides" how many acts that partnerships 
will comprise. 
2) Transmission probability varied by risk-group 
Equation 2.10 in the original model specification is replaced with equation 6.10; 
„ ,.. ipxL+f/'y'.'+ni'Xi+w) 
- ...^D. lu; 
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P„,x,r,nAf) is the probability of infection through sexual partnerships with individuals 
of the opposite gender in the f" age group and in sexual activity group m; / 3 \ , 
and are the per act probabilities of transmission of HIV during acute infection, 
latent infection and pre-AIDS, respectively: is the product of the chance that either 
partner has an STI and the associated multiplicative-increase in the transmission 
probability of HIV, to reflect a stable STI prevalence in the higher risk groups. This 
provides a very basic way to reflect that transmission within and from those with the 
riskiest sexual behaviour is likely to be enhanced by co-factor STIs [105]. 
3) Incidence calculation 
Incidence (cases per person-years at risk) is calculated: 
2 3 
EES K , J ' ) 
k=] m=\ /=1 i I. , 
, 3 ^ 
ZEE 
Where and b, and U, are, respectively, the lower and upper age limits of the age-
group and calculated from equation 2.3. This output is then discreetised 
into units of duration t . / , , is calculated using on simulation runs where no 
interventions is assumed and l^/is calculated using on simulations where an 
intervention is included (see below). 
4) Background Behaviour Change 
To reflect the recent behaviour and epidemic changes in Manicaland [91], between 
simulation year 19 and 24 the overall mean rates of partner change (M^ ,.) and the 
overall frequency of condom use (^,„,,•„•) change linearly. In most simulations, the 
change are: 
^k.i 0.85M^ ,. 
The initial values of these parameters are fitted such that behaviour in the year 1998 
matches that observed in the Manicaland behavioural survey [40]. The timing and 
scale of these changes are informed by the analyses in chapter 2. 
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When the effect of different degrees of bacl<ground behaviour change are 
investigated, two others scenarios are devised - "small" and "medium" amounts of 
behaviour change, defined as: 
"small": M . , 
"medium": M , , ^ 0 . 8 5 M , _ , & ^,^,,,^ -^2^, ^ ,^. 
4) Simulated Intervention 
When the intervention is simulated, it is assumed that for members of the highest risk 
group, the proportion of sex acts in which a condom is used increases A times and 
the chance that either they or any sexual partner has an STI decreases by a fraction 
6; in all analyses, A=4 and 6=0.9. These changes start in simulation year 20 and are 
completed within 3 years but the speed of behaviour change is specified by the 
fraction of the change completed by time t, f(t) ( see equation 6.1 and Figure 6.2). 
= f o r t < 2 0 
= + f o r 2 0 < t ^ 2 3 . . . ( 6 . 1 2 ) 
= + k r t > 2 3 
Vj = Vj = 0 
fort < 2 0 
a\ prc-intv ...(6.13) 
- S / ( 0 V 2 f o r 2 0 < t < 2 3 
ixe-intv 
Vj (t) = (1 - B)v2 for t > 23 
5) Other changes made to the model 
• Number of risk groups reduced from five to three, so that "high-risk" {m=^) 
and "low-risk" (m=2,3) groups can be easily identified. 
• Age-groups width increased from one year to five years for computational 
speed. 
• Method of integration changed from Runge-Kutta to Euler, for computational 
speed. 
• Difference in rates of partner change by group, re-parameterised by 
arithmetic mean and proportional differences between groups (not geometric 
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where Mi^ j is the gender- and age-specific arithmetic mean of partnership 
formation rate and independently determines the ratio of rate of 
partnership formation in each sexual-activity group relative to the lowest 
sexual-activity group (m=3). 
Tables 6.2 to 6.5 give the parameters used in all simulations unless otherwise 
specified. Values not given here are the same as used in Chapter 2. 
Parameter Value Symbol (or 
formula) 
Default Value Justification 
or reference 
M o r t a l i t y r a t e M(a) T a b l e 2 . 2 [ 2 9 2 ] 
F e r t i l i t y r a t e T a b l e : [ 2 9 2 ] 
M e a n t i m e i n p r i m a r y i n f e c t i o n s t a g e 1/V,2 3 m o n t h s [ 4 7 ] 
M e a n t i m e i n s e c o n d a r y i n f e c t i o n s t a g e 
. 
8 y e a r s ( a l l a g e s ) [ 4 7 ] 
M e a n t i m e i n t e r t i a r y i n f e c t i o n s t a g e % 6 m o n t h s [ 4 7 ] 
A d d i t i o n a l h a z a r d o f d e a t h f o r t h o s e w i t h A I D S a 6 m o n t h s [ 4 7 ] 
T r a n s m i s s i o n p r o b a b i l i t y p e r u n p r o t e c t e d s e x a c t 
( l a t e n t i n f e c t i o n ) 
/f 0 . 0 0 1 Fitted* 
T r a n s m i s s i o n p r o b a b i l i t y ( p r i m a r y i n f e c t i o n , p r e -
A I D S a n d f u l l b l o w n A I D S ) 
0 . 0 1 [ 9 7 ] 
P r o d u c t o f p r e v a l e n c e o f S T I c o - f a c t o r ( b y 
a c t i v i t y - g r o u p ) a n d m u l t i p l i c a t i v e i n c r e a s e i n 
t r a n s m i s s i o n o f H I V . 
^ pre-inl v 0 . 5 Predicted[93] 
P r o b a b i l i t y o f v e r t i c a l t r a n s m i s s i o n 0 . 3 5 [ 3 1 7 ] 
F r a c t i o n o f c o n t a c t s m a d e r a n d o m l y w i t h r e s p e c t 
t o s e x u a l a c t i v i t y c l a s s 
g 0 . 5 Fitted* 
P r o p o r t i o n o f p o p u l a t i o n b o m i n t o e a c h a c t i v i t y 




0 . 6 
0 . 3 
0 . 1 
Fitted* 
R e l a t i v e r a t e s o f s e x u a l p a r t n e r c h a n g e i n s e x u a l 
a c t i v i t y - g r o u p s 1 a n d 2 c o m p a r e d t o g r o u p 3 
( m a l e a n d f e m a l e ) . ^2 
1 0 0 
2 0 
Fitted* 
B a l a n c e p a r a m e t e r ( e x t e n t t o w h i c h m i x i n g 
p a t t e r n d e t e r m i n e d b y m a l e s ) 
Fitted* 
Table 6.2; Default parameter values (used for baseline simulation and others unless otherwise stated). 
* These values were selected to give a realistic rate of spread and eventual epidemic magnitude. Where 
the effect is of interest to the current analysis, the sensitivity of the model to the value of these 
parameters is discussed in the main text. 
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Table 6.3: Estimated Mean number of partnerships formed per year in 1998. Based on fitting to age 
and gender-specific HIV prevalence for Manicaland study population at baseline (1998). Note, values 
change through time to simulate background behaviour change. 
Number of sex acts per 
partnership 
Female 
m=Q (lowest) m=l m=2 
Male 
m=0 (lowest) 100 40 4 
m=l 40 40 4 
m=2 (highest) 4 4 4 
Table 6.4: Number of sex acts per partnership. 
Proportion of sex acts in which condom used 





Age Female aged <25 Female aged 25+ 
Oorl <30 0.25 0.4 30+ 0.1 0.1 
2 
<30 &45 0.3 
30+ 0.2 0.15 
Table 6.5: Proportion of sex acts in which condom is used throughout correctly in 1998. Based on data 
collected from the Manicaland study population at baseline (1998). Note, values change through time 
to simulate background behaviour change. 
183 
Chapter 7: Determining the Optimal Monitoring 




For a decade, patients in developed countries that are advancing towards AIDS have 
been offered combination anti-retroviral therapy (ART) which has led to a sharp 
decline in the rate of AIDS-related deaths [150]. More recently, the humanitarian 
crisis associated with the general spread of HIV in many African countries has led to 
an unprecedented financial and logistical commitment to providing ART to those in 
need [124, 284, 285]. initial planning focussed on identifying those currently requiring 
treatment rather than on how to monitor those with future treatment needs [177]. 
However, decisions need to be taken about how to care for all HIV infected patients, 
and these decisions will determine prognosis when ART is eventually initiated and 
the expected demand for ART and other health and social services across the 
population. 
The potential for success of ART depends on the state of the immune-system 
when treatment is begun [8, 157]. Whilst, in western countries, the decision to initiate 
ART is informed by a range of high-technology tools [169, 170], in poorer countries, a 
more pragmatic public-health approach has been adopted [171]. The World Health 
Organisation (WHO) has recommended using CD4 counting machines (CD4 cells 
are the main target of the virus) to decide when treatment should be initiated [177] 
and in the "3 by 5" program, the campaign to get 3 million on therapy by 2005, 
almost all the focus countries followed these guidelines [178]. In many other settings, 
the decision to start therapy is taken without any laboratory support and will makes 
use of standard symptom staging criteria [171]. However, studies from India and 
Africa show that although early signs of disease can be apparent within a few years 
of infection [172, 173], advanced immune depletion is not always associated with 
severe clinical symptoms [174-176]. 
The success and efficiency of ART delivery will be determined by the health-
care environment into which ART provision is incorporated and the way in which 
patients are cared for before they need ART. Contextual factors, such as the 
effectiveness of referrals from ante-natal clinics (ANC) to ART specialists, uptake of 
voluntary testing and the availability of CD4 counting machines, will determine 
opportunities for initiating ART. The number of health-care workers that can clinically 
stage patients or use CD4 machines will determine how actively patients can be 
monitored. Providing a high-standard of care for HIV patients is a key objective in 
programmes such as PEPFAR [163, 284] (The (American) President's Emergency 
Plan for AIDS Relief) and it has been suggested that synergies between care, 
prevention and treatment could alleviate future care needs (for example, caring for 
those with failing treatment and for AIDS-orphans). 
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Whilst a great deal of work has focussed on the optimal state at which to 
initiate ART [154, 155, 326, 327], the way in which the overall effectiveness is 
determined by other aspects of the health-care environment has not received close 
attention. In clinical trials it would be unethical to compromise patient management 
and impossible to compare the full range of management strategies. Understanding 
how the health-care environment influences the practical implementation of an 
initiation strategy and its effect on key health indicator outcomes will help inform best-
practice guidelines and facilitate more accurate projections of future health-care 
needs. However, making predictions of the effect of ART at the population level is 
complicated by the variability between patients in the rate of disease progression, the 
uncertainty in CD4 measurement and other stochastic effects, such as unrelated 
causes of mortality, opportunities for diagnosing women during pregnancies and 
missed appointments. To address these complexities, a new mathematical simulation 
model was developed that follows a theoretical cohort of infected individuals as the 
disease progresses; tracking when symptoms occur; how they are diagnosed; how 
the clinician monitors the individuals' advancing disease; and the decision to initiate 
ART and the effect this has on survival. 
7.2 Methods 
The model stochastically simulates the progression to AIDS and death of a cohort of 
HIV-infected individuals and tracks the services they receive and key health indicator 
outcomes. Each individual is realised independently and the properties of the 
individual, the timing of events and outcomes are calculated based on a series of 
rules and random draws from probability distributions (described below). Random 
draws from particular distributions are simulated by transforming standard uniform 
deviates from the pseudo-random number generator in 'Matlab' software (The 
Mathworks). The data used to parameterise the disease-progression part of the 
model are taken from several African studies, and it was decided that the 
characteristics of the cohort would be parameterised to reflect the current 
epidemiological conditions in eastern Zimbabwe. 
7.2.1 Characteristics of the simulated cohort 
The composition of the cohort is based on the gender and age-distribution of newly 
infected individuals in the Manicaland cohort study (1998-2002) [91] (Table 7.1). To 
capture the range of possible outcomes, the number of people in the cohort is 
chosen to be 1000, which may be assumed to come from a total population of 
-70 ,000 (e.g. the size of a small town in Zimbabwe). Mortality from non-HIV/AIDS 
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related causes among children are: 53 per 1000 live births for infants (0-1 years), and 
a total of 90 per 1000 live births die before their fifth birthday (deaths distributed 
exponentially with parameters 0.054 for 0-1 year-olds, and 0.010 for 1-4 year-olds) 
[328]. The chance of dying between ages 5 and 99 is Weibull distributed such that 
median life-expectancy in the absence of HlV/AlDS is 48.8 years for men and 52.5 
years for women [263] (shape and scale parameters for males: 7 and 57.5; for 
females 7 and 61.8). 
Distribution of Incident Infections 
Age-group Males Females 
15-19 0.047 0.111 
20-24 0.095 0.146 
25-29 0.100 0.148 
30-34 0.089 0.032 
35-39 0.084 0.026 
40-44 0.025 0.016 
45-49 0,033 0.013 
50-54 0.034 0.111 
Table 7.1 Distribution of incident infections with respect to age and gender, based on incident infection 
in Manicaland 1998-2002 [91]. 
7.2.2 Clinical progression 
For the i"' individual, the CD4 count (CD4,.(?)) declines over time since infection {t) 
according to the function: 
^CD4,( f ) = o, -bft 
b. ~ Nijiil, (Tj) } if infected when age < 35 years 
~ N(jul, a I,) } if infected when age > 35 years 
The unit of CD4,.(f) is the number of cells per microlitre of peripheral blood (//Z)"'. A 
steady decline in the square-root of CD4 count is theoretically [329] and clinically 
[179] justified and makes use of parameters that are directly comparable to those 
evaluated in several statistical analyses [330-332]. Although this is not likely to be a 
good description of CD4 decline immediately after infection, it should be sufficient for 
our analyses, which involve using CD4 count information once the infection is 
established. 
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The values of = 25.91, a , =0 .61 and =1 .32 are taken from a study of 
populations in Western and West-Centra! Africa [333]. The value - 1 matches a 
Bayesian shrinkage estimate [331] of the variance in the rate of decline of CD4 
counts. This means that, in the model, 68% of individuals younger than 35 years are 
assigned rates of CD4 decline within one standard deviation of the mean (0.3 to 2.3) 
and, of the rest, half are assigned a rate of decline less than 0.3 (slow-progressors) 
and half are assigned a rate of decline greater than 2.3 (fast-progressors) (Figure 
7.1(a)). The value of jul = 2.0 is chosen to reproduce shorter survival times for older 
people [230, 234]. 
Each measurement of CD4 count is modelled as an observation of CD4, (f) 
plus random error (with standard deviation (T„, ). The error derives partly from 
technical factors [334], but mostly from short-timescale physiological fluctuations in 
the true CD4 count [335-337]. In laboratory studies where counts have been 
repeated on the same blood sample and on blood samples taken within the same 
few weeks, the combined variation is estimated to have a standard deviation of 
approximately 50. In the model, it is assumed that this variation is distributed 
uniformly, with mean zero. The value upon which the clinical decision is taken 
(m.{t)) can be a function {t) of several ( 1 , 2 , . m e a s u r e m e n t s that are taken on 
separate occasions. 
m.(t) = CDA.{t)+ 
Figure 7.1(b) show successive CD4 measurements for five randomly-chosen 
individuals. 
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Figure 7.1 Decline in patients' CD4 counts in the model, (a) The distribution of rate of decline of CD4 
count (root transform of value in number per micrclitre) for those infected when younger than 35 years 
(solid lines) and when 35 years or older (dashed lines). Green line (left axis) give probability density 
function (pdf) and blue line (right axis) give cumulative distribution, (b) Change in CD4 count over 
time since infection. Thick line gives mean trend and other lines show the progression of five 
randomly-chosen individuals observed once a year. 
It is not clear how closely clinical signs of immune-suppression (WHO stage III or IV) 
are correlated with severe immune-suppression. To incorporate this uncertainty into 
the model, three alternative scenarios were defined (Figure 7.2). Scenario I (the 
default) is based on observations from Uganda [174] and Ethiopia [175] (Double 
Weibull distribution with first shape and scale parameters 2,2 and 80.0 and second 
shape and scale parameters 12.4 and 399.3, respectively, weighting to first 0.53). 
The precise shape of this distribution is chosen for its biological plausibility, as well 
as the fit to the data. In scenario II, 90% of individuals develop symptoms by the time 
their CD4 count has dropped below 200 (///)~^ (Weibull distribution shape parameter 
3, scale parameter 355) and in scenario III, 15% of individuals develop symptoms by 
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the time tlieir CD4 count has dropped below 200 {pi) ' (Weibull distribution shape 
parameter 1.5, scale parameter 130). 
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Figure 7.2 Fraction with severe stage III and stage IV clinical signs by CD4 count. Scenario I (green 
line) and scenario II (red line) for CD4 level when symptoms of severe symptoms of immune-
suppression (WHO stage III and IV) develop. Squares show data points from studies in Uganda [174] 
and triangles show data points from Ethiopia [175]. 
Survival after CD4 count falls below 200 (///)~' is assumed to be exponentially 
distributed with a median survival of 11 months, in accordance with a review of 
studies from resource-poor settings [338]. Survival from infection to death for 
individuals infected when 30 years-old has been estimated to be 10.9 years in 
Western populations [234] and 9.8 years in Uganda [230], although other studies 
have suggested lower survival rates in African populations (reviewed by Jaffar et al. 
[247]). Despite being based on independent data sources, the model is in good 
agreement with these results; in the model survival of people infected when younger 
than 35 years had a median of -9.5 years (Figure 7.3) and follows a similar 
distributional form. There are few data on survival of people infected when older than 
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Figure 7.3 Modelled survival distribution for infected cohort in the absence of treatment (median 9.5 
years). 
7.2.3 Diagnosis of infection 
Individuals may be diagnosed with HIV in one of three ways, whichever comes first. 
Once the infection is diagnosed, clinical monitoring of the individual can begin (see 
below). 
1. Individual falls pregnant and attends ante-natal clinic (ANC). 
Recent estimates of fertility rates in Zimbabwe [297, 339] and measurements 
of sub-fertility over the course of infection [47] are used to capture patterns of 
ANC attendance (Table 7.2). For each pregnancy, the probability that the 
woman will attend an ante-natal clinic, have her infection diagnosed and be 
referred to the anti-retroviral treatment (ART) programme can be 10% ("poor 
referral" scenario; estimated to currently be the case in Zimbabwe) or 90% 
("good referral" scenario). It is assumed that attendance at ANC is exactly six 
months before delivery. 
2. Individuals go for voluntary counselling and testing (VCT). 
It is assumed that the probability that an individual goes for VCT is constant 
over time. "Low VCT uptake" means that 5% of individuals (randomly 
selected) go for VCT and are referred and "High VCT uptake" means that 
70% of individuals go for VCT and are referred. Individuals go for VCT at 
some time (uniformly distributed) before they would otherwise present at a 
clinic (see below), it is assumed that individuals that do not go for VCT are 
either geographically isolated from services or unwilling to attend for other 
reasons. High VCT uptake could be achieved following scale-up of services 
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[248], including home-based testing [307], or if policies are changed to allow 
routine 'opt-out' testing at all medical facilities [146, 306]. 
Individual develops symptoms and goes to a health-service provider 
The CD4 level at which an individual develops symptoms sufficiently severe 
to seek medical attention is determined by when the depletion of the immune-
system reaches a predetermined threshold. This threshold varies between 
individuals and is drawn stochastically from a distribution based on the CD4 
levels of those attending a clinic in Cote d'lvoire [340]: Weibull distribution, 
shape parameters 0.8, scale parameter 194.1 (Figure 7.4). Two alternative 
scenarios are also included, whereby individuals present at the clinic earlier 
(e.g. in response to minor symptoms [172, 173]: Weibull distribution, shape 
parameters 2.2, scale parameter 400.0) or later (Weibull distribution, shape 
parameters 0.9, scale parameter 80.0). 
Age 

















Assumed fertility for infected women, by 
years before AIDS^ 
4 + 2 - 3 0 - 1 A I D S 
( R R = 0 . 7 9 ) ( R R = 0 . 4 5 ) { R R = 0 . 2 7 ) ( R R = 0 . 1 9 ) 
15-19 112 0.15 0.84 115 91 52 31 22 
20-24 199 0.25 0^5 207 163 93 56 39 
180 0.36 0^8 195 154 88 53 37 
30-34 135 0J3 0.65 153 121 69 41 29 
35-39 108 0.31 0^3 122 96 55 33 23 
40-44 46 0.21 0.65 50 39 22 13 9 
45-49 15 0.15t 0.65 16 13 7 4 3 
Table 7.2 Assumed fertility of HIV-infected women in the model cohort, tFertility rate 
expressed as number of live births per 1000 women per year. * These rates based on all women 
in Zimbabwe, some of whom will be infected. $ Data not available for this age-group; value 
interpolated. !! Fertility of uninfected women calculated assuming that observed fertility in 
DHS survey is composed of infected and uninfected women in proportion to HIV-prevalence 
at nationally representative antenatal clinics in 2002, and that sub-fertility among all infected-
women is as measured in rural areas between 1995 and 2000. §Fertility has been shown to 
decrease with progressing infection [47]. RR is the observed ratio of fertility of infected 
women relative to uninfected women in Uganda, and this was used to estimate fertility of 
infected women in Zimbabwe for the model. In the model, AIDS is defined as when CD4 
count falls below 200. It is assumed that women on ART have the same fertility as women 
with AIDS. 
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CD4 distribution for symptoms at presentation 
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- 40% = 
20% E Alternative 
scenano II (later) 
600 
CD4 count (number/microiitre) 
Figure 7.4 The assumed distributions of CD4 level at which individuals present at a clinic if they have 
not already been diagnosed. The red line is the default scenario and is based on CD4 counts among 
those presenting at an urban clinic in Cote dTvoire [340] (white squares). The blue and the green lines 
are alternative scenarios, whereby individuals present at a clinic earlier or later, respectively. 
7.2.4 Clinical Monitoring 
Once the infection is diagnosed, individuals can visit a health service provider so that 
their need for ART can be assessed. It is assumed that when an individual is first 
diagnosed (whether at VCT, ANC or when they develop symptoms sufficiently severe 
to seek care), they immediately visit the health service provider. At each visit to a 
health service provider the date of the next appointment is arranged. Following 
others [341], the scheduled interval between appointments can depend on the stage 
of HIV infection; a patient not eligible for ART should return after t , , which depends 
on age and the CD4 measurement (Table 7.3), whereas a patient on therapy should 
return a f t e r = 6 months. Individuals may be lost-to-follow-up while not receiving 
ART and do not attend the next or any subsequent appointment (e.g. due to out-
migration, incapacity, forgetting etc.). The hazard of loss to follow-up is constant, 
(with the exponential parameter/z = 0.05) and such that -5% of individuals are lost in 
the first year. 
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Time until next scheduled appointment 
CD4 measurement Infected when aged Infected when 
(number/mi crolitre) 
m.{t) 
< 35 years aged 35+ years 
Scenario I Any 1 year 1 year 
Scenario II Any 6 months 6 months 
Scenario III Any 3 months 3 months 
Scenario IV m,.(0 < 350 3 months 3 months 
350 < <500 6 months 6 months 
"!,• (0 > 500 1 year 1 year 
Scenario V m.{t) <350 6 months 3 months 
350 < ;n, (0 <500 1 year 6 months 
m. (0 > 500 2 years 1 year 
Scenario VI Any 1 year 6 months 
Scenario Vll Any None scheduled^ 
Table 7.3 Possible strategies for scheduling the next appointment. ^Individuals may attend another 
appointment when they develop symptoms. 
7.2.5 Decision to Start ART 
At each visit to the health service provider a decision is taken about whether to offer 
ART to the individual if they are not already on ART and have not used ART in the 
past. The algorithm is to start ART if certain criteria regarding clinical symptoms and, 
where available, CD4 measurements are met (Table 7.4). The recommendations of 
the WHO [177] are to start ART if the CD4 count is below 200 (///)"' or below 
350 {piy^ if the patient already has severe symptoms (code 7 in Table 7.4). 
7.2.6 The effect of ART 
When starting ART, an individual is assigned a duration of time until they die as a 
result of treatment failure and/or AIDS (in the absence of other competing causes of 
mortality not related to HIV/AIDS). A meta-analysis of cohort studies from high-
income settings (ART-Cohort Collaboration: http://www.art-cohort-collaboration.org/) 
has quantified three-year survival for individuals starting therapy, stratified by 
baseline CD4 and the presence of WHO stage 11 I/I V symptoms [157]. The ART-LINC 
collaboration of cohorts also finds evidence that the risk of death is higher in low-
income settings in the first few months of ART, but similar to the rate in high-income 
countries later [8]. In the absence of a systematic aggregation of survival rates over a 
longer period from African cohorts, three survival scenarios were defined ("best", 
"medium" and "worst"). These scenarios are parameterised in the following way: 
i. First-year survival is equal to aggregated estimates from low-income 
settings[8]. The "medium" scenario uses the point estimate and the "best" 
and "worst" scenarios use the limits of the 95% confidence intervals. 
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ii. The relationship between CD4 count, symptoms and hazard of death after 
the first year is based on data from high-income countries[157]. In the 
"best" scenario, the hazard of mortality observed in the first three years of 
therapy is assumed to stay constant; in the default scenario it increases 
gradually: and in the pessimistic scenario the hazard of death increases 
sharply with time on ART. 
Survival time is Weibuil distributed for all scenarios (Figure 7.5). The parameters for 
the survival time scenarios are given in Table 7.5. The "medium" scenario, which is 
used in simulations unless otherwise stated, produces four-year survival rates of 
-75% for those starting with CD4 count below 50 and 90% for those starting with 
CD4 count between 200 and 349, which is in good agreement with longer-term 
analyses of the ART-LINC cohort data, which have not yet been published [342]. 
O p t i m i s t i c s c e n a r i o D e f a u l t S c e n a r i o P e s s i m i s t i c S c e n a r i o 
W H O s t a g e 
I I I / I V & 
h i g h v i r a l 
l o a d a t 
b a s e l i n e 
C D 4 c o u n t 
w h e n 
t r e a t m e n t 
s t a r t e d * f 1 F i r s t -y e a r f a i l u r e f 1 F i r s t -y e a r f a i l u r e i cn 1 F i r s t -y e a r f a i l u r e 
Y e s 0 - 5 0 1 . 0 3 4 . 2 g j * 1 .6 1 3 . 7 1 0 . 9 % 2 . 5 7 . 9 1 2 . 1 % 
5 0 - 9 9 1 . 0 4 3 . 7 5 3 * 1 . 6 1 6 . 0 6 . 7 % 2 . 5 8 . 8 7 . 4 % 
1 0 0 - 1 9 9 1 . 0 4 7 . 8 3 ^ * 1 . 6 1 6 . 9 4 j * 2 . 5 9 . 1 5 . 1 % 
2 0 0 - 3 4 9 1 . 0 7 9 . 7 1 . 4 % 1 .6 2 3 . 3 1 ^ * 2 . 5 1 1 . 1 1 . 9 % 
3 5 0 + 1 . 0 1 4 1 . 0 1 4 * 1 .6 3 3 . 3 I J * 2 . 5 1 4 . 0 1 . 9 % 
N o 0 - 5 0 1 . 0 8 5 . 8 6 8 J * 1 . 6 2 4 . 4 1 0 . 9 % 2 . 5 1 1 . 5 1 2 . 1 % 
5 0 - 9 9 1 . 0 1 0 9 . 7 0 5 J * 1 . 6 2 8 . 4 6 J * 2 . 5 1 2 . 7 7 . 4 % 
1 0 0 - 1 9 9 1 . 0 1 1 9 . 9 2 3 . 6 % 1 . 6 3 0 . 1 4 . 6 % 2 . 5 1 3 . 1 5 . 1 % 
2 0 0 - 3 4 9 1 . 0 1 9 9 . 9 7 1 . 4 % 1 . 6 4 1 . 4 1 . 7 % 2 . 5 1 6 . 1 1 . 9 % 
3 5 0 + 1 . 0 3 5 3 . 8 4 1 . 4 % 1 . 6 5 9 . 1 1 . 7 % 2 . 5 2 0 . 2 1 . 9 % 
Table 7.5 Parameters for Weibuil distribution of survival time from start of ART to death. These rates 
do not take into account mortality from causes unrelated to HIV/AIDS. *Number per microlitre of 
peripheral blood. 
195 
Code ART Initiation rule 
Number of CD4 measurements 
Symptoms No Symptoms 
Decision to initiate ART 
Symptoms No Symptoms 
i.1 Sytiaffirriic initiation 0 0 Start Do not start 
2 Initial CD4 measurement, thereafter symptomatic initiation 0* 0' Start Start if CD4<200* 
3 SI + CD4 confirmation if symptomatic 1 0 Start if CD4<350 Do not start 
4 SI + CD4 confirmation if asymptomatic 0 1 Start Start if CD4<200 
5 CD4 monitoring: high blanket threshold 1 1 Start if CD4<350 Start if CD4<350 
6 CD4 monitoring: low blanket threshold 1 1 Start if CD4<200 Start if CD4<200 
7 WHO-CD4 recommendations 1 1 Start if CD4<350 Start if CD4<200 
8 * " WHO recommendations with 2 CD4 measurements (take mean) 2 2 Start If CD4<350 Start if CD4<200 
9 ' " WHO recommendations with 2 CD4 measurements (take min) if first close" 1-2 1-2 Start if CD4<350 Start if CD4<200 
t 
"No measurement after the first appointment. 
"A measurement is "close" if it is no more than 20cells/microlitre greater than the appropriate initiation threshold. 
" " I f a second measurement is made, another appointment is required 
§ S 
C 











Symptoms: CD4 CD4 0-50 
Symptoms: CD4 50-99 
Symptoms: CD4 100-199 
Symptoms: CD4 200-349 
Symptoms: CD4 350+ 
No symptoms: CD4 0-50 
No symptoms; CD4 50-99 
No symptoms: CD4 100-199 
No symptoms: CD4 200-349 
No symptoms: CD4 350+ 
10 # 30 






Years on HAART 
Symptoms: CD4 CD4 0-50 
Symptoms: CD4 50-99 
Symptoms: CD4 100-199 
- - Symptoms: CD4 200-349 
Symptoms: CD4 350+ 
No symptoms: CD4 0-50 
No symptoms: CD4 50-99 
No symptoms: CD4 100-199 
No symptoms: CD4 200-349 







Years on HAART 
-Symptoms: CD4 C04 0-50 
-Symptoms: CD4 50-99 
-Symptoms: CD4 100-199 
- Symptoms; CD4 200-349 
-Symptoms: CD4 350+ 
- N o symptoms; CD4 0-50 
-No symptoms: CD4 50-99 
-No symptoms; CD4 100-199 
-No symptoms: CD4 200-349 
-No symptoms; CD4 350+ 
Figure 7.5 S u r v i v a l f r o m c o m m e n c e m e n t o f A R T w i t h d e f a u l t , o p t i m i s t i c a n d p e s s i m i s t i c a s s u m p t i o n , b y p r e s e n c e 
o r a b s e n c e o f s y m p t o m s a n d t r u e - t i m e a v e r a g e d C D 4 c o u n t a t c o m m e n c e m e n t . B a c k g r o u n d s u r v i v a l i s i n c l u d e d 
f o r a m a l e s t a r t i n g A R T a g e d 3 5 y e a r s . 
7.2.7 Pregnancy and mother-to-child transmission 
Pregnant women that have had their infection diagnosed and have not been lost to 
follow-up are eligible to receive treatment to prevent mother-to-child transmission 
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(PMTCT) if they are not already on ART. Following other analyses for Zimbabwe 
[328], it is assumed that the probability that a woman who has had her infection 
diagnosed, is able to receive treatment to prevent mother-to-child transmission 
is = 0.3 and the probability of acceptance is - 0 .5. The probability that the 
baby is infected from its mother is (5^ = 0.24 if she has been received PMTCT and 
y5~=0.32 if she has not. This approximates the case for 7-17 months of 
breastfeeding and treatment being a single dose of Nevirapine [343, 344]. The 
probability that a baby is infected from its mother who is permanently on ART is 
P** = 0.04 [344]. Following the recommendations of UNAIDS [344], the additional 
mortality hazard of an infected baby in the absence of any treatment is taken to be 
distributed as a double-Weibull (first shape and scale parameters 0.97 and 1.52, 
second shape and scale parameters 5.39 and 10, respectively, weighting to first 
0.65) [345]. This distribution has two components; the first represents the fast 
progressors, who are infected inutero and intrapartum; the second represents the 
slow progressors, who are infected during breast feeding. HIV infected babies of 
mothers that had been diagnosed at the time of delivery are assumed to be eligible to 
receive ART. In one African cohort study [346], mean age of starting ART was 7.2 
years and survival after one year was 91% and, in the model it is assumed that this 
chance of yearly survival remains constant over the next years of life. It is implicitly 
assumed that infected babies of women that were not diagnosed at delivery but are 
subsequently diagnosed whilst the baby is still alive do not receive the benefits of 
ART because the opportunity to initiate ART at the appropriate time has been 
missed. A "child death" is counted if they die before their 15"^  birthday and a child is 
assumed to be (maternally) orphaned if their mother dies whilst they are alive and 
before their eighteenth birthday. 
7.2.8 Distribution Notation 
If U. are uniform random deviates between 0 and 1, then: 
• E. are exponentially distributed with mean fj,; 
...(7.3) 
-y" 
• W, are Weibull distributed with shape parameter k and scale parameter K; 
W , = X { - \ n { U , ) f ' ...(7.4) 
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D. are distributed as a double Weibull with first shape and scale parameters 
and/I, and second shape A^and scale parameters and weighting to 
first w : 
. (7.5) 
D. - ^ ( - l n ( t / , . } otherwise 
7.3 Contributions 
This work has benefited from useful discussion with Peter White, T Deirdre 
Hollingsworth (both Imperial College London), Frank de Wolfe (Imperial College 
London & HIV Monitoring Foundation) and my supervisors. Sources for some data 
used in the model parameterisatlon were suggested by Stacie Greby and Eileen 
Burke (both at the Centers for Disease Control and Prevention). 
7.4 Resuits 
The model predicts that, in the absence of treatment, infected individuals will each 
lose, on average, ~22 years of life (range over stochastic realisations ± two standard 
deviations from mean: 21.4-22.6) and die aged 39 (38.6-39.6) years having 
experienced severe symptoms for - 7 0 0 (638-774) days (Table 7.6). 
If patients are initiated on ART only when they develop symptoms of immune-
suppression (syndromic initiation), referral of infected women from ANC to the ART 
programme is low and uptake of VCT is low, then the impact of ART on these 
population level indicators is small (Table 7.6: column A). Although the life of those 
treated is extended by between six and seventeen years (depending upon the effect 
of ART assumed), the average life-years saved among all those infected (treated or 
not) is equivalent to only two to five years per person. The effect of ART is limited by 
the failure to diagnose many individuals and by starting treatment late when the 
immune system is already weakened. Cumulative mortality in the first few years of 
infection is similar to the scenario where treatment is not available because most 
fast-progressors die without being treated and the opportunity to save life-years is 
only available for those with advanced disease (Figure 7.6(a)). 
A CD4 count can provide an early warning of immune system depletion 
before symptoms develop. When a CD4 count is used to help decide when to initiate 
ART in the manner recommended by WHO [177], -60% more individuals are started 
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on ART and the extension of life for those treated rises to between seven and 
nineteen years (Table 7.6: column B and Figure 7.6(b)). 
(a) B; WHOCD4 Initialion; monitored every 6 months: low ANC ref & lowVCT 
2 0.6 3 0.6 
30 40 50 60 70 20 30 40 60 
(C)C:W 
50 
Time since infection 
WH0-CD4 Initiation; monitored eveiy 3 months; tow ANC ref & tow VCT 
3 0^  
3 02 
M M M 
Time since infection 
D: WH0-CD4 Initiation: monitored every 3 months; high ANC ref & high VCT 
20 30 40 SO 
Time since infection 
10 20 30 40 50 60 70 
Time since infection 
Figure 7.6: Survival distribution of an infected cohort if there is no treatment available (solid black 
line) or if ART is available and its assumed effect is worst (blue line), middle (green line) or best (red 
line) (See Table 7.5 and Figure 7.5 for details). The survival of an age and gender-matched cohort that 
is not infected is shown for comparison (dashed black line). 
Our model shows that the frequency with which patients are monitored also 
determines the impact of ART (Table 7.6: column C and Figure 7.6(c)). With more 
frequent monitoring there is a better chance that ART can be started at the right time, 
and with the same initiation rule, patients that are monitored every three months 
instead of every six months, are expected to live approximately half a year longer 





Monitoring every 6 months 
Low ANC referral 
Low VCT uptake 
B 
WH0-CD4 initiation 
Monitoring every 6 months 
Low ANC referral 
Low VCT uptake 
C 
WH0-CD4 initiation 
Monitoring every 3 months 
Low ANC referral 
Low VCT uptake 
D 
WH0-CD4 initiation 
Monitoring every 3 months 
High ANC referral 
High VCT uptake 
Per 1000 infected 
ART effect: 
worst med best worst med best worst med best worst med best 
Person-years lost to HIV/AIDS (1000s) 22 
Mean age at death 39 
Number of "sick days" (1000s) 717 
Number of child deaths (<15 years) 172 
Number of maternal orphanlnqs 300 
20 18 17 
41 43 44 
504 490 471 
171 173 171 
286 253 237 
19 16 13 
42 45 48 
519 502 465 
175 176 176 
275 208 184 
19 16 13 
43 46 48 
516 497 461 
172 174 176 
267 216 182 
17 12 8 
45 49 53 
335 297 253 
167 1 72 172 
250 151 98 
Life-years saved (1000s) n/a 
Years on ART (1000s) n/a 
Percent ever diagnosed n/a 
Number of monitoring appts (1000s) n/a 
CD4 tests per person diagnosed n/a 
1.8 3.4 5.0 
2.5 4.1 5.7 
51 51 51 
4.0 4.1 4.1 
0 0 0 
3.4 6.3 8.6 
4.3 7.2 9.5 
51 51 51 
3.7 3.7 3.8 
7 7 7 
3.5 6.5 9.0 
4.5 7.5 9.9 
51 51 52 
6.7 6.6 6.7 
13 13 13 
5.6 10.4 14.4 
7.3 12.1 16.1 
81 81 81 
17.4 17.3 17.2 
21 21 21 
Number treated n/a 
Life-years saved per person diagnosed n/a 
Years on ART per person treated n/a 
Life-years saved per person treated n/a 
292 293 288 
3.5 6.7 9.7 
8.4 14.1 19.6 
6.0 11.7 17.1 
466 464 474 
6.7 12.3 17.0 
9.2 15.4 20.5 
7.3 13.4 18.5 
482 484 486 
7.0 12.8 17.4 
9.3 15.5 20.3 
7.4 13.5 18.3 
765 762 757 
6.8 12,8 17.7 
9.5 16.0 21,1 
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The effect of the ART delivery programme is further improved if referral from 
ANC and uptake of VCT is improved so that more individuals are diagnosed and 
monitored from earlier in the infection (Table 7.6: column D and Figure 7.6(d)). The 
model predicts that with achievable levels of referral from ANC and VCT uptake, 
almost all HIV-infected individuals would enter care, in this scenario, the total number 
of person-years saved is almost double compared to the case when referral is low. 
With earlier diagnosis of infection, there are also fewer sick days because clinical 
signs can be used to initiate ART promptly. 
Low ANC referral, low VCT uptake 
15 
10 
Presented at clinic Referred from ANC Referred from VCT 
High ANC referral, high VCT uptake 
Presented at clinic Refen'ed from ANC Referred from VCT 
Figure 7.7 The impact of increasing the frequency of monitoring individuals in care on average life-
years saved per person diagnosed, by the route through which they enter care. Individuals in care are 
monitored every 12 months (dark grey bars), every 6 months (light giey bars) or every 3 months (white 
bars). In the upper panel, it is assumed that referral from ANC is low and uptake of VCT is low; in the 
lower panel, it is assumed that referral from ANC is high and uptake of VCT is high. ART is initiated 
with CD4 counts in the manner recommended by WHO (code 7; Table 7.4). 
Increasing opportunities for early diagnosis has two benefits: first, it allows 
more people to enter care and receive ART before they die; and second, it increases 
the chance that ART can be initiated at the right time. To quantify the latter effect, 
alternative cohorts are compared where either all individuals enter care through 
referral (from ANC or VCT) or individuals can only enter care by presenting at a clinic 
with symptoms. With referral, the CD4 count at which ART is started tends to be 
higher (Figure 7.8(a-b)) and the life-years saved by ART is greater (Figure 7.8(c-d)). 
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Referral of women from ANC is especially productive because they are typically 
young and disease-free (Figure 7.9(a)). However, the apparent effectiveness of ART 
at the population level may not improve when more individuals are diagnosed earlier 
through VCT (Figure 7.9(b)). This is because those progressing to AIDS fastest, who 
would otherwise die outside of the ART programme, will start ART when already 
immune-suppressed and die within the programme, bringing down measures such as 
average survival time on ART. 
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Figure 7.8 Alternative cohorts are compared where either all individuals enter care through referral 
(from ANC or VCT; light grey bars) or individuals can only enter care by presenting with symptoms 
(dark grey bars). Different assumptions are made about when individuals present at clinic (Figure 7.4): 
the 'default' scenario is based on data [340], the 'early' scenario represents individuals presenting at 
clinic is response to minor symptoms and the 'later' scenario represents individuals presenting at clinic 
after a longer delay. The measured outcome is the mean CD4 count at which ART is begun (a-b), and 
the mean number of life-years saved per person that is treated (c-d). Treatment is initiated 
syndromically (code 1; Table 7.4) (a,c) or using CD4 counts in the manner recommended by WHO 













Presented at clinic 
I I Referred from ANC 
• • Referred from VCT 
Syndromic Initiation WH0-CD4 Initiation 
A Average survival time on ART 
• Average life-years saved by ART 
low ANC ret good ANC ref + tiigh VCT uptake 
Opportunities for early diagnosis 
Figure 7.9 The iinpact of ART, by 
route of entry to care, (a) Average 
life-years saved by ART for those 
who enter the ART programme 
through ANC referral (blue bars), 
VCT refeiral (green bars) and those 
who present at clinic with symptoms 
(red bars), when ART is initiated 
syndromically or using CD4 counts 
in the manner recommended by 
WHO (codes 1 and 7; Table 7.4). (b) 
The effect of increasing 
opportunities for diagnosis on the 
average survival time on ART 
(triangles) and average life-years 
saved by ART (squares). Values 
shown are the difference (in years) 
relative to where referral from ANC 
is low and VCT uptake is low. The 
initiation rule is the WHO 
recommendations (code 7). In both 
panels, individuals are monitored 
every 6 months; ANC referral is 
assumed to be high and VCT uptake 
is assumed to be low. 
Altogether, these three factors - the way in which ART is initiated, the 
opportunities for early diagnosis of infection and the frequency with which patients in 
care are monitored - combine to determine the improvement in life-expectancy at 
infection due to the availability of ART (Figure 7.10). Upgrading from syndromic 
initiation with low ANC referral rates, low VCT uptake and monitoring every twelve 
months will allow more individuals to enter care, more individual in care to be started 
on ART, and individuals on ART to have better survival chances (Figure 7.11). In 
total, this could save six more life-years per person treated, and improve overall life-
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Figure 7 .10 Improvemen t s in l i fe -expectancy at infect ion due to the availabil i ty of A R T . In the upper 
panel only s y m p t o m s are used to initiate A R T (code 1); in the lower panel one C D 4 measurement is 
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• Syndromic initiation, monitoring every 12 months, low ANC referral low VCT uptake 
• WH0-CD4 initiation, monitoring every 3 months, high ANC referral and VCT uptake 
Figure 7.11 "Best" (dark grey bars) and "worst" (light grey bars) alternative ART programmes are 
compared. These scenarios are equivalent to the lowest and liighest bars in Figure 7.10, but here the 
components of the reported increase in life-expectancy at infection are quantified. With CD4 initiation 
and more frequent monitoring from earlier, more individuals can enter care, more individuals in care 
can start ART, and individuals on ART can have better survival chances. 
When more individuals are diagnosed and diagnosed at an earlier stage, 
there will be a greater case-load for the ART programme (Table 7.6). This will 
increases out of proportion to the overall benefit (life-years saved) because 
individuals that do not immediately need ART and would not otherwise enter care 
(slow-progressors and those at an early stage of infection) are unnecessarily 
monitored for many years. The efficiency of ART, as measured by the number of life-
years saved per year on ART, also decreases if infections are diagnosed earlier, 
because some patients will start ART too soon (due to random error in CD4 
measurement or early symptoms), when they would survive for some years more 
without. 
Alternative strategies were investigated that could use the resources of the 
ART programme more efficiently (Tables 7.3, 7.4 and 7.7). In terms of life-years 
saved per person diagnosed and life-years saved per year of ART (a measure of 
efficiency), there is a clear advantage of using CD4 counts to check that 
asymptomatic individuals are not severely immune suppressed (Figure 7.12; codes 
1-3 versus 4-7). If treatment is initiated at a higher CD4 level than WHO recommends 
(code 5) then more life-years are saved but with less efficiency since many 
individuals would survive for years after reaching this threshold without ART. The 
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opposite is true if ART is used more selectively by initiating at lower CD4 levels (code 
6), where fewer life-years are saved but with greater efficiency. 
Years saved per person d iagnosed 
1 II 111 IV V VI VII 
Initltation Strateqv enn 3 [III] 12-3 (depn CD4) [IV] 6-24 {depn CD4 & age) [VI 6-12 (depn age) fVIl On symptoms [VIII 
1 6 . 5 8 . 9 7 3 6 3 6 3 6 . 6 2 3 
2 5 . 8 8 . 4 6 3 6 . 4 6 .1 5 . 8 0 3 
3 6 . 5 6 . 7 6 . 8 6 3 6 .1 6 . 5 2 . 7 
4 1 1 . 9 1 & 8 1 3 3 1 3 . 4 1 2 3 1 1 3 5 .1 
5 1 5 3 1 5 a 1 5 2 1 5 2 1 5 3 15 .4 8 3 
6 9 . 3 1 1 4 1 1 . 9 1 1 3 1 1 . 1 9 . 8 3 3 
7 1 1 . 8 1 2 3 1 3 2 1 3 3 1 2 . 7 1 1 3 4 . 9 
8 1 2 . 0 1 3 a 1 4 3 1 4 3 1 3 4 1 2 2 5 .1 
9 1 2 . 7 1 4 4 1 4 3 1 4 3 1 3 . 9 1 2 3 5 2 
Years soent on A R T MOOOs^ 
Initltation Strateqv 6 nil 3 mil 12-3 fdepn CD4) [IVl 6-24 (depn C04 & age) fVI 6-12 (depn age) [VII On symptoms [VIII 
1 4 ^ 5 2 3 5 5.503 4.889 4 . 3 9 0 4 . 9 4 8 2 . 0 5 1 
2 4 . 3 9 0 4 . 8 2 3 5 2 2 0 4 3 2 8 4 . 4 6 3 4 . 4 1 1 & m 8 
3 4 . 8 3 5 5 .12G 5 U 7 9 4 3 8 3 4 3 1 6 4 3 M 1 . 9 8 3 
4 8 . 4 1 4 9 2 0 1 9 3 4 3 9 3 1 6 8 . 9 3 0 8 . 4 6 9 3 3 6 1 
5 1 1 2 9 3 1 1 3 4 2 i r * M r L W B 1 1 2 8 4 1 1 . 4 7 9 6 3 8 2 
6 6 . 2 9 6 7 ^ 1 8 3 5 4 8 . 1 0 8 7 . 6 1 3 6 . 6 0 9 2 2 6 3 
7 8 . 3 3 5 8 . 8 9 6 9 . 4 4 8 9 . 4 5 4 9 . 0 6 5 8 . 4 2 1 3 . 4 7 2 
8 8 . 5 8 9 9 . 6 4 8 1 0 . 3 7 8 1 0 3 5 8 9 . 4 8 5 8 . 7 3 9 3 . 5 2 3 
9 8 . 9 7 7 1 & M M i & a # 1 0 . 7 2 8 9 . 9 8 8 9 . 0 8 9 3 . 6 2 1 
Years saved per vear on A R T 
Inltitatlon Strategy snn s n m 12-3 (depn CD4) [IVl 6-24 {depn CD4 & age) [VI 6-12 {depn age) [VI? On symptoms [VIII 
1 0 . 8 0 3 0 3 0 3 0 3 0 3 0 3 
2 0 . 8 0 3 0 . 8 0 3 0 3 0 . 8 0 3 
3 0 . 8 0 3 0 . 8 0 3 0 3 0 . 8 0 3 
4 0 . 9 0 3 0 3 0 3 0 3 0 . 9 0 3 
5 0 . 8 0 3 0 3 0 3 0 3 0 . 8 0 3 
6 0 . 9 0 3 0 3 0 3 0 3 0 . 9 0 3 
7 0 . 9 0 3 0 . 9 0 3 0 3 0 . 9 0 3 
8 0 . 9 0 3 0 . 9 0 3 0 3 0 . 9 0 3 
9 0 . 9 0 3 0 3 0 . 9 0 3 0 3 0 3 
N u m b e r of a D D o l n t m e n t s MOOOsl 
Inltitatlon Strateqv 6 nil 3| l» l 12-3 fdepn CD4) flVl 6-24 {depn CD4 & age) [VI 6-12 {depn age) [Vfl On symptoms [Vll| 
1 4 . 0 7 3 1 3 2 3 3 2 3 4 2 1 .0 
2 4 .1 7 2 1 3 3 5 .1 3 2 4 . 4 1 3 
3 3 . 9 7 .1 1 3 2 4 3 2 3 4 2 1 3 
4 3 . 7 6 6 1 2 2 6 3 3 3 4 . 0 1 3 
5 2 . 9 5 3 9 2 3 3 2 . 4 3 . 1 0 3 
6 4 . 2 7 3 1 4 3 8 3 5 2 4 . 6 1 .0 
7 3 . 7 6 3 1 2 2 8 3 4 3 3 . 9 1 3 
8 7 . 5 1 2 8 2 3 . 4 1 2 2 7 3 8 . 0 1 3 
9 3 . 7 6 . 4 1 1 . 4 5 3 3 . 7 4 . 0 1 3 
Number of C D 4 tests per person i l a o n o s e d 
Inititatlon Strateqv 12 6 nil 3 m 12-3 (depn CD4) [IVl 6-24 (depn CD4 & age) [VI 6-12 {depn age) [VII On symptoms [VIFI 
1 0 . 0 0.0 0 3 0 3 0 3 0 . 0 0 3 
2 1 . 0 1.0 1.0 1 3 1 3 1 . 0 1 3 
3 0 . 5 0 3 0 3 0 3 0 3 0 . 6 0 2 
4 5 . 5 9 3 1 9 3 1 0 2 5 3 5 . 9 1 3 
5 4 . 7 8 3 1 4 3 8 .1 3 3 5 . 0 1 3 
6 6 . 8 1 2 3 2 3 . 6 1 4 3 8 3 7 . 3 1 3 
7 6 . 1 1 0 4 1 9 3 1 0 3 6 3 8 . 4 1 3 
8 12 .1 2 0 . 7 3 7 . 7 1 9 J 12.1 1 2 3 3 .1 
9 6 . 0 1 0 3 1 8 3 9 . 4 5 3 6 . 4 1 3 
Table 7.7 Key indicator outcomes for alternative initiation rules and intervals between scheduled 
appointments. In all cases, the values relate to a cohort of 1000 HIV-infected individuals. ANC referral 
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Figure 7.12 Comparison 
of possible initiation 
strategies (details in Table 
7.4) in years saved per 
person diagnosed (grey 
bars on left axis) and 
years saved per year on 
ART (circles on right 
axis). Appointments are 
scheduled for every 6 
months. Errorbars show ± 
2 standard deviations 
from 20 stochastic runs. 
Comparing all strategies together, those which use more CD4 counts tend to 
save more life-years and are more efficient. The advantage of CD4 counts is greater 
when the association between CD4 level and symptoms is weak (Figure 7.13). 
However, the model suggests that CD4 counts remains advantageous under a 
variety of scenarios for this relationship (Figure 7.13). The alternative strategies of 
testing everyone (code 7), and only testing those without symptoms (code 4) are 
similarly effective and efficient, although the latter requires up to 20% fewer CD4 
counts, depending on the timing of entry to the health-care system and the functional 
relationship between symptoms and CD4 level (Table 7.7). 
The physiological variability of CD4 counts means that taking two 
measurements instead of one could lead to better clinical decision making (Figure 
7.12 and 7.14). In the model, when the decision to initiate ART (in the manner 
recommended by WHO) is based on the average of two measurements, 
approximately one extra life-year is saved per person diagnosed. However, this 
requires double the number of monitoring appointments and CD4 count laboratory 
resources. A more efficient way to overcome the variability in CD4 counts is to only 
make a second count if the first is just above the initiation threshold. Compared to 
using only one count, with this strategy on average there are 1.5 more life-years 
saved per person diagnosed. Moreover, the resources required (appointments and 
number of CD4 counts) is no greater than when only one count is made, since some 
border-line individuals start ART sooner and therefore require less pre-ART 
monitoring (Figure 7.14). 
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Figure 7.13 Comparison of possible initiation strategies in years saved per person diagnosed (triangles 
and solid line on left axis) and years saved per year on ART (squares and dashed line on right axis) 
plotted against the number of CD4 test used per person diagnosed. Lines arc linear trends for ease of 
reading. The panels show the result when different assumptions on the timing of symptoms are made 
(see Figure 7.2): (a) Scenario I (default); (b) Scenario II (symptoms earlier than data suggest); (c) 
Scenario III (symptoms later than data suggest). Points are labelled with the initiation code (Table 7.4) 
to which they refer. 
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Figure 7.14 Key indicator outcomes for alternative initiation rules. Rule 7 is initiation as per WHO 
recommendation using one CD4 count (code 7; Table 7.4); rule 8 is the same but uses the mean of two 
CD4 counts; and, rule 9 instead only uses a second CD4 count if the first is close to the appropriate 
threshold (see Table 7.4). Appointments are scheduled for every 6 months, ANC referral is assumed to 
be high and V C T uptake is assumed to be low. 
With frequent monitoring, the chosen ART initiation strategy can be 
implemented more accurately and more life-years can be saved (Figure 7.15). 
Scheduling appointments is essential because relying on individuals to attend when 
they experience symptoms excludes the advantages of early diagnosis. However, the 
incremental benefit of increasing the frequency of monitoring more than every six 
months is small although the additional number of appointments required is great. An 
efficient allocation of appointments is to schedule patients with high CD4 count to be 
monitored less frequently that those with low CD4 counts (code IV). The number of 
appointments is reduced further without a substantial reduction in the life-years 
saved if the scheduling system also takes account of age (code V), where young 
people are monitored less frequently that older people. The model predicts that in 
this system, there would be almost the same number of diagnostic appointments (0.3 
more, per person infected) as if everyone is monitored every twelve months, but with 
7-10% more life-years saved per person diagnosed. 
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Figure 7.15 Comparison of different monitoring strategies (details in Table 7.4) in years saved per 
person (bars and numbers) and total number of appointments (line), each given relative to scheduling 
appointment every 12 months. The initiation scenario is the WHO recommendation with CD4 counts 
(code 7), ANC referral is assumed to be high and VCT uptake is assumed to be low. 
7.5 Discussion 
There is great potential for ART to alleviate premature death due to AIDS in 
resource-poor settings but poor management of those not yet needing treatment 
could prevent this potential from being realised. This modelling shows that using CD4 
count to initiate ART could greatly increase the number of life-years saved because it 
enables individuals to receive ART before the immune system is severely weakened, 
when the effect of therapy is greatest [8, 157]. However, the full benefits of using 
CD4 counts will not be realised unless the health care system is competent at finding 
those in need of treatment and then monitoring patients regularly. Individuals tend to 
present at clinics once they have developed severe symptoms [340] which means 
that many will die before they are diagnosed or that they can only be given ART after 
their immune system is weakened. Regularly monitoring patients from early in their 
infection improves their prognosis because there will be the opportunity to start ART 
at the right time. Rates of early diagnosis may be improved by encouraging 
individuals to attend testing centres and in some settings, testing is now routine [306, 
347]. Another way to start monitoring infected individuals early is by effectively 
referring women that have tested positive at ANCs. 
These changes will dramatically increase the number of appointments with 
health-care workers and the amount of ART required, and without careful 
management this could be out of proportion to the benefits derived. The CD4 count is 
a more reliable indication of need for ART than the presence of symptoms, so CD4 
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initiation is expected to enable a more efficient use of ART. However, starting 
patients at higher CD4 thresholds than the WHO recommends (below 350 CD+ T-
cells per microlitre of peripheral blood for those with symptoms and below 200 
otherwise) will save fewer life-years per years on therapy. Avoiding testing those who 
have already developed symptoms could reduce the number of tests required without 
sacrificing effect because seldom do individuals have symptoms and a CD4 count 
higher than 350 {///)"'. With more frequent monitoring, it is more likely that ART can 
be initiated at the right time, whether syndromic or CD4-based initiation is used. The 
efficiency of appointment scheduling can be improved by prioritising older and more 
immune-suppressed patients to be monitored more frequently than others, since they 
will need ART first. Relying on individuals to return to the clinic when they develop 
symptoms would reduce the number of appointments required but is not an effective 
way to manage patients because symptoms unreliably predict the need for ART. 
Early diagnosis and close monitoring of patients, though burdensome to the 
health-care system in the short-term, can help reduce future health-care needs. 
There will be less morbidity before therapy because it can be initiated promptly when 
required. Treating patients before symptoms develop could also help limit the onward 
transmission of HIV [222] and other infectious diseases that are enhanced by HIV 
infection, such as malaria [217], tuberculosis [218] and sexually transmitted infections 
[105], which may have not been diagnosed otherwise. Treatment of opportunistic 
infections from an earlier point could also help reduce the rate of immune-system 
deterioration, extending life-years before ART is required. 
The model is limited by the lack of data on the relationship between the WHO 
staging criteria and CD4 count, which underlies the quantitative estimation of the 
benefits of different type of initiation. Although the average CD4 count among 
patients with certain conditions has been reported in many studies [172, 173, 348], it 
is not possible to know which of these patients a clinician would have staged as 
indicating for ART. The data that were used to parameterise the model come from a 
large study in Uganda [174] and a smaller study in Ethiopia [175] which both indicate 
that many individuals with low CD4 count would not be indicated for ART under WHO 
guidelines, although the exact functional relationship is not known. The sensitivity of 
the conclusions to the assumed relationship was investigated (Figure 7.9) and the 
model indicates that CD4 counting is still advisable even if symptoms develop before 
severe immune-suppression in the majority of people. In the absence of more 
detailed data, the model does not differentiate between WHO stage 3 and 4 disease 
and cannot replicate the clinical judgement which should be used in assessing how 
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soon patients witli stage 3 symptoms should be started on ART [177]. Instead it 
identifies individuals that develop "severe symptoms of immune-suppression" which 
is analogous to WHO stage 3 and we explore the effects of using different CD4 
thresholds for starting ART. Under the WHO recommendations, patients with stage 4 
disease should be started on ART regardless of their CD4 level but in the model they 
will only be started if their CD4 count falls below the threshold being used for starting 
any symptomatic patient. However, patients with stage 4 disease will seldom have 
higher CD4 counts than this so we expect the model to only slightly underestimate 
the effect of following WHO recommendations. Another limitation is that the model 
does not capture other advantages and disadvantages to the timing of ART initiation 
besides survival, such as the chance of drug resistance developing or the impact of 
treatment on HIV transmission [154, 222]. 
A public-health approach to delivering ART has to consider how to initiate 
ART and organise the health-care delivery system to maximise the benefit for the 
population overall. Diagnosing infections earlier (through referrals from ANC or VCT), 
regularly monitoring patients and using CD4 counts to initiate ART will save more life-
years and reduce future health-care needs. Without caring for patients at all stages of 
infection in this way, the long-awaited chance to substantially reduce AIDS-mortality 
with ART could be squandered. 
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8.11ntroduction 
The unfolding HIV pandemic has been remarkably different in populations across the 
globe and across Africa, with the most extensive spread in southern Africa. As with 
any infectious disease there is a threshold combination of epidemiological 
parameters which allow for the spread of the virus. The differences between 
populations generating the very different epidemics have been subtle and difficult to 
measure reliably, but it appears that a combination of high transmission probabilities 
associated with other sexually transmitted infections and a lack of male circumcision 
and the contact patterns provided by commercial sex or by many with long standing 
overlapping casual partnerships allow for devastating epidemics. Much previous work 
has been done on how to capture the epidemiology of HIV in models and illustrating 
the relationship between interventions and control of the virus. However, much of this 
work has been broad in scope with qualitative insights into the pattern of effect of 
interventions. In this thesis, the focus has been on the application of models to 
practical policy related questions. The thesis illustrates how through the synthesis of 
questions posed by policy makers, empirical data and carefully tailored models, 
theoretical analyses can generate important insights. 
Three inter-related areas have been covered: surveillance, behavioural 
interventions and anti-retroviral therapy (ART). What emerges is the need for more 
concerted efforts in prevention if the gains in treatment are to be capitalised upon. 
However, much still needs to be done to understand HIV prevention. Advocates, 
taken up by the emergency of a pandemic, have often said that 'we know what 
works'. In reviewing the evidence in this thesis it is clear that not only do we not know 
what works, but also that our epidemiological tools to evaluate what works are 
underdeveloped. This thesis provides a step in developing more appropriate 
evaluation of HIV interventions. In this Chapter some of these themes arsing from 
earlier chapters are expanded upon, along with some examples of how this work 
might be further developed. 
8.2 Discussion on Themes Arising From All Chapters 
> HIV testing could be the most Important determinant of the success of 
prevention and treatment Interventions. 
In Chapter 1, several hypotheses for why HIV has spread widely in southern Africa 
and have so far escaped control were discussed; one important factor is that HIV can 
be transmitted by apparently healthy people [286]. This means that neither the 
infected person nor those uninfected persons, with whom they form sexual 
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partnerships, is aware that there is risk of transmission. This sets HIV apart from 
most other infectious diseases, where infectious individuals show symptoms, 
enabling actions to be taken that limit opportunities for transmission [38]. With HIV 
infection, symptoms may not develop until the individual is severely immune-
suppressed [174], by which time they have typically put others at risk for over a 
decade. Furthermore, by the time symptoms develop, the potential impact of ART on 
survival is much less than if ART had been started sooner [8]. 
Diagnostic tests indicating an HIV infection are now cheap and simple to use, 
and testing services are being scaled-up in many African countries [143, 149, 248, 
347]. With HIV testing, individuals can find out whether they could transmit the 
infection or if they are at risk of acquiring it. The greater efficacy of behaviour change 
counselling that accompanies a test result, or that is conducted with couples found to 
be sero-discordant, has been demonstrated in trials [136, 303]. In a mathematical 
model of heterosexual transmission in Zimbabwe (Chapter 5), it was shown that if 
testing and counselling (TC) could generate long-lasting protective behavioural 
changes, then over the next decades, more than 20% of infections could be averted 
and the total number of patients starting ART could be reduced by several million. 
The other important role of testing is that, following a positive test result, 
individuals can enter the health-care system. Compared with individuals that present 
at clinics and are diagnosed with HIV when already ill, those attending VCT whilst 
healthy stand a much better chance of surviving on ART for longer [8, 340]. Africa is 
not the only setting where delaying being tested is bad for one's health; in the 
Netherlands, the chance of dying in the first three years of ART was found to be half 
the national average in the hospital which admits men who are regularly tested for 
HIV in a cohort study [349]. Models of disease progression (Chapter 7) showed the 
advantage of monitoring individuals from earlier in the infection is especially great 
when CD4 counting machines are used; they can provide an early warning for 
immune-suppression while the potential impact of ART is greatest. Although these 
have become cheaper and easier to use [334], some countries still choose to rely on 
the symptoms of the patient alone [178]. 
Cheap HIV tests could provide a powerful way to reduce the insidious spread 
of HIV. However, data suggest that currently VCT is not serving either of these 
purposes very well [139,146, 250]. This may be to do with the perceived antagonism 
between the two roles; in the rush to deliver ART to as many people as possible, 
behaviour change counselling of those not yet infected is neglected, and the profile of 
VCT clients is shifting towards those that already have severe symptoms [350]. Thus, 
uninfected individuals are not effectively counselled to change their behaviour, and 
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infected but liealtliy individuals are not entering care early enough. Two studies in 
Zimbabwe have indicated, alarmingly, that uninfected individuals receiving VCT 
services have increased their risk behaviour [146, 250]. Importantly, the VCT 
services used in these situations were quite minimal - in the study where VCT was 
not provided in a formal trial, 30% reported not having received any post-test 
counselling, and a further 45% reported having ten minutes or less. Whilst this 
highlights the need for higher quality services, official guidelines from the Centers for 
Disease Control and Prevention [351] are now more focussed on providing VCT in a 
clinical setting and substantially reducing the counselling training for those that 
administer the tests. This will allow more infected individuals to be monitored from 
earlier in their infection, but will do little to bolster behaviour change counselling for 
the greater part of patients who are not infected. 
In another development, new prevention initiatives have been focussed on 
people living with HIV/AIDS (PLWHA), with the rationale that this efficiently directs 
efforts to the minority in the population that will transmit infection [352]. This seems 
like a promising step, and brings HIV control interventions into line with traditional 
epidemiological methods of 'case-finding'. Indeed, modelling alternative patterns of 
increasing condom use (Chapter 5) suggests that near consistent condom use in 
partnerships known to be sero-discordant could drive greater reductions in 
transmissions than substantial changes in condom use irrespective of sero-status. 
However, this limitation is that this requires very high levels of sero-status knowledge 
and currently the vast majority (75-92%) of PLWHA do not know they are infected 
[145]. This is an approach for the future, when testing is universal, re-testing is 
frequent, and highly-infectious new ('window period') infections can be detected 
[353]. For now, as VCT services are scaled-up, most clients counselled will be HIV 
negative and, modelling in this thesis makes it clear that the population level impact 
of VCT rests on behavioural changes amongst this group. 
With the vast resources devoted to VCT, and the remarkable global increases 
in service availability [164], the results here illustrate that serious programmatic 
changes need to be made to balance providing increased opportunities for HIV 
diagnosis and enhancing the behaviour change counselling delivered to the 
uninfected majority. 
> The population level Impact of interventions cannot be inferred from 
individual level observational analysis of risk or be predicted accurately 
Ideas for behavioural interventions are often based on statistical analyses of risk 
factors for infection. However, it not always appreciated that individual level changes 
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do not necessarily translate into similar population level epidemiological effects. The 
impact of behavioural changes depends on many (unmeasured) variables, such as 
the distribution of risk behaviour, the phase of the epidemic and extent of contact 
between high and low risk populations. These factors have been summarised as the 
"epidemiological context" [86]. 
In this thesis, the impact of several potential behaviour change interventions 
on the heterosexual spread of HIV was studied. Delaying first sex, choosing sexual 
partners of the same age (Chapter 4) and choosing sexual partners on the basis of 
sero-status (Chapter 5), were all found to have minimal effects on overall 
transmission in the population. This is despite clear evidence that young women that 
start sex early and have older partners are more likely to be infected [40, 127], and 
contradicts our intuition about the benefit of selectively forming sero-concordant 
partnerships. It seems that the individual protective effects of these changes are 
small, and the benefit can be overwhelmed by behavioural adjustments in other parts 
of the population [135]. In the case of sero-sorting, infrequent testing can lead to 
inaccurate knowledge of sero-status, so that some individuals could selectively form 
sero-discordant partnerships (having been infected since their last negative test). 
In other instances, the impact of behaviour change can be enhanced at the 
population level if young individuals and/or those with the highest risk behaviour are 
selectively targeted (Chapters 5 and 6). These groups contribute disproportionately 
to the onward spread of the epidemic, and, for this reason, it can be efficient to focus 
intervention effort on patients with sexually transmitted infections, mobile populations, 
sex workers and their clients. Although the contribution to transmission of high-risk 
groups is greatest in the early phase of the epidemic, models of the mature 
Zimbabwean epidemic indicate that these groups can still play an important part in 
sustaining high endemic levels (Chapter 6). 
The epidemiological impact of an intervention can also be greater when the 
overall level of risk is lower, meaning that interventions can operate synergistically, 
and that crediting one intervention with a particular epidemiological outcome can be 
misleading. In Uganda several behavioural changes occurred at once, but reduction 
in concurrent partners has been singled out as the most important in driving the 
declines in incidence and prevalence [24]. In Zimbabwe, it seems that the situation is 
further complicated because sexually transmitted infections were successfully 
controlled and condom use reached high levels before prevalence data were 
systematically collected [17] (Chapter 2). 
The impact of other interventions could be large or small depending on the 
pattern of partnership formation (e.g. in the case of interventions targeted to high-risk 
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groups; Chapter 6) and the degree to which this is controlled by men or women (e.g. 
in the case of young women delaying first sex; Chapter 4). These rather abstract 
properties of models cannot be measured directly, so the predicted impact of these 
interventions remains somewhat uncertain. Although it can be inconvenient, it is 
important to recognise this uncertainty and quantify it as far as possible. Over-
estimating the impact of an intervention could lead, for example, to recruiting too few 
individuals to a community-randomised control trial, meaning that it would be under-
powered (Chapter 6). On the other hand, under-estimating the potential impact of an 
intervention could lead to the credit for reduced incidence being wrongly attributed to 
another intervention. 
Other types of uncertainty in the projected impact of interventions could be 
reduced through observational studies. The impact of VCT is very sensitive to how 
long any behavioural changes last but, since the trials have lasted only a few years, 
this is not known. Given the ongoing debate about the best policy direction for VCT, it 
is important to refine these predictions so that the potential impact of VCT can be 
properly compared with those of other types of intervention. This is an example of 
how mathematical modelling can highlight investigations that could contribute most to 
resolving pressing dilemmas in public health policy [201, 275]. 
> Population benefits versus individual benefits 
Although the impact of public health interventions must be maximised for the 
population, it can be difficult to set aside individual needs. In these circumstances, 
mathematical models are useful decision-making tools because they can quantify 
individual and population benefits in the short and longer term [201]. In this thesis, 
models have been used to develop several recommendations that apparently go 
against the benefit of the individual, but could be advantageous if the spared 
resources go elsewhere; 
i. VCT centres should not aim to repeatedly test 'low-risk' individuals 
(Chapters); 
ii. VCT centres should not devote their resources to finding individuals 
that have already developed severe symptoms of immune-
suppression (Chapter 5 and 7); 
ill. Individuals with CD4 counts higher than 350 should not start ART 
(Chapter 7); 
iv. Young patients should not be the priority for intensive monitoring for 
ART needs (Chapter 7). 
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The common theme is that, at the expense of others, those groups that contribute 
most to the transmission of HIV should be prioritised for infection-prevention 
interventions and that those who could benefit most from health-care system 
resources should be prioritised for treatment interventions. 
With new interventions (such as providing emotional support services for 
PLWHA, male circumcision or any new approach/technology), it is repeatedly stated 
that they should not be funded at the expense of other interventions [354]. With the 
exponentially increasing funds available [83, 164, 355], this may actually be 
theoretically possible, although when funding reaches a plateau, some tougher 
choices will have to be made. This is routine for other institutions like the National 
Institute for Health and Clinical Excellence (NICE) in the UK that seeks to optimise 
public spending on new medicines and has restricted proven life-saving treatments 
that are considered to be too expensive [356, 357]. However, the task is more 
formidable in the case of HIV interventions, where the benefits of interventions 
averting infections are theoretical and uncertain, and trade-offs between averting 
future infections or current morbidity and mortality are central. 
Misalignments between the individual and population levels can be identified 
and quantified, if not resolved, with the help of the mathematical modelling. An 
important current debate is about whether HIV testing should be compulsory [306, 
358]. Models quantify the benefit - the more people that are tested, the better 
prevention and intervention programmes can operate (Chapters 4 and 7) - but it 
must be left to others to consider how this compares with the cost of limiting the 
individuals' right 'not to know'. The 'Siracusa Principles' [359, 360] set out conditions 
under which it may be acceptable to restrict individual rights for the population benefit 
(for example, that restrictions must be strictly provided for by law, neither arbitrary 
nor discriminatory, based on objective considerations, necessary to respond to a 
pressing social need, proportional to the social aim, and no more restrictive than 
necessary to achieve the intended purpose). These were met when individuals were 
forcibly quarantined in the 2003 SARS epidemic [361], and in 2007 when a man 
arrived in America with a highly-resistant strain of Tuberculosis [362]. A British HIV-
infected man was convicted in 2005 of causing grievous bodily harm to a woman 
whom he knowingly placed at risk of infection [363]. But, does this mean it is time for 
testing to become compulsory i.e. no longer voluntary? In South Africa, public 
opinion may be heading in that direction [364] but this seems premature. A key issue 
is whether every non-mandatory strategy as been exhausted - which for testing is 
Africa is not yet the case. 
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> Measuring the effectiveness of interventions is diffiouit in trials, but may be 
possible through analysis of sentinel surveillance. 
In the light of the complicated relationship between individual behaviour and 
population level epidemiological impact, it is essential that the success of 
interventions is properly assessed. Two types of methods for doing this are explored 
in this thesis: analysis of sentinel surveillance data (Chapter 2), and conducting 
formalised cluster/community-randomised control trials (CRCTs) (Chapter 6). Whilst 
the latter is recognised to provide a higher standard of evidence, a number of 
practical factors can limit the usefulness of this type of study. 
Modelling in Chapter 6 showed that, in response to an intervention, HIV 
incidence can reduce slowly at first and gather pace over time. Targeting high-risk 
groups can further slow the reduction in incidence in the general population because 
it takes time for prevalence in high-risk groups to subside. This means that for a trial 
to be sufficiently powered, the constraints on the similarity between clusters, the 
follow-up rate of participants, the number of participants in each community and the 
duration of follow-up are more stringent than at first it appears. Therefore, most 
feasible 3 or 4 year CRCTs would be underpowered, allowing few conclusions to be 
drawn from a negative result. Although high-quality, adequately powered trials are in 
the public interest so that resources can be invested efficiently, running long duration 
CRCTs could be considered to go against the interest of individuals, because those 
in the control arm are denied access to the intervention for longer. It also takes 
longer for society to benefit from the lessons of the trials. 
In fact, even with a positive trial result, it would not necessarily be clear that 
the intervention would work in another setting [86, 119]. The epidemiological context 
will modulate its impact and it is unlikely the intervention could be applied as 
assiduously when scaled-up as it can be in a trial. For these reasons, using data 
collected at the national level, when an intervention is already to scale, seems like a 
promising option [70,118]. 
Monitoring the evolution of the HIV epidemic has relied on sentinel 
surveillance estimates of HIV prevalence among women attending antenatal clinics, 
and latterly, also on behavioural surveys [53, 365]. Unfortunately, sufficient credence 
is not always leant to analyses based on such data. This may be for several reasons. 
First, the comparison is "ecological", meaning that regionally-aggregated prevalence 
and behavioural trends are used, potentially obscuring confounding variables at the 
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individual level. Second, it has been recognised that the diminishing availability of 
susceptible individuals in the population and the shifting risk distribution can mean 
that declines in either incidence or prevalence do not necessarily signify behavioural 
changes [54]. Lastly, prevalence among pregnant women may not represent 
prevalence in the general population as HIV infection and fertility could be positively 
associated (because they arise from similar behaviours) or negatively associated 
(because HIV-infection can lead to sub-fertility) and this could change over time [17, 
48, 49]. 
However, work in this thesis has shown that greater use could be made of 
sentinel surveillance data by incorporating these complexities (in so far that they 
modulate the result of the interest) in mathematical models and comparing simulated 
output with observations. By simulating an epidemic scenario that included, to 
extreme levels, all those factors that could potentially contribute to a prevalence 
decline not related to behavioural changes, a conservative conclusion could be 
drawn that behaviour change had played a role in observed prevalence downturns in 
Zimbabwe, Kenya and Haiti (Chapter 2). Further weight is leant to such findings if 
concomitant behavioural surveys indicate substantial behavioural changes, and this 
was the case for Zimbabwe and Kenya. 
It is important that conclusions drawn about prevalence declines are robust 
and conservative, lest the furore that surrounded the declines observed in Uganda 
[82, 85] be repeated. The greatest magnitude of prevalence decline can be 
generated by maximising the initial heterogeneity in risk behaviour (to ignite a large 
epidemic), by allowing AIDS mortality to deplete the population of those with the 
greatest risk (so that incidence settles to a lower level), and by minimising the 
survival time with HIV (so that prevalence trends follow more closely the sharp 
decline in incidence). The modelling work also suggested that although biases in the 
sample of pregnant women probably lead to inaccurate estimates of the absolute 
prevalence level in the general populations, trends in prevalence are not obscured or 
artificially generated. This is because fertility declines with early HIV infection, 
meaning that the subfertility bias will have excluded infected women from the ANC 
sample since the earliest records. 
Furthermore, in Chapter 3, methods to estimate incidence from successive 
measures of prevalence were developed from previous work [67, 69, 255] and their 
performance was tested using simulated data and actual data from three community-
based cohort studies in Africa. These methods could be used with the new rounds of 
Demographic and Health Surveys (DHS) that measure HIV prevalence in the general 
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population. With these methods, changes in incidence could be detected sooner and 
characterised more accurately than when using prevalence data only. 
8.3 Future Work 
Two lines of research emerge from this work that could usefully be pursued; further 
development of existing theoretical frameworks and the development of a new 
framework. These are now briefly discussed in turn. 
8.3.1 Development of Existing Theoretical Frameworks 
The analysis of prevalence trends in the future will contend with further complications 
than are considered here. As access to ART increases, prevalence in the general 
population will increase as those infected live longer [222], but long-term survival on 
ART is not known, and it seems likely that it will change as methods of initiation and 
patient management evolve. Whether prevalence rises in ANC measures will also 
depend on how fertility rates recover on therapy. Prevalence trends among young 
people may escape these biases but these data can have smaller sample sizes and 
be distorted by shifting patterns of sexual debut [49]. Also, as the coverage of 
sentinel surveillance sites has expanded, the disparity between urban and rural 
epidemics has become clear, raising new issues for interpreting aggregated trends in 
prevalence. Only by aggregating trends over multiple sites do we get the statistical 
precision required to detect changes, but how will these changes be altered if sub-
regional epidemics are out of phase? 
For simplicity and generalisability, the contribution of STIs to HIV transmission 
has not been explicitly described in the models used here. This is despite evidence 
that some infections can increase the chance of acquisition and transmission of HIV 
[105]. It was hoped that by varying the average chance of transmission of HIV 
between different settings (to match greater epidemic prevalence in Kenya than Haiti, 
for example: Chapter 2) and allowing the risk of infection and transmission to vary 
within a population (between the risk groups), would implicitly capture different 
compositions and rates of STIs in those population and sub-populations, that are 
thought to have contributed to alternative epidemic trajectories. However, it is 
possible that an explicit description of STI transmission in maturing epidemics would 
reveal processes that could contribute to observed downturns in prevalence. If STI 
epidemics are more likely to fade-out when the riskiest part of the population is 
depleted then transmission from that group would decline further than these models 
have predicted. The much greater-than-observed heterogeneity in risk used in these 
models, though, is likely to have exaggerated possible declines in prevalence (so that 
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conservative conclusions can be drawn in comparison with observation), even 
though this particular effect has not been included. 
In the ART era, the age-specific mortality rates that can be used to estimate 
HIV incidence from successive measures of prevalence will also have to be updated 
and the performance of these methods re-evaluated. Although it is unlikely to be the 
case in the short-term [9], if the pattern of ART access is similar in many countries in 
the long-term, standard mortality rates could still be used. 
The predicted impact of interventions will also have to take account of an 
increasing fraction of the population receiving ART. For instance, transmission 
between older men and younger women may decrease as more of the older men 
start ART. Alternatively, increased survival of older men on ART could generate more 
demand for sexual partnerships with young women, increasing transmission overall. 
ART could prolong marriages, but could mean that more orphans are left behind, 
who can be the most likely to fall into riskier sexual behaviours, such as starting sex 
early and forming partnerships with older men [366]. Increased survival amongst 
those with the riskiest sexual behaviour could also sustain higher endemic levels of 
STIs, indirectly promoting HIV transmission [367, 368] and offsetting the direct 
advantages in reduced HIV transmissibility [286]. 
With an increasing number of expensive options for preventing new infection 
(including ART, circumcision, vaginal microbicides), it will be more important to 
develop priorities and make effectiveness and cost-effectiveness comparisons 
between a variety of intervention 'packages'. Analysing the impact of new 'bio-
medical' interventions will require greater understanding of how these options would 
be used together and whether this leads to behavioural disinhibition. In the same way 
that people who use sunscreen tend to over-compensate for the reduced risk of 
melanoma by spending much more time the sun [369], women may start to use 
microbicides gels instead of condoms, putting themselves at greater risk [195]. By 
the same token, if a male is circumcised and his perception of the reduced risk of 
infection and transmission leads to riskier sexual practices, then, at the population 
level, the benefit of circumcision interventions will be undermined and the burden of 
infection will be shifted further onto women [27, 370], which has important 
implications for the demographic impact of the epidemic [354]. More complicated 
interventions introduce further uncertainties to estimates and projections, and, as 
before, these can be best identified with the help of models, but only fully quantified 
with further data collection. 
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8.3.2 A New Theoretical Framework: The Influence of the Changes in Risk over the 
Life-Course 
In this thesis, it was important to restrict as far as possible the complexity of the 
models used, to avoid unnecessary details interfering with the particular analysis of 
interest. However, in comparing these models with behavioural data and considering 
further analyses concerning long-term projections and demographic and 
epidemiological feedback mechanisms, an intriguing limitation was apparent; existing 
models fail to identify how an individual's risk (in terms of the types of partnerships 
they form) can change over the lifetime, and how this personal journey will be 
responsive to life-course events that happen to the individuals and to others in the 
community. 
As discussed in Chapter 1, heterogeneity in the risk of infection is an 
important factor in the generalised spread of HIV [37] and the extent of contact 
between "high" and "low" risk groups partly determines the speed and extent of 
epidemic spread and the potential effect of behaviour change interventions [42, 371]. 
In concentrated epidemics, where most transmission is driven by high-risk behaviour, 
simple descriptions of risk have had great explanatory power [72]. However, in the 
mature generalised epidemics of Africa, a more detailed account of risk may now be 
needed. A minority of infections are attributed to paid-for sex [371, 372] and the large 
number of sero-discordant marital partnerships [307, 373, 374] indicates that in the 
coming years most new infections could occur within mutually-faithful monogamous 
marital partnerships. The models in this thesis aim to qualitatively capture the range 
of types of sexual partnerships (casual partnerships of short duration and a small 
number of unprotected sex acts versus regular partnerships of longer duration and a 
large number of unprotected sex acts) but partners are not explicitly identified, fertility 
is not linked to partnership status, parenthood is not traced, and the mixture of 
partnerships formed by each individual is constant over their life or changes 
according to the prevailing population structure. 
Observations from cross-sectional studies, longitudinal studies and trials have 
accumulated that are not readily explained by existing transmission models. A 
substantial proportion (in some settings, a majority) of discordant partnerships in 
Africa include an infected women and an uninfected man [374], whilst standard ideas 
predict that men should typically be the source of infection to their wives [40, 375]. In 
the Manicaland HIV/STD intervention trial, protective behavioural changes among 
men attending beer halls, did not translate into reduce incidence in their communities 
as expected [94]. Community-based cohort studies in Uganda, Tanzania and 
Zimbabwe show that there are two periods when women are most at risk of infection; 
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when they are young and when they are middle-aged (unpublished analyses from the 
ALPHA Network group of cohort studies [376]). These regularities are also detected 
in other African settings, where incidence is estimated from DHS sero-surveys 
(Chapter 3). 
Sexual behaviour changes substantially over the life-course. Among young 
people, different risk behaviours can be associated [127, 377] and this can be linked 
to the socio-economic circumstances of the immediate family [92], having relocated 
[377] and being orphaned [366]. In general, however, indicators of recent risk 
behaviour are not correlated with long-term indicators [378] and whilst long-term 
indicators do roughly predict the distribution of infection [127, 378], marital status is 
always a key modifying variable [377, 379]. Many young unmarried women tend to 
form concurrent partnerships with much older men, but they typically marry men or a 
more similar age to their own [40]. In recent times, young men have started marrying 
later, possibly because they cannot afford the bride price, and, in the interim, they 
may be forming more casual partnerships [372]. Although most married men do not 
pay for sex directly, many have long-term extramarital partnerships [375]. 
The HIV epidemic could also directly interact with the life-course through its 
effect on fertility [47], which could increase the likelihood of divorce [380], and 
mortality, which could alter the demographic composition of the population and drive 
trends in the age difference between sexual and marital partners. Following the death 
of their husband, formerly "low-risk" women may form new short-term partnerships 
[270] - putting others at risk if they are already infected, or themselves at risk if not. 
An important prediction of existing models (that was central to Chapter 2) is 
that in maturing epidemics, incidence may decrease because those with the riskiest 
sexual behaviour will be selectively removed by AIDS mortality [54, 91, 231]. On the 
other hand, if being widowed forces women to seek new partners, orphaning leads to 
increased risk and sub-fertility promotes marital instability, then epidemics may be 
fuelled rather than slowed as they mature. Understanding which of these alternative 
scenarios is more likely will contribute to the interpretation of observed 
epidemiological trends; for instance, it could be that stable HIV prevalence is the 
hallmark of protective behavioural changes counterbalancing the natural tendency for 
epidemics to 'self-excite'. 
Optimising and prioritising interventions will be clearer from the perspective of 
the life-course so that the effect of gaps, overlaps and dynamic interactions can be 
identified. Interventions to change sexual behaviour are often directed towards 
particular life-courses stages (e.g. abstinence for young people, faithfulness for 
married couples [284]) and their effects could be modified by behaviour at other life-
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stages [381]. interventions may even alter the life-course: voluntary counselling and 
testing aimed at married/pre-marital couples [382] can lead to separation if they are 
sero-discordant [142]. Furthermore, for many, the point of entry to testing and 
treatment will be at a key life-course event - pregnancy, marriage or the death of a 
spouse - and understanding the position of individuals in the sexual network at these 
times will help predict where demand will arise and the potential effect of treatment 
on transmission. Understanding how ART will reshape the overall demographic 
impact of the epidemic also demands an explicit account of behaviour, transmission 
and disease progression in the partnerships that produce children and leave behind 
orphans. 
8.4 Final Remarks 
The HIV epidemic is accelerating into its second quarter-century but funding, data 
and technical insights are accumulating that could finally bring it under control. 
Uganda and Zimbabwe have shown that interventions that encourage ordinary 
people to change their sexual behaviour can turn back the epidemic. In the next 
twenty-five years, several high-tech tools will be added to the public health arsenal, 
which, in combination with existing efforts in testing and counselling for behaviour 
changes, may be sufficient to drive the epidemic down to much lower levels 
throughout the world. The public health research agenda between now and then will 
be focussed on carefully assessing interventions - perhaps in small trials or on a 
larger scale using sentinel surveillance - and finding programmatic strategies that 
optimally share resources between interventions to protect individual and 
communities. Mathematical modelling will be at the centre of this research, providing 
a precise framework that can incorporate all the necessary biological and behavioural 
processes to guide policy in the short and long term. 
227 
References 
1. Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly, 1981. 30: p. 250-
2. 
2. UNAIDS, 2006 Report on the global AIDS epidemic. 2006: Geneva, p. 
http://www.unaids.orayen/HIV data/2006GlobalReDort/defauit.asD. 
3. Sarngadharan, M.G., et al., Antibodies reactive with human T-lymphotropic 
retroviruses (HTLV-III) in the serum of patients with AIDS. Science, 1984. 224(4648): 
p. 506-8. 
4. Popovic, M., et al., Detection, isolation, and continuous production ofcytopathic 
retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science, 1984. 
224(4648): p. 497-500. 
5. Gallo, R.C., et al.. Frequent detection and isolation of cytopathic retroviruses (HTLV-
III) from patients with AIDS and at risk for AIDS. Science, 1984. 224(4648): p. 500-3. 
6. Stover, J., et al.. Can we reverse the HIV/AIDS pandemic with an expanded 
response? Lancet, 2002. 360(9326): p. 73-7. 
7. Stover, J., et al.. The global impact of scaling up HIV/AIDS prevention programs in 
low- and middle-income countries. Science, 2006. 311(5766): p. 1474-6. 
8. Braitstein, P., et al.. Mortality of HIV-1-infected patients in the first year of 
antiretroviral therapy: comparison between low-income and high-income countries. 
Lancet, 2006. 367(9513): p. 817-24. 
9. Boerma, J.T., et al., Monitoring the scale-up of antiretroviral therapy programmes: 
methods to estimate coverage. Bull World Health Organ, 2006. 84(2): p. 145-50. 
10. Salomon, J.A., et al.. Integrating HIV prevention and treatment: from slogans to 
impact. PLoS Med, 2005. 2(1): p. e l 6 . 
11. U.S. Census Bureau International Data Base, Midyear Population, by Age and Sex. 
available from httD://www.census.aov/ipc/www/world.html. 2007. 
12. UNICEF, Monitoring the situation of children and women, http://www.childinfo.ora/. 
2007. 
13. UNAIDS, UNICEF, and USAID, Children on the Brink - A joint report of new orphan 
estimates and a framework for action. 2004. 
14. Birmingham, K., UN acknowledges HIV/AIDS as a threat to world peace. Nat Med, 
2000. 6(2): p. 117. 
15. Asamoah-Odei, E., J.M. Garcia Calleja, and J.T. Boerma, HIV prevalence and trends 
in sub-Saharan Africa: no decline and large subregional differences. Lancet, 2004. 
364(9428): p. 35-40. 
16. Mahomva, A., et al., HIV prevalence and trends from data in Zimbabwe, 1997-2004. 
Sex Transm Infect, 2006. 82 Supp11: p. i42-7. 
17. UNAIDS, Evidence for HIV decline in Zimbabwe: a comprehensive review of the 
epidemiological data. 2005. p. wvw.epidem.org. 
228 
18. Shelton, J.D., D.T. Halperin, and D. Wilson, Has global HIV incidence peaked? 
Lancet, 2006. 367(9517): p. 1120-2. 
19. Carael, M., Sexual behaviour, in Sexual behaviour and AIDS in the developing world, 
J. Cleland and B. Ferry, Editors. 1995, Taylor and Francis: London. 
20. Halperin, D.T. and H. Epstein, Concurrent sexual partnerships help to explain Africa's 
high HIV prevalence: implications for prevention. Lancet, 2004. 364(9428): p. 4-6. 
21. Wellings, K., et a!.. Sexual behaviour in context: a global perspective. Lancet, 2006. 
368(9548): p. 1706-28. 
22. Boily, M.C., C.M. Lowndes, and S. Gregson, Population-level risk factors for HIV 
transmission and 'the 4 Cities Study': temporal dynamics and the significance of 
sexual mixing patterns. Aids, 2002.16(15) : p. 2101-2. 
23. Morris, M. and M. Kretzschmar, Concurrent partnerships and the spread of HIV. Aids, 
1997.11 (5) : p. 641-8. 
24. Stoneburner, R.L. and D. Low-Beer, Population-level HIV declines and behavioral risk 
avoidance in Uganda. Science, 2004. 304(5671): p. 714-8. 
25. Ferry, B., et al.. Comparison of key parameters of sexual behaviour in four African 
urban populations with different levels of HIV infection. Aids, 2001 .15 SuppI 4: p. 
S41-50. 
26. Auvert, B., et al., Male circumcision and HIV infection in four cities in sub-Saharan 
Africa. Aids, 2001 .15 SuppI 4: p. 831-40. 
27. Williams, B.G., et al., The potential impact of male circumcision on HIV in Sub-
Saharan Africa. PLoS Med, 2006. 3(7): p. e262. 
28. Weiss, H.A., M.A. Quigley, and R.J. Hayes, Male circumcision and risk of HIV 
infection in sub-Saharan Africa: a systematic review and meta-analysis. Aids, 2000. 
14(15): p. 2361-70. 
29. Siegfried, N., et al., HIV and male circumcision-a systematic review with assessment 
of the quality of studies. Lancet Infect Dis, 2005. 5(3): p. 165-73. 
30. Auvert, B., et al.. Randomized, controlled intervention trial of male circumcision for 
reduction of HIV infection risk: theANRS 1265 Trial. PLoS Med, 2005. 2(11): p. e298. 
31. Bailey, R.C., et al., Male circumcision for HIV prevention in young men in Kisumu, 
Kenya: a randomised controlled trial. Lancet, 2007. 369(9562): p. 643-56. 
32. Gray, R.H., et al., Male circumcision for HIV prevention in men in Rakai, Uganda: a 
randomised trial. Lancet, 2007. 369(9562): p. 657-66. 
33. Aidsmap, Women may be at heightened risk of HIV infection immediately after male 
partner is circumcised http://www.aidsmap.com/en/news/3GBF12A3-A1AG-4A0E-
A79C-54FC6EF93E28.asp (accessed 14th August 2007), 2007. 
34. Kapiga, S.H., et al.. The incidence of HIV infection among women using family 
planning methods in Dar es Salaam, Tanzania. Aids, 1998.12(1 ) : p. 75-84. 
35. de Gourville, E.M., et al.. Risk factors for concordant HIV infection in heterosexual 
couples in Trinidad. Int J STD AIDS, 1998. 9(3): p. 151-7. 
229 
36. Gray, R.H., et al., Male circumcision and HIV acquisition and transmission: cohort 
studies in Rakai, Uganda. Rakai Project Team. Aids, 2000.14(15) : p. 2371-81. 
37. Anderson, R.M. and R.M. May, Infectious diseases of humans. 1991, Oxford: Oxford 
university press. 
38. Fraser, C., et al.. Factors that make an infectious disease outbreak controllable. Proc 
Natl Acad Sci U S A , 2004.101 (16) : p. 6146-51. 
39. French, K., S. Riley, and G. Garnett, Simulations of the HIV epidemic in sub-Saharan 
Africa: sexual transmission versus transmission through unsafe medical injections. 
Sex Transm Dis, 2006. 33(3): p. 127-34. 
40. Gregson, S., et al.. Sexual mixing patterns and sex-differentials in teenage exposure 
to HIV infection in rural Zimbabwe. Lancet, 2002. 359(9321): p. 1896-903. 
41. Luke, N. and K.M. Kurz, Cross-generational and transactional sexual relationships in 
Sub-Saharan Africa. 2002, International Centre for Research on Women: 
Washington, D.C. 
42. Garnett, G.P. and R.M. Anderson, Factors controlling the spread of HIV in 
heterosexual communities in developing countries: patterns of mixing between 
different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci, 1993. 
342(1300): p. 137-59. 
43. Museveni, Y.K., AIDS is a socioeconomic disease, in What is Africa's problem?, E. 
Kanyogonya, Editor. 2000, University of Minnesota Press: Minneapolis, p. 247-255. 
44. Chin, J., Public health surveillance of AIDS and HIV infections. Bull World Health 
Organ, 1990. 68(5): p. 529-536. 
45. Chin, J. and J. Mann, Global surveillance and forecasting of AIDS. Bull World Health 
Organ, 1989. 67(1): p. 1-7. 
46. Zaba, B. and S. Gregson, treasuring the impact of HIV on fertility in Africa. Aids, 
1 9 9 8 . 1 2 S u p p l 1 : p . S41-50. 
47. Ross, A., et al., HIV-1 disease progression and fertility: the incidence of recognized 
pregnancy and pregnancy outcome in Uganda. Aids, 2004.18(5) : p. 799-804. 
48. Garnett, G.P. and S. Gregson, Monitoring the course of the HIV-1 epidemic: the 
influence of patterns of fertility on HIV-1 prevalence estimates. Mathematical 
Population Studies, 2000. 8(3): p. 251-277. 
49. Zaba, B., T. Boerma, and R. White, Monitoring the AIDS epidemic using HIV 
prevalence data among young women attending antenatal clinics: prospects and 
problems. Aids, 2000.14 (11) : p. 1633-45. 
50. Gregson, S. and G.P. Garnett, Contrasting gender differentials in HIV-1 prevalence 
and associated mortality increase in eastern and southern Africa: artefact of data or 
natural course of epidemics? Aids, 2000 .14 SuppI 3: p. S85-99. 
51. Glynn, J.R., et al.. Factors influencing the difference in HIV prevalence between 
antenatal clinic and general population in sub-Saharan Africa. Aids, 2001.15(13) : p. 
1717-25. 
230 
52. Gregson, S., et al., Study of bias in antenatal clinic HIV-1 surveillance data in a high 
contraceptive prevalence population in sub-Saharan Africa. Aids, 2002.16(4) : p. 643-
52. 
53. Ghys, P.O., et al., Measuring trends in prevalence and incidence of HIV infection in 
countries with generalised epidemics. Sex Transm Infect, 2006. 82(suppl_1): p. 152-
56. 
54. UNAIDS Reference Group on Estimates Modelling and Projections, Trends in HIV 
incidence and prevalence: natural course of the epidemic or results of behavioural 
change?, in UNAIDS Best practice collection. 1999; Geneva, Switzerland. 
55. Kilian, A.M., et al., Reductions in risk behaviour provide the most consistent 
explanation for declining HIV-1 prevalence in Uganda. Aids, 1999.13 (3) : p. 391-8. 
56. World Health Organization/United Nations Joint Programme on AIDS, Second 
Generation Surveillance for HIV: the Next Decade. 2000: Geneva. 
57. Zaba, B., et al.. The role of behavioral data in HIV surveillance. Aids, 2005 .19 SuppI 
2; p. S39-52. 
58. Garnett, G.P., et al.. Behavioural data as an adjunct to HIV surveillance data. Sex 
Transm Infect, 2006. 8 2 ( s u p p M ) : p. 157-162. 
59. UNAIDS Reference Group on Estimates Modelling and Projections, Improved 
methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: 
Recommendations of the UNAIDS Reference Group on Estimates, Modelling and 
Projections. Aids, 2002.16(9) : p. W1-14. 
60. Stover, J., Projecting the demographic consequences of adult HiVprevalence trends: 
the Spectrum Projection Package. Sex Transm Infect, 2004. 80 S u p p 1 1 : p. i14-18. 
61. Demographic and Health Surveys - Providing information for informed decisions in 
population, health and nutrition. httD://wvm. measuredhs. com. 
62. Boerma, J.T., P.O. Ghys, and N. Walker, Estimates of HIV-1 prevalence from national 
population-based surveys as a new gold standard. Lancet, 2003. 362(9399): p. 1929-
31. 
63. McDougal, J.S., et al.. Surveillance for HIV-1 incidence using tests for recent infection 
in resource-constrained countries. Aids, 2005 .19 SuppI 2: p. S25-30. 
64. Parekh, B.S., et al., Quantitative detection of increasing HIV type 1 antibodies after 
seroconversion: a simple assay for detecting recent HIV infection and estimating 
incidence. AIDS Res Hum Retroviruses, 2002.18(4) : p. 295-307. 
65. McDougal, U.S., et al., Comparison of HIV type 1 incidence observed during 
longitudinal follow-up with incidence estimated by cross-sectional analysis using the 
BED capture enzyme immunoassay. AIDS Res Hum Retroviruses, 2006. 22(10): p. 
945-52. 
66. UNAIDS, Statement on the use of the BED-assay for the estimation of HIV-1 
incidence for surveillance or epidemic monitoring. Report of a meeting of the UNAIDS 
231 
Reference Group on Estimates, Modeiiing and Projections. Athens, Greece, 13-15th 
Decemeber 2005. 2005, UNAIDS; Geneva. 
67. Batter, V., et al., l-ligh HIV-1 incidence in young women masl^ed by stable overall 
seroprevalence among childbearing women in Kinshasa, Zaire: estimating incidence 
from serial seroprevalence data. Aids, 1994. 8(6): p. 811 -7. 
68. Adas, A.E. and G.F. Medley, Estimates of disease incidence in women based on 
antenatal or neonatal seroprevalence data: HIV in New York City. Stat Med, 1994. 
13(18): p. 1881-94. 
69. Gregson, S., et al.. Demographic approaches to the estimation of incidence of HIV-1 
infection among adults from age-specific prevalence data in stable endemic 
conditions. Aids, 1996.10(14): p. 1689-97. 
70. Hallett, T.B., P.J. White, and G.P. Garnett, The appropriate evaluation of HIV 
prevention interventions: from experiment to full scale implementation. Sex Transm 
Infect, 2007. 
71. UNAIDS, Evaluation of the 100% condom program in Thailand, available from 
http://data.unaids.ora/Publications/IRC-pub01/JC275-100pCondom en.pdf. 2000. 
72. Morris, M., et al.. Bridge populations in the spread of HIV/AIDS in Thailand. Aids, 
1996.10(11): p. 1265-71. 
73. Nelson, K.E., et al., Changes in sexual behavior and a decline in HIV infection among 
young men in Thailand. N Engl J Med, 1996. 335(5): p. 297-303. 
74. Nelson, K.E., et al., HIV infection in young men in northern Thailand, 1991-1998: 
increasing role of injection drug use. J Acquir Immune Defic Syndr, 2002. 29(1): p. 
62-8. 
75. Hearst, N. and 8. Chen, Condom promotion for AIDS prevention in the developing 
world: is it working?Stud Fam Plann, 2004. 35(1): p. 39-47. 
76. STD/AIDS Control Program - Ministry of Health Uganda, STD/HIV/AIDS Surveillance 
Report, available from: http://www.health.ao.ua/docs/hiv0603.pdf. 2003. 
77. Okware, S., et al.. Revisiting the ABC strategy: HIV prevention in Uganda in the era 
of antiretrovirai therapy. Postgrad Med J, 2005. 81(960): p. 625-8. 
78. Hogle, A. J., What happened in Uganda? Declining HIV prevalence, behavior change 
and the national response. 2002, U.S. Agency for International development,. 
79. STD/AIDS Control Program - Ministry of Health Uganda, National condom policy and 
strategy - draft. 2003: Kampala. 
80. Asiimwe-Okiror, G., et al., Change in sexual behaviour and decline in HIV infection 
among young pregnant women in urban Uganda. Aids, 1997.11(14): p. 1757-63. 
81. Mbulaiteye, S.M., et al.. Declining HIV-1 incidence and associated prevalence over 
10 years in a rural population in south-west Uganda: a cohort study. Lancet, 2002. 
360(9326): p. 41-6. 
82. Parkhurst, J.O., The Ugandan success story? Evidence and claims of HIV-1 
prevention. Lancet, 2002. 360(9326): p. 78-80. 
232 
83. The Global Fund to Fight AIDS Tuberculosis and Malaria, The Global Fund to Fight 
AIDS, Tuberculosis and Malaria, www.thealobalfund.ora. 
84. The President's Emergency Plan for AIDS Relief U.S. Five-year global HIV/AIDS 
strategy. www.Depfar.aov. 
85. Gill, P., Body Count: Fixing the Blame for the Global AIDS Catastrophe. 2006: 
Thunder's Mouth Press. 208. 
86. Grassly, N.C., et al.. The effectiveness of HIV prevention and the epidemiological 
context. Bull World Health Organ, 2001. 79(12): p. 1121-32. 
87. Halperin, D.T., et al.. The time has come for common ground on preventing sexual 
transmission of HIV. Lancet, 2004. 364(9449): p. 1913-5. 
88. Human rights watch. II. The United States' "War on Comdoms". 2004 [cited 2005 
February 22]. 
89. American Foundation for AIDS Research, The effectiveness of condoms in 
preventing HIV transmission. 2005, American Foundation for AIDS Research,. 
90. Shafer, LA., et al. H/l/ prevalence and incidence are no longer falling in Uganda - a 
case for renewed prevention efforts: evidence from a rural population cohort 1989-
2005, and from ANC surveillance (THLB0108). in XVI International AIDS Conference. 
2006. Toronto, Canada. 
91. Gregson, S., et al., HIV decline associated with behavior change in eastern 
Zimbabwe. Science, 2006. 311(5761): p. 664-6. 
92. Gregson, S., H. Waddell, and S. Chandiwana, School education and HIV control in 
sub-Saharan Africa: From discord to harmony? Journal Of International Development, 
2001.13: p. 467-485. 
93. UNAIDS. Follow-up to the declaration of commitment on HIV/AIDS (UNGASS). 
http://data.unaids.ora/pub/Report/2006/2006 country proaress report Zimbabwe en 
.pdf 2006 [cited 2006 16th October]. 
94. Gregson, S., et al.. Impact and Process Evaluation of Integrated Community and 
Clinic-Based HIV-1 Control: A Cluster-Randomised Trial in Eastern Zimbabwe. PLoS 
Med, 2007. 4(3): p. e l 02. 
95. McKusick, L , W. Horstman, and T.J. Coates, AIDS and sexual behavior reported by 
gay men in San Francisco. Am J Public Health, 1985. 75(5): p. 493-6. 
96. Holmes, K.K., R. Levine, and M. Weaver, Effectiveness of condoms in preventing 
sexually transmitted infections. Bull World Health Organ, 2004. 82(6): p. 454-61. 
97. Pinkerton, S.D. and P.R. Abramson, Effectiveness of condoms in preventing HIV 
transmission. Soc Sci Med, 1997. 44(9): p. 1303-12. 
98. Bracher, M., G. Santow, and S.C. Watkins, Assessing the potential of condom use to 
prevent the spread of HIV: a microsimulation study. Stud Fam Plann, 2004. 35(1): p. 
48-64. 
99. Baggaley, R., et al.. Systematic review of HIV-1 transmission probabilities in absence 
of antiretroviral therapy. In preparation. 
233 
100. Garnett, G. P. and R.M. Anderson, Strategies for limiting the spread of HIV in 
developing countries: conclusions based on studies of the transmission dynamics of 
the virus. J Acquir Immune Defic Syndr Hum Retroviral, 1995. 9(5): p. 500-13. 
101. Albert, A.E., et al.. Condom use among female commercial sex v\forkers in Nevada's 
legal brothels. Am J Public Health, 1995. 85(11): p. 1514-20. 
102. Magnani, R.J. and A.M. Karim, ABCs: The Youth Perspective, available at 
http://www.svneravaids.eom/Documents/6 Robert maanani.pdf. 2002. 
103. Mills, S., et al., HIV risk behavioral sun/eillance in Bangkok, Thailand: sexual behavior 
trends among eight population groups. Aids, 1997. 11 Supp11: p. S43-51. 
104. Hearst, N., et al.. Reducing AIDS risk among port workers in Santos, Brazil. Am J 
Public Health, 1999. 89(1): p. 76-8. 
105. Rottingen, J.A., D.W. Cameron, and G.P. Garnett, A systematic review of the 
epidemiologic interactions between classic sexually transmitted diseases and HIV: 
how much really is known? Sex Transm Dis, 2001. 28(10): p. 579-97. 
106. Pepin, J., et al.. The interaction of HIV infection and other sexually transmitted 
diseases: an opportunity for intervention. Aids, 1989. 3(1): p. 3-9. 
107. Grosskurth, H., et al., Impact of improved treatment of sexually transmitted diseases 
on HIV infection in rural Tanzania: randomised controlled trial. Lancet, 1995. 
346(8974): p. 530-6. 
108. Grosskurth, H., et al.. Control of sexually transmitted diseases forHIV-1 prevention: 
understanding the implications of the Mwanza and Rakai trials. Lancet, 2000. 
355(9219): p. 1981-7. 
109. Wawer, M.J., et al., Control of sexually transmitted diseases for AIDS prevention in 
Uganda: a randomised community trial. Rakai Project Study Group. Lancet, 1999. 
353(9152): p. 525-35. 
110. Kamali, A., et al.. Syndromic management of sexually-transmitted infections and 
behaviour change interventions on transmission of HIV-1 in rural Uganda: a 
community randomised trial. Lancet, 2003. 361(9358): p. 645-52. 
111. Orroth, K.K., et al., Higher risk behaviour and rates of sexually transmitted diseases 
in l\/lwanza compared to Uganda may help explain HIV prevention trial outcomes. 
Aids, 2003.17(18): p. 2653-60. 
112. Orroth, K.K., et al., Comparison of STD prevalences in the Mwanza, Rakai, and 
Masaka trial populations: the role of selection bias and diagnostic errors. Sex Transm 
Infect, 2003. 79(2): p. 98-105. 
113. Wald, A. and K. Link, Risk of human immunodeficiency virus infection in herpes 
simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis, 2002.185(1): 
p. 45-52. 
114. Freeman, E.E., et al.. The proportion of new HIV infections attributable to HSV- 2 
increases over time: simulations of the changing role of sexually transmitted 
infections in sub-Saharan African HIV epidemics. Sex Transm Infect, 2007. 
234 
115. Boily, M.C., C.M. Lowndes, and M. Alary, Complementary hypothesis concerning the 
community sexually transmitted disease mass treatment puzzle in Rakai, Uganda. 
Aids, 2000.14(16): p. 2583-92. 
116. Hudson, C.P., Community-based trials of sexually transmitted disease treatment: 
repercussions for epidemiology and HIV prevention. Bull World Health Organ, 2001. 
79(1): p. 48-58. 
117. Orroth, K.K., et al.. Empirical observations underestimate the proportion of human 
immunodeficiency virus infections attributable to sexually transmitted diseases in the 
Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. 
Sex Transm Dis, 2006. 33(9): p. 536-44. 
118. Alary, M., C.M. Lowndes, and M.C. Boily, Community randomized trials for HIV 
prevention: the past, a lesson for the future? Aids, 2003.17(18): p. 2661-3. 
119. White, R.G., et al.. Can Population Differences Explain the Contrasting Results of the 
Mwanza, Rakai, and Masaka HIV/Sexually Transmitted Disease Intervention Trials?: 
A Modeling Study. J Acquir Immune Defic Syndr, 2004. 37(4): p. 1500-1513. 
120. White, R.G. Treating STIs to prevent HIV in Africa: Still an effective control strategy? 
in 17th ISSTDR. 2007. Seattle, USA. 
121. Laga, M., et al., To stem HIV in Africa, prevent transmission to young women. Aids, 
2001.15(7): p. 931-4. 
122. Genuis, S.J. and S. K. Genuis, Adolescent behaviour should be priority. Bmj, 2004. 
328(7444): p. 894. 
123. Green, E.G. and J. Berman, Liaisons fueling AIDS in Africa, in The Washington 
Times. 2003. 
124. UNAIDS, 2004 Report of the global AIDS epidemic. 2004: Geneva. 
125. AIDSMark, Cross-generational sex fueling the HIV/AIDS epidemic in sub-Saharan 
Africa. 2003, International Centre for Research on Women (ICRW) and Population 
Services International (PSI). 
126. Kelly, R.J., et al., Age differences in sexual partners and risk of HIV-1 infection in 
rural Uganda. J Acquir Immune Defic Syndr, 2003. 32(4): p. 446-51. 
127. Pettifor, A.E., et al., Early age of first sex: a risk factor for HIV infection among women 
in Zimbabwe. Aids, 2004.18(10): p. 1435-1442. 
128. Drain, P.K., et al.. Correlates of National HIV Seroprevalence: An Ecoiogic Analysis 
of 122 Developing Countries. J Acquir Immune Defic Syndr, 2004. 35(4): p. 407-420. 
129. Hallett, T.B., et al.. Age at first sex and HIV infection in rural Zimbabwe. Stud Fam 
Plann, 2007. 38(1): p. 1-10. 
130. Population Services International, Dangerous Liasons, in PSI Research Brief. 2003. 
131. Cohen, J., Asia and Africa: on different trajectories? Science, 2004. 304(5679): p. 
1932-8. 
132. Konings, E., et al.. Sexual behaviour survey in a rural area of northwest Tanzania. 
Aids, 1994. 8(7): p. 987-93. 
235 
133. Longfield, K., et al., Relationships between older men and younger women: 
implications for STIs/HIVin Kenya. Stud Fam Plann, 2004. 35(2): p. 125-34. 
134. Buve, A., K. Bishikwabo-Nsarhaza, and G. Mutangadura, The spread and effect of 
HIV-1 infection in sub-Saharan Africa. Lancet, 2002. 359(9322): p. 2011-7. 
135. Boily, M.C. and B. Masse, Mathematical models of disease transmission: a precious 
tool for the study of sexually transmitted diseases. Can J Public Health, 1997. 88(4): 
p. 255-65. 
136. Kamb, M.L., et al., Efficacy of risk-reduction counseling to prevent human 
immunodeficiency virus and sexually transmitted diseases: a randomized controlled 
trial. Project RESPECT Study Group. JAMA, 1998. 280(13): p. 1161-7. 
137. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group, Efficacy of 
voluntary HIV-1 counselling and testing in individuals and couples in Kenya, 
Tanzania, and Trinidad: a randomised trial. Lancet, 2000. 356(9224): p. 103-12. 
138. Sweat, M., et al.. Cost-effectiveness of voluntary HIV-1 counselling and testing in 
reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet, 2000. 
356(9224): p. 113-21. 
139. Weinhardt, L.S., et al.. Effects of HIV counseling and testing on sexual risk behavior: 
a meta-analytic review of published research, 1985-1997. Am J Public Health, 1999. 
89(9): p. 1397-405. 
140. Corbett, E.L., et al., HIV incidence during a cluster-randomized trial of two strategies 
providing voluntary counselling and testing at the workplace, Zimbabwe. Aids, 2007. 
21(4): p. 483-9. 
141. Sherr, L., et al.. Voluntary counselling and testing: Uptake and impact on sexual 
behaviour and HIV incidence in a rural Zimbabwean prospective cohort, in 
preparation. 
142. Grinstead, O.A., et al.. Positive and negative life events after counselling and testing: 
the Voluntary HIV-1 Counselling and Testing Efficacy Study. Aids, 2001.15(8): p. 
1045-52. 
143. Oberzaucher, N. and R. Baggaley, HIV Voluntary Counselling and Testing: a gateway 
to prevention and care. 2002, Joint United Nations Programme on HIV/AIDS 
(UNAIDS). 
144. Population Services International, Marketing HIV Counseiing and Testing, available at 
http://www.psi.orq/resources/pubs/New-Start-auaust-06.pdf. 2006. 
145. WHO, UNAIDS, and UNICEF, Towards Universal Access: Scaling up priority 
HIV/AIDS interventions in the health sector Progress Report (available from 
httD://www.who.int/hiv/mediacentre/univeral access oroaress report en.odf). April, 
2007: Geneva. 
146. Corbett, E.L., et al.. Uptake of workplace HIV counselling and testing: a cluster-
randomised trial in Zimbabwe. PLoS Med, 2006. 3(7): p. e238. 
236 
147. Weiser, S.D., et al., Routine HIV testing in Botswana: a population-based study on 
attitudes, practices, and human rights concerns. PLoS Med, 2006. 3(7): p. e261. 
148. Dube, S., et al., Optimising the Population Level Impact of Voluntary Counselling and 
Testing in Zimbabwe: Insights from Mathematical Models. 2005, Department of 
infectious Disease Epidemiology, Imperial College London; Centers for Disease 
Control and Prevention (CDC), Atlanta, USA. 
149. Nyamato, E., et al. VCT+: The Road to ART (abstract 178). in The 2006 HIV/AIDS 
PEPFAR Implementers' Meeting. 2006. Durban, South Africa. 
150. Sepkowitz, K.A., AIDS-the first 20 years. N Engl J Med, 2001. 344(23): p. 1764-72. 
151. Hammer, S.M., et al., A controlled trial of two nucleoside analogues plus indinavir in 
persons with human immunodeficiency virus infection and CD4 cell counts of 200 per 
cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med, 
1997. 337(11): p. 725-33. 
152. Staszewski, S., et al., Efavirenz plus zidovudine and lamivudine, efavirenz plus 
indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 
infection in adults. Study 006 Team. N Engl J Med, 1999. 341(25): p. 1865-73. 
153. Carr, A. and D.A. Cooper, Adverse effects of antiretroviral therapy. Lancet, 2000. 
356(9239): p. 1423-30. 
154. Wood, E., et al.. When to initiate antiretroviral therapy in HIV-1-infected adults: a 
review for clinicians and patients. Lancet Infect Dis, 2005. 5(7): p. 407-14. 
155. Lane, H.C. and J.D. Neaton, When to start therapy for HIV infection: a swinging 
pendulum in search of data. Ann Intern Med, 2003.138(8): p. 680-1. 
156. Ho, D.D., Time to hit HIV, early and hard. N Engl J Med, 1995. 333(7): p. 450-1. 
157. Egger, M., et al.. Prognosis of HIV-1-infected patients starting highly active 
antiretroviral therapy: a collaborative analysis of prospective studies. Lancet, 2002. 
360(9327): p. 119-29. 
158. Deeks, S.G., Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet, 2003. 
362(9400): p. 2002-11. 
159. Yeni, P.O., et al.. Treatment for adult HIV infection: 2004 recommendations of the 
International AIDS Society-USA Panel. Jama, 2004. 292(2): p. 251-65. 
160. Quinn, T.C., et al.. Viral load and heterosexual transmission of human 
immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med, 2000. 
342(13): p. 921-9. 
161. Baggaley, R.F., N.M. Ferguson, and G.P. Garnett, The epidemiological impact of 
antiretroviral use predicted by mathematical models: a review. Emerg Themes 
Epidemiol, 2005. 2: p. 9. 
162. Kabugo, C., et al., Long-term experience providing antiretroviral drugs in a fee-for-
sen/ice HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count 
responses. J Acquir Immune Defic Syndr, 2005. 38(5): p. 578-83. 
237 
163. Office of the United States Global AIDS Coordinator, The President's Emergency 
Plan for AIDS Reiief. U.S. Five-year global HIV/AIDS strategy. 2004. 
164. Office of the United States Global AIDS Coordinator, The United States President's 
Emergency Plan for AIDS Relief. http://www.DeDfar.aov. accessed 8th March, 2007. 
165. Schwartlander, B., et al., AIDS. Resource needs for HIV/AIDS. Science, 2001. 
292(5526): p. 2434-6. 
166. The Gleaneagles communique on Africa. Climate change, energy, sustainable 
development G8 Summit 2005. available at 
http://www.fco.aov.uk/Files/kfile/PostG8 Gleneagles Communique.O.pdf. 2005. 
167. Attaran, A., Adherence to HAART: Africans take medicines more faithfully than North 
Americans. PLoS Med, 2007. 4(2): p. e83. 
168. Mills, E.J., et al., Adherence to antiretroviral therapy in sub-Saharan Africa and North 
America: a meta-analysis. Jama, 2006. 296(6): p. 679-90. 
169. Gazzard, B., British HIV Association (BHIVA) guidelines for the treatment of HIV-
infected adults with antiretroviral therapy (2005). HIV Med, 2005. 6 SuppI 2: p. 1 -61. 
170. United States Department of Health and Human Services (DHHS), Guidelines for use 
of antiretroviral agents in HIV-1 infected adults and adolescents. 2006, Available 
from: http://aidsinfo.nih.aov/ContentFiles/AdultandAdolescentGL.pdf (accessed 26th 
Septemeber, 2006). 
171. Gilks, C.F., et al.. The WHO public-health approach to antiretroviral treatment against 
HIV in resource-limited settings. Lancet, 2006. 368(9534): p. 505-10. 
172. Morgan, D., et al., Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. Aids, 
1998.12(6): p. 591-6. 
173. Morgan, D., et al.. Progression to symptomatic disease in people infected with HIV-1 
in rural Uganda: prospective cohort study. Bmj, 2002. 324(7331): p. 193-6. 
174. Kagaayi, J., et al. WHO Staging Criteria Versus CD4 Screening for Antiretroviral 
Eligibility in Rural Rakai District, Uganda, in The 2006 HIV/AIDS PEPFAR 
Implementers' Meeting. 2006. Durban, South Africa. 
175. Kassa, E., et al., Evaluation of the World Health Organization staging system for HIV 
infection and disease in Ethiopia: association between clinical stages and laboratory 
markers. Aids, 1999.13(3): p. 381-9. 
176. Attili, V.S., et al.. Validity of existing CD4+ classification in north Indians, in predicting 
immune status. J Infect, 2005. 51(1): p. 41-6. 
177. World Health Organization, Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS 
Case Definitions for Surveillance: Africa Region. 2005: Geneva. 
178. Beck, E.J., et al., National adult antiretroviral therapy guidelines in resource-limited 
countries: concordance with 2003 WHO guidelines? A\ds, 2006. 20(11): p. 1497-502. 
179. Margolick, J.B., et al.. Failure of T-cell homeostasis preceding AIDS in HIV-1 
infection. The l\/lulticenter AIDS Cohort Study. Nat Med, 1995.1(7): p. 674-80. 
238 
180. Mukherjee, J.S., et al., Tackling HIV in resource poor countries. Bmj, 2003. 
327(7423): p. 1104-6. 
181. Merson, M.H., The HIV-AIDS pandemic at 25--the global response. N Engl J Med, 
2006. 354(23): p. 2414-7. 
182. UNAIDS, Statement On South African Trial Findings Regarding Male Circumcision 
And Hiv. 2005. 
183. UNAIDS, Statement on Kenyan and Ugandan trial findings regarding male 
circumcision and HIV. available at 
http://data.unaids.ora/pub/PressStatement/2006/20061213 Male Circumcision ioint 
PR en.pdf. 2006. 
184. UNAIDS, WHO and UNAIDS announce recommendations from expert meeting on 
male circumcision for HIV prevention, available at 
http://data.unaids.ora/pub/PressRelease/2007/20070328 pr mc recommendations 
en.pdf, 2007. 
185. Kahn, J.G., E. Marseille, and B. Auvert, Cost-effectiveness of male circumcision for 
HIV prevention in a South African setting. PLoS Med, 2006. 3(12): p. e517. 
186. Koelle, D.M. and L. Corey, Recent progress in herpes simplex virus immunobiology 
and vaccine research. Clin Microbiol Rev, 2003.16(1): p. 96-113. 
187. Freeman, E.E., et al., Herpes simplex virus 2 infection increases HIV acquisition in 
men and women: systematic review and meta-analysis of longitudinal studies. Aids, 
2006. 20(1): p. 73-83. 
188. Watson-Jones, D., et al. Impact of HSV-2 suppressive therapy on HIV incidence in 
HSV-2 seropositive women: a randomised controlled trial in Tanzania, in 4th IAS 
Conference on Pathogensis, Treatment and Prevention. 2007. Sydney, Australia. 
189. Nagot, N., et al., Reduction of HIV-1 RNA levels with therapy to suppress herpes 
simplex virus. N Engl J Med, 2007. 356(8): p. 790-9. 
190. Bailey, G.P. Impact of episodic acyclovir therapy on genital ulcer duration and HIV 
shedding from herpetic ulcers among men in South Africa, in 17th ISSTDR. 2007. 
Seattle, USA. 
191. Paz-Bailey, G., et al.. Changes in the etiology of sexually transmitted diseases in 
Botswana between 1993 and 2002: implications for the clinical management of 
genital ulcer disease. Clin Infect Dis, 2005. 41 (9): p. 1304-12. 
192. Weber, J., K. Desai, and J. Darbyshire, The development of vaginal microbicides for 
the prevention of HIV transmission. PLoS Med, 2005. 2(5): p. e l 42. 
193. Balzarini, J. and L. Van Damme, Microbicide drug candidates to prevent HIV 
infection. Lancet, 2007. 369(9563): p. 787-97. 
194. Foss, A.M., et al., Shifts in condom use following microbicide introduction: should we 
be concerned? Aids, 2003.17(8): p. 1227-37. 
195. Smith, R.J., et al., Evaluating the potential impact of vaginal microbicides to reduce 
the risk of acquiring HIV in female sex workers. Aids, 2005.19(4): p. 413-21. 
239 
196. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan. PLoS Med, 2005. 
2(2): p. e25. 
197. Anderson, R.M. and G.P. Garnett, Low-efficacy HIV vaccines: potential for 
community-based intervention programmes. Lancet, 1996. 348(9033): p. 1010-3. 
198. Blower, S.M., H.B. Gershengorn, and R.M. Grant, A tale of two futures: HIV and 
antiretroviral therapy in San Francisco. Science, 2000. 287(5453): p. 650-4. 
199. International AIDS Vaccine Initiative, Estimating the Impact of an AIDS Vaccine in 
Developing Countries (Policy breifing). Available at 
http://www.iavi.ora/file.cfm?fid=42539. 2006. 
200. Cassell, M.M., et al., Risk compensation: the Achilles' heel of innovations in HIV 
prevention? Bm\, 2006. 332(7541): p. 605-7. 
201. Anderson, R.M. and G.P. Garnett, Mathematical models of the transmission and 
control of sexually transmitted diseases. Sex Transm Dis, 2000. 27(10): p. 636-43. 
202. Bernoulli, D., Essai d'une novelle analyse de la mortalite causee par la petite verole 
et des advantages de I'inoculation pour la prevenir. Mem Math Phys Acad R Sci 
Paris, 1760: p. 1-45. 
203. Hamer, W.H., Epidemic disease in England. The Lancet, 1906.1: p. 733-739. 
204. Ross, R., Some a prioripathometric equations. 1, 1915: p. 546-547. 
205. Anderson, R.M., et al., A preliminary study of the transmission dynamics of the 
human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math AppI 
Med Biol, 1986. 3(4): p. 229-63. 
206. Anderson, R.M., et al.. The spread of HIV-1 in Africa: sexual contact patterns and the 
predicted demographic impact of AIDS. Nature, 1991. 352(6336): p. 581-9. 
207. Anderson, R.M., et al.. Age-dependent choice of sexual partners and the 
transmission dynamics of HIV in Sub-Saharan Africa. Philos Trans R Soc Lond B Biol 
Sci, 1992. 336(1277): p. 135-55. 
208. Jacquez, J.A., et al.. Role of the primary infection in epidemics of HIV infection in gay 
cohorts. J Acquir immune Defic Syndr, 1994. 7(11): p. 1169-84. 
209. Anderson, R.M. and G.F. Medley, Epidemiology of HIV infection and AIDS: incubation 
and infectious periods, survival and vertical transmission. Aids, 1988. 2 Supp11: p. 
S57-63. 
210. Dietz, K. and K.P. Hadeler, Epidemiological models for sexually transmitted diseases. 
J Math Biol, 1988. 26(1): p. 1-25. 
211. Ghani, A.C. and G.P. Garnett, Risks of acquiring and transmitting sexually 
transmitted diseases in sexual partner networks. Sex Transm Dis, 2000. 27(10): p. 
579-87. 
212. Ghani, A.C. and S.O. Aral, Patterns of sex worker-client contacts and their 
implications for the persistence of sexually transmitted infections. J Infect Dis, 2005. 
191 Supp11: p. S34-41. 
240 
213. Gupta, S., R.M. Anderson, and R.M. May, Networks of sexual contacts: implications 
for the pattern of spread of HIV. Aids, 1989. 3(12); p. 807-17. 
214. Anderson, R.M., S. Gupta, and W. Ng, The significance of sexual partner contact 
networks for the transmission dynamics of HIV. J Acquir Immune Defic Syndr, 1990. 
3(4): p. 417-29. 
215. Kretzschmar, M. and K. Dietz, The effect of pair formation and variable infectivity on 
the spread of an infection without recovery. Math Biosci, 1998.148(1): p. 83-113. 
216. Ferguson, N.M. and G.P. Garnett, More realistic models of sexually transmitted 
disease transmission dynamics: sexual partnership networks, pair models, and 
moment closure. Sex Transm Dis, 2000. 27(10): p. 600-9. 
217. Abu-Raddad, L.J., P. Patnail<, and J.G. Kublin, Dual infection with HIV and malaria 
fuels the spread of both diseases in sub-Saharan Africa. Science, 2006. 314(5805): 
p. 1603-6. 
218. Currie, G.S., et al.. Tuberculosis epidemics driven by HIV: is prevention better than 
cure? Aids, 2003.17(17): p. 2501-8. 
219. Korenromp, E.L., et al., Determinants of the impact of sexually transmitted infection 
treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, 
Rakai, and Masaka intervention trials. J Infect Dis, 2005.191 Supp11: p. SI 68-78. 
220. Anderson, R.M., R.M. May, and A.R. McLean, Possible demographic consequences 
of AIDS in developing countries. Nature, 1988. 332(6161): p. 228-34. 
221. Garnett, G.P., et al., Antiretroviral therapy to treat and prevent HIV/AIDS in resource-
poor settings. Nat Med, 2002. 8(7): p. 651-4. 
222. Baggaley, R.F., G.P. Garnett, and N.M. Ferguson, Modelling the Impact of 
Antiretroviral Use in Resource-Poor Settings. PLoS Med, 2006. 3(4): p. e l 24. 
223. Blower, S.M. and A.R. McLean, Prophylactic vaccines, risk behavior change, and the 
probability of eradicating HIV in San Francisco. Science, 1994. 265(5177): p. 1451-4. 
224. Garnett, G.P., The basic reproductive rate of infection and the course of HIV 
epidemics. AIDS Patient Care STDS, 1998.12(6): p. 435-49. 
225. Nagelkerke, N.J., et al., Modelling the public health impact of male circumcision for 
HIV prevention in high prevalence areas in Africa. BMC Infect Dis, 2007. 7: p. 16. 
226. Gray, R.H., et al.. The impact of male circumcision on HIV incidence and cost per 
infection prevented: a stochastic simulation model from Rakai, Uganda. Aids, 2007. 
21(7): p. 845-50. 
227. Clark, S.J. and J. Eaton Population Impact of Male Circumcision to Prevent HIV 
Transmission, Results from Microsimulation. in Demography and Infectious Disease 
Symposium. 2007. Stanford University, California. 
228. Gregson, S., et al., Methods to reduce social desirability bias in sex surveys in low-
development settings: experience in Zimbabwe. Sex Transm Dis, 2002. 29(10): p. 
568-75. 
241 
229. Anderson, R.M. and R.M. May, Epidemiological parameters of HIV transmission. 
Nature, 1988. 333(6173): p. 514-9. 
230. Morgan, D., et al., HIV-1 infection in rural Africa: is there a difference in median time 
to AIDS and survival compared with that in industrialized countries? Aids, 2002. 
16(4); p. 597-603. 
231. Boily, M.C., et al., The impact of the transmission dynamics of the HIV/AIDS epidemic 
on sexual behaviour: a new hypothesis to explain recent increases in risk taking-
behaviour among men who have sex with men. Med Hypotheses, 2005. 65(2): p. 
215-26. 
232. Anderson, R.M., Transmission dynamics of sexually transmitted infections, in 
Sexually Transmitted Diseases, S.P. Holmes KK, Mardh P-A, et al.. Editor. 1999, 
McGraw-Hill: New York. 
233. UNAIDS Reference Group on Estimates Modelling and Projections, Evidence and 
causes of decline in HIV prevalence and incidence in countries with generalised 
epidemics. Report based on a metting held in Harare, Zimbabwe, 15-17th November 
2004. 2005. p. http://www.eDidem.ora/PubliGations/Harare2004 report.pdf. 
234. Collaborative Group on AIDS Incubation and HIV Survival, Time from HIV-1 
seroconversion to AIDS and death before widespread use of highly-active 
antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS 
Incubation and HIV Survival including the CASCADE EU Concerted Action. 
Concerted Action on Seroconversion to AIDS and Death in Europe. Lancet, 2000. 
355(9210): p. 1131-7. 
235. Cote d'lvoire: DHS, 1994 - Final Report (French). 
http://www.measuredhs.com/pubs/pub details.cfm?ID=107&srchTp=advanced 
(accessed 14-8-07). 
236. Gaillard, E.M., et al., Understanding the reasons for decline of HIV prevalence in 
Haiti. Sex Transm Infect, 2006. 82 Supp11: p. 114-20. 
237. Gheluget, B., et al., Evidence for population level declines in adult HIV prevalence in 
Kenya. Sex Transm Infect, 2006. 82 Supp11: p. 121-6. 
238. Bello, G.A., J. Chipeta, and J. Aberle-Grasse, Assessment of trends in biological and 
behavioural sun/eillance data: is there any evidence of declining HIV prevalence or 
incidence in Malawi? Sex Transm Infect, 2006. 82(suppl_1): p. i9-13. 
239. Kayirangwa, E., et al.. Current trends in Rwanda's HIV/AIDS epidemic. Sex Transm 
Infect, 2006. 82(suppM): P-127-31. 
240. Kirungi, W.L., et al.. Trends in antenatal HIV prevalence in urban Uganda associated 
with uptake of preventive sexual behaviour Sex Transm Infect, 2006. 82(suppM): p. 
136-41. 
241. HIadik, W., et al., HIV/AIDS in Ethiopia: where is the epidemic heading? Sex Transm 
Infect, 2006. 82(suppl_1): p. 132-35. 
242. The MathWorks Inc., MATLAB version 7.01.1.24704 (R14) SP1. 2004. 
242 
243. Lewis, J.J., et al., The population impact of HIV on fertility in sub-Saharan Africa. 
Aids, 2004.18 Suppl 2: p. S35-43. 
244. Wawer, M.J. Declines in HIV prevalence in Uganda: not as simple as ABC. in Twelfth 
Annual Retrovirus Conference. 2005. Boston. 
245. Mundandi, C., et al., No difference in HIV incidence and sexual behaviour between 
out-migrants and residents in rural Manicaland, Zimbabwe. Trop Med Int Health, 
2006. 11(5): p. 705-11. 
246. Hallett, T.B., B.A. Lopman, and S. Gregson, Why HIV Rates Have Declined in 
Zimbabwe in Presentation to the UNAIDS Reference Group Steering Committee. 
2006: Harare, Zimbabwe. 
247. Jaffar, S., et al., The natural history of HIV-1 and HIV-2 infections in adults in Africa: a 
literature review. Bull World Health Organ, 2004. 82(6): p. 462-9. 
248. Population Services International, New Hope with New Start. 2002: Washington, D.C. 
p. available at http://www.psi.ora/resources/pubs/New-Start-auaust-06.pdf. 
249. Machekano, R., et al., impact of HIV counselling and testing on HIV seroconversion 
and reported STD incidence among male factory workers in Harare, Zimbabwe. Cent 
Afr J Med, 1998. 44(4): p. 98-102. 
250. Sherr, L., et al.. Voluntary counselling and testing: uptake, impact on sexual 
behaviour, and HIV incidence in a rural Zimbabwean cohort. Aids, 2007. 21(7): p. 
851-860. 
251. Hallett, T.B., et al.. Declines in HIV prevalence can be associated with changing 
sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm 
Infect, 2006. 82 Suppl 1: p. 11-18. 
252. Garcia-Calleja, J.M., E. Gouws, and P.O. Ghys, National population based HIV 
prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS 
estimates. Sex Transm Infect, 2006. 82 Suppl 3: p. 11164-70. 
253. Rangsin, R., et al., The natural history of HIV-1 infection in young Thai men after 
seroconversion. J Acquir Immune Defic Syndr, 2004. 36(1): p. 622-9. 
254. Podgor, M.J. and M.C. Leske, Estimating incidence from age-specific prevalence for 
irreversible diseases with differential mortality. Stat Med, 1986. 5(6): p. 573-8. 
255. Adas, A.E., Serial HIV seroprevalence surveys: interpretation, design, and role in 
HIV/AIDS prediction. J Acquir Immune Defic Syndr Hum Retrovirol, 1995. 9(5): p. 
490-9. 
256. Sakarovitch, C., et al.. Estimating incidence of HIV infection in childbearing age 
African women using serial prevalence data from antenatal clinics. Stat Med, 2007. 
26(2): p. 320-35. 
257. Williams, B., et al.. Estimating HIV incidence rates from age prevalence data in 
epidemic situations. Stat Med, 2001. 20(13): p. 2003-16. 
258. White, R.G., et al., HIV epidemic trend and antiretroviral treatment need in Karonga 
District, Malawi. Epidemiol Infect, 2007: p. 1-11. 
243 
259. Saidel, T., et al., Validation of a mettiod to estimate age-specific fiuman 
immunodeficiency virus (HiV) incidence rates in developing countries using 
population-based seroprevaience data. Am J Epidemiol, 1996.144(3): p. 214-23. 
260. Brisson, M., et al., IHighiights of the sexual activity of the heterosexual population in 
the province of Quebec. Sex Transm Infect, 1999. 75(5): p. 296-9. 
261. Zaba, B., et al., Age- and sex- specific mortality patterns in HiV infected individuals: a 
comparative analysis of six community studies in five African countries. . 
Forthcoming. 
262. Zaba, B., et al. Survival following l-iiV infection in the pre-ART era in a rural 
Tanzanian cohort, in 16th International AIDS Conference. 2006. Toronto, Canada. 
263. Lopman, B.A., et al.. Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -
2003). Bull World Health Organ, 2006. 84(3): p. 189-97. 
264. Glynn, J.R., et al.. Survival from i-ilV-l seroconversion in Southern Africa: a 
retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up. 
Aids, 2007. 21(5): p. 625-632. 
265. Mulder, D.W., et al., HiV-1 incidence and HIV-1-associated mortality in a rural 
Ugandan population cohort. Aids, 1994. 8(1): p. 87-92. 
266. Boerma, J.T., et al., Spread of l-lIV infection in a rural area of Tanzania. Aids, 1999. 
13(10): p. 1233-40. 
267. Lopman, B., et al., Determinants of HIV incidence after 3 years follow-up in a cohort 
recruited between 1998 and 2000 in Manicaland, Zimbabwe. In preparation. 
268. Mitwa, W., et al. Prevalence and incedence trends in rural population in Northern 
Tanzania during 1994-2004 (CDC0362). in XVI International AIDS Conference. 2006. 
Toronto, Canada. 
269. Kamali, A., et al.. Seven-year trends in HIV-1 infection rates, and changes in sexual 
behaviour, among adults In rural Uganda. Aids, 2000.14(4): p. 427-34. 
270. Lopman, B.A., et al.. The role of widows in the heterosexual transmission of HIV in 
l\/lanicaiand, Zimbabwe, 1998/2003. In preparation. 
271. Kiwanuka, N., et al.. The incidence of HIV-1 associated with injections and 
transfusions in a prospective cohort, Rakai, Uganda. Aids, 2004.18(2): p. 342-4. 
272. Schmid, G.P., et al., Transmission of HIV-1 infection in sub-Saharan Africa and effect 
of elimination of unsafe injections. The Lancet, 2004. 363(9407): p. 482-488. 
273. Lopman, B.A., et al.. Individual Level Injection History: A Lack of Association with HIV 
Incidence in Rural Zimbabwe. PLoS Med, 2005. 2(2): p. e37. 
274. Garnett, G.P., An introduction to mathematical models in sexually transmitted disease 
epidemiology. Sex Transm Infect, 2002. 78(1): p. 7-12. 
275. Aral, S.O. and R. Roegner, Mathematical modeling as a tool in STD prevention and 
control: a decade of progress, a millennium of opportunities. Sex Transm Dis, 2000. 
27(10): p. 556-7. 
244 
276. Keeling, M.J., et al., Dynamics of the 2001 UK foot and mouth epidemic: stochastic 
dispersal in a heterogeneous landscape. Science, 2001. 294(5543): p. 813-7. 
277. Riley, S., et al., Transmission dynamics of the etiological agent of SARS in Hong 
Kong: impact of public health interventions. Science, 2003. 300(5627): p. 1961-6. 
278. Ferguson, N.M., et al., Strategies for containing an emerging influenza pandemic in 
Southeast Asia. Nature, 2005. 437(7056): p. 209-14. 
279. Garnett, G.P. and R.M. Anderson, Balancing sexual partnerships in an age and 
activity stratified model of HIV transmission in heterosexual populations. IMA J Math 
AppI Med Biol, 1994.11(3): p. 161-92. 
280. Duncan, M.E., et al.. First coitus before menarche and risk of sexually transmitted 
disease. Lancet, 1990. 335(8685): p. 338-40. 
281. Moss, G.B., et al.. Association of cervical ectopy with heterosexual transmission of 
human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J 
Infect Dis, 1991.164(3): p. 588-91. 
282. Zaba, B., et al.. Age at first sex: understanding recent trends in African demographic 
surveys. Sex Transm Infect, 2004. 80 SuppI 2: p. 1128-35. 
283. Glynn, J.R., et al.. Why do young women have a much higher prevalence of HIV than 
young men? A study in Kisumu, Kenya and Ndola, Zambia. Aids, 2001.15 SuppI 4: 
p. S51-60. 
284. Action today, a foundation for tomorrow: The President's Emergency Plan for AIDS 
Relief. Second Annual Report to Congress. 2006: Washington, D.C. p. 
(www.pepfar.gov). 
285. UNAIDS and World Health Organization, Progress on global access to HIV 
antiretroviral therapy. An update on "3 by 5". 2005. 
286. Gray, R.H., et al., Probability of HIV-1 transmission per coital act in monogamous, 
heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet, 2001. 357(9263): 
p. 1149-53. 
287. UNAIDS, UNAIDS Action plan on intensifying HIV prevention, available at 
http://data.unaids.ora/pub/ReDort/2007/ic1218 preventionactionplan en.pdf. 2006. 
288. De Cock, K.M., D. Mbori-Ngacha, and E. Marum, Shadow on the continent: public 
health and HIV/AIDS in Africa in the 21st century. Lancet, 2002. 360(9326): p. 67-72. 
289. Kippax, S., A public health dilemma: a testing question. AIDS Care, 2006.18(3): p. 
230-5. 
290. Technical Expert Panel Review of CDC HIV Counseling Testing and Referral 
Guidelines, Revised Guidelines for HIV Counseling, Testing, and Referral. MMWR 
Recomm Rep, 2001. 50: p. 1-58. 
291. Glick, P., Scaling up HIV voluntary counseling and testing in Africa: what can 
evaluation studies tell us about potential prevention impacts? Eval Rev, 2005. 29(4): 
p. 331-57. 
245 
292. Padian, N.S., S.C. Shiboski, and N.P. Jewell, Female-to-male transmission of human 
immunodeficiency virus. Jama, 1991. 266(12): p. 1664-7. 
293. Nicolosi, A., et al.. The efficiency of male-to-female and female-to-male sexual 
transmission of the human immunodeficiency virus: a study of 730 stable couples. 
Italian Study Group on HIV Heterosexual Transmission. Epidemiology, 1994. 5(6): p. 
570-5. 
294. Zimbabwe: DNS, 1988 - Final Report (English). 
http://www.measuredhs.com/Dubs/pub details.cfm?ID=324&srchTp=advanced 
(accessed 10-5-07). 
295. Zimbabwe: DHS, 1994 - Final Report (English). 
http://www.measuredhs.com/pubs/pub details.cfm?ID=103&srchTp=advanced 
(accessed 10-5-07). 
296. Zimbabwe: DHS, 1999 - Final Report (English). 
http://www.measuredhs.com/pubs/pub details.cfm?ID=296&srchTp=advanced 
(accessed 10-5-07). 
297. Terceira, N., et al.. The contribution of HIV to fertility decline in rural Zimbabwe, 1985-
2000. Popul Stud (Camb), 2003. 57(2): p. 149-64. 
298. Hallett, T.B., et al.. Declines in HIV prevalence can be associated with changing 
sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm 
Infect, 2006. 82(suppM): p. i1-8. 
299. Zimbabwe: DHS, 2005-6 - Preliminary Report. 
http://harare.usembassv.aov/uploads/imaaes/ErYMhCdkkmrinsEXXPvtlA/Zimbabwe 
Preliminarv-A4 paper.pdf (accessed 10-5-07). 
300. World Bank, World development report-1991. 1991, New York: Oxford University 
Press. 
301. Kamenga, M., et al., Evidence of marked sexual behavior change associated with low 
HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: 
experience at an HIV counselling center in Zaire. Aids, 1991. 5(1): p. 61 -7. 
302. Allen, S., et al.. Confidential HIV testing and condom promotion in Africa. Impact on 
HIV and gonorrhea rates. Jama, 1992. 268(23): p. 3338-43. 
303. Allen, S., et al.. Effect of serotesting with counselling on condom use and 
seroconversion among HIV discordant couples in Africa. Bmj, 1992. 304(6842): p. 
1605-9. 
304. Jackson, D.J., et al., Decreased incidence of sexually transmitted diseases among 
trucking company workers in Kenya: results of a behavioural risk-reduction 
programme. Aids, 1997.11(7): p. 903-9. 
305. Matovu, J., Voluntary HIV counseling and testing acceptance, sexual risk behavior 
and HIV incidence in Rakai, Uganda. AIDS, 2005.19(5): p. 503-511. 
306. De Cock, K.M., E. Marum, and D. Mbori-Ngacha, A serostatus-based approach to 
HIV/AIDS prevention and care in Africa. Lancet, 2003. 362(9398): p. 1847-9. 
246 
307. Mulongo, M. and F. Wasagami. High Rate of Discordance Among Clients Receiving 
Antiretroviral Therapy at TASO Uganda (abstract 118). in The 2006 HIV/AIDS 
PEPFAR Implementers' Meeting. 2006. Durban, South Africa. 
308. Kalamya, J., et al. Routine HIV Counselling and Testing for Prevention of l^other-to-
Child Transmission (PMTCT) of HIV in a Rural Ugandan Hospital (abstract 101). in 
The 2006 HIV/AIDS PEPFAR Implementers' Meeting. 2006. Duran, South Africa. 
309. Allen, S., et al., Sexual behavior of HIV discordant couples after HIV counseling and 
testing. Aids, 2003.17(5): p. 733-40. 
310. UNAIDS, Intensifying HIV prevention. 2005: Geneva. 
311. WHO and UNAIDS, Guidance On Provider-Initiated HIV Testing And Counselling In 
Health facilities (available from httD://www. who. int/hiv/topics/vct/PITCauidelines.odf). 
2007: Geneva. 
312. Rojanapithayakorn, W. and R. Hanenberg, The 100% condom program in Thailand. 
Aids, 1996.10(1): p. 1-7. 
313. Kumar, R., et al.. Trends in HIV-1 in young adults in south India from 2000 to 2004: a 
prevalence study. The Lancet. 367(9517): p. 1164-1172. 
314. Stephenson, J. and J. Imrie, Why do we need randomised controlled trials to assess 
behavioural interventions? Bml, 1998. 316(7131): p. 611-3. 
315. Susser, M., Some principles in study design for preventing HIV transmission: rigor or 
reality. Am J Public Health, 1996. 86(12): p. 1713-6. 
316. Donner, A. and N. Klar, Design and Analysis of cluster randomization trials in health 
research. 2000: A Hodder Arnold Publication. 
317. Hayes, R.J. and S. Bennett, Simple sample size calculation for cluster-randomized 
trials. Int J Epidemiol, 1999. 28(2): p. 319-26. 
318. Localio, A.R., J .A. Berlin, and T.R. Have, Longitudinal and repeated cross-sectional 
cluster-randomization designs using mixed effects regression for binary outcomes: 
bias and coverage of frequentist and Bayesian methods. Stat Med, 2006. 25(16): p. 
2720-36. 
319. Moerbeek, M., Power and money in cluster randomized trials: when is it worth 
measuring a covariate? Stat Med, 2006. 25(15): p. 2607-17. 
320. Eldridge, S.M., D. Ashby, and S. Kerry, Sample size for cluster randomized trials: 
effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol, 
2006. 35(5): p. 1292-300. 
321. Campbell, M.J., A. Donner, and N. Klar, Developments in cluster randomized trials 
and Statistics in Medicine. Stat Med, 2007. 26(1): p. 2-19. 
322. Brookmeyer, R. and Y.Q. Chen, Person-time analysis of paired community 
intervention trials when the number of communities is small. Stat Med, 1998.17(18): 
p. 2121-32. 
323. Martin, D.C., et al.. The effect of matching on the power of randomized community 
intervention studies. Stat Med, 1993.12(3-4): p. 329-38. 
247 
324. Freedman, L.S., S.B. Green, and D.P. Byar, Assessing the gain in efficiency due to 
matching in a community intervention study. Stat Med, 1990. 9(8): p. 943-52. 
325. Edmunds, W.J., et al., t\Aixing patterns and the spread of close-contact infectious 
diseases. Emerg Themes Epidemiol, 2006. 3(1): p. 10. 
326. Schackman, B.R., et al.. Cost-effectiveness implications of the timing of antiretroviral 
therapy in HIV-infected adults. Arch Intern Med, 2002.162(21): p. 2478-86. 
327. Badri, M., et al.. When to initiate highly active antiretroviral therapy in sub-Saharan 
Africa? A South African cost-effectiveness study. Antivir Ther, 2006.11(1): p. 63-72. 
328. Dube, S., Should breastfeeding in the era of HIV/AIDS still be considered? In 
preparation. 
329. Fraser, C., et al.. The role of antigenic stimulation and cytotoxic T cell activity in 
regulating the long-term immunopathogenesis of HIV: mechanisms and clinical 
implications. Proc Biol Sci, 2001. 268(1481): p. 2085-95. 
330. DeGruttola, V., N. Lange, and U. Dafni, Modeling the progression of HIV infection. 
Journal of the American Statistical Association, 1991. 86(415): p. 569-577. 
331. McNeil, A.J., Bayes estimates for immunological progression rates in HIV disease. 
Stat Med, 1997. 16(22): p. 2555-72. 
332. Lepri, A.C., et al.. Is there a general tendency for CD4 lymphocyte decline to speed 
up during human immunodeficiency virus infection? Evidence from the Italian 
Seroconversion Study. J Infect Dis, 1997.175(4): p. 775-80. 
333. Laurent, C., et al., No difference in clinical progression between patients infected with 
the predominant human immunodeficiency virus type 1 circulating recombinant form 
(CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-
Central Africa: a four-year prospective multicenter study. J Infect Dis, 2002.186(4): p. 
486-92. 
334. Manasa, J., et al., Evaluation of the Partec flow cytometer against the BD 
FACSCalibur system for monitoring immune responses of human immunodeficiency 
virus-infected patients in Zimbabwe. Clin Vaccine Immunol, 2007.14(3): p. 293-8. 
335. Malone, J.L., et al., Sources of variability in repeated T-helper lymphocyte counts 
from human immunodeficiency virus type 1-infected patients: total lymphocyte count 
fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr, 1990. 3(2): 
p. 144-51. 
336. Raboud, J.M., et al.. Quantification of the variation due to laboratory and physiologic 
sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J 
Acquir Immune Defic Syndr Hum Retrovirol, 1995.10 SuppI 2: p. S67-73. 
337. Levi, F.A., et al., Seasonal modulation of the circadian time structure of circulating T 
and natural killer lymphocyte subsets from healthy subjects. J Clin Invest, 1988. 
81(2): p. 407-13. 
248 
338. Schneider, M., M. Zwahlen, and IVl. Egger, Natural history and mortality in HIV-
positive individuals living in resource-poor settings. Available from www.epidem.ora. 
2004. 
339. Central Statistical Office [Zimbabwe] and Macro International Inc., Zimbabwe 
demographic and health survey 1999. 2000, Calverton, Maryland; Central Statistical 
Office and Macro International Inc. 
340. Adu-Sarkodie, Y., et al.. Distribution of CD4+ T-lymphocytes levels in patients with 
clinical symptoms of AIDS in three west African countries. J Clin Virol, 1998.11(3): p. 
173-81. 
341. Hagopian, A. and M. Micek. Calculating How Many Health Workers are Needed at 
Full Scale-up in Mozambique, in The 2006 HIV/AIDS PEPFAR Implementers' 
Meeting. 2006. Durban, South Africa. 
342. Egger, M. Outcomes of Antiretroviral Treatment in Resource Limited and 
Industrialized Countries, in 14th Conference on Retroviruses and Opportunistic 
Infections (httD://www.retroconference.ora/2007/data/files/webDaae for CROi.htm). 
2007. Los Angeles. 
343. De Cock, K.M., et al.. Prevention of mother-to-child HIV transmission in resource-
poor countries: translating research into policy and practice. Jama, 2000. 283(9): p. 
1175-82. 
344. Stover, J., et al.. Projecting the demographic impact of AIDS and the number of 
people in need of treatment: updates to the Spectrum projection package. Sex 
Transm Infect, 2006. 82 SuppI 3: p. iii45-50. 
345. Marston, M., et al.. Estimating the net effect of HIV on child mortality in African 
populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr, 
2005. 38(2): p. 219-27. 
346. Fassinou, P., et al.. Highly active antiretroviral therapies among HIV-1-infected 
children in Abidjan, Cote d'lvoire. Aids, 2004.18(14): p. 1905-13. 
347. Weiser, S.D., et al., Routine HIV Testing in Botswana: A Population-Based Study on 
Attitudes, Practices, and Human Rights Concerns. PLoS Med, 2006. 3(7): p. e261. 
348. Bakari, M., et al., The natural course of disease following HIV-1 infection in dares 
salaam, Tanzania: a study among hotel workers relating clinical events to CD4 T-
lymphocyte counts. Scand J Infect Dis, 2004. 36(6-7): p. 466-73. 
349. Smit et al., Comparison of ART survival outcomes in Dutch Hospitals. In preparation. 
350. Hatzold, K. and N. Taruberekera. Effect of Perceived Treatment Availability on HIV 
Prevalence Among T&C Clients in Zimbabwe (abstract 155). in The 2006 HIV/AIDS 
PEPFAR Implementers' Meeting. 2006. Durban, South Africa. 
351. Schilsky, A., et al. Clinicians or counselors? Challenges to the scale-up of HIV testing 
and counselling in Health Facilities (abstract 487). in The 2006 HIV/AIDS PEPFAR 
Implementers' Meeting. 2007. Kigali, Rwanda. 
249 
352. Bunnell, R., et al.. Changes in sexual behavior and risk of HIV transmission after 
antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 2006. 20(1): 
p. 85-92. 
353. Fiscus, S.A., et al., Rapid, real-time detection of acute HIV infection in patients in 
Africa. J Infect DIs, 2007.195(3): p. 416-24. 
354. WHO and UNAIDS, New Data on Male Circumcision and HIV Prevention: Policy and 
Programme Implications (available at 
httD://data.unaids.ora/Dub/ReDort/2007/mc recommendations en.Ddf?Dreview=true). 
2007. 
355. UNAIDS, AIDS Epidemic Update, (available from 
http://data.unaids.orq/pub/EpiReport/2006/2006 EpiUpdate en.pdf), 2006. 
356. National Institute for Health and Clinical Excellence, http://www.nice.ora.uk/. 
accessed 25th June, 2007. 
357. BBC News, Alzheimer's drugs court challenge. 
http://news.bbc.co.Uk/1/hi/health/6230530.stm. accessed 25th June, 2007. 
358. De Cock, K. Rolling Out Opt-Out and Other New Approaches: Updated Guidelines 
(G1). in The 2006 HIV/AIDS PEPFAR Implementers' Meeting. 2007. Kigali, Rwanda. 
359. United Nations Economic and Social Council, The Siracusa Principles on the 
limitations and derogation provisions in the international covenant on civil and political 
rights, (available from httD://www.article23.ora.hl</enalish/research/ICCPR.doc). UN 
Doc. E/CN.4/1985/4 (1985). Annex. 
360. Haigh, F., Human rights approach to health. Croat Med J, 2002. 43(2): p. 166-9. 
361. Pang, X., et al.. Evaluation of control measures implemented in the severe acute 
respiratory syndrome outbreak in Beijing, 2003. Jama, 2003. 290(24): p. 3215-21. 
362. USA Today, TB-infected traveler quarantined. 
http://www.usatodav.eom/news/health/2007-05-29-tb N.htm. accessed 25th June, 
2007. 
363. BBC News, HIV man guilty of infecting lover. Web: www.bbc.co.uk/news.. Accessed 
31/01/06. 
364. The Sunday Times (South Africa), Make HIV tests compulsory for South Africans. 
http://www.sundavtimes.co.za/PrintEdition/Article.aspx?id=481394, accessed 25th 
June, 2007. 
365. Garnett, G.P., et al., Behavioural data as an adjunct to HIV surveillance data. Sex 
Transm Infect, 2006. 82(suppM): p. 157-62. 
366. Gregson, S., et al., HIV infection and reproductive health in teenage women 
orphaned and made vulnerable by AIDS in Zimbabwe. AIDS Care, 2005.17(7): p. 
785-94. 
367. Scheer, S., et al., Effect of highly active antiretroviral therapy on diagnoses of 
sexually transmitted diseases in people with AIDS. Lancet, 2001. 357(9254): p. 432-
5. 
250 
368. Stolte, I.G., et al., Increase in sexually transmitted infections among homosexual men 
in Amsterdam in relation to HAART. Sex Transm Infect, 2001. 77(3): p. 184-6. 
369. Autier, P., et al., Sunscreen use, wearing clothes, and number ofnevi in 6- to 7-year-
old European children. European Organization for Research and Treatment of 
Cancer Melanoma Cooperative Group. J Natl Cancer Inst, 1998. 90(24): p. 1873-80. 
370. Smith, J., et al. Understanding the Impact of Male Circumcision as an Intervention 
(abstract 1673). in The 2006 HIV/AIDS PEPFAR Implementers' Meeting. 2007. Kigali, 
Rwanda. 
371. Boily, M.C., C. Lowndes, and M. Alary, The impact of HIV epidemic phases on the 
effectiveness of core group interventions: insights from mathematical models. Sex 
Transm Infect, 2002. 78 Supp11: p. 178-90. 
372. Cowan, F.M., et al., Is sexual contact with sex worl<ers important in driving the HIV 
epidemic among men in rural Zimbabwe? J Acquir Immune Defic Syndr, 2005. 40(3): 
p. 371-6. 
373. Were, W., et al. Undiagnosed HIV Infection and Couple HIV Discordance Among 
Household Members of HIV-infected People Receiving Antiretroviral Therapy in 
Uganda (abstract 134). in The 2006 HIV/AIDS PEPFAR Implementers' Meeting. 
2006. Durban, South Africa. 
374. Mishra, V., et al. Why Do So Many HIV-Dlscordant Couples in Sub-Saharan Africa 
Have Female Partners Infected, Not Male Partners? (abstract 1717). in The 2006 
HIV/AIDS PEPFAR Implementers' Meeting. 2007. Kigali, Rwanda. 
375. Coffee, M.P., et al.. Patterns of movement and risk of HIV infection in rural 
Zimbabwe. J Infect Dis, 2005.191 Supp11: p. SI 59-67. 
376. Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network), 
httD://www.Ishtm.ac.uk/cos/abha/. London School of Hygiene & Tropical Medicine. 
377. Hallett, T.B., et al.. Age at First Sex and HIV in Rural Zimbabwe - Trends and 
Determinants. In press. 
378. Lewis, J.J.C., et al. Patterns of sexual behaviour and the risk of HIV infection in rural 
Zimbabwe, in XIV International AIDS Conference. 2002. Barcelona, Spain. 
379. Lewis, J. J., et al.. Evaluating the proximate determinants framework for HIV infection 
in rural Zimbabwe. Sex Transm Infect, 2007. 
380. Boerma, J.T., et al., Sociodemographic context of the AIDS epidemic in a rural area 
in Tanzania with a focus on people's mobility and marriage. Sex Transm Infect, 2002. 
78Suppl 1: p. i97-105. 
381. Hallett, T., et al. Modelling the Decline in HIV Risk in Generalised Epidemics and the 
Potential Impact of ABC Behavioural Interventions and VCT. in Infectious Diseases 
Society of America 43rd Annual Meeting. 2005. San Francisco. 
382. Aberle-Grasse, J., et al. Potential for Advancing HIV Prevention Through Increased 
Pre-Marital Testing, in The 2006 HIV/AIDS PEPFAR Implementers' Meeting. 2006. 
Durban, South Africa. 
251 
Appendix A: Declines in HIV prevalence can be 
associated with changing sexual behaviour in 
Uganda, urban Kenya, Zimbabwe, and urban 
Haiti (published manuscript) 
251 
Downloaded from sti.bmjjoumals.com on 7 April 2006 
Declines in HIV prevalence can be associated with changing 
sexual behaviour in Uganda, urban Kenya, Zimbabwe, and 
urban Haiti 
T B Hallett, J Aberle-Grasse, G Bello, L-M Boulos, M P A Cayemittes, B Cheluget, J Chipeta, 
R Dorrington, S Dube, A K Ekra, J M Garcia-Calleja, G P Garnett, 5 Greby, S Gregson, J T Grove, 
S Hader, J Hanson, W Hiadik, S Ismail, S Kassim, W Kirungi, L Kouassi, A Mahomva, L Marum, 
C Maurice, M Nolan, T Rehle, J Stover, N Walker 
SexJransm /n/iscf 2006;82(Suppl I):il-i8. doi: 10.1136/sfi.2005.016014 
Objective: To determine whether observed changes in HIV prevalence in countries with generalised HIV 
epidemics are associated with changes in sexual risk behaviour. 
Methods: A mathematical model was developed to explore the relation between prevalence recorded at 
antenatal clinics (ANCs) and the pattern of incidence of infection throughout the population. To create a 
null model a range of assumptions about sexual behaviour, natural history of infection, and sampling 
biases in ANC populations were explored to determine which factors maximised declines in prevalence in 
the absence of behaviour change. Modelled prevalence, where possible based on locally collected 
behavioural data, was compared with the observed prevalence data in urban Haiti, urban Kenya, urban 
Cote d'lvoire, Malawi, Zimbabwe, Rwanda, Uganda, and urban Ethiopia. 
Results: Recent downturns in prevalence observed in urban Kenya, Zimbabwe, and urban Haiti, like 
Uganda before them, could only be replicated in the model through reductions in risk associated with 
changes in behaviour. In contrast, prevalence trends in urban Cote d'lvoire, Malawi, urban Ethiopia, and 
Rwanda show no signs of changed sexual behaviour. 
Conclusions: Changes in patterns of HIV prevalence in urban Kenya, Zimbabwe, and urban Haiti are quite 
recent and caution is required because of doubts over the accuracy and representativeness of these 
estimates. Nonetheless, the observed changes are consistent with behaviour change and not the natural 
course of the HIV epidemic. 
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Th e p r e v a l e n c e o f H I V a m o n g w o m e n a t t e n d i n g a n t e n a t a l c l i n i c s ( A N C s ) , c o l l e c t e d o v e r t i m e f r o m t h e s a m e s i t e s , i s f u n d a m e n t a l t o e s t i m a t i n g t h e s c a l e o f t h e e p i d e m i c . T h e 
i n t e r p r e t a t i o n o f t r e n d s i n p r e v a l e n c e i s i m p o r t a n t i n u n d e r -
s t a n d i n g c h a n g e s i n p o p u l a t i o n l e v e l r i s k b u t i s c o m p l i c a t e d 
b y t h e n e e d t o d i s t i n g u i s h b e t w e e n t h e e x p e c t e d n a t u r a l 
h i s t o r y o f t h e e p i d e m i c a n d m o r e p r o n o u n c e d c h a n g e s a r i s i n g 
f r o m c h a n g e s t o i n d i v i d u a l s ' s e x u a l b e h a v i o u r . ' I n t h e c a s e o f 
U g a n d a a n d T h a i l a n d t h i s h a s b e e n p o s s i b l e a n d c h a n g e s i n 
t h e p r e v a l e n c e o f H I V h a v e b e e n a c c e p t e d t o b e t h e p r o d u c t o f 
w i d e s p r e a d a l t e r a t i o n s i n s e x u a l r i s k b e h a v i o u r . " T h e s e 
n a t i o n a l s u c c e s s s t o r i e s h a v e h a d p r o f o u n d i m p l i c a t i o n s f o r 
g l o b a l p o h c y o n H T V c o n t r o l l e a d i n g t o t h e d e v e l o p m e n t o f 
p r e v e n t i o n s t r a t e g i e s a n d t h e i n v e s t m e n t o f s i g n i f i c a n t 
r e s o u r c e s . " W h e n t h e d o w n t u r n i n p r e v a l e n c e w a s f i r s t 
d e t e c t e d i n U g a n d a t h e b e l i e f t h a t b e h a v i o u r c h a n g e w a s 
r e s p o n s i b l e w a s s t r e n g t h e n e d t h r o u g h c o m p a r i n g o b s e r v e d 
p r e v a l e n c e t r e n d s w i t h t h o s e g e n e r a t e d b y m a t h e m a t i c a l 
m o d e l s w i t h a n d w i t h o u t c h a n g e s i n risk b e h a v i o u r . ^ 
M a t h e m a t i c a l m o d e l s a r e a p r e c i s e w a y o f d e s c r i b i n g 
a s s u m p t i o n s a b o u t t h e t r a n s m i s s i o n d y n a m i c s o f a n i n f e c -
t i o u s d i s e a s e a n d c a n b e u s e d t o g e n e r a t e p r e d i c t i o n s . I t i s 
p o s s i b l e t o g e n e r a t e p r e d i c t i o n s o f H I V p r e v a l e n c e w i t h a n d 
w i t h o u t b e h a v i o u r c h a n g e a n d t e s t w h i c h p r e d i c t i o n s a r e 
c o n s i s t e n t w i t h o b s e r v e d p a t t e r n s o f p r e v a l e n c e . M o d e l s o f 
H I V t r a n s m i s s i o n d y n a m i c s h a v e a l o n g h i s t o r y a n d m a n y 
c o m p l e x i t i e s h a v e b e e n e x p l o r e d , i n c l u d i n g t h e i m p a c t o f 
v a r i a t i o n i n risk b e h a v i o u r , " p a t t e r n s o f d i s e a s e a n d 
i n f e c t i o u s n e s s o v e r t i m e , ' a n d t h e i m p a c t o f d e t a i l s o f t h e 
d y n a m i c n e t w o r k o f s e x u a l b e h a v i o u r . H o w e v e r , m o d e l s h a v e 
a l s o b e e n d e v e l o p e d t o e x p l o r e s p e c i f i c q u e s t i o n s s u c h a s t h e 
i m p a c t o f H I V o n d e m o g r a p h y , ' " t h e i m p a c t o f p a r t i c u l a r 
i n t e r v e n t i o n s l i k e h y p o t h e t i c a l v a c c i n e s " a n d t h e i m p o r -
t a n c e o f p a r t i c u l a r s e x u a l n e t w o r k p a r a m e t e r s . " S u c h m o d e l s 
a r e b e s t d e v e l o p e d i n a s t e p w i s e f a s h i o n t e s t i n g t h e 
i m p o r t a n c e o f e a c h p a r t i c u l a r a s s u m p t i o n . F o r s i m p h c i t y 
t h e m o d e l s h o u l d b e p a r s i m o n i o u s a n d i n c l u d e o n l y a s m u c h 
d e t a i l a s i s r e l e v a n t t o t h e q u e s t i o n i n h a n d . " I n d e v e l o p i n g 
m o d e l s t o e x p l o r e t h e p o t e n t i a l c h a n g e s i n H I V p r e v a l e n c e i t 
i s i m p o r t a n t t h a t t h e y c o n t a i n t h e a s s u m p t i o n s t h a t c a n 
i m p a c t o n t h e r e s u l t s o f i n t e r e s t . 
I n t h i s s u p p l e m e n t t r e n d s i n H I V p r e v a l e n c e a n d a s s o c i a t e d 
e v i d e n c e f r o m s e x u a l b e h a v i o u r s u r v e y s f r o m a n u m b e r o f 
c o u n t r i e s h a v e b e e n d e s c r i b e d a n d i n t e r p r e t e d . S u c h i n t e r -
p r e t a t i o n w i l l b e s t r e n g t h e n e d t h r o u g h a c o m p a r i s o n o f 
p r e d i c t e d t r e n d s u n d e r a r a n g e o f a s s u m p t i o n s i n m a t h e m a -
t i c a l m o d e l s . B e c a u s e t h e d a t a i n A N C p o p u l a t i o n s a r e 
o b v i o u s l y f r o m w o m e n a n d i n c l u d e r e c o r d s o f a g e , c o m p a r -
a b l e m o d e l p r e d i c t i o n s s h o u l d b e s e x a n d a g e s t r u c t u r e d . 
O t h e r k e y e l e m e n t s t o e x p l o r e a r e t h e r e l a t i o n b e t w e e n 
i n c i d e n c e a n d p r e v a l e n c e , a n d t h e s p e e d a n d v a r i a n c e i n 
p a t t e r n s o f i n c i d e n c e a n d s u b s e q u e n t m o r t a l i t y . " F u r t h e r , 
w h i l e a n e x a c t d e s c r i p t i o n o f t h e p a t t e r n o f s e x u a l b e h a v i o u r 
i s u n n e c e s s a r y , i t i s i m p o r t a n t t o e x p l o r e c h a n g e s i n 
t h e d i s t r i b u t i o n o f s e x u a l risk b e h a v i o u r s r e s u l t i n g f r o m 
Abbreviations: AIDS, acquired immune deficiency syndrome; ANC, 
antenatal clinic; HIV, human immunodeficiency virus 
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d i f f e r e n t i a l A I D S a s s o c i a t e d m o r b i d i t y a n d m o r t a l i t y s o t h a t 
t h e y c a n b e d i s t i n g u i s h e d f r o m " e x o g e n o u s " c h a n g e s 
b r o u g h t a b o u t b y i n t e r v e n t i o n s . " A n o t h e r f a c t o r t h a t c a n 
a l t e r t h e t r e n d s i n p r e v a l e n c e i s H I V a s s o c i a t e d s u b - f e r t i l i t y 
t h a t c o u l d i n t r o d u c e b i a s e s i n A N C a t t e n d a n c e t h a t c h a n g e 
o v e r t i m e . " 
H e r e w e d e s c r i b e t h e e x p e c t e d d y n a m i c s o f a g e n e r a l i s e d 
H I V e p i d e m i c u s i n g a n e w l y d e v e l o p e d m a t h e m a t i c a l m o d e l , 
a n d c o m p a r e t h e p r e v a l e n c e d a t a f r o m c o u n t r i e s i n c l u d e d i n 
t h i s r e p o r t w i t h m o d e l p r e d i c t i o n s . W h e r e t h e m o d e l c a n 
r e p r o d u c e t h e o b s e r v e d c h a n g e s i n p r e v a l e n c e w i t h " e n d o -
g e n o u s " c h a n g e s o n l y ( t h a t i s , t h o s e c a u s e d b y H I V a n d A I D S 
n a t u r a l d y n a m i c s ) i t c a n n o t b e a r g u e d f r o m t h e d a t a t h a t t h e 
p o p u l a t i o n l e v e l r i s k s o f H I V i n f e c t i o n h a v e b e e n a l t e r e d b y 
t h e a d o p t i o n o f s a f e r s e x u a l b e h a v i o u r . O n t h e o t h e r h a n d , i f 
t h e m o d e l c a n n o t r e p r o d u c e t h e o b s e r v e d e p i d e m i o l o g i c a l 
t r e n d s w i t h o u t a l s o a s s u m i n g c h a n g e s i n r i s k b e h a v i o u r , t h i s 
p r o v i d e s e v i d e n c e t h a t t h e p r o x i m a t e d e t e r m i n a n t s o f H I V 
i n c i d e n c e h a v e b e e n a l t e r e d t h r o u g h a d o p t i o n o f s a f e r s e x u a l 
p r a c t i c e s . 
METHODS 
W e d e v e l o p e d a d e t e r m i n i s t i c m a t h e m a t i c a l m o d e l o f t h e 
h e t e r o s e x u a l t r a n s m i s s i o n o f H I V i n a s e x , a g e , a n d s e x u a l 
a c t i v i t y ( d e f i n e d a c c o r d i n g t o t h e r a t e o f s e x u a l p a r t n e r 
c h a n g e ) s t r a t i f i e d p o p u l a t i o n , b a s e d o n e a r l i e r p u b l i s h e d 
m o d e l s . " T o f o c u s o n t r e n d s i n p r e v a l e n c e i n y o u n g w o m e n 
a t t e n d i n g A N C s t h e m o d e l i n c l u d e d a d e t a i l e d y e a r l y a g e 
s t r u c t u r e o f y o u n g a d u l t s a l l o w i n g c h a n g e s i n a g e o f s e x u a l 
d e b u t a n d r a t e s o f p a r t n e r c h a n g e i n t h o s e r e c e n t l y e n t e r i n g 
t h e s e x u a l l y a c t i v e p o p u l a t i o n . F u l l d e t a i l s o f t h e m o d e l c a n 
b e f o u n d i n t h e s u p p l e m e n t a r y m a t e r i a l ( s e e o n l i n e a t h t t p : / / 
s t i . b m j j o u m a l s . c o m / s u p p l e m e n t a V ) b u t t h e k e y a s s u m p t i o n s 
i n t h e m o d e l a r e d e s c r i b e d h e r e . H I V i s a s s u m e d t o b e 
t r a n s m i t t e d t h r o u g h s e x u a l p a r t n e r s h i p s o r a t t h e t i m e o f 
b i r t h f r o m a n i n f e c t e d m o t h e r t o h e r c h i l d . T h e p o p u l a t i o n i s 
d i v i d e d i n t o f i v e s e x u a l a c t i v i t y g r o u p s w i t h d i f f e r e n t 
n u m b e r s o f s e x u a l p a r t n e r s h i p s f o r m e d p e r y e a r . O n s e x u a l 
d e b u t m o s t i n d i v i d u a l s e n t e r t h e g r o u p w i t h t h e l o w e s t 
s e x u a l a c t i v i t y , b u t a m i n o r i t y e n t e r g r o u p s w i t h m u c h h i g h e r 
s e x u a l a c t i v i t y . I n r e s p o n s e t o d i f f e r e n t i a l m o r t a l i t y t w o 
a s s u m p t i o n s a r e p o s s i b l e : ( 1 ) t h e h i g h e s t s e x u a l a c t i v i t y 
g r o u p s c a n b e d e p l e t e d i f t h o s e w i t h h i g h r i s k s u f f e r g r e a t e r 
m o r t a l i t y ; a n d ( 2 ) t h e r e l a t i v e s i z e s o f t h e g r o u p s a r e 
m a i n t a i n e d b y r e c r u i t i n g i n d i v i d u a l s f r o m o t h e r s e x u a l 
. a c t i v i t y g r o u p s i n t o t h e h i g h e r a c t i v i t y g r o u p s . 
A n i n d i v i d u a l o f a p a r t i c u l a r s e x , a g e , a n d s e x u a l a c t i v i t y 
f o r m s a n u m b e r o f s e x u a l p a r t n e r s h i p s e a c h y e a r , w i t h 
p a r t n e r s h i p s p r e f e r e n t i a l l y d i r e c t e d b e t w e e n o l d e r m e n a n d 
y o u n g e r w o m e n a n d w i t h i n d i v i d u a l s o f t h e s a m e s e x u a l 
a c t i v i t y c l a s s . T r a n s m i s s i o n o f H I V i s a s s u m e d t o b e 
p r e v e n t e d b y c o n s i s t e n t u s e o f c o n d o m s v t d t h t h e p r o b a b i l i t y 
o f c o n s i s t e n t u s e d e p e n d e n t o n t h e a g e o f b o t h p a r t n e r s . T o 
r e p r e s e n t t h e l o n g a n d v a r i a b l e i n c u b a t i o n p e r i o d a n d t h e 
h i g h e r t r a n s m i s s i o n p r o b a b i l i t y a s s o c i a t e d w i t h i n i t i a l a n d 
l a t e r s t a g e s o f i n f e c t i o n , t h o s e i n f e c t e d p r o g r e s s t h r o u g h 
t h r e e s t a g e s o f a s y m p t o m a t i c i n f e c t i o n p r i o r t o A I D S ; a f i r s t 
s t a g e l a s t i n g t h r e e m o n t h s w i t h a h i g h t r a n s m i s s i o n 
p r o b a b i l i t y ; a s e c o n d s t a g e l a s t i n g s e v e r a l y e a r s w i t h t h e 
l o w e s t t r a n s m i s s i o n p r o b a b i l i t y ; a n d a t h i r d s t a g e l a s t i n g s i x 
m o n t h s w i t h a h i g h t r a n s m i s s i o n p r o b a b i l i t y . 
A m o d e l s c e n a r i o w i t h n o e x o g e n o u s b e h a v i o u r c h a n g e 
w a s c o m p a r e d w i t h o n e w h e r e b e h a v i o u r c h a n g e w a s 
a s s u m e d t o r e d u c e t h e r a t e o f s e x u a l p a r m e r c h a n g e o r t h e 
t r a n s m i s s i o n p r o b a b i l i t y ( t h r o u g h i n c r e a s e d c o n d o m u s e ) . 
W h e r e b e h a v i o u r d a t a w e r e a v a i l a b l e ( u s i n g t h e s a m e 
i n d i c a t o r i n s u c c e s s i v e s u r v e y s ) t h e s e w e r e u s e d t o e s t i m a t e 
t h e c h a n g e i n p a r a m e t e r v a l u e s f o r a n a l t e r n a t i v e r u n o f t h e 
m o d e l . I f n o s u c h d a t a w e r e a v a i l a b l e a s t e p w i s e c h a n g e i n 
t h e t r a n s m i s s i o n p r o b a b i l i t y p e r p a r t n e r s h i p w a s u s e d 
i n s t e a d . 
F r o m e a c h c o u n t r y t h e f o l l o w i n g d a t a w e r e s o u g h t f o r 
m o d e l p a r a m e t e r i s a t i o n : m e d i a n a g e a t f i r s t s e x f o r m a l e s 
a n d f e m a l e s , a g e s p e c i f i c u s e o f c o n d o m s ( a t l a s t s e x / w i t h 
n o n - r e g u l a r p a r t n e r ) , a g e s p e c i f i c m e a n n u m b e r o f s e x u a l 
p a r t n e r s i n l a s t y e a r , a n d a g e o f s p o u s e o r l a s t p a r t n e r . T h e s e 
p o p u l a t i o n a v e r a g e s f a i l t o s p e c i f y s o m e o f t h e d e t a i l s o f 
i n d i v i d u a l b e h a v i o u r r e q u i r e d t o f u l l y p a r a m e t e r i s e t h e 
m o d e l . T o o v e r c o m e t h i s l a c k o f d e t a i l i n c o u n t r y w i d e d a t a 
w e u s e d d e t a i l e d s e x u a l b e h a v i o u r d a t a f r o m a h o u s e h o l d 
b a s e d p o p u l a t i o n s u r v e y i n r u r a l Z i m b a b w e " t o s p e c i f y t h e 
h e t e r o g e n e i t y i n r a t e s o f c h a n g e o f s e x u a l p a r t n e r s a n d t h e 
d e p e n d e n c y o f c o n d o m u s e o n a g e o f b o t h p a r t n e r s . F o r e a c h 
c o u n t r y a l l v a l u e s w e r e a l t e r e d t o g e n e r a t e t h e o b s e r v e d 
a v e r a g e s . T h e m e a n a g e d i f f e r e n c e b e t w e e n s e x u a l p a r t n e r s 
w a s e s t i m a t e d b y e i t h e r t h e m e a n a g e d i f f e r e n c e b e t w e e n 
s p o u s e s o r t h e d i f f e r e n c e i n t h e m e d i a n a g e o f m a r r i a g e 
b e t w e e n m e n a n d w o m e n . W h e r e n o d a t a w e r e a v a i l a b l e 
d e f a u l t m o d e l p a r a m e t e r s w e r e b a s e d o n r u r a l Z i m b a b w e 
d a t a , " w i t h t h e e x c e p t i o n o f p a r t n e r a c q u i s i t i o n r a t e s a s a 
f u n c t i o n o f a g e , w h i c h w e r e b a s e d i n s t e a d o n o b s e r v e d 
p a t t e r n s r e p o r t e d i n C o t e d ' l v o i r e f o r 1 9 9 4 . A l l s i m u l a t i o n s 
w e r e r u n u s i n g c o m m o n d e m o g r a p h i c b a c k g r o u n d r a t e s " 
s u c h t h a t i n t h e a b s e n c e o f i n f e c t i o n t h e p o p u l a t i o n w o u l d 
g r o w a t a p p r o x i m a t e l y 4 % p e r y e a r w i t h l i f e e x p e c t a n c y a t 
b i r t h f o r m a l e s a n d f e m a l e s 5 2 . 1 a n d 5 4 . 7 , r e s p e c t i v e l y . T h e 
b e h a v i o u r d a t a u s e d t o p a r a m e t e r i s e t h e m o d e l a r e s u m -
m a r i s e d i n t a b l e 1 a n d t h e s o u r c e s a r e i d e n t i f i e d i n t h e 
s u p p l e m e n t a r y m a t e r i a l . A l l m o d e l p a r a m e t e r s a r e l i s t e d i n 
t a b l e s S 1 - S 6 i n t h e s u p p l e m e n t a r y m a t e r i a l ( s e e o n l i n e a t 
h t t p : / / s t i . b m j j o u m a l s . c o m / s u p p l e m e n t a l / ) . 
A b r i e f s u m m a r y o f t h e H I V p r e v a l e n c e d a t a u s e d f o l l o w s ; 
• H a i t i — 5 u r b a n A N C s i t e s f r o m 1 9 9 3 t o 2 0 0 3 ™ 
• K e n y a — 1 3 u r b a n A N C s i t e s f r o m 1 9 9 0 t o 2 0 0 3 " 
• Z i m b a b w e — n a t i o n w i d e A N C s i t e s f r o m 2 0 0 0 t o 2 0 0 4 
( G e n s c r e e n t e s t ) ^ 
• C o t e d ' l v o i r e — 1 0 u r b a n s i t e s f r o m 1 9 9 7 t o 2 0 0 2 
• M a l a w i — 1 9 n a t i o n w i d e s i t e s f r o m 1 9 9 6 t o 2 0 0 3 " 
• R w a n d a — 2 4 n a t i o n w i d e A N C s i t e s i n 2 0 0 2 a n d 2 0 0 3 " 
• U g a n d a — 5 A N C s i t e s f r o m 1 9 9 2 t o 2 0 0 2 ( S t M a r y ' s 
H o s p i t a l , L a c o r , G u l u ( n o r t h e r n U g a n d a ) , S t F r a n c i s 
H o s p i t a l , K a m p a l a ( c e n t r a l U g a n d a ) , M b a r a r a H o s p i t a l 
( s o u t h w e s t e m U g a n d a ) , J i n j a H o s p i t a l ( e a s t e r n U g a n d a ) 
a n d M b a l e H o s p i t a l ( e a s t e r n U g a n d a ) ^ ' 
• E t h i o p i a — u r b a n s i t e s f r o m 2 0 0 1 t o 2 0 0 3 . ^ ' 
T o a v o i d t r e n d s i n p r e v a l e n c e r e f l e c t i n g c h a n g e s i n t h e 
p o p u l a t i o n s a m p l i n g , o n l y d a t a c o l l e c t e d f r o m t h e s a m e A N C s 
o v e r t i m e w e r e i n c l u d e d i n o u r a n a l y s i s . W h e r e s a m p l e s i z e s 
w e r e a v a i l a b l e w e c o u l d c o n s t r u c t 9 5 % c o n f i d e n c e i n t e r v a l s 
a r o u n d t h e p r e v a l e n c e e s t i m a t e s ( d a t a p o o l e d b y s i t e a n d a g e 
i f n o w e i g h t i n g i n f o r m a t i o n a v a i l a b l e ) . I f s u c h d a t a w e r e n o t 
a v a i l a b l e w e a r b i t r a r i l y i n c l u d e a 3 % u n c e r t a i n t y i n t e r v a l o r 
g i v e t h e r a n g e o f e s t i m a t e s f o r s p e c i f i c s i t e s . 
T h e p r e d i c t e d g r o w t h i n t h e p r e v a l e n c e o f H I V f r o m t h e 
m o d e l w a s r o u g h l y m a t c h e d t o p r e v a l e n c e b y a d j u s t i n g 
t h e t r a n s m i s s i o n p r o b a b i l i t y p e r s e x u a l p a r t n e r s h i p a n d t h e 
a s s o r t a t i v e n e s s o f m i x i n g b e t w e e n t h e h i g h a n d l o w s e x u a l 
a c t i v i t y g r o u p s . O t h e r m o d e l p a r a m e t e r s v a l u e s w e r e c h o s e n 
t o m a x i m i s e t h e n a t u r a l d e c l i n e i n H I V p r e v a l e n c e a n d c r e a t e 
a r o b u s t " n u l l m o d e l " o f t r e n d s w i t h o u t e x t r i n s i c b e h a v i o u r 
c h a n g e . T h e s e a s s u m p t i o n s a r e o u t l i n e d i n t h e r e s u l t s . I f t h e 
r e c o r d e d c h a n g e s i n p r e v a l e n c e c o u l d n o t b e r e p r o d u c e d 
w i t h o u t a s s u m i n g c h a n g e s i n s e x u a l b e h a v i o u r , s t e p w i s e 
c h a n g e s i n b e h a v i o u r a l p a r a m e t e r s w e r e m a d e t o r e f l e c t t h e 
t r e n d s i n s e x u a l b e h a v i o u r o b s e r v e d i n s u c c e s s i v e s u r v e y s . 
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Declines in HIV prevalence can be associated with changing sexual behaviour i3 
Table 1 Behavioural parameters used in the model 
Haiti Kenya Zimbabwe 
Uganda (N, Uganda Cote 
C, W)* (E}* Ethiopia d'lvoire Malawi Rwanda 
Baseline settings 
, Age at first sex 
Males 18 17 17t 17 17 20 18 18 17t 
Females 19 17 17t 17 17 16 16 17 I7t 
Probability of consistent condom per partnership 0.09 0.29 0.06 0.42 0.42 0.11 0.27 0.32 0.32t 
(male <24 with female <24} 
Mean age difference between partners 6.4 5.4 7.3t 7.3t 7.3t 7.3t 8.6 5.8 7.3t 
(male age — female age) 
Behavioural changes 
(year implemented) 
Probability of HIV transmission N/A N/A 50% 75% 80% N/A N/A N/A N/A 
(proportionate reduction) (2000) (1990) (1994) 
Delay in age at first sex, males (years) N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Delay in age at first sex, females (years) N/A +1 (1999) N/A N/A N/A N/A N/A N/A N/A 
Number of sexual partnerships per year 10% F30% N/A N/A N/A N/A N/A N/A N/A 





Probability of consistent condom per partnership 100% N/A N/A N/A N/A N/A N/A N/A N/A 
(profrartionate increase) (1.995) 
"Uganda sites were provided separately as N—north (St Mary's Hospital, Lacor, Gulu), C—central (St Francis Hospital, Nsambyo, Kampala), west (Mbarara 
Hospital,), E—eastern (Jin(a Hospital and Mbale Hospital). 
fTbe default pararneter was used in place of country specific data. 
Sources for behaviour data are listed in the supplementary material {see online at http://sti.bmiiournols.com/supplemental/). 
F, females; M, males; N/A, not available. 
T h e s e c h a n g e s w e r e i n c l u d e d a t t h e t i m e p o i n t s b e t w e e n t h e 
s u r v e y s g i v i n g a l i k e l y m a t c h b e t w e e n t h e m o d e l a n d t h e 
d a t a . 
RESULTS 
T h e a i m o f m o d e l l i n g t h e t r a n s m i s s i o n d y n a m i c s o f H I V h e r e 
w a s t o p r e d i c t t h e c o u r s e o f t h e e p i d e m i c i n t h e a b s e n c e o f 
b e h a v i o u r c h a n g e . T h i s a l l o w s u s t o e x c l u d e t h e n a t u r a l 
h i s t o r y o f t h e e p i d e m i c i n i n t e r p r e t i n g a n y o b s e r v e d r e d u c -
t i o n s i n p r e v a l e n c e . F o r a c o n s e r v a t i v e a n a l y s i s w e n e e d t o 
a d o p t a s s u m p t i o n s t h a t m a x i m i s e t h e p r e d i c t e d d e c l i n e s i n 
p r e v a l e n c e . 
A s H I V s p r e a d s f i r s t a m o n g t h o s e w i t h t h e h i g h e s t r i s k o f 
a c q u i r i n g i n f e c t i o n , i n c i d e n c e i n c r e a s e s s h a r p l y , b u t a s t h o s e 
h i g h r i s k i n d i v i d u a l s d i e t h e r i s k o f i n f e c t i o n t h e y p o s e t o 
o t h e r s i s r e m o v e d s o t h a t i n c i d e n c e m a y s u b s e q u e n t l y d e c l i n e 
( f i g l A ) . A d e c l i n e i n p r e v a l e n c e 1 0 - 2 0 y e a r s i n t o t h e 
e p i d e m i c c o u l d b e t h e p r o d u c t o f t h a t h i s t o r i c a l r e d u c t i o n i n 
i n c i d e n c e o r a m o r e r e c e n t r e d u c t i o n i n i n c i d e n c e a s s o c i a t e d 
w i t h t h e d e l i b e r a t e a d o p t i o n o f s a f e r s e x u a l b e h a v i o u r . 
U n d e r s t a n d i n g t h e d e t e r m i n a n t s o f t h a t i n i t i a l d e c l i n e i n 
i n c i d e n c e a n d h o w i t i n f l u e n c e s l a t e r t r e n d s i n p r e v a l e n c e i s 
c m c i a l i n o u r a n a l y s i s . T h e r a p i d l o c a l " s a t u r a t i o n " o f t h o s e 
a t h i g h e s t r i s k i s a c o n s e q u e n c e o f t h e e x t r e m e v a r i a n c e i n 
s e x u a l a c t i v i t y w i t h i n t h e p o p u l a t i o n ' " " w i t h t h e m a j o r i t y 
f o r m i n g f e w n e w s e x u a l p a r t n e r s h i p s e a c h y e a r a n d a 
m i n o r i t y f o r m i n g v e r y m a n y m o r e . ' " S o o n a f t e r t h e 
i n f e c t i o n i s i n t r o d u c e d t o t h e p o p u l a t i o n t h o s e i n d i v i d u a l s 
w i t h t h e r i s k i e s t s e x u a l b e h a v i o u r b e c o m e i n f e c t e d , e s p e c i a l l y 
i f t h e r e i s a h i g h t r a n s m i s s i o n p r o b a b i l i t y o f t h e v i r u s i n t h o s e 
r e c e n t l y i n f e c t e d ( f i g l A ) . S u b s e q u e n t i n f e c t i o n m a i n l y 
o c c u r s i n t h o s e w i t h l o w e r r i s k s e x u a l b e h a v i o u r a n d t h e 
n u m b e r o f n e w c a s e s a n d t h e risk p e r s u s c e p t i b l e d e c r e a s e s 
( B a g g a l e y R , B o i l y M C , W h i t e R G , et a!. S y s t e m a t i c r e v i e w o f 
H I V - 1 t r a n s m i s s i o n p r o b a b i l i t i e s i n a b s e n c e o f a n t i r e t r o v i r a l 
t h e r a p y . M a n u s c r i p t i n p r e p a r a t i o n ) . W h e t h e r t h i s i n i t i a l 
d e c l i n e i n i n c i d e n c e g e n e r a t e s a s u b s e q u e n t f a l l i n p r e v a l e n c e 
i s d e t e r m i n e d b y h o w c l o s e l y i n c i d e n c e a n d p r e v a l e n c e a r e 
c o u p l e d — t h a t i s , t h e i n t e r v a l b e t w e e n i n f e c t i o n a n d d e a t h . " 
A l o n g i n t e r v a l l e a d s p r e v a l e n c e t o r e c o r d i n f o r m a t i o n a b o u t 
t h e r i s k e x p e r i e n c e a c c u m u l a t e d o v e r m a n y y e a r s w i t h t h e 
e a r l y r e d u c t i o n i n i n c i d e n c e n o t m a n i f e s t , b u t a s h o r t e r 
i n t e r v a l a l l o w s p r e v a l e n c e t o f o l l o w t h e d r o p i n i n c i d e n c e 
m o r e c l o s e l y " ( f i g l A ) . T h e r e l a t i o n b e t w e e n p r e v a l e n c e a n d 
i n c i d e n c e i s e a s i e r t o i n t e r p r e t i n y o u n g p e o p l e b e c a u s e 
i n f e c t i o n s w i l l h a v e b e e n a c q u i r e d r e c e n t l y a s t h e y h a v e o n l y 
r e c e n t l y b e c o m e a t r i s k ( a s t h e y b e g i n s e x u a l a c t i v i t y ) . T h u s , 
i n y o u n g a d u l t s p r e v a l e n c e i s m o r e a r e f l e c t i o n o f t h e c u r r e n t 
p a t t e r n o f H I V t r a n s m i s s i o n a n d i s l e s s i n f l u e n c e d b y d e a t h s 
a m o n g t h o s e i n f e c t e d . C h a n g e s i n p r e v a l e n c e f o l l o w i n g t h e 
a d o p t i o n o f s a f e r s e x u a l b e h a v i o u r s h o u l d a p p e a r f i r s t a n d 
m o s t c l e a r l y a m o n g y o u n g p e o p l e " ( f i g I B ) . 
F o l l o w i n g t h e i n i t i a l g r o w t h o f a n H I V e p i d e m i c , a n d a s 
t h o s e w i t h r i s k i e s t s e x u a l b e h a v i o u r w h o a r e i n f e c t e d d i e o r 
r e d u c e t h e i r s e x u a l a c t i v i t y d u e t o i l l n e s s , t h e s t r u c t u r e o f t h e 
s e x u a l n e t w o r k c o u l d b e g i n t o c h a n g e ; b o t h b e c a u s e t h e h i g h 
r i s k b e h a v i o u r i t s e l f i s l o s t , a n d b e c a u s e t h e o p p o r t u n i t y f o r 
o t h e r i n d i v i d u a l s t o f o r m h i g h r i s k p a r t n e r s h i p s i s r e m o v e d . 
T h i s d e p e n d s u p o n h o w a n i n d i v i d u a l ' s r i s k b e h a v i o u r 
c h a n g e s a s t h e y a g e a n d t h e c h a n g e i n r i s k b e h a v i o u r o f 
t h o s e w h o r e m a i n f o l l o w i n g t h e d e a t h s o f t h o s e m o s t a t r i s k . 
A t o n e e x t r e m e , i f i n d i v i d u a l s r e m a i n a t t h e s a m e l e v e l o f r i s k 
t h r o u g h o u t t h e i r l i f e , a v e r a g e s e x u a l b e h a v i o u r n a t u r a l l y 
b e c o m e s s a f e r a s t h o s e w i t h r i s k y b e h a v i o u r d i e ( f i g I C ) . F o r 
t h i s r e a s o n , c h a n g e s i n a v e r a g e s e x u a l b e h a v i o u r s h o u l d b e 
i n t e r p r e t e d w i t h s o m e c a u t i o n s i n c e t h e s a f e r a v e r a g e 
b e h a v i o u r m a y n o t b e a c o n s e q u e n c e o f t h e d e l i b e r a t e 
a d o p t i o n o f s a f e r b e h a v i o u r s . I n t h e m o d e l i t i s a l s o p o s s i b l e 
t o a s s u m e t h a t a s t h e n u m b e r o f h i g h risk i n d i v i d u a l s 
d e c l i n e s l e s s r i s k y i n d i v i d u a l s c a n a d o p t h i g h e r r i s k b e h a -
v i o u r t o k e e p c o n s t a n t a v e r a g e r a t e o f p a r t n e r a c q u i s i t i o n . I n 
t h i s c a s e , i n c i d e n c e r e m a i n s h i g h a n d m a y b a l a n c e t h e s u r g e 
i n A I D S r e l a t e d m o r t a l i t y , m a i n t a i n i n g a s t e a d y p r e v a l e n c e o f 
i n f e c t i o n ( f i g I D ) . 
I n i n t e r p r e t i n g t r e n d s i n H I V p r e v a l e n c e w e a l s o n e e d t o b e 
c o n c e r n e d w i t h c h a n g i n g b i a s e s i n t h e A N C p o p u l a t i o n a s a 
s a m p l e o f w o m e n . " F i r s t l y , r e d u c t i o n s i n f e r t i l i t y c a u s e d b y 
t h e p r o g r e s s i o n o f H I V i n f e c t i o n c o u l d e x a g g e r a t e t h e d e c l i n e 
i n p r e v a l e n c e s e e n i n t h e A N C s a m p l e r e l a t i v e t o t h e g e n e r a l 
p o p u l a t i o n . R e c e n t d a t a s u g g e s t t h a t f e r t i l i t y i s s u p p r e s s e d 
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Figure 1 Natural dynamics of generalised HIV epidemic. (A) Predicted HIV incidence per 100 person years at risk (ttiick black line) and HIV 
prevalence among women for varying periods from infection to death. For 25 year olds mean interval from infection until death is 11 years (thin block 
line), 9 years (dait grey line), 7 years (light grey line), 5 year (dashed line), and 3 years (dotted/dashed line). (B) HIV prevalence among v/omen aged 
20-24 years (grey lines) and 3C^35 years (black lines) v/ithout behaviour change (solid lines) and v/ith the transmission probability halving at year 15 
(dashed lines). (C) The proportion of men and women currently forming more than one sexual partnership per year. (D) Predicted HIV incidence per 
100 person years at risK (solid lines) and HIV prevalence among women (dashed lines) with the relative size of sexual activity groups being allowed to 
change freely (grey lines) and being held constant with recruitment to the high activity groups from lower activity groups (black lines). 
b e f o r e t h e f i n a l s t a g e s o f H I V i n f e c t i o n . " S i m u l a t i o n s s h o w 
t h a t t h i s s u b - f e r t i U t y a n d e x c l u s i o n f r o m t h e A N C s a m p l e o f 
t h o s e i n f e c t e d w i l l o c c u r r a p i d l y ( f i g 2 A ) . S e c o n d l y , t h e A N C 
s a m p l e m i g h t o v e r r e p r e s e n t t h e w o m e n m o s t l i k e l y t o b e 
i n f e c t e d w i t h H I V , s i n c e s e x u a l b e h a v i o u r t h a t e x p o s e s t h e 
w o m e n t o t h e i n f e c t i o n ( f o r e x a m p l e , u n p r o t e c t e d s e x ) a l s o 
e x p o s e s t h e w o m e n t o t h e r i s k o f p r e g n a n c y . " B e c a u s e 
p r e v a l e n c e a m o n g h i g h r i s k w o m e n r i s e s q u i c k l y a n d f a l l s 
s t e e p l y a n A N C s a m p l e m a y r e p r e s e n t t h e e x t r e m e c h a n g e s i n 
p r e v a l e n c e ( f i g 2 B ) . 
O u r e x p l o r a t o r y a n a l y s i s f o u n d t h a t t h e m o s t e x t r e m e 
n a t u r a l d e c l i n e s i n p r e v a l e n c e a r i s e f r o m t h e g r e a t e s t c o n t r a s t 
b e t w e e n t h e i n i t i a l p e a k a n d s u b s e q u e n t l o w i n c i d e n c e l e v e l , 
a n d f r o m t h e s h o r t e s t p e r i o d f r o m i n f e c t i o n t o d e a t h . V / i t h i n 
r e a s o n a b l e l i m i t s w e m a x i m i s e d t h e i n i t i a l h e t e r o g e n e i t y i n 
r a t e o f s e x u a l p a r t n e r s h i p f o r m a t i o n a n d t h e v a r i a t i o n i n 
t r a n s m i s s i o n p r o b a b i l i t y v n t h s t a g e o f H I V i n f e c t i o n . T h e 
a c u t e p e a k i n i n c i d e n c e r e f l e c t s a l a c k o f g e o g r a p h i c s p a c e , 
s t o c h a s t i c e f f e c t s , a n d w a i t i n g t i m e s b e t w e e n s e x u a l p a r t n e r -
s h i p f o r m a t i o n a n d H I V t r a n s m i s s i o n . A l l o f t h e s e d i s t r i b u t e 
t h e p e a k i n i n c i d e n c e o v e r t i m e a n d l e s s e n t h e p r e d i c t e d 
p r e v a l e n c e d e c l i n e ( r e s u l t s n o t s h o v r a ) . P r e v a l e n c e d e c l i n e s 
m o s t w h e n t h e r e i s n o c o m p e n s a t o r y r e c r u i t m e n t i n t o t h e 
h i g h s e x u a l a c t i v i t y g r o u p s i n r e s p o n s e t o d i f f e r e n t i a l 
m o r t a l i t y a n d a p p e a r s m o s t e x t r e m e w h e n a s s u m i n g t h a t 
t h e A N C o v e r - s a m p l e s h i g h r i s k i n d i v i d u a l s . A l l m o d e l 
p a r a m e t e r s a r e l i s t e d i n t a b l e s S 1 - S 6 i n t h e s u p p l e m e n t a r y 
m a t e r i a l ( s e e o n l i n e a t h t t p : / / s t i . b m j j o u m a l s . c o m / s u p p l e m e n -
t a l / ) . I n t h e c a s e o f U g a n d a , u r b a n K e n y a , Z i m b a b w e , a n d 
u r b a n H a i t i , u n d e r a r a n g e o f r e a l i s t i c a n d e x t r e m e 
a s s u m p t i o n s ( n o t a l l s h o w n ) , o u r m o d e l c a n o n l y r e p l i c a t e 
o b s e r v e d d e c l i n e s i n p r e v a l e n c e b y a s s u m i n g t h a t r i s k 
b e h a v i o u r h a s a l s o d e c l i n e d . 
T h e d a t a a n a l y s e d f r o m M a l a w i , u r b a n C o t e d ' l v o i r e , a n d 
R w a n d a s h o w n o s i g n o f a d e c r e a s e i n p r e v a l e n c e a m o n g a l l 
a d u l t s , o r s e l e c t e d a g e g r o u p s ( f i g 4 ) . T h e r e i s s o m e e v i d e n c e 
t h a t t h e p r o p o r t i o n o f m e n a n d w o m e n h a v i n g h a d m o r e 
t h a n o n e o r t w o s e x u a l p a r t n e r s i n t h e l a s t 1 2 m o n t h s h a s 
d e c r e a s e d i n M a l a w i a n d C o t e d ' l v o i r e . ^ ' 
T h e d e c l i n e i n U g a n d a i s t h e e a r l i e s t a n d m o s t 
r e s e a r c h e d . ^ ' S i t e s i n n o r t h , c e n t r a l , a n d w e s t U g a n d a h a v e 
a s i m i l a r e p i d e m i c c u r v e w i t h p r e v a l e n c e a m o n g b o t h 1 5 - 4 9 
y e a r o l d a n d 2 0 - 2 4 y e a r o l d w o m e n d e c l i n i n g f r o m 
a p p r o x i m a t e l y 3 0 % t o 1 0 % ( f i g 3 A , B ) . T h e s e d e c l i n e s c o u l d 
b e g e n e r a t e d i n o u r m o d e l w i t h a r e d u c t i o n i n t h e 
t r a n s m i s s i o n p r o b a b i l i t y o f 7 5 % i n 1 9 9 2 — a s i m i l a r r e d u c t i o n 
t o t h a t p r e v i o u s l y e s t i m a t e d . ' ' N o s u b s e q u e n t r e d u c t i o n i s 
n e c e s s a r y t o g e n e r a t e t h e o b s e r v e d t r e n d s a n d t h e a s s u m e d 
c h a n g e i n r i s k p r e - d a t e s o b s e r v a t i o n a l c o h o r t d a t a f r o m R a k a i 
u s e d t o a r g u e t h a t i n c i d e n c e h a s n o t f a l l e n . " I n e a s t e r n s i t e s 
( J i n j a H o s p i t a l a n d M b a l e H o s p i t a l ) t h e d e c l i n e i n p r e v a l e n c e 
i n w o m e n a g e d 1 5 - 4 9 y e a r s f r o m a p p r o x i m a t e l y 1 5 % t o 5 % 
( f i g 3 C ) i s o n l y p o s s i b l e w i t h b e h a v i o u r c h a n g e , w h e r e a s 
p r e v a l e n c e e s t i m a t e s f o r w o m e n a g e d 2 0 - 2 4 y e a r s s h o w m o r e 
f l u c t u a t i o n s a n d a r e p o s s i b l e t o m o d e l w i t h o u t r i s k b e h a v i o u r 
c h a n g i n g ( f i g 3 D ) . S u c h s e e m i n g l y c o n t r a d i c t o r y r e s u l t s m a y 
a r i s e f r o m t h e g r e a t e r e r r o r i n p r e v a l e n c e e s t i m a t e s f r o m a 
m o r e r e s t r i c t e d a g e g r o u p ( s a m p l e s i z e s w e r e n o t a v a i l a b l e t o 
e s t i m a t e c o n f i d e n c e i n t e r v a l s ) , o r f r o m s h i f t i n g b e h a v i o u r a l 
p a r a m e t e r s ( i n p a r t i c u l a r , a g e a t f i r s t s e x ) , w h i c h a l t e r t h e 
d i s t r i b u t i o n o f t h e i n f e c t i o n w i t h r e s p e c t t o a g e a t t h e s a m e 
t i m e a s o v e r a l l p r e v a l e n c e i s d e c r e a s i n g . 
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Figure 2 Biases in antenatal clinic (ANC) sample. (A) Ratio of percentage of women attending ANCs who are HIV+ and percentage of all HIV+ 
women, assuming that the probability of women being included in the ANC sample depends on stage of HIV (solid line) and the fraction of HIV coses in 
late stage of infection (tertiary stage or full-blown AIDS) (dashed line). (B) Percentage of women attending ANC who are HIV+ (dashed line) and 
percentage of all women HIV+ (said line), assuming that the probability of being included in the ANC sample depends on sexual activity group. 
I n p a r t s o f u r b a n K e n y a H I V p r e v a l e n c e a m o n g w o m e n 
a g e d 1 5 a n d o v e r f e l l f r o m a p p r o x i m a t e l y 1 2 % i n 2 0 0 1 t o 9 % 
i n 2 0 0 3 w i t h a c o n c o m i t a n t d e c l i n e i n t h o s e a g e d 2 0 - 2 4 y e a r s 
f r o m 1 3 % t o 1 0 % . T h e d o w n t u r n i n p r e v a l e n c e w a s 
p a r t i c u l a r l y p r o n o u n c e d i n f o u r u r b a n s i t e s ( B u s i a , M e r u , 
N a k u r u , a n d T h i k a ) w h e r e m e d i a n p r e v a l e n c e f e l l f r o m 2 8 % 
i n 1 9 9 9 t o 9 % i n 2 0 0 3 a m o n g 1 5 ^ 9 y e a r o l d w o m e n a n d f r o m 
2 9 % i n 1 9 9 8 t o 9 % i n 2 0 0 2 a m o n g 1 5 - 2 4 y e a r o l d s ( f i g 3 E , F ) . 
A g a i n , t o r e p r o d u c e t h e s e c h a n g e s r e q u i r e s a s s u m i n g t h a t 
risk b e h a v i o u r h a s c h a n g e d . B e t w e e n b e h a v i o u r a l s u r v e y s i n 
1 9 9 3 , 1 9 9 8 , a n d 2 0 0 3 t h e r e w e r e s u b s t a n t i a l r e d u c t i o n s i n t h e 
p r o p o r t i o n s o f m e n a n d w o m e n h a v i n g m o r e t h a n o n e s e x u a l 
p a r t n e r . I n a d d i t i o n , b e t w e e n 1 9 9 8 a n d 2 0 0 3 , m e d i a n a g e a t 
f i r s t s e x f o r f e m a l e s i n c r e a s e d . T o r e p r e s e n t t h e s e c h a n g e s i n 
t h e m o d e l , a g e s p e c i f i c r e d u c t i o n s o f t h e m e a n r a t e o f p a r t n e r 
c h a n g e w e r e a s s u m e d i n 1 9 9 8 a n d 2 0 0 1 a n d a n i n s t a n t a -
n e o u s i n c r e a s e i n f e m a l e a g e a t f i r s t s e x w a s i n c l u d e d i n 
2 0 0 1 . T h e d e c r e a s e i n p r e v a l e n c e , t h o u g h , i s b e t t e r m a t c h e d 
w i t h a r e d u c t i o n i n t h e t r a n s m i s s i o n p r o b a b i l i t y o f 7 0 % i n 
1 9 9 7 ( d o t t e d l i n e s ) . F o u r o t h e r u r b a n s i t e s ( G a r i s s a , K i s i i , 
K i t u i , a n d N y e r i ) a l s o e x p e r i e n c e d a r e d u c t i o n i n m e d i a n 
p r e v a l e n c e ; 1 4 % i n 2 0 0 0 t o 7 % i n 2 0 0 3 a m o n g 1 5 - 4 9 y e a r 
o l d s , a n d s a m e b e h a v i o u r c h a n g e s w e r e a s s u m e d t o b r i n g t h e 
m o d e l i n t o a g r e e m e n t w i t h t h e d a t a ( f i g 3 G ) . H o w e v e r , t h e 
t r e n d i n p r e v a l e n c e a m o n g 1 5 - 2 4 y e a r o l d s i s l e s s c l e a r a n d 
d o e s n o t s e e m i n c o n s i s t e n t w i t h t h e n u l l m o d e l ( f i g 3 H ) . 
I n Z i m b a b w e b e t w e e n 2 0 0 2 a n d 2 0 0 4 a d e c l i n e i n 
p r e v a l e n c e f r o m 2 9 % t o 2 4 % i s r e c o r d e d a m o n g 1 5 - 4 4 y e a r 
o l d w o m e n a n d f r o m 2 5 % t o 2 0 % a m o n g 1 5 - 2 4 y e a r o l d 
w o m e n ( f i g 3 1 , J ) . I n b o t h c a s e s , t h e o b s e r v e d c h a n g e s c a n n o t 
b e r e p r o d u c e d t h r o u g h t h e n a t u r a l e v o l u t i o n o f t h e e p i d e m i c 
a l o n e , b u t c a n b e g e n e r a t e d v t d t h i f t h e o v e r a l l p r o b a b i l i t y o f 
i n f e c t i o n i s r e d u c e d b y h a l f i n 2 0 0 1 . 
I n u r b a n H a i t i , p r e v a l e n c e h a s d e c r e a s e d s i n c e 2 0 0 0 f r o m 
a p p r o x i m a t e l y 5 . 5 % t o 3 % a m o n g 1 5 - 4 4 y e a r o l d w o m e n — a 
d e c l i n e t h a t c o u l d n o t b e g e n e r a t e d i n t h e a b s e n c e o f b e h a v i o u r 
c h a n g e ( f i g 3 K ) . A m o n g 1 5 - 2 4 y e a r o l d s , p r e v a l e n c e h a s a l s o 
d e c l i n e d a l t h o u g h t h e u n c e r t a i n t y a s s o c i a t e d w i t h t h e s e 
e s t i m a t e s n o t d o e s r u l e o u t t h e p o s s i b i l i t y t h a t p r e v a l e n c e h a s 
r e m a i n e d c o n s t a n t . I n b e h a v i o u r a l s u r v e y s t h e r e w a s a 2 0 % 
d e c l i n e i n t h e m e a n n u m b e r o f s e x u a l p a r t n e r s b e t w e e n 1 9 9 4 
a n d 2 0 0 0 a n d c o n d o m u s e i n c r e a s e d t w o f o l d t o t h r e e f o l d 
b e t w e e n 2 0 0 0 / 0 1 a n d 2 0 0 3 . T h e s e c h a n g e s w e r e r e p r e s e n t e d i n 
t h e m o d e l b y a s t e p - c h a n g e i n p a r t n e r c h a n g e r a t e s i n 1 9 9 4 a n d 
i n c o n d o m u s e i n 1 9 9 9 . 
A d u l t p r e v a l e n c e ( 1 5 - 4 9 y e a r s ) i n u r b a n E t h i o p i a f e l l f r o m 
1 4 % i n 2 0 0 1 t o 1 2 % i n 2 0 0 3 ( f i g 4 A ) a n d f r o m 1 5 % t o 1 3 % 
o v e r t h e s a m e t i m e a m o n g 2 0 - 2 4 y e a r o l d s ( f i g 4 B ) . T h e s e 
m o d e s t d e c l i n e s c o u l d b e r e p r o d u c e d b y t h e m o d e l w i t h o u t 
a s s u m i n g a n y c h a n g e s t o s e x u a l r i s k b e h a v i o u r . 
DISCUSSION 
O u r m o d e l i l l u s t r a t e s t h e p o t e n t i a l f o r H I V p r e v a l e n c e t o 
d e c l i n e v w t h o u t a d e l i b e r a t e a d o p t i o n o f s a f e r s e x u a l 
b e h a v i o u r s . H o w e v e r , t h e i n a b i l i t y o f t h e m o d e l t o r e p l i c a t e 
t h e e x t e n t o f t h e o b s e r v e d d e c l i n e s a l l o w s u s t o b e m o r e 
c o n f i d e n t t h a t c h a n g e s i n p r e v a l e n c e i n U g a n d a , p a r t s o f 
u r b a n K e n y a , Z i m b a b w e , a n d u r b a n H a i t i a r e u n l i k e l y t o b e a 
p r o d u c t o f t h e s e n a t u r a l d y n a m i c s . T h e d e c l i n e s o b s e r v e d c a n 
b e c o n t r a s t e d w i t h u r b a n E t h i o p i a , w h e r e t h e p r e v a l e n c e 
p a t t e r n s c o u l d b e r e p r o d u c e d w i t h s e x u a l b e h a v i o u r a n d H I V 
t r a n s m i s s i o n r e m a i n i n g u n c h a n g e d , a n d u r b a n C o t e d ' l v o i r e , 
M a l a w i , a n d R w a n d a w h e r e a g g r e g a t e d p r e v a l e n c e h a s n o t 
r e c e n t l y d e c r e a s e d . T h i s d o e s n o t e x c l u d e t h e p o s s i b i l i t y , 
h o w e v e r , t h a t b e h a v i o u r c h a n g e h a s h a d a s i g n i f i c a n t i m p a c t 
o n t h e H I V e p i d e m i c . 
T h e m o d e l o f H I V t r a n s m i s s i o n i s i n f l u e n c e d b y a l a r g e 
n u m b e r o f i n t e r a c t i n g v a r i a b l e s w h i c h , w i t h o u t a d r a m a t i c 
i n c r e a s e i n d a t a s o u r c e s , l i m i t s o u r a b i l i t y t o s t a t i s t i c a l l y f i t 
t h e m o d e l a n d e s t i m a t e t h e m o s t l i k e l y v a l u e o f p a r t i c u l a r 
p a r a m e t e r s . A s t a t i s t i c a l i n t e r p r e t a t i o n o f o u r r e s u l t s d e p e n d s 
u p o n t h e c o n f i d e n c e i n t e r v a l s a r o u n d t h e p r e v a l e n c e e s t i -
m a t e s a t p a r t i c u l a r t i m e p o i n t s a n d w h e t h e r o u r e x t r e m e 
d e c l i n e i n p r e v a l e n c e f a l l s w i t h i n t h e m . I t s h o u l d b e n o t e d 
t h a t s o m e o f t h e p r e v a l e n c e e s t i m a t e s u s e d h e r e d i d n o t h a v e 
r e p o r t e d s a m p l e s i z e s o r s t a t i s t i c a l c o n f i d e n c e i n t e r v a l s . I n 
a d d i t i o n t o s t a t i s t i c a l e r r o r , c h a n g i n g b i a s e s c o u l d l e a d t o t h e 
o b s e r v e d a n d p r e d i c t e d t r e n d s s e p a r a t i n g . O n e s u c h b i a s i s 
s u g g e s t e d b y r e c e n t d a t a i n d i c a t i n g t h a t f e r t i l i t y i s s u p p r e s s e d 
b e f o r e t h e f i n a l s t a g e s o f H I V i n f e c t i o n . " S u b - f e r t i l i t y i n t h o s e 
w i t h l o n g s t a n d i n g H I V i n f e c t i o n c o u l d l e a d t o t h e i r e x c l u s i o n 
f r o m t h e A N C s a m p l e , b u t o u r m o d e l i n d i c a t e s t h a t t h e 
e f f e c t s o f t h i s b i a s w i l l p r e - d a t e t h e d e c l i n e s i n p r e v a l e n c e w e 
a r e n o w o b s e r v i n g . N a t i o n a l l y , e s t i m a t e s o f p r e v a l e n c e o f t e n 
f a l l a s s a m p l e s a r e r e c r u i t e d f r o m p r o g r e s s i v e l y m o r e r e m o t e 
p o p u l a t i o n s o r a s H I V t e s t s b e c o m e m o r e s p e c i f i c . T o a v o i d 
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Figure 3 ANC prevalence data (dots), model output assuming no behaviour change (full lines) and model output assuming behaviour change (dashed 
lines). Uganda; St Mar /s Hospital, Locor, Gulu, St Francis Hospital, Nsombya, Kampala, and Mbarara Hospital (A) 15-49 years olds ancl (B) 20-24 
year olds; Jinio Hospital (C) 15-49 year olds and (D) 20-24 year olds (error bars + 3%). Urban Kenya: Busia, Meru, Nakuru, and Thika (E) 15-49 
year olds and (F) 15-24 year olds (error bars shov/ range); Gorissa, Kisii, Kitui and Nyeri (G) 15-49 year olds and (H) 15-24 year olds (error bars 
shovf range). Zimbabwe: (1)15-44 year olds and (J) 15-24 year olds, (error bars ± 3%). Urban Haiti: (K) 15-44 year olds ana (L) 15-24 year olds 
(error bars + 95% CI). 
t h e s e p r o b l e m s w e h a v e o n l y p r e s e n t e d d a t a f r o m c l i n i c s 
c o n s i s t e n t l y i n c l u d e d . 
R e s t r i c t i n g H I V p r e v a l e n c e d a t a t o t h e y o u n g e r a g e g r o u p s 
o f t e n f a i l s t o h e l p i d e n t i f y r e c e n t r e d u c t i o n s i n H I V i n c i d e n c e . 
I n y o u n g a g e g r o u p s t h e c o n f o u n d i n g e f f e c t s o f m o r t a l i t y a n d 
s u b - f e r t i l i t y o n p r e v a l e n c e t r e n d s a r e m i n i m i s e d a n d r e d u c -
t i o n s i n i n c i d e n c e w i l l b e t r a n s l a t e d r a p i d l y i n t o r e d u c e d 
p r e v a l e n c e . H o w e v e r , t h e u n c e r t a i n t y a s s o c i a t e d w i t h t h e 
p r e v a l e n c e p o i n t e s t i m a t e s i s o f t e n t o o g r e a t t o d e t e c t t r e n d s . 
I n c o n t r a s t , a l t h o u g h p r e v a l e n c e e s t i m a t e s f r o m a c r o s s a l l 
a d u l t a g e s a r e p r o n e t o n a t u r a l r e d u c t i o n s , t h e y m a y b e 
d e t e r m i n e d m o r e p r e c i s e l y a n d s o a l l o w t r e n d s d u e t o t h e 
n a t u r a l e v o l u t i o n o f t h e e p i d e m i c a n d d u e t o b e h a v i o u r 
c h a n g e t o b e d i s t i n g u i s h e d . 
O n e o f t h e p r o b l e m s i n r e c o n s t r u c t i n g H I V e p i d e m i c s i s 
t h a t c u r r e n t s e x u a l b e h a v i o u r a l r e a d y i n c l u d e s r e d u c t i o n s i n 
www.stiioumal.com 
D o w n l o a d e d f rom s t i .bmj journa ls .com on 7 Apr i l 2 0 0 6 
Declines in HIV prevalence can be associated with changing sexual behaviour 
> 
X 
Urban Ethiopia: 20-24 year olds Urban Ethiopia: 15-49 year olds 
1985 
1990 1995 2000 
Rwanda: 20-24 year olds 
1990 1995 2000 2005 
Malawi: Females 15-34 year olds 
Urban Cote D'lvoire: Females 
15—49 year olds 
1980 1985 1990 1995 2000 2005 
1990 1995 2000 2005 1985 1990 1995 2000 2005 
Figure 4 ANC prevalence data (dots) and model output assuming no behaviour change (full lines). Urban Ethiopia: (A) 15-49 year olds, and (B) 20-
24 year olds (error bars + 95% CI). (C) Urban Cote d'lvoire 15-49 year olds (error bars ore ± 3%). (D) Rwanda 20-24 year olds (error bars are 
±3%). (E) Malawi: 15-34 year olds (error bars are ± 3%). 
r i s k y s e x u a l b e h a v i o u r b r o u g h t a b o u t b y t h e H I V e p i d e m i c 
a n d a s s o c i a t e d m o r t a l i t y i n t h o s e w h o w e r e p r e v i o u s l y a t t h e 
g r e a t e s t risk o f i n f e c t i o n . W e a r e f o r c e d t o a s s u m e t h a t t h e 
h e t e r o g e n e i t y i n s e x u a l p a r t n e r c h a n g e r a t e s w a s o r i g i n a l l y 
g r e a t e r t h a n t h a t o b s e r v e d t o d a y . I n a d d i t i o n , w h i l e w e 
a t t e m p t e d a r e c o n s t r u c t i o n o f c o u n t r y s p e c i f i c e p i d e m i c s , 
l o c a l p a t t e r n s o f r i s k w e r e o f t e n n o t a v a i l a b l e , n e c e s s i t a t i n g 
t h e a d o p t i o n o f s t a n d a r d p a t t e r n s f o r c o n d o m u s e a n d a g e 
s p e c i f i c p a r t n e r c h a n g e r a t e s . F o r t u n a t e l y , d e s p i t e b e i n g 
i m p o r t a n t f o r f i t t i n g a g e a n d s e x s p e c i f i c p r e v a l e n c e , t h e s e 
p a t t e r n s h a v e l i t t l e b e a r i n g o n t h e c o u r s e o f t h e e p i d e m i c 
o n c e i t s m a g n i t u d e i s e s t a b l i s h e d . 
I n s u m m a r y , o u r a n a l y s i s s u p p o r t s a b e l i e f t h a t b e h a v i o u r 
c h a n g e a n d d e c r e a s e d i n c i d e n c e i s r e d u c i n g p r e v a l e n c e i n 
f o u r c o u n t r i e s w i t h g e n e r a h s e d e p i d e m i c s . I n a l l b u t U g a n d a 
t h e d e c l i n e s i n p r e v a l e n c e a r e q u i t e r e c e n t t h o u g h t h e 
e v i d e n c e o f b e h a v i o u r c h a n g e i n p a r t s o f u r b a n K e n y a i s 
K e y m e s s a g e s 
• Twenty years ' into the general ised epidemics of sub-
Saharon Af r i ca , evidence is emerg ing f rom some 
countries that HIY prevalence is fal l ing. Prevalence 
declines can result not Only f rom individuals adop t ing 
safer sexual behaviour but also through AIDS asso-
ciated moi l 
• A mathemat ica l mode l has been used to assess 
whether the observed declines could be the result only 
of mortal i ty a n d not of chang ing sexual behaviour . 
• In Uganda , parts of u rban Kenya, Z imbabwe, and 
urban Hai t i , HIV prevalence has decl ined further than 
wou ld be expected through the effects of mortal i ty 
alone, suggesting that in these settings individuals hove 
begun to adop t safer sexual behaviour. 
a c c u m u l a t i n g w h e r e s e v e r a l s e q u e n t i a l H I V p r e v a l e n c e 
e s t i m a t e s h a v e s h o w n a c o n t i n u e d d e c l i n e . A l t h o u g h a 
s u b s t a n t i a l p r e v a l e n c e d e c l i n e i n Z i m b a b w e h a s o n l y b e e n 
d e t e c t e d r e c e n t l y , c r e d e n c e i s l e n t t o t h i s o b s e r v a t i o n b y t h e 
i n c r e a s i n g e v i d e n c e o f b e h a v i o u r a l c h a n g e ( G r e g s o n S , 
G a m e t t G P , N y a m u k a p a C A , et al. H I V d e c l i n e a s s o c i a t e d 
w i t h b e h a v i o u r c h a n g e i n e a s t e r n Z i m b a b w e . S u b m i t t e d f o r 
p u b l i c a t i o n ) . T h e o b s e r v e d d i p i n p r e v a l e n c e i n u r b a n H a i t i , 
o n t h e o t h e r h a n d , c o u l d t u r n o u t t o b e a n o m a l o u s . F o r a l o n g 
t i m e U g a n d a ^ ' a n d T h a i l a n d ' ' ' h a v e b e e n t h e k e y n a t i o n a l 
l e v e l e x a m p l e s o f s u c c e s s i n r e d u c i n g H I V i n c i d e n c e a n d t h e 
m a i n s o u r c e o f e v i d e n c e o n H I V p r e v e n t i o n . P e r h a p s i t i s t i m e 
f o r K e n y a a n d Z i m b a b w e t o b e a d d e d t o t h e h s t . 
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Background: Sexual behavioural change is essential to prevent HIV infections in Africa and statistical analysis 
of risk factors at the individual-level may be used to design interventions. The importance of reducing cross-
generational sex (young women having sex with older men) and delaying age at first sex on the spread of HIV 
at the population-level has been presumed but not scientifically investigated and quantified. 
Methods: A mathematical model of heterosexual spread of HIV was developed to predict the population-level 
impact of reducing cross-generational sex and delaying sexual debut. 
Results: The impact of behaviour change on the spread of HIV is sensitive to the structure and reaction of the 
sexual network. Reducing cross-generational sex could have little impact on the risk of infection unless it is 
accompanied by a reduction in the number of risky sexual contacts. Even peer-to-peer sexual mixing can 
support high endemic levels of HIV. The benefit of delaying sexual debut is comparatively small and is 
reduced if males continue to prefer young partners or if young women spend more time unmarried. In 
Manicaland, Zimbabwe, if older men were to use condoms as frequently as young men, the reduction in risk 
of infection could exceed that generated by a two-year delay in first sex. 
Conclusions: At the individual-level avoiding sex with older partners and delaying sexual debut can decrease 
the risk of infection but at the population-level these interventions may do little to limit the spread of HIV 
without wider-ranging behavioural changes throughout the sexual network. 
The HIV pandemic continues to spread devastation globally.' In the generalised epidemics in sub-Saharan Africa, most of the risk is associated with heterosexual sex,^ '^  and 
behaviour change is essential to reduce the number of new 
infections. Funding has been made available for interventions 
to promote behaviour change,' ^ but care must be taken to 
target resources at changing those aspects of sexual behaviour 
that are most important in the spread of HIV. 
Observational studies show that usually HIV prevalence 
among young women far exceeds that among young men.® This 
has prompted some to emphasise the importance of protecting 
young women from infection in particular.^ Statistical 
malyses of individual behaviour data show that the risk of 
HIV infection is lower among women who avoid older sexual 
partners'^ " and begin sexual activity later.'^ For this 
reason, it has been suggested that behaviour interventions 
should focus on reducing cross-generational sex (young women 
forming sexual partnerships with older men) and delaying 
sexual debut.®" " The importance of these changes at the 
population level has been presumed but not scientifically 
investigated and quantified.® " " 
Mathematical models allow an assessment of the potential 
tffects of proposed behaviour interventions and can provide a 
Suide to the factors most critical to their success.^' Increasingly, 
•he insights gained from mathematical models are well 
understood and applied,""" and consulting mathematical 
lodels before implementing epidemiological interventions 
ks become standard practice for emerging epidemiological 
problems."-" It can be argued that the same approach should 
k used to assess the effects of proposed behavioural change 
interventions on generalised HIV epidemics. 
"w.stijou mal.com 
In the present study we considered two questions about 
proposed behavioural change interventions: 
• What population-level effect could discouraging cross-gen-
erational sex and promoting delayed age at first sex have on 
the HIV epidemic? 
• What properties of the sexual network determine the size of 
this impact? 
To answer these questions we designed a deterministic 
mathematical model of the heterosexual transmission of HIV 
with a detailed yearly age structure of young adults so that 
changes in age at sexual debut, ages of sexual partners and 
rates of partner change in those recently entering the sexually 
active population could be investigated. We have parameterised 
the model using data collected in a cross-sectional survey in 
rural Zimbabwe'^ to provide a detailed and well-informed 
example to illustrate the qualitative results rather than provide 
an exhaustive description of the various generalised HIV 
epidemics in Africa. 
METHODS 
Data sources 
A stratified population-based survey was carried out in the 
Manicaland province of eastern Zimbabwe between July 1998 
and January 2000.'^ A follow-up survey was completed after 
three years.^ ® A structured face-to-face interview was conducted 
with almost 10 000 men and women in 12 distinct commu-
nities: two forestry plantations, two tea and coffee estates, two 
small towns, two roadside trading centres and four subsistence 
farming areas. In three-quarters of interviews with literate 
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respondents, the answers to sensitive questions about sexual 
behaviour were recorded using a confidential voting method, 
the use of which has been associated with reporting of greater 
sexual activity." Condoms were used in all reported sex acts in 
the last sexual partnership by 17% of males and 8% of females 
who reported a sexual partnership in the past month. Sex acts 
were self-defined in the questionnaire, but here we assume that 
all sex acts are insertive penile-vaginal. The distribution of age 
difference between sexual partners (male's age minus female's 
age) takes a similar form for women of all ages and can be 
modelled by a log-logistic function (figs SI and S2 in the 
supplementary material, see http://sti.bmj.com/supplemental). 
The mean age difference is 7 years, and in approximately 25% of 
partnerships the age difference is 10 years or more. 
Mathematical simulation model 
We developed a deterministic mathematical model of the 
heterosexual transmission of HIV in a sex, age and activity-
stratified population. The model is defined by a set of partial 
differential equations with respect to time and age that are 
solved numerically with a four-stage Runge-Kutta algorithm 
(time-step = 0.02 years). Full details of the model can be found 
in the online supplementary material (see http://sti.bmj.com/ 
supplemental) but the key assumptions in the model are 
described here. 
HIV is assumed to be transmitted through heterosexual 
partnerships or at the time of birth from an infected mother to 
her child. To represent the long and variable incubation period 
and stage-dependent HIV transmission probability, those 
infected progress through three stages of asymptomatic 
infection prior to AIDS: the first stage lasts three months and 
is associated with a high transmission probability; the second 
stage lasts for several years (up to a mean of 10 years, 
depending on age) and is associated with a low transmission 
probability; and the third stage lasts six months and is 
associated with a high transmission probabiUty. 
The population is divided into several sexual activity groups 
with different numbers of sexual partnerships formed in a year. 
To permit study of the effect of varying age at first sex and the 
pattern of partnership formation with respect to age, a detailed 
yearly age structure was incorporated. On sexual debut most 
individuals enter the group with the lowest sexual activity, but 
a few enter groups vyith much higher sexual activity. An 
individual of a particular sex, age and sexual activity forms a set 
number of sexual partnerships each year that are directed 
preferentially towards those in a similar sexual activity class 
and between older men and younger women. The fraction of 
women's partnerships that are formed with men a given 
number of years older is determined by the log-logistic 
function. This distribution allows the age difference to be 
moderate in most sexual partnerships but much greater in 
others. It can be parameterised so that the pattern of partner-
ship formation matches that observed in Manicaland or varied 
lo represent alternative scenarios (fig S3 in the supplementary 
material, see http://sti.bmj.com/supplemental). Two types of 
intervention to reduce cross-generational mixing are simulated: 
• a change in the distributional form of the allocation of young 
women's partnerships among older men, preserving the total 
number of partnerships formed; and 
• removal of a fraction of partnerships with a given age 
difference, so that there are less partnerships in total. 
Both of these interventions generate the same reduction in the 
fraction of young women's sexual partnerships that are "cross-
generational" but the former replaces those cross-generational 
partnerships with partnerships among peers whereas the latter 
does not. For consistency, the derived pattern of partnership 
formation for one sex must match that of the other, and the 
extent to which males' demand for sexual partnerships is 
accommodated by the female population (or vice versa) has to 
be specified. 
Mortality and fertility rates were chosen to represent an 
African population in the pre-AIDS era and the model was run 
for 100 years to establish a stable population structure. The 
infection was introduced to 0.01% of males aged 25-29 years in 
the highest sexual activity group. 
RESULTS 
Running the model with the different mixing patterns showed 
that with more cross-generational mixing, endemic prevalence 
(among those aged 15-49 years) was slightly higher (fig lA 
(bars)). Female-to-male prevalence ratios for 15-24-year-olds 
at least equal to those observed can be created in the model 
without assuming any difference in susceptibility to HIV 
infection between men or women or over age (fig lA (line)). 
If all sexual partnerships are formed between peers the 
epidemic cannot become established (fig IB). If 1% of sexual 
partnerships are formed with partners one year older or younger, 
HIV can become endemic. Simulating an intervention that 
reduced cross-generational mixing but preserved the total 
number of sexual partnership formed, showed that such a 
behavioural change could substantially reduce HIV prevalence 
among young women but prevalence among young men might 
rise (fig IC (solid lines)). With this intervention, the lifetime risk 
of infection (the expected chance at birth that an individual will 
have been infected with HIV by their fifty-fifth birthday) is 
reduced by 10% for females and 5% for males. In contrast, if the 
same reduction in cross-generational mixing is simulated but 
without any compensatory increase in the number of partner-
ships among peers (dashed lines), prevalence among males can 
decrease and prevalence among females can decrease further. 
With this intervention, the lifetime risk of infection is reduced 
much more: by 25% for females and 22% for males. 
This pattern of sexual mixing (young women forming 
partnerships with older men) means that the impact of young 
women delaying sexual debut is sensitive to the behavioural 
response of older men—that is, if males' would-be young 
sexual partners become abstinent, they may seek to replace 
those last partnerships with the youngest sexually active 
females available. Females' risk of infection in the first years 
of sexual activity is therefore linked to whether or not males 
seek to replace lost partnerships and the extent to which males 
control the structure of the sexual network (fig 2A). If males do 
seek to replace the lost partnerships, incidence is increased 
among women for the first years of sexual activity and this 
effect is greater if males are able to control the structure sexual 
network. The reduction in lifetime risk of infection for women 
is greater if males do not seek to replace lost partnerships 
(fig 2B). The benefit of delaying sexual debut is even greater if 
women become less susceptible to infection as they get older. 
However, in all scenarios the reduction in lifetime risk of 
infection associated with delaying sexual debut is relatively 
small. 
Another issue is the relative timing of sexual debut and 
marriage." The risk of infection when sexually active but not 
married (2% per person-year at risk during the first three years 
of follow-up in this population) is greater than when married 
(1% per person-year). This means that the benefit of delaying 
first sex depends on the time spent unmarried. For example, 
increasing the age at first sex from 18 to 21 could lead to 
lifetime risk of infection being reduced by 9% (if women are 
unmarried for 12 months less), reduced by 6% (no change in 
relative timing of marriage) or remain almost unchanged (if 
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Figure 1 The Impact of reducing cross-generational sex on the 
lieferosexual spread of HIV. (A) HIV prevalence among 15-49-year-olds 
Ibors) and female-to-male prevalence among 15-24-year-olds (line) v/lth 
different levels of cross-generational mixing (percent of females' 
partnerships formed witn males 10 or more years older), 20 years after 
infection introduced. (B) HIV prevalence over time if all partnerships are 
formed between Individuals tne same age (grey line) or If 1% of 
Partnerships are formed between Individuals one year older or younger 
pad line), or If an intervention eliminates any non-peer-to-peer 
partnerships at year 20 (dashed line). (C) HIV prevalence over time for 15-
24-year-old males (black) and females (grey) If the proportion of cross-
|enerational partnerships is reduced from 20% to 5% at year 20 and if 
"lere is replacement wItn peer-to-peer partnerships (solid lines) or If there is 
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Figure 2 The Impact of delaying age at first sex on tfie heterosexual 
spread of HIV. (A) HIV Incidence ratio for women when age at first sex is 
delayed by two years for both sexes if males seek to maintain their current 
level of sexual activity and if mixing Is determined by males (black line), 
females (grey line) or Is an equal compromise (dashed line). (B) Relative 
lifetime risk of infection when age at first sex Is Increased from 16 years If 
males seek to maintain their number of sexual partnerships (black line) or If 
partnerships are not replaced (grey line) or if partnerships are not replaced 
and susceptibility to Infection decreases with age (dashed line). 
In rural Zimbabwe, the probability of reporting having used a 
condom consistently with their most recent sexual partner is 
particularly low for older men (25 years or older) but is higher if 
either the man or his partner has had many sexual partners 
(fig 3A). If condom use by older men is increased to the level 
currently reported by younger men, the lifetime risk of infection 
could be reduced by —20% for both males and females. This 
exceeds the impact of doubling condom use in the whole 
population or males and females delaying sexual debut by two 
years under the most optimistic assumptions (fig 3B). 
DISCUSSION 
Sexual behaviour change is crucial to prevent HIV infections in 
sub-Saharan Africa.^ Cross-sectional surveys of individuals' 
self-reported sexual behaviour show that young women who 
have had sex with an older man or begun sexual activity when 
young are more Ukely to have been infected with HIV.'^'" On 
this basis, interventions aiming to change behaviour have been 
proposed that focus on discouraging cross-generational sex and 
delaying sexual debut." " " Although it is clear that these 
changes will somewhat reduce the risk of infection to the 
individual it was not known what impact they could have on 
the spread of HIV through the population. Despite this 
uncertainty the importance of cross-generational sex in 
supporting high HIV prevalence has been presumed," and an 
increase in abstinence among young people has been partially 
zO 
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figure 3 The Impact of increasing condom use on the heterosexual 
spread of HIV. (A) The proportion of reported partnerships in which 
condoms were used in all sex acts, by the age of each parser and whether 
eiftier one of the partners reported having had six or more previous sexual 
partners (highly sexually active). (B) Relative lifetime risk or infection for 
males and females if (1) condom use among males older than 25 increases 
b the level reported by males under 25 (open bars), (2) condom use overall 
is doubled (grey bars). The horizontal grey shading gives the comparable 
range of effects that could be expectecTif age at first sex for males and 
females is increased by two years. 
credited with the decline in HIV prevalence rates in Uganda.^' " 
In this study we used a mathematical model to quantify the 
reduction in the average lifetime risk of HIV infection that 
reducing cross-generational sex and delaying first sex could 
bring. The model was carefully parameterised using detailed 
data from a rural district in eastern Zimbabwe" and we expect 
that the quahtative insights will be generalisable to other 
African settings with epidemics. 
Our model simulations suggest that HIV prevalence is only 
slightly higher with much more cross-generational mixing. 
Furthermore, even if 99% of sexual partnerships are formed 
between peers, HIV can still reach a high endemic level. This is 
contrary to the suggestion that without cross-generational 
nixing HIV could not persist endemically." Cross-generational 
% helps increase prevalence because few of the partnerships of 
infected older males are with older females who are already 
Key messages 
The impact of behaviour change on HIV spread is 
sensitive to the structure and reaction of the sexual 
network. 
Reducing cross-generational sex may have little effect on 
the risk of infection unless it is accompanied by a 
reduction in the number of risky sexual contacts. 
The benefit of delaying age at sexual debut is compara-
tively small and is reduced if males continue to prefer 
young partners or if young women spend more time 
unmarried. 
infected too and more will probably be with uninfected younger 
females. However, the link is not strong because the infection 
will reach all age groups eventually under almost any mixing 
scenario, and then young women will be exposed instead to the 
high rates of sexual activity of their male peers. Sex with older 
men is more risky than sex with younger men partly because of 
the greater possibility of the former to be infected with HIV, 
having been exposed to the risk of infection for longer. 
However, the observed gradient in HIV prevalence among 
males by age is partly a result of the cross-generational mixing; 
prevalence among young men is suppressed by cross-genera-
tional mixing because they have only limited access to their 
peers and instead have sex with even younger uninfected 
women or not at all. A switch to peer-to-peer mixing will 
increase prevalence among young men making, from a female 
perspective, formerly "low-risk" contacts increasingly "high 
risk". In this way, the benefit of peer-to-peer over cross-
generational mixing to the young women is negatively 
frequency dependent; one young woman will put herself at 
less risk by choosing partners her own age over older men but 
as more women come to do the same the benefit of this 
behaviour change is reduced as HIV prevalence among young 
men increases. 
The real impact of cross-generational sex on the population-
level spread of HIV is the power imbalance in those partner-
ships and the implications this has for the chance that condoms 
vwll be used.'^ " Our results show that behaviour change 
interventions should aim to minimise unprotected sexual 
contact by young women with anyone and should not target 
the age difference between sexual partners per se. Nonetheless, 
this pattern of partnership formation between older men and 
younger women does seem to underlie the high female-to-male 
HIV prevalence ratio among young people; the model generates 
ratios at least as extreme as those observed without assuming 
any difference in susceptibility to infection by sex or age. Cross-
generational mixing must be considered when examining other 
types of behavioural intervention; the demand for their sexual 
partnerships could undermine the benefit young women get 
from remaining abstinent for longer and the importance of 
transmission from older men makes the frequency with which 
they use condoms especially important. 
Abstinence (through delaying the onset of sexual activity) 
removes the risk of infection for only a few years—a small 
fraction of one's lifetime exposure. This period may be 
important because the first years of a woman's sexual activity 
may carry the greatest risk of transmission for a number of 
biological""'' and behavioural" reasons. However, even 
assuming that susceptibility declines strongly with age, the 
lifetime benefit of delaying sex for two years is expected to be, 
at most, only 8%. The benefit is smaller (3%) if the "demand" 
for their sexual partnerships is not reduced. Although 
www.stiiournal.com 
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abstinence undeniably reduces the risk of infection, its impact 
on the spread of HIV and the average chance of infection over a 
lifetime is small. It is probable, therefore, that the dramatic 
prevalence decline in Uganda" was primarily mediated through 
increased condom use and fidelity rather than the two-year 
delay in first sex that was also reported." 
In the coming years, ongoing and proposed behaviour 
interventions will be assessed and their potential effect 
estimated. This modelling work has highUghted the sensitivity 
of the efficacy of some behaviour changes to unknown 
properties of the sexual network (eg the response of males to 
female behaviour change) and projections should incorporate 
this uncertainty. 
From an individual-level perspective it is possible to identify 
those elements of sexual behaviour that are associated with the 
highest risk of infection. However, without a dynamic descrip-
tion of HIV transmission it is not clear how these changes will 
limit the spread of HIV at the population level. The chance of 
Infection is only partly determined by one's own sexual 
behaviour and interventions should not be narrowly targeted 
at particular at-risk groups (for example, young women) but 
instead should tackle risky behaviour throughout the sexual 
network. 
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Appropriate evaluation of HIV prevention interventions: from 
experiment to full-scale implementation 
Timothy B Hallett, Peter J White, Geoff P Garnett 
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Background: Preventing HIV infection is still an essential goal in tackling the HIV/AIDS pandemic. 
Remarkably little is known about hov/ best to reduce HIV incidence because most trials focus on the reduction 
of risk behaviours and assume an effect on HIV incidence. 
Objective: To discuss the evidence for the effectiveness of HIV prevention strategies, exploring the different 
types of evidence available: individual and community randomised controlled trials, and observational 
studies. 
Results; Although providing a gold standard for evidence, trials have been limited in their scope and are 
difficult to interpret and generalise. There have been examples of national level successes in preventing HIV 
which have been detected in sur/eillance data and understood through behavioural and modelling studies. 
These have the advantage of being to scale and indicating effectiveness rather than efficacy. 
Conclusions: Although randomised trials are important because of their scientific rigor, it is also important 
that evidence from observational epidemiology is not overlooked. Only if good quality, consistent data are 
available can the history of the HIV epidemic be appropriately analysed. 
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Substantial resources have been committed globally to the treatment and prevention of HIV and AIDS' and advances are being made in providing antiretroviral treatments in 
resource-poor settings.^ Such advances will be unsustainable 
without successes in HIV prevention.' However, remarkably 
little, is known about the effectiveness of preventive interven-
tions in reducing the incidence of HIV itself." In part, the 
"emergency" nature of the HIV epidemic has required 
implementation of interventions to run ahead of evidence of 
effectiveness. In plarming a response to the global pandemic 
assumptions have been made about what works, using limited 
evidence from theory, the measurement of processes or 
intermediate intervention outcomes, such as behaviour 
change.' 
Here we discuss how interventions have been evaluated and 
interpreted and the epidemiological and methodological issues 
that have been learned. National surveillance, with behavioural 
data collection as an adjunct, can provide the most powerful 
and relevant test of HIV interventions. 
INDIVIDUAL RANDOMISED CONTROLLED TRIALS 
The randomised controlled trial (RCT) provides the "gold 
standard" for testing the efficacy of medical interventions, 
providing a clear experimental design to demonstrate the 
presence or absence of an effect.' ' This study design works well 
when there is a straightforward replicable intervention linked 
to the disease outcome. 
The majority of RCTs in research on the prevention of HIV 
use outcome measures of risk behaviour rather than HIV 
incidence itself. This is appropriate for interventions aimed at 
HIV-positive individuals, which show decreased unprotected 
sex and sexually transmitted infections (STIs),® and when the 
STIs are themselves the outcome of interest.' It is less clear how 
useful intermediate outcomes are in other situations exploring 
the risks of HIV either in the individual or in the community, 
for example, a recent measure of an HIV intervention in a 
community in Uganda found that condom use increased and 
numbers of sex partners decreased.'" Many HIV intervention 
•rials have now been performed and are summarised in 
systematic reviews, but the focus has been on how to change 
lisk behaviour, with a concentration in the USA and on men 
who have sex with men,""''' and less emphasis on populations 
in developing countries" or on HIV incidence as an outcome. 
There are many reasons why interventions to prevent the 
spread of HIV are not always readily assessed in individual 
RCTs. 
• A key problem is the low incidence of HIV in many 
industrialised countries where intervention trials are well 
resourced. The adoption of intermediate outcomes such as 
increased condom use, reduced numbers of sexual partners 
or reduced incidence of other STIs is common. Data on self-
reported behaviour change may be unreliable. Even if the 
changes are genuine it is not clear that such changes will 
actually alter HIV incidence depending as they do on the 
epidemiological context.'' Changes in risk behaviour could be 
overwhelmed by high levels of exposure or could differen-
tially influence lower risk contacts. Even where HIV 
incidence is sufficiently high to measure without prohibi-
tively large sample sizes, the complexity and cost of 
measuring incident HIV infection has led to the use of proxy 
outcomes. 
• Interventions aimed at HIV prevention are often complex, 
requiring skilled staff to carry out counselling and education 
to motivate and facilitate the adoption of safer sexual 
behaviours. Difficulties in ensuring that interventions are 
appropriately implemented create uncertainty about nega-
tive trial results and concerns about replicating the inter-
vention outside the context of the trial. 
• Other HIV interventions are not amenable to individual 
randomisation if the focus is the group, community or 
population—for example, the use of mass media advertising 
or educational drama can only be dehvered to groups. 
• Conceptually, the focus on individuals may not be appro-
priate because individual behaviour is greatly affected by 
social and cultural norms, making interventions targeted 
only at selected individuals largely ineffective. This is 
particularly the case with sexual behaviour, which must 
Abbreviations: CRCT, community RCT; RCT, randomised controlled trial; 
STI, sexually transmitted infection 
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involve at least one other person. These norms vary between 
settings and through time within a setting, limiting the 
generalisability of RCT findings. 
The relationship between behaviour and risk of infection is 
complex and dynamic. An individual's risk of acquiring an 
infection depends not only on their behaviour but also on their 
position within the dynamic network of contacts through 
which infection spreads." This is particularly important in the 
case of STIs and HIV, in which there is extreme heterogeneity in 
individual sexual behaviours and hence in the risk of acquiring 
and transmitting infection, with a small group of individuals 
dominating the spread of infect ion . '^At a population level, 
the impact of an individual changing their number or choice of 
sexual partners or their treatment-seeking behaviour for STI 
symptoms, or the course of infectiousness over time, all depend 
on their role in the transmission dynamics of the infection." " 
COMMUNITY RCTS 
The failure of individual-level trials to determine the commu-
nity-level impact of interventions has led to a number of 
community RCTs (CRCTs) of HIV and STI interventions.""" In 
these, the intervention is targeted at communities which are 
randomised to treatment or control arms. Randomisation is 
used to distribute all the differences between the communities 
(known and unknown) evenly to both arms of the trial. The 
appropriate circumstances for a CRCT have been listed by 
Susser '^ as requiring: 
(1) a well-defined, narrow hypothesis, so that the key to the 
intervention success or failure can be identified; 
(2) a measurable intervention, to be able to assess its 
implementation; 
(3) adequate statistical power; and 
(4) well-defined, measurable outcomes. 
Unfortunately, the first three criteria are often absent in CRCTs 
aimed at preventing HIV. The complexity of HIV interventions 
and their deUvery can be a problem for CRCTs just as it can for 
individual RCTs, but CRCTs also suffer from their scale, which 
presents major challenges of logistics and resources, often 
leading to compromises in the numbers of communities 
randomised. Because health promotion builds over time as 
knowledge increases and cultural norms and practices change, 
it is possible that it will take some time for the interventions to 
impact on incident HIV. Furthermore, the effect of changes in 
one group can take time to percolate to the rest of the 
population (Hallett et al, submitted for publication). The 
extended follow-up period thus required increases the risks of 
study biases caused by poor follow-up rates, migration and 
changes in the background epidemiological context, such as 
epidemic maturation or an increase in the availability of 
antiretroviral therapy. 
The impact of STI control on HIV transmission has been a 
focus of CRCTs in the HIV field with conflicting results. In HIV 
epidemiology the question of whether the presence of another 
STI increased susceptibility to, or transmissibility of, HIV could 
not be answered using observational epidemiological studies. 
Other STIs and HIV have common risk factors which carmot be 
adequately controlled for by measuring their influence in 
individuals. The Mwanza trial of syndromic management of 
STIs, a ground-breaking study in 12 communities in Tanzania, 
found 40% lower HIV incidence in all six intervention 
communities compared with their matched control corrmiu-
nities." However, subsequent trials which have included mass 
sntibiotic administration aimed at controlling asymptomatic 
STIs (Rakai, Uganda'"), the use of syndromic management of 
STIs in one arm combined with information, education and 
"wv.stijournal.com 
communication in a third arm (Masaka, Uganda^') and the use 
of syndromic management combined with peer-led education 
targeting high-risk sexual behaviours (Manicaland, 
Zimbabawe") have all shown no population-level impact on 
the incidence of HIV infections, despite changing patterns of 
risk within the intervention communities. The last provides an 
interesting example, where the result could be overinterpreted 
in determining policy on how much STI control through 
syndromic management should be a part of HIV prevention, 
because bacterial STIs were already well controlled and the 
main focus of the study was the behavioural intervention. 
Interpreting positive CRCT results 
A positive result of a CRCT conclusively demonstrates that the 
intervention has worked in a particular setting. However, 
questions remain: 
• What are the necessary components of the intervention? 
• What quahty of intervention is required to maintain 
effectiveness in other settings? 
• How well can the intervention be scaled up to a wider 
population or to a national level? 
Essentially there is a problem translating the efficacy observed in 
trial conditions to effectiveness on a larger scale because 
interventions are often implemented less well when scaled-up 
(ie they can be less intensive, less carefully monitored and 
carried out in unselected populations with lower motivation). 
The costs of the intervention will probably be less outside the 
trial setting but at the same time this could compromise the 
effectiveness. In addition to problems of scale there is the 
question of whether the intervention will work in other 
epidemiological, social and cultural contexts. For example, the 
syndromic management of STIs significantly reduced HIV 
incidence in the Mwanza trial" but this result has not been 
reproduced in the other trials of STI control targeting HIV 
incidence. The influence of other STIs appears to be greatest in 
the early stages of an HIV epidemic when infection is 
concentrated in high-risk parts of the population and when 
the curable bacterial STIs are more important than infections 
such as genital herpes, which cannot be cured. 
Interpreting negative CRCT results 
Negative CRCT results are even more difficult to interpret. They 
tell us that the intervention, as implemented, did not produce 
significant results, but there are a number of potential 
explanations. The study may have been inadequately powered 
because sample-size calculations require knowledge of the 
variation of incidence between the populations studied, and 
accurate forecasts of future patterns of incidence without 
interventions (Hallett et al, submitted for publication). Because 
of the dynamic nature of epidemics such future patterns may 
not be consistent with past incidence rates, and variation in 
recorded prevalence at baseline may be a misleading proxy of 
variation in incidence. Implementation of the intervention may 
not have been adequate; however, because effectiveness is more 
important than efficacy, and as within intervention trials the 
interventions are likely to be more assiduously implemented 
than when scaled-up, this may seem a minor problem. 
Nonetheless, the complex nature of many interventions means 
that a failure of implementation rather than efficacy can be 
claimed and failing interventions be continued. More reason-
ably, the generalisability of the negative result to other 
epidemiological contexts can be debated. For individual RCTs, 
repetition of the trial in the same and in other contexts can 
eliminate doubts through comparison and meta-analyses of 
multiple trials. Unfortunately, these are not easily achieved 
with long and costly CRCTs. 
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OBSERVATIONAL STUDIES 
The urgency required in responding to the spread of a lethal 
infectious disease has led to many interventions being 
implemented before the evidence from trials has become 
available. In some cases where large-scale interventions have 
been implemented, associated observational epidemiological 
and behavioural studies have identified changes in HIV 
prevalence that can only be attributed to changes in HIV 
incidence and have been linked to changes in specific risk 
b e h a v i o u r s . S u c h observational studies have the advantage 
of assessing interventions at the regional or national scale. This 
immediately avoids many problems of trials, as the interven-
tions are already to scale and measure effectiveness. However, 
in the hierarchy of evidence, such observational epidemiology is 
considered to be weak. Biases such as changes in the 
representativeness of antenatal cUnics included in sentinel 
surveillance, changes in fertility due to HIV affecting data from 
antenatal clinics,'" trends unrelated to the interventions, and 
the natural dynamics of the incidence of STI and HIV can lead 
to spurious measures of success or failure. Nonetheless, if such 
biases can be predicted and measured their effects can be 
excluded" and powerful arguments of what works can be based 
on observational epidemiological data. 
In the late 1980s and early 1990s, in response to the high 
prevalence of HIV, the government of Uganda implemented an 
HFV prevention strategy acknowledging and promoting the 
discussion of HIV risks and advocating a reduction in sexual 
risk behaviour," The prevalence of infection was seen to decline 
in young women attending antenatal clinics. Cross-sectional 
population-based survey data showed decreases in reported 
numbers of sexual partners.^'" Such dechnes, particularly in 
those age groups too young to have had HIV-infected 
individuals removed by death or subfertility, could only be 
explained if HIV incidence had decUned and provided a much-
needed national level success story. Subsequent debate has 
continued over the cause of the success, with the neologism 
ABC—abstinence, be faithful, use condoms—bang introduced, 
and competing claims being made over the relative importance 
of condom use and abstinence." " A similar national level 
change in patterns of prevalence and incidence was achieved in 
Thailand. Here, studies that found sex work was the major 
focus of HIV transmission. This led to an intervention that both 
discouraged cUents from purchasing sex and encouraged 
universal condom use by sex workers. Behaviour change was 
observed—high rates of condom use among sex workers and 
decreased reported visits to sex workers—and was comple-
mented by biological outcomes: reduced incidence of sexually 
transmitted diseases and HIV infection in military recruits. At 
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the population level, this translated into reduced prevalence of 
HIV among women attending antenatal clinics in sentinel 
surveillance." " 
These two examples have had a profound influence on 
discussion of HIV prevention strategies, but they had not been 
repeated until recently. In the past years HIV prevalence has 
declined from very high levels in a few countries, including 
Zimbabwe and parts of urban Kenya." As in the case of 
Uganda, the current observations are of declines in HIV 
prevalence, a measure reflecting cumulative risk, rather than 
HIV incidence, which would provide more up-to-date informa-
tion. Care needs to be taken in analysing dechnes in prevalence 
because the natural pattern of incidence (ie without any 
behaviour change) in an epidemic is to increase until the at-risk 
population is saturated and then to decUne to a new lower level 
matching the supply of new susceptible individuals (fig 1)." 
Prevalence can then fall if HIV mortality associated with tlie 
earlier higher incidence exceeds the acquisition of new 
infections. Such a decline could be expected approximately a 
decade after the period of most rapid HIV spread. These natural 
dynamics need to be excluded as an explanation of decreases in 
HIV prevalence if we are to detect success in HIV control. The 
trends in prevalence observed in Zimbabwe and parts of urban 
Kenya were not reproduced by a "null model" of these natural 
dynamics." Observational studies exploring national reductions 
in HIV prevalence require mathematical models of the 
transmission dynamics of HIV to create a null model describing 
the trajectories of incidence and prevalence in the absence of 
the intervention. It is then possible to compare the observed 
data vrith this null model to estimate the impact of the 
intervention.^'"" " " Such analyses can give striking insights— 
for example, it was estimated that the decline in prevalence in 
Uganda was mediated by a reduction in incidence roughly 
equivalent to an 80% efficacious vaccine given to everyone in 
the population." 
The analyses of HIV trends in Zimbabwe and Kenya were 
restricted to those antenatal clinics sampled continuously over 
time. This will have hmited the extent to which the country's 
population is represented as such clinics are mostly located in 
urban centres. However, it avoids the artificial declines in 
prevalence that could be expected from the expansion of clinics 
to include those serving more rural populations over recent 
years. The requirement for settings with consistently sampled 
clinics will limit the number of places where prevalence trends 
can be explored. Another way of dealing with problem of 
sampling biases that change over time is to explicitly explore 
them. The comparison of random sample population-based 
surveys with sentinel surveillance data allows the identification 
y 0.05 o 20 
> 0.04 
0.03 
1985 1990 1995 2000 2005 2010 
Year 
Figure 1 Modelled HIV prevalence and 
incidence in a generalised epidemic 
assuming no behaviour change (solid line) 
and behaviour change amounting to a 50% 
reduction in the risk of infection. The timing 
of this behaviour change occurs in year 
1990, 1995 or 2000 (arrows). 
1980 1985 1990 1995 2000 2005 2010 
Year 
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of biases, which can then be included in mathematical models. 
For example, there is a concern that HIV-associated subfertility 
will increase over the course of an infection, thereby decreasing 
the proportion of HIV-infected women becoming pregnant as 
an epidemic ages. In mathematical models this effect is 
counteracted by the decreasing bias caused subfertility due to 
bacterial STIs, which becomes less important after HIV has 
spread beyond those most likely to have STIs and as HIV-
related mortality selectively removes such individuals from the 
population." 
Once we are confident that declines in HIV prevalence exceed 
those expected from the natural dynamics the obvious question 
is what has caused the declines. Questions of attribution are 
important as we need to know which risks are amenable to 
change and how they might be changed. There are two causal 
levels of interest: first, what change in the distribution of risk 
explains the reduction in HIV incidence, and second, can these 
changes in risk be attributed to particular interventions? 
Unfortunately, in Uganda there has been much scope for 
speculation and appropriation of the success story to support a 
priori beliefs because of the lack of representative, contempora-
neous and detailed risk-behavioural data. However, despite the 
lack of behavioural data it is possible to draw some conclusions 
from the observed pattern of prevalence decline. Fitting a model 
to the decline in Kampala shows that the reduction in 
aggregate risk must have begun during the late 1980s (fig 2), 
which indicates it probably was not driven by the increased use 
of socially marketed condoms that happened later." " On the 
other hand, it seems that the dramatic turnaround would not 
have been possible without all three types of behaviour change 
across the population—that is, delaying commencing sexual 
activity by two years, lowering partner change rates and 
increasing condom use^* (fig 2). 
In Zimbabwe the situation is clearer because the observed 
national-level decline in HIV prevalence" coincided with 
population-based surveys of sexual behaviour in the rural 
eastern highlands^' and observed reductions in incidence 
among postnatal women and male factory workers in the 
urban population." The former suggested that in these rural 
communities declines in numbers of sexual partners and an 
increase in age of sexual debut were associated with the 
dianging incidence, but the latter observed that an increase in 
40 r -
I ' ' I I I 
"ABC" 
1975 1980 1985 1990 1995 2000 2005 
[igure 2 The epidemic in Kampala, Uganda, and the effect of "ABC" 
interventions. HIV epidemic model fitted (line "ABC") to antenatal clinic 
HIV prevalence estimates (black bars with 95% CI). (Source: US Census 
'ureau.^') Also shown are epidemic projections assuming no behavioural 
tliange (—line), increases in condom use (line "C" ) , and increase in 
random use and two-year average delay in first sex (line "AC" ) , 
porameterised according to observed behaviour change." The horizontal 
"kslied line shows peak prevalence and is for ease of reading. 
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condom use was associated with changes in risk in Harare. 
Behavioural data can be used to identify the components 
leading to HIV declines when the observed behaviour changes 
can have a direct influence on the risk of acquisition and 
transmission of HIV and other similar risk behaviours have not 
changed. Only if the proximate determinants of HIV infection 
change can interventions alter the course of the HIV epidemic. 
The proximate determinants of HIV incidence are those factors 
influencing": 
• exposure of uninfected individuals to HIV-positive indivi-
duals; 
• transmission probability of the virus when such exposure 
occurs; and 
• duration of infectiousness of HIV-positive individuals. 
Social, demographic, economic, and other, factors that affect 
HIV incidence ultimately act through their effect on these 
proximate determinants. 
Beyond attributing reduced HIV incidence to particular 
behaviour changes, relating those behaviour changes to 
particular interventions requires data measuring exposure to 
the interventions, perceived responses to those interventions, 
and plausible mechanisms hnking the interventions and the 
observed changes. Such attribution will always be weak if there 
are multiple interventions and societal changes. A failure to 
change risk over the long term may be indicative of unsuccess-
ful interventions, but behaviour change that is consistent with 
an intervention's goals suggests that the intervention has 
worked and that the replication and expansion of the 
approaches taken might be warranted. Too often such evidence 
is ignored because it does not meet the requirements of 
"rigorous" evaluation. Although observed trends in risks within 
populations do not provide definitive evidence of the failure or 
success of an intervention generally, the same is true for CRCTs 
where results from trials of interventions designed to target 
specific groups or behaviours cannot be generalised. 
Use of national-level surveillance data is not suitable for all 
epidemiological questions. It would not be possible to resolve 
the difference between the natural, intrinsic course of the 
epidemic from an epidemic where extrinsic changes alter the 
course of a growing epidemic (ie when incidence has not 
already reached a peak) because patterns of risk cannot be 
adequately assessed in order to predict the peak prevalence. If 
behaviour changes before the incidence saturates, then the 
epidemic will settle to a lower level than it would have 
otherwise but the decline in prevalence will look like the 
natural dynamics only, leading to the erroneous conclusion that 
behaviour has not changed (fig 1). 
Another problem is the ability of surveys of risk behaviour to 
capture the details of sexual behaviour necessary to accurately 
assess the potential for epidemic spread. The distribution of 
numbers of sexual partners, the pattern of sexual partner 
choice, the overlap between sexual partners, and the number 
and type of sex acts within partnerships, all influence the 
acquisition and transmission of HIV and many advances in 
study design have improved our ability to measure such detail. 
However, some uncertainty is inevitable. Details about the 
sexual contacts of one's sexual contacts cannot be measured in 
ordinary population-based surveys. In addition, as the highest-
risk individuals are typically a small proportion of the 
population—and may be under-represented in household 
surveys (eg sex workers, injecting drug users)—it is difficult 
to obtain reUable estimates of their behaviour although they 
contribute disproportionately to the transmission. This matters 
if declines in HIV incidence are not explained in surveys or if 
observed changes are insufficient to explain the magnitude of 
declines. However, it is unlikely that less-obvious changes in 
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Key messages 
Demonstrating that an intervention is successful at 
changing individual sexual behaviour does not necessa-
rily mean it is effective at reducing the transmission of 
sexually transmitted infections. 
Community randomised controlled trials are the best 
standard of evidence of the effectiveness of an interven-
tion but questions remain about impact on a larger scale, 
and how strongly study design influences whether there is 
a significant beneficial outcome. 
High-quality sentinel surveillance data in conjunction with 
behavioural and modelling studies can be used to assess 
the effectiveness of scaled-up interventions. 
behaviour will explain dramatic decreases in HIV incidence, 
especially as surveys are well designed, with reasonably large 
sample sizes. 
The expansion in funding for HIV prevention activities 
associated with the creation of the Global Fund for AIDS, 
Tuberculosis and Malaria''" and the (US) President's Emergency 
Plan for AIDS Relief (PEPFAR)'" and associated increases in 
representative HIV surveillance and behaviour data from 
sentinel sites and from Demographic and Health Surveys with 
HIV serological surveys {DHS+) has increased both the 
imperative and the opportunities for testing the large-scale 
success of interventions. Large-scale interventions must be 
associated with the collection of sufficiently detailed data to 
allow their evaluation using mathematical models to determine 
the magnitude of their impact and for its attribution to 
different components of the intervention. DHS4- and second-
generation surveillance data'*^  should be explored to determine 
whether it is possible to link behaviour change to particular 
interventions. The above-described methods using observa-
tional studies in conjunction with mathematical models have 
the advantage of exploring the actual implementation of 
interventions at the scale of interest, and, if performed 
rigorously, provide a set of tools for epidemiology and the 
development of health policy. 
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Age at First Sex and HIV Infection 
in Rural Zimbabwe 
Timothy B. Hallett, James J.C. Lewis, Ben A. Lopman, Constance A. Nyamukapa, 
Phyllis Mushati, Mainford Wambe, Geoff P. Garnett, and Simon Gregson 
Beginning sexual activity introduces an individual to the risk of acquiring sexually transmitted 
infections. In this study, cross-sectional behavioral data linked to HlV-status from 4,138 men 
and 4,948 women interviewed in rural Zimbabwe are analyzed to investigate the distribution and 
consequences of early first sex. We find that age at first sex (at a median age of 19 years for males and 
18 years for females) has declined among males over the past 30 years but increased recently among 
females. Those in unskilled employment, those not associated with a church, and women without a 
primary education begin to have sex earlier than others. Early sexual debut before marriage precedes 
a lifetime of greater sexual activity but with more consistent condom use. Women who begin to 
have sex earlier than others of their age are more likely to be infected with HIV. This finding can be 
explained by their having a greater lifetime number of sexual partners than those whose first sexual 
experience occurs later. (STUDIES IN FAMILY PLANNING 2007 ; 38[1]: 1 - 1 0 ) 
The age at which individuals become sexually active 
has been associated with a number of important demo-
graphic and sociological outcomes. For example, age at 
first sex has been shown to be a primary determinant of 
fertility (Bongaarts and Potter 1983). An increasing aver-
age age at first sex may indicate higher female status and 
autonomy (Dyson and Moore 1983), whereas beginning 
sexual activity early is associated with dropping out of 
school prematurely, early marriage and pregnancy, and 
a resulting reduction in future life opportunities (Blanc 
2000). The timing of sexual debut also has consequences 
for risk of infection with HIV and other sexually trans-
mitted infections (STls). One reason early onset of sexual 
activity is a risk factor for acquiring an STI is that the pe-
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riod of potential exposure to infection is longer. Addition-
ally, for young women, physiological and immunological 
immaturity of the female genital tract may increase sus-
ceptibility (Duncan et al. 1990; Moss et al. 1991; Royce et 
al. 1997; Glynn et al. 2001; Drain et al. 2004; Pettifor et al. 
2004; Kaestle et al. 2005). Furthermore, young girls who 
have sex with older men are unlikely to be able to insist 
on the use of condoms (Gregson et al. 2002a; Luke and 
Kurz 2002; Longfield et al. 2004). For these reasons, en-
couraging young people to delay the onset of sexual ac-
tivity has been an objective of the United Nations since 
1994 (as expressed in the Programme of Action recom-
mended at the United Nations International Conference 
on Population and Development [ICPD] held in Cairo) 
and has been made a key objective of the (United States) 
President's Emergency Plan for AIDS Relief (PEPFAR) 
(Laga et al. 2001; Office of the United States Global AIDS 
Coordinator 2004; UN AIDS 2004). 
Developing an appropriate psychosocial program 
aimed at persuading individuals to delay first sex re-
quires a detailed understanding of the influences and 
motivations for beginning sexual activity. Identifying 
the characteristics of young people who are likely to start 
having sex early could help to improve the targeting of 
such a program. In developed countries, many socioeco-
nomic variables have been shown to be associated with 
the timing of sexual debut Qohnson et al. 1994; Laumann 
et al. 1994; Spira et al. 1994). In many parts of Africa, 
young women commonly exchange sex with older men 
("sugar daddies") for goods (Gregson et al. 2002a; Luke 
and Kurz 2002); an obvious root cause of this behavior 
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is poverty (Longfield et al. 2004). In sub-Saharan Africa, 
men and women who are more educated tend to delay 
sexual initiation longer than others (Gupta and Mahy 
2003), and the most educated individuals are considered 
to be more likely than others to change their behavior 
in response to the HIV/AIDS pandemic (Gregson et al. 
2001). Knowledge of the risk of acquiring HIV / AIDS may 
also deter individuals from initiating sexual activity. Re-
productive practices have also been linked to exposure 
to family planning messages presented through the mass 
media (Adamchak and Mbizvo 1991). 
Although delaying sexual debut would reduce an in-
dividual's risk of becoming infected if no other aspect of 
her or his sexual behavior changed, studies based on the 
application of mathematical models (Hallett et al. 2007) 
suggest that the impact on the spread of HIV of delaying 
first sex may be small unless delaying sex also translates 
into reduced sexual activity later in life. In this study, we 
examine the trends in and determinants of age at first sex 
in Zimbabwe, where fertility has declined steadily since 
the mid-1980s (CSO and Macro International 2000) fol-
lowing the socioeconomic development associated with 
achieving independence in 1980, Zimbabweans' concomi-
tant increased access to secondary education (UNDP 2000), 
and the relentless spread of the HIV pandemic (UNAIDS 
2005; UNAIDS/WHO 2005). We address four questions 
about the age of sexual debut in Zimbabwe: (1) Has the 
average age of sexual debut changed recently? (2) Which 
groups of young people are likely to begin to have sex ear-
lier than others? (3) Do individuals who begin to have sex 
early go on to be more sexually active than others? (4) Are 
individuals who become sexually active at an early age 
more likely than others to become infected with HIV? 
known households in the study areas. One man or wom-
an from each married couple in a household was invited 
to participate in the survey. In total, 4,331 men aged 17-54 
and 5,149 women aged 15-44 agreed to participate (77 
percent of those eligible). 
Structured interviews were conducted face to face 
by trained social science graduates familiar with the lo-
cal culture but from outside the study area. The ques-
tion about the age at which the subject first had sex came 
midway through the interview and after an informal 
discussion designed to build rapport between the inter-
viewer and the subject. Responses to sensitive questions 
about sexual behavior were recorded using an informal 
confidential voting interview (ICVI) method in 75 per-
cent of the interviews with literate respondents (selected 
at random) (Gregson et al. 2002b). By this method, the 
participant writes his or her responses to certain ques-
tions on a card so that the interviewer cannot read them 
and deposits them in a locked box. Interviews using this 
method have been shown to elicit from respondents re-
ports of having more sexual partners than are reported 
in interviews conducted using other methods, suggest-
ing that data collected in this way may be subject to less 
sodal-desirability bias. 
Written informed consent was sought as a condition 
of enrollment, and free voluntary HIV counseling and test-
ing and free STI treatment were made available in each 
study area. Prior ethical approval for the study was ob-
tained from the Research Council of Zimbabwe and from 
the Applied and Qualitative Research Ethics Committee 
in Oxford, UK. Custom-made forms in SPSS-PC version 
5.0 software were used for data entry and validation, and 
STATA version 8.0 software was used for data analysis. 
Methods 
Analyzing trends in sexual debut, including the associa-
tion between age at first sex and personal characteristics, 
and the relationships between age at first sex and (a) 
subsequent sexual behavior and (b) the risk of acquiring 
HIV infection requires gathering sensitive information 
about sexual behavior, linked HIV-test results, and other 
potentially correlated social, economic, and geographic 
variables. Such detailed data were collected in a strati-
fied population-based survey carried out in the Manica-
land province of rural Zimbabwe between July 1998 and 
January 2000. The population strata comprised 12 dis-
tinct communities: two forestry plantations, two tea and 
coffee estates, four subsistence farming areas, two small 
towns, and two roadside trading centers. A preliminary 
household census enumerated 8,233 (98 percent) of 8,386 
Trends in Age at First Sex 
Quartiles of reported age at first sex are reported by re-
spondents' age category, and Mantel-Haenszel estimates 
of the rate ratio of having first sex are calculated with 
reference to the oldest age group (40^4 for females and 
45-54 for males). Because older cohorts were at risk of ex-
periencing sex before younger cohorts, this method can 
be used to estimate the trend in the "hazard" of first sex 
over the past 30 years. The hazard is the chance that an in-
dividual has experienced first sex at age A, given that he 
or she had not had sex before their A* birthday. The ratio 
of hazard between cohorts is assumed to be constant. 
Personal Characteristics Associated with Timing 
of First Sex 
We treat age at first sex as time-to-event data to allow for 
first sex being censored (that is, the event—first sex— 
2 Studies in Family Planning 
may not have occurred by the time of the survey). In the 
model, individuals are born as virgins and "survive" 
until they first have sex. The eventual age at first sex of 
individuals who were not sexually experienced at the 
time of the survey is said to be "censored." Because indi-
viduals were recruited for the study before anything was 
known of their sexual history, censoring is independent 
with respect to the outcome of interest. The analysis of 
the personal characteristics associated with age at sexual 
debut is restricted to those younger than 25 because the 
responses of older individuals may not be representative 
of their characteristics at the time of sexual debut (for ex-
ample, the respondent's current level of wealth may not 
correspond to his or her wealth at the time of first sex). 
We expected that the factors associated with first sex 
for males and for females would differ (Paul et al. 2000; 
Gupta and Mahy 2003). Therefore, we analyzed data for 
males and females separately throughout. Individuals 
whose reported age, date of birth, and / or age at first sex 
were inconsistent were excluded. 
Mantel-Cox Hazard Ratios were used in the prelimi-
nary imivariate analyses. Mantel-Cox tests (log-rank 
tests) were performed for each comparison. Multivari-
ate analyses used the Cox Proportional-Hazards Model, 
and the Breslow method was used for ties. A multivariate 
model was found by means of backward stepwise elimi-
nation using the likelihood-ratio test (psO.05) for exclu-
sion. The scaled Schoenfeld Residuals from the multi-
variate model were tested for trend with age, and those 
variables that did not conform to the proportional-hazard 
assumption were broken down so that effect of "exposure 
X" was replaced with "exposure X for individuals aged 
0-yrj" and "exposure X for individuals aged yr^-24." The 
cutoff point (yr^) was chosen after examination of the haz-
ard profile. 
Age at First Sex and Sexual Behavior 
To explore how age at first sex is related to subsequent 
sexual behavior, logistic and linear regression models 
were constructed for which the outcome variable was 
sexual behavior and the explanatory variables were 
young-age-at-first-sex (younger than 18 years) and age 
(continuous variable). The sexual behavior variables were 
as follows: number of lifetime partners, number of cur-
rent sexual relationships, number of sexual partners in 
the past month, number of sex acts in the past two weeks 
(all continuous variables), consistent condom use in the 
past two weeks (dichotomous variable, recorded as posi-
tive if the respondent reported that a condom was used in 
each sexual encounter), and ever divorced (dichotomous 
variable). The analysis was stratified by whether the first 
sexual experience occurred within the first marriage (or 
long-term cohabiting relationship). 
Age at First Sex and HIV Status 
Logistic regression was used to assess the association be-
tween HIV serostatus (outcome variable) and age at first 
sex for those who had experienced sexual activity (ex-
planatory variable). Adjustment was made for the length 
of time an individual had been sexually active and his or 
her lifetime number of sexual partners. All explanatory 
variables were divided into quartiles. 
Results 
Respondents were asked at what age they first had sex 
(they were given the option of responding that they had 
not yet had sex). Forty-nine males (1 percent) and 20 fe-
males (0.4 percent) did not answer this question. Of those 
who responded, 142 males (3 percent) and 180 females (4 
percent) were excluded because information they gave 
about their age and their age at first sex were inconsistent. 
In total, data from 4,138 males and 4,948 females were 
analyzed, of whom 83 percent of males and 81 percent of 
females reported that they had begun sexual activity. For 
7 percent of men and 71 percent of women, age at first sex 
coincided with their age when they first entered a long-
term or cohabiting relationship or married. 
Overall, females began sexual activity before males; 
median age at first sex was 18 years for females and 19 
years for males (see Table 1 and Figure 1) (the log-rank 
test for equality of survivorship functions: - 32.32,1 df, 
p<0.0001). Over the past 30 years, males have been ear-
lier in starting to have sex (the log-rank test for trend; 
= 64.11,1 df, p<0.0001). Although average age at first sex 
for females has not changed over the past 20 years, it may 
have increased in recent years (log-rarJc test for trend for 
all ages: %^=5.53,1 df, p<0.019). 
Determinants of Age at First Sex 
Of those aged 24 or younger at the time of the interview, 
2,113 males and 2,164 females gave consistent responses 
to questions about age at first sex. Sixty-nine percent of 
men and 58 percent of women reported having begun 
sexual activity. 
Males 
As shown in Table 2, univariate tests suggest that the haz-
ard of having experienced first sex was significantly high-
er for males who live on agricultural estates, in towns, 
and in roadside trading centers, for those who watch tele-
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Table 1 Percentage distribution of respondents surveyed, age at first sex by quartile, and Mantei-Haenszel estimate of rate ratio 
of liaving experienced first sex, by age group and sex, rural Manicaiand province, Zimbabwe, 1998-2000 
Age 
Year when mean age 
of respondents was 20 Percent 
Age by which respondents experienced first sex 
(N) 25 percent 50 percent 75 percent 
Rate ratio of 
first sex 
Males 
17-19 2000 23 (953) 16 18 — • 1.65*" 
20-24 1998 26 (1,060) 16 18 20 1.89"* 
25-29 1991 18 (755) 17 19 21 1,53"" 
30-34 1986 10 (432) 17 19 21 1.51*" 
35-39 1981 9 (354) 17 19 21 1.52"* 
40-44 1976 6 (249) 18 19 22 1.25* 
45-54 (r) 1969 8 (337) 18 20 23 1.00 
Total 
-
100 (4,140) 17 19 21 
-
Females 
15-19 2001 24 (1,177) 17 — • 0.77** 
20-24 1996 20 (987) 17 18 20 1.08 
25-29 1991 17 (836) 17 19 20 1.02 
30-34 1986 13 (642) 17 18 20 0.93 
35-39 1981 13 (646) 16 18 20 1.20* 
40-44 (r) 1976 13 (661) 17 19 20 1.00 
Total 
-
100 (4,949) 17 18 20 
-
•Significant at psO.05; "psO.01; ***ps0.001. (r) = Reference category. — = Not applicable. 
•For age groups in which fewer than 75 percent or 50 percent of respondents have become sexually active, no value is given. 
vision every week, who belong to a traditional church or 
no church, and for those who belong to a minority tribe 
or have relocated from a rural area. The hazard of having 
experienced first sex was lower for males who have com-
pleted primary education, who were students or were 
unemployed, and for those who possess above-average 
knowledge of HIV/AIDS. Only "church," "tribe," and 
"employment status" were retained by the multivariate 
model selection process. Those respondents belonging 
to traditional churches or to one of the minority "otiier" 
tribes had a significantly greater hazard of having had 
first sex, whereas students and the unemployed had a 
significantly lower hazard of having had first sex. The 
Figure 1 Kaplan-Meier estimates of survival until first sex 
for females and males, rural Manicaiand province, Zimbabwe, 










multivariate model conforms to the proportional-haz-
ards assumption (the test for trend in scaled Schoenfeld 
residuals: x^= 12.32,14 df, p = 0.5805). 
Females 
As shown in Table 3, univariate tests suggest that the haz-
ard of having experienced first sex was higher for females 
who live in towns, who belong to a traditional church or 
no church, or one of the "other" smaller churches, who 
belong to the Zezuru tribe or to one of the minority tribes, 
or who have relocated from either an urban or a rural 
area. The hazard of having experienced first sex was low-
er for females who are literate, who have completed pri-
mary education, who are professionals or skilled workers, 
who are unemployed or are students, who have above-
average knowledge of HIV/AIDS, who read the news at 
least once a week, who watch television every week, who 
listen to the radio every day, or who live in a household 
that has a radio or in a dwelling with a cement floor. Five 
variables remained after the multivariate model selec-
tion process: "completion of primary education," "em-
ployment status," "listening to radio every day," "tribe," 
and "relocation." The hazard ratio of the variable "com-
pleted primary education" was not constant over age, so 
it was calculated separately for females aged 15-19 and 
20-24. Having completed primary education was signifi-
cantly associated with a lower hazard of having experi-
enced first sex only for females in the younger age group. 
Skilled or professional females, students, and those who 
listen to the radio every day had a lower hazard of having 
had first sex. Members of the minority tribes, those who 
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Table 2 Percentage distribution, median age at, and hazard 
ratio for first sex for males, by selected explanatory variables, 
rural Manicaland province, Zimbabwe, 1998-2000 












Agricultural estate 37 (746) 18 1.24"" -
Subsistence farm (r) 32 (635) 19 1.00 -
Town 16 (320) 18 1.44"* -
Roadside 15 (312) 18 1.26" -
Total 100 (2,013) 18 
- -
Literate 
No (r) 3 (63) 18 1.00 -
Yes 97 (1,937) 18 0,75 — 
Total 100 (2,000) 18 - -
Completed primary 
education 
No(r) 19 (379) 18 1.00 -
Yes 81 (1,634) 18 0.84* -
Total 100 (2,013) 18 
- -
Employment status 
Professional or skilled 7 (146) 18 0.91 0.93 
Manual (r) 49 (966) 18 1.00 -
Unemployed 27 (528) 18 0.79** 0.86* 
Student 17 (336) 20 0.54*** 0.61*" 
Total 100 (1,976) 18 
- -
AIDS knowledge 
Below average (r) 42 (821) 18 1.00 -
Above average 58 (1,144) 18 0.86* -
Total 100 (1,965) 18 
- -
Reads news once a week 
No (r) 61 (1,207) 18 1.00 -
Yes 39 (757) 18 1.06 -
Total 100 (1,964) 18 - -
Watches television every 
week 
No(r) 69 (1,377) 18 1.00 -
Yes 31 (629) 18 1.16* — 
Total 100 (2,006) 18 
- -
Listens to radio every day 
No(r) 37 (742) 18 1.00 -
Yes 63 (1,267) 18 1.04 -
Total 100 (2,009) 18 
- -
Church 
Traditional 11 (229) 18 1.58"* 1.39" 
Methodist 7 (131) 19 0.94 0.96 
Anglican (r) 25 (497) 18 1.00 -
Roman Catholic 16 (322) 18 1.07 1.03 
Apostolic 2 (43) 19 1.07 0.99 
None 10 (201) 18 1.30* 1.21 
Other 29 (590) 18 0.98 0.97 
Total 100 (2,013) 18 
- • -
Tribe 
Karanga 5 (105) 18 1.00 0.95 
Manyika (r) 57 (1,137) 18 1.00 
Maungwe 16 (329) 18 1.02 1.08 
Ndau 8 (160) 18 0.92 0.87 
Zezuru 5 (101) 18 1.29 1.23 
Other 9 (173) 17 1.46** 1.25* 
Total 100 (2,005) 18 
- -
Household has radio 
No (r) 41 (793) 18 1.00 -
Yes 59 (1,154) 18 1.03 -









hazard ratio hazard ratio 
(univariate (multivariate 
test) test) 
House has cement floor 
No (r) 17 (338) 18 1.00 -
Yes 83 (1,601) 18 1.00 -
Total 100 (1,939) 18 
— — 
Residence tiistory 
In survey location 
since birth (r) 49 (977) 18 1.00 -
Previously in urban area 11 (219) 18 1.23 -
Previously in rural area 40 (796) 18 1.20** -
Total 100 (1,992) 18 
— — 
(continued) 
"Significant at psO.05; "psO.01; '"psO.OOl. (r) = Reference category. 
— = Not applicable. 
Note: Hazard ratios greater than one convey that the age at first sex is younger 
than the age at first sex for the reference category. 
do not belong to a church, and those who have relocated 
from urban and from rural areas had a higher hazard 
of having experienced first sex. The multivariate model 
conformed to the proportional-hazards assumption (the 
test for trend in scaled Schoenfeld residuals: = 22.26, 
13 df ,p = 0.0515). 
Association between Age at First Sex and Sexual 
Behavior 
Males who began to have sex outside of marriage before 
they were 18 tended to have more lifetime sexual part-
ners, to have more sexual partners in the past month, to 
engage in more acts of sexual intercourse in the past two 
weeks, and to be involved in more sexual relationships 
at the time of the interview (as shown in Table 4). Males 
who began to have sex just as early but did so within their 
first marriage did not go on to engage in riskier sexual 
behavior than males who started to have sex when they 
were older. Females who began to have sex early tended 
to be more sexually active than those who started to have 
sex later, and this association was stronger for females en-
gaging in premarital sex. Males and females who had first 
sex early and outside of marriage, however, were more 
likely to use condoms consistently thereafter. 
Age at First Sex and HIV Infection 
According to a univariate analysis for which results were 
adjusted for years of sexual activity, females who began 
to have sex when they were 12 to 16 were more likely to 
be infected with HIV than those who began at age 21 or 
later. When number of lifetime sexual partners was taken 
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Table 3 Percentage distribution, median age at, and 
hazard ratio for first sex for females, by selected explanatory 
variables, rural Manicaland province, Zimbabwe, 1998-2000 
Mantel-Cox Adjusted 
Median hazard ratio hazard ratio 
Per- age at (univariate (multivariate 
Variable cent (N) first sex test) test) 
Table 3 (continued) 
Residence 
Agricultural estate 28 (611) 18 1.18 -
Subsistence farm (r) 37 (808) 19 1.00 -
Town 16 (343) 18 1.28* -
Roadside 19 (402) 19 0.92 -
Total 100 (2,164) 19 
— -
Literate 
No (r) 2 (52) 18 1.00 — 
Yes 98 (2,097) 19 0.50*** -




No (r) 26 (557) 17 1.00 
Yes 74 (1,607) 19 0.41*** -
15-19 years' - ' - = — ' - 0.70"*' 
20-24 years' - • - 1.10 
Total 100 (2,164) 19 
— -
Employment status 
Professional or skilled 2 (39) 20 0.34**" 0.50*' 
Manual (r) 33 (694) 18 1.00 1.00 
Unemployed 43 (919) 18 0.85* 0.90 
Student 22 (475) — • 0.11*** 0.20*" 
Total 100 (2,127) 18 
- -
AIDS knowledge 
Below average (r) 44 (918) 18 1.00 -
Above average 56 (1,175) 19 0.80** — 
Total 100 (2,093) 18 
- -
Reads news once a week 
No(r) 76 (1,617) 18 1.00 -
Yes 24 (514) 19 0.62*** -
Total 100 (2,131) 19 
- -
Watches television every 
week 
No(r) 87 (1,875) 18 1.00 — 
Yes 13 (288) 19 0.64*" -
Total 100 (2,163) 19 
- -
Listens to radio every day 
No (r) 59 (1,275) 18 1.00 — 
Yes 41 (881) 19 0.70"' 0.80** 
Total 100 (2,156) 19 
- -
Church 
Traditional 3 (57) 17 2.56*" -
IVlethodist 10 (212) 19 0.96 — 
Anglican (r) 28 (602) 19 1.00 
— 
Roman Catholic 17 (375) 19 1.07 — 
Apostolic 2 (36) 18 1.50 -
None 4 (89) 18 2.30*** — 
Other 37 (793) 18 1.35" — 
Total 100 (2,164) 19 
- -
Tribe 
Karanga 4 (97) 19 1.32 1.10 
Manyika (r) 55 (1,187) 19 1.00 -
Maungwe 19 (418) 19 1.07 1.10 
Ndau 3 (74) 18 1.14 0.90 
Zezuru 8 (181) 18 1.43" 1.10 
Other 9 (200) 18 2.16*" 1.50"* 
Total 100 (2,157) 18 
- -
Household has radio 
No(r) 45 (937) 17 1.00 -
Yes 55 (1,160) 17 0.72*** — 






Median hazard ratio hazard ratio 
age at (univariate (multivariate 
first sex test) test) 
House had cement floor 
No (r) 16 (339) 16 1.00 — 
Yes 84 (1,760) 17 0.62*** — 
Total 100 (2,099) 17 — — 
Residence history 
In survey location 
since birth (r) 46 (979) 18 1.00 — 
Previously urban area 17 (359) 17 1.56*" 1.30*' 
Previously rural area 38 (805) 16 2.00*** 1.40*" 
Total 100 (2,143) 17 
— 
-
'Significant at psO.05; "psO.01; "*ps0.001. (r) = Reference category. 
— = Not applicable. 
'For age groups in which fewer than 75 percent or 50 percent of respondents have 
become sexually active, no value is given. 
Note: Hazard ratios greater than one convey that the age at first sex is younger 
than the age at first sex for the reference category. 
Table 4 Coefficients from regressions of early first sex on 
the association between various sexual-behavior outcomes, 
rural Manicaland province, Zimbabwe, 1998-2000 
Variable 
Regression coefficient: 
first sex prior to age 18" 
tVlales whose first sex was within marriage' 
(population: 7 percent of sexually experienced males) 
Lifetime partners' 
Lifetime partners adjusted for years of sexual activity 
Number of partners in past month" 
Number of sex acts in past two weel<s= 
Number of cunent sexual relationships' 
Consistent condom use past two weeks' 
Divorced" 
Males whose first sex was before marriage'" 
(population: 93 percent of sexually experienced males) 
Lifetime partners" 
Lifetime partners adjusted for years of sexual activity' 
Number of partners in past month' 
Number of sex acts in past two weeks' 
Number of current sexual relationships' 
Consistent condom use past two weeks' 
Divorced" 
Females whose first sex was within marriage' 
(population: 67 percent of sexually experienced females) 
Lifetime partners' 
Lifetime partners adjusted for years of sexual activity 
Number of partners in past month' 
Number of sex acts in past two weeks' 
Number of cuffent sexual relationships' 
Consistent condom use past two weeks" 
Divorced" 
Females whose first sex was before marriage" 
(population: 33 percent of sexually experienced females) 
Lifetime partners' 
Lifetime partners adjusted for years of sexual activity 
Number of partners in past month' 
Number of sex acts in past two weeks' 
Number of current sexual relationships' 































'Significant at ps0.05; "psO.01; ""psO.001. 
'"First sex at younger age than 18" is the explanatory variable used in the regres-
sion model; it is adjusted for age category. A positive value implies that eariy first 
sex is associated with a higher value of the sexual-behavioral outcome variable 
or is affirmative for a dicholomous variable. " The term "marriage," as used here, 
includes long-term cohabiting relationships. ' A linear model is used for this 
continuous variable. " A logistic model is used for this dicholomous variable. 
6 Studies in Family Planning 
Table 5 Odds ratios of having acquired HIV infection, by age at first sex for males and females, rural Manicaland province, 
Zimbabwe, 1998-2000 
Multivariate test 
A g e at f i rst sex Percent of sample 
Univariate test 
Odds ratio p -va iue 
Odds ratio 
adjusted for years 
of sexual activity p-value 
Odds ratio 
adjusted for number 
of l ifetime partners p-value 
Mates 
1 2 - 1 6 27 0.75 0 .02 0.79 0.07 0 .59 0.07 
1 7 - 1 8 30 0.96 0.71 1.11 0.38 0.82 0.10 
1 9 - 2 0 22 1.18 0.17 1.30 0.17 1.07 0.13 







1 2 - 1 6 27 1.49 0.00 1.60 0.00 1.14 0.23 
1 7 - 1 8 30 1.07 0.55 1.11 0.32 0.94 0.55 
1 9 - 2 0 22 1.18 0.12 1.23 0,06 1.11 0.37 




(r) = Reference category. — = Not applicable. 
into account, however, no statistically significant associa-
tion was found (see Table 5). Males who began to have 
sex when they were young were less likely than others to 
be infected with HIV. 
Discussion 
In rural Zimbabwe, we found a median age of sexual de-
but of 18 years for women and 19 years for men, medians 
that lie in the middle of international estimates (Singh 
et al. 2000) but are relatively high for African countries 
(Zaba et al. 2004). Thus, the magnitude of the HIV epi-
demic in this rural population—the prevalence at the 
time of the survey was 19 percent among males aged 17-
54 and 26 percent among females aged 15-44—does not 
appear to be explained by early sexual debut. The lower 
age of debut for women compared with men may be ex-
plained in part by the number of older men who seek out 
young sexual partners, behavior that also could contrib-
ute to the scale of the HIV spread in Zimbabwe (Gregson 
et al. 2002a). 
In contrast to survey results from industrialized 
countries (for France see Spira et al. 1994; for Great Brit-
ain see Johnson et al. 1994; and for North America see 
Laumann et al. 1994), we found few associations between 
socioeconomic and geographic variables and age at first 
sex. Although in a cross-sectional survey such as this the 
sequence of events is unclear, these data do not suggest 
that early sexual debut leads to a spiral of decline and 
riskier sexual behavior. Rather, they point toward other 
influences linking early sexual debut and subsequent 
higher risk. The Zimbabwean Demographic and Health 
Survey (DHS) suggests that the most educated and the 
wealthiest men and women experience sexual debut later 
than their less educated and poorer counterparts (CSO 
and Macro International 2000). This finding suggests 
that a primary motive for young women to begin sexual 
activity may be to obtain money and gifts from an older 
partner (Gregson et al. 2002a). 
In common with other settings (Johnson et al. 1994; 
Laumann et al. 1994; Spira et al. 1994; Gupta and Mahy 
2003), young women in Manicaland who completed pri-
mary education and young men and women who are 
students were at less risk of starting to have sex. Whether 
being in school or university reduces the risk of experi-
encing first sex or whether young women who have be-
come sexually active (and perhaps become pregnant) are 
more likely to drop out of school or university is unclear. 
The preference among young women to form partner-
ships with employed men (Gregson et al. 2002a) may also 
help explain the relatively early sexual debut of manual 
laborers and the later debut of male students. The lack 
of an effect of primary education among 20-24-year-old 
women could indicate that early education becomes a less 
important determinant of behavior as women age or may 
be the result of random or differential recall bias. 
The effect of primary education on age at first sex has 
increased over time; the univariate rate ratio of first sex 
for primary education was 0.85 among 40-44-year-old 
women having a mean age of 20 years in 1969, compared 
with 0.42 for 20-24-year-old women having a mean age 20 
years in 1996 (not shown). That educated women lead the 
trend in delaying first sex is consistent with the recently 
reported downturn in HIV prevalence among more edu-
cated groups (Gregson et al. 2006). This finding echoes 
the pattern of behavioral change observed when medical 
facilities and methods of family planning became widely 
available (Rogers 1983; Gregson et al. 2001). No such pat-
tern for females was detected in the data collected for the 
Zimbabwe DHS between 1994 and 1999, although the 
proportion of the most-educated 15-24-year-old men re-
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porting having had sex declined (OR = 0.7; psO.OOl) (not 
shown). Further analysis based on education beyond the 
primary level (such as highest level of education attained) 
was not possible because we did not know what the even-
tual educational level would be for respondents currently 
attending school, nor their educational status when they 
first had sex. Another limitation of this cross-sectional 
data is the absence of information on the socioeconomic 
status of the individual at the time of first sex. Although 
the average interval between experience of first sex and 
the interview was only three to four years, 23 percent of 
males and 19 percent of females relocated during this 
time, increasing the likelihood that their circumstances 
could have changed substantially. 
Individuals' reports of their sexual behavior are sus-
ceptible to social desirability bias (Catania et al. 1990). In 
the survey upon which this study's analyses are based, 
measures were taken when asking sensitive questions to 
encourage honest reporting. These measures tend to be 
associated with reports of less socially desirable outcomes 
(Gregson et al. 2002b), giving us greater confidence in the 
accuracy of these self-reports of sexual behavior. 
A young age at sexual debut has been associated 
with greater subsequent sexual activity (Greenberg et 
al. 1992; Drain et al. 2004; Pettifor et al. 2004; Kaestle et 
al. 2005), and our findings support this association. A 
key modifying factor, however, is whether early first sex 
occurs within early marriage; if it does, the association 
with greater risk is markedly reduced. We also found 
a greater tendency to use condoms among those who 
began sex early than among others, which is consistent 
with the finding that those reporting the riskiest sexual 
behavior also report the greatest use of condoms (Mbizvo 
et al. 1994; Mnyika et al. 1996; Gregson et al. 2002a), pos-
sibly because they are more aware than others of the risks 
they face. For females, however, the protective benefits of 
higher rates of condom use did not appear to outweigh 
the increased risk of HIV infection associated with having 
more sexual partners. 
Whether early sex is causally related to subsequent 
high levels of sexual activity—through pathways such 
as pregnancy, leaving school, and engaging in commer-
cial sex—or is correlated through psychological, social, 
or economic factors is unclear. The association between 
early first sex and HIV infection in this rural population 
can be explained, however, by subsequent behavioral dif-
ferences. This explanation does not support delaying age 
at first sex specifically to prevent transmission of HIV; 
rather, it suggests that decreasing casual sex is likely to 
have a greater effect in reducing the spread of infection. 
Although delaying sexual debut would reduce the life-
time risk of HIV infection at the individual level, at the 
population level it would have a limited effect, because 
those who begin sexual activity early tend to have more 
partners, engage more frequently in sexual activity, and 
have a higher concurrency of sexual partnerships tlian 
others. The casual nature of their sexual activity rather 
than their early sexual debut appears to be what leads to 
their infection. Among young women in urban Zimba-
bwe, by contrast, the association between age at first sex 
and HIV infection has been found to be statistically sig-
nificant even when subsequent sexual behavior is taken 
into account (Pettifor et al. 2004). 
With other factors being equal, we would expect 
that males who begin to have sex early would be more 
likely than others to be HIV positive. The observation 
from our findings that males who began sex early were 
less likely to have been infected might indicate that their 
higher-than-average condom use is sufficient to offset 
their greater exposure to HIV. This result, however, could 
also arise from unreliable reports of age at first sex (for 
example, males with the fewest sexual partners or latest 
sexual debut may have reported that they were younger 
when they first had sex than, in fact, they were). 
An encouraging finding is that in recent years young 
women have begun sexual activity later than in the past. 
The long-term trend among men for lower age at first sex 
is a cause for concern, however, especially if this trend is 
exacerbated by messages aimed at reducing the age dif-
ference between partners in order to limit young wom-
en's risk of acquiring infection from older men (Gregson 
et al. 2002a; Hallett et al. 2007). Alternatively, the trend 
could be generated by recall bias or by the selective effects 
of mortality; men in older cohorts who began to have sex 
early may have died of AIDS, so that only those who 
began to have sex later could be surveyed. In fact, the 
DHS data indicate that between 1994 and 1999, a slight 
decrease was found in the proportion of 15-24-year-olds 
who had begun to have sex. 
A current focus of many HIV interventions is delay-
ing first sex, often by emphasizing abstinence as part of 
the ABC plan that also endorses being faithful to one part-
ner and using condoms (Office of the United States Glob-
al AIDS Coordinator 2004). Our results show that such 
programs could benefit from focusing on the employed 
rather than students and the unemployed. Members of 
traditional churches and those who report no religious 
affiliation should also be targeted. The shorter period that 
elapsed between first sex and marriage for males than for 
females among traditional church members suggests that 
faithfulness within marriage may be a more appropriate 
message to promote for this group. That the small group 
of women (4 percent) who were not associated with a 
church reported younger age at sexual debut and a long-
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er period before marriage suggests that this group may 
be an appropriate focus for abstinence programs. 
Young women who have relocated should also be 
targeted for interventions. Relocation can be a source of 
intense anxiety and can lead to feelings of low self-worth 
and poor social integration (Paul et al. 2000; Pedersen 
et al. 2003). Young women in this position may be more 
vulnerable to demands for sex, particularly from older 
men (Gregson et al. 2002a; Longfield et al. 2004). The as-
sociation between younger age at sexual debut and hav-
ing relocated could also arise, however, as a result of 
this society's tradition of patrilocal marriage, whereby a 
newly married woman moves to her husband's place of 
residence. More women who had relocated were married 
at the time of the interview (68 percent) than were those 
who had stayed in the same location since birth (34 per-
cent), and slightly more women who had begun having 
sex early (before they were 18) reported moving because 
of a partner's work than their counterparts who began 
sexual activity later (12 percent versus 9 percent). 
Men who had regular access to the mass media (in-
cluding radio, television, and newspapers) tended to be-
gin sexual activity earlier than women who had similar 
access. This pattern is echoed in other sub-Saharan coun-
tries (Gupta and Mahy 2003) and may reflect a greater re-
ceptivity among women to the safe-sex messages that are 
broadcast in the media and may reflect women's use of 
this information to negotiate for safe sexual behavior with 
their partners. Additional research is needed to investi-
gate how mass-media campaigns could have a greater 
impact on young men's behavior. 
Cross-sectional data, such as those analyzed here, 
are not amenable to analysis in terms of the sequence of 
events; we cannot, for example, distinguish which hap-
pened first: beginning to have sex early or leaving school 
without a primary education. Furthermore, a survey 
cannot hope to untangle fully the complex interactions 
between all the social, cultural, demographic, behavior-
al, and epidemiological variables. Nonetheless, a local 
picture for this area of rural Zimbabwe emerges: sexual 
debut occurs at a late median age but early sexual debut 
precedes greater sexual activity, which leads to a greater 
risk for HIV infection among women but not among men 
in this area of high HIV prevalence. The lower risk for 
men may exist because men who have early and frequent 
sex tend to use condoms more often than others. 
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